CodeSystem |
https://ncez.mzcr.cz/fhir/CodeSystem/registering-provider-service-type-cz-cs  | Registering Provider Service Type Cz |
https://smartforms.csiro.au/ig/CodeSystem/HealthChecksSCTSupplement  | SNOMED CT Supplement for Aboriginal and Torres Strait Islander Health Check |
http://ehealth.sundhed.dk/snomed.info/sct/supplement  | SNOMED CT Code System Supplement |
https://demis.rki.de/fhir/CodeSystem/translationEvidence  | Übersetzung Symptom und Manifestation |
https://www.medizininformatik-initiative.de/fhir/core/modul-diagnose/CodeSystem/mii-cs-diagnose-lebensphase-supplement-snomed  | MII_CS_Diagnose_Lebensphase_Supplement_SNOMED |
https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/snomed-pce-supplement  | SNOMED Supplement CodeSystem |
http://hl7.org/fhir/us/davinci-hrex/ConceptMap/CareTeamMember-NUCCFunction  | SNOMED Care Team Member Function to NUCC Map |
http://hl7.org/fhir/us/davinci-hrex/ConceptMap/NUCC-CareTeamMemberFunction  | NUCC to SNOMED Care Team Member Function Map |
http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsDevice  | Vitals Device used to SNOMED code |
http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsLaterality  | Vitals Laterality used to SNOMED code |
http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsMethod  | Vitals Method used to SNOMED code |
http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsPosition  | Vitals Position used to SNOMED code |
http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsSite  | Vitals Site used to SNOMED code |
https://www.ehealth.fgov.be/standards/fhir/mycarenet/ConceptMap/BeCMISOToothSnomedCT  | BeCMISOToothSnomedCT |
http://hl7.org/fhir/us/vrdr/ConceptMap/CertifierTypesCM  | CertifierTypes Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/ContributoryTobaccoUseCM  | ContributoryTobaccoUse Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/MannerOfDeathCM  | MannerOfDeath Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/MethodOfDispositionCM  | MethodOfDisposition Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/PlaceOfDeathCM  | PlaceOfDeath Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/TransportationIncidentRoleCM  | TransportationIncidentRole Concept Map |
http://fhir.ch/ig/ch-term/ConceptMap/DocumentEntryClassCodeToDocumentEntryTypeCode  | DocumentEntryClassCodeToDocumentEntryTypeCode |
http://fhir.ch/ig/ch-term/ConceptMap/HCProfessionalHCProfessionSpecialisationMap  | HCProfessionalHCProfessionSpecialisationMap |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-targetdiseases-vaccines-cm  | TargetDisease To VaccineCode Mapping |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sct-sm-cm  | Snomed CT VaccineCode To SwissMedic VaccineCode |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sct-targetdiseases-cm  | Snomed CT VaccineCode To TargetDisease Mapping |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sm-sct-cm  | SwissMedic VaccineCode To Snomed CT VaccineCode |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-targetdiseases-cm  | VaccineCode To TargetDisease Mapping |
http://fhir.ch/ig/ch-core/ConceptMap/documententry-confidentialitycode-to-fhir  | DocumentEntry.confidentialityCode to FHIR mapping |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapBirthAttendantTitlesVitalRecords  | BirthAttendantTitles Concept Map |
http://hl7.org/fhir/us/mcode/ConceptMap/TG263CM  | TG263 Concept Map |
http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-to-foph-patient-name-representation  | CH ELM Results To FOPH Patient Name Representation |
http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-to-interpretation-code  | CH ELM Results To Interpretation Code |
http://fhir.org/guides/who/anc-cds/ConceptMap/SNOMED-CT  | SNOMED-CT |
https://nhicore.nhi.gov.tw/pas/ConceptMap/nhi-sct-body-site  | 臺灣健保署身體部位代碼對應SNOMED CT |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-do-missing-measurement  | Activitydefinition-code to do missing measurement |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-do-reminder  | Activitydefinition-code to do reminder |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-measurement-resource-type  | Activitydefinition-code to measurement resource type |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-perform-sharing  | Activitydefinition-code-to-perform-sharing |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyIntoleranceCategory  | CCDA to FHIR Allergy Intolerance Category |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyIntoleranceType  | CCDA to FHIR Allergy Intolerance Type |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyStatus  | C-CDA to FHIR Allergy Status |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-NoKnownAllergies  | C-CDA to FHIR No Known Allergies |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-ProblemStatus  | C-CDA Problem Status value to FHIR Condition clinicalStatus |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-Severity  | C-CDA Severity to FHIR Severity |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyIntoleranceCategory  | FHIR to CCDA Allergy Intolerance Category |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyIntoleranceType  | FHIR Allergy Intolerance Type to CCDA value |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyStatus  | FHIR to C-CDA Allergy Status |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-ImmunizationRefusal  | FHIR Immunization Status Reason to C-CDA Immunization Refusal |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-ImmunizationSite  | FHIR Immunization Site to C-CDA Immunization approachSiteCode |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-NoKnownAllergies  | FHIR to C-CDA No Known Allergies |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-ProblemStatus  | FHIR Condition clinicalStatus to C-CDA Problem Status value |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-Severity  | FHIR Severity to C-CDA Severity |
http://hl7.org/fhir/us/davinci-alerts/ConceptMap/direct-alerts  | Direct ADT to Da Vinci Alerts ConceptMap |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/health-professional-tw  | 臺灣醫事司醫事人員類別代碼對應SNOMED CT及臺灣醫事司醫事人員類別 |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medical-consultation-department-nhi-tw  | 臺灣健保署就醫科別代碼對應SNOMED CT |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medical-treatment-department-nhi-tw  | 臺灣健保署診療科別代碼對應SNOMED CT |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medication-path-tw  | 臺灣健保署給藥途徑代碼對應SNOMED CT |
http://hl7.org/fhir/us/bfdr/ConceptMap/BirthAttendantTitlesCM  | BirthAttendantTitles Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/BirthDeliveryOccurredCM  | BirthDeliveryOccurred Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/DeliveryRoutesCM  | DeliveryRoutes Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalDeathCauseOrConditionCM  | FetalDeathCauseOrCondition Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalDeathTimePointsCM  | FetalDeathTimePoints Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalPresentationCM  | FetalPresentation Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/InfectionsDuringPregnancyLiveBirthCM  | InfectionsDuringPregnancyLiveBirth Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/NewbornCongenitalAnomaliesCM  | NewbornCongenitalAnomalies Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/PerformedNotPerformedPlannedCM  | PerformedNotPerformedPlanned Concept Map |
http://fhir.hl7.nl/zorgviewer/ConceptMap/epic-rolcode  | Epic Provider Type naar SNOMED-CT Mapping |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_DPE_Declaration_Type_German  | Art der Erklärung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Implant_German  | Medizinprodukt |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Person_Institution_German  | BAI_ART |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Procedure_German  | Prozedur SNOMEDCT |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Reaction_Allergy_German  | Allergie Manifestation |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Runaway_Risk_German  | Weglaufgefährdung |
https://fhir.cohesiondata.com/clinemr/ConceptMap/treatment-region-tw  | 臺灣診療部位代碼對應SNOMED CT |
https://fhir.ee/ConceptMap/person-relationship-mpi-v3  | Mapping of MPI person relationship to legacy V3 |
https://fhir.ee/ConceptMap/person-relationship-v3-mpi  | Mapping of legacy V3 person relationship to MPI |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Terminology_Complete_German  | KBV_CM_Base_Terminology_Complete_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Apgar_Score_Identifier_German  | KBV_CM_Base_Apgar_Score_Identifier_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Apgar_Score_Value_German  | KBV_CM_Base_Apgar_Score_Value_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Height_Snomed_German  | KBV_CM_Base_Body_Height_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Weight_Method_Snomed_German  | KBV_CM_Base_Body_Weight_Method_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Weight_Snomed_German  | KBV_CM_Base_Body_Weight_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Diagnosis_Severity_German  | KBV_CM_Base_Diagnosis_Severity_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Head_Circumference_BodySite_Snomed_German  | KBV_CM_Base_Head_Circumference_BodySite_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Head_Circumference_Snomed_German  | KBV_CM_Base_Head_Circumference_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Practitioner_Function_German  | KBV_CM_Base_Practitioner_Function_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Stage_Life_German  | KBV_CM_Base_Stage_Life_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Temp_Snomed_German  | KBV_CM_Base_Body_Temp_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Heart_Rate_German  | KBV_CM_Base_Heart_Rate_German |
http://fhir.tasmc.org.il/ConceptMap/tasmc-snomedct-specimen-type  | Mapping from Sourasky local specimen types to SNOMED CT |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_LAB_ELGA_Specimen_Type_SNOMED_German  | ELGA Probenart SNOMED |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_IHEXDS_AuthorSpeciality_Restricted_German  | KBV_CM_MIO_Vaccination_IHEXDS_AuthorSpeciality_Restricted_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German  | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed  | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_Titer_Immunity_German  | Titer Immunität |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Prior_Disease_German  | VaccinationrelevantDisease |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Prior_Disease_Snomed_ICD  | KBV_CM_MIO_Vaccination_Prior_Disease_Snomed_ICD |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Source_of_Information_German  | Source_of_Information |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_ATC_Snomed  | KBV_CM_MIO_Vaccination_Vaccine_ATC_Snomed |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_German  | Vaccine |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_Targetdisease  | KBV_CM_MIO_Vaccination_Vaccine_Targetdisease |
http://nictiz.nl/fhir/ConceptMap/Alcoholgebruik-to-AlcoholGebruikStatusCodelijst  | Alcoholgebruik-to-AlcoholGebruikStatusCodelijst |
http://nictiz.nl/fhir/ConceptMap/Rookgedrag-to-TabakGebruikStatusCodelijst  | Rookgedrag-to-TabakGebruikStatusCodelijst |
http://nictiz.nl/fhir/ConceptMap/WerkelijkePlaatsBaring-to-ActEncounterCode  | WerkelijkePlaatsBaring-to-ActEncounterCode |
http://fhir.ch/ig/ch-emed-epr/ConceptMap/CHEMEDEPRAmountQuantityUnitCodeToCdTyp9  | CHEMEDEPRAmountQuantityUnitCode -> CdTyp9 |
http://fhir.ch/ig/ch-emed-epr/ConceptMap/CdTyp9ToCHEMEDEPRAmountQuantityUnitCode  | CdTyp9 -> CHEMEDEPRAmountQuantityUnitCode |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_AB0_System_First_Examination_After_Childbirth_German  | AB0-System des Kindes im Wochenbett |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_AB0_System_German  | AB0-System |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Biometrics_II_III_German  | Biometrie II und III |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Biometrics_I_German  | Biometrie I |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Birth_Mode_German  | Geburtsmodus |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Breastfeeding_Behavior_German  | Stillverhalten der Mutter |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Catalogue_A_German  | Anamneseerhebung bei Erstuntersuchung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Child_Position_German  | Kindslage |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Counselling_German  | Beratung von Schwangeren |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Direct_Coombstest_German  | Direkter Coombstest |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Interpretation_German  | Interpretation der Messergebnisse hinsichtlich der Immunität |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Result_Qualitative_German  | Qualitative Beurteilung der Messergebnisse |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Snomed_German  | Laboruntersuchungen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Findings_Required_Control_German  | Kontrollbedürftige Befunde |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_General_Information_German  | Allgemeine Angaben zum Fötus beim ersten Ultraschallscreening |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Heart_Sounds_Child_German  | Herztöne des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Immunization_Status_German  | Nachweise der prophylaktischen Impfungen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Localisation_Placenta_German  | Lokalisation/Struktur der Plazenta |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Morphology_German  | Morphologie |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Other_Ultrasound_Studies_German  | Weitere Ultraschalluntersuchungen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Practitioner_Function_German  | Funktionen/Rollen des Behandelnden |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Pregnancy_Information_German  | Angaben zur Schwangerschaft beim Ultraschallscreening |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Rhesus_System_Fetus_German  | Rhesus-System des Fötus |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Rhesus_System_German  | Rhesus-System |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Special_Findings_German  | Befundkatalog Besondere Befunde |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_oGTT_Diagnosistest_German  | Oraler Glucosetoleranztest (oGTT) Diagnosetest |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_oGTT_Pretest_German  | Oraler Glucosetoleranztest (oGTT) Vortest |
http://smart.who.int/ddcc/ConceptMap/lab-test-pathogen-snomed-to-icd11  | Lab Test - Result - Pathogen - Mapping SNOMED CT to ICD-11 |
http://smart.who.int/ddcc/ConceptMap/lab-test-qual-result-snomed-to-icd11  | Lab Test - Result - Mapping SNOMED CT to ICD-11 |
http://smart.who.int/ddcc/ConceptMap/vaccine-covid19-snomed-to-icd11  | Vaccine - COVID-19 - Mapping SNOMED to ICD-11 |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-agent-targeted  | ConceptMap from ICD-11 to SNOMED CT for Agent Targeted |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-disease-targeted  | ConceptMap from ICD-11 to SNOMED CT for Disease or Agent Targeted |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-test-result  | ConceptMap from ICD-11 to SNOMED CT for Test Result |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-vaccines  | ConceptMap from ICD-11 to SNOMED CT for Vaccines |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-ichi-sct-specimen-origin  | ConceptMap from ICHI to SNOMED CT for Specimen Origin |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-ichi-sct-type-of-test  | ConceptMap from ICHI to SNOMED CT for Type of Test |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-loinc-sct-type-of-test  | ConceptMap from LOINC to SNOMED CT for Type of Test |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-sct-ichi-specimen-origin  | ConceptMap from SNOMED CT to ICHI for Specimen Origin |
https://fhir.hl7.org.uk/STU3/ConceptMap/CareConnect-AllergySeverity-1  | Concept Map - Allergy Severity |
https://fhir.hl7.org.uk/STU3/ConceptMap/CareConnect-AllergyVerificationStatus-1  | Concept Map - Allergy Verification Status |
https://fhir.hl7.org.uk/STU3/ConceptMap/CareConnect-ConditionEpisodicity-1  | Concept Map - Condition Episodicity |
https://demis.rki.de/fhir/ConceptMap/LOINCMaterialToSNOMEDMaterial  | LOINCMaterialToSNOMEDMaterial |
https://demis.rki.de/fhir/ConceptMap/LOINCMethodToSNOMEDMethod  | LOINCMethodToSNOMEDMethod |
http://nictiz.nl/fhir/ConceptMap/AllergieCategorieCodelijst-to-AllergyIntoleranceCategory  | AllergieCategorieCodelijst to AllergyIntoleranceCategory |
http://nictiz.nl/fhir/ConceptMap/ErnstCodelijst-to-AllergyIntoleranceSeverity  | ErnstCodelijst to AllergyIntoleranceSeverity |
http://nictiz.nl/fhir/ConceptMap/InterpretatieVlaggenCodelijst-to-ObservationInterpretationCodes  | InterpretatieVlaggenCodelijst to ObservationInterpretationCodes |
http://nictiz.nl/fhir/ConceptMap/MateVanKritiekZijnCodelijst-to-AllergyIntoleranceCriticality  | MateVanKritiekZijnCodelijst to AllergyIntoleranceCriticality |
http://nictiz.nl/fhir/ConceptMap/ProbleemStatusCodelijst-to-ConditionClinicalStatusCodes  | ProbleemStatusCodelijst to ConditionClinicalStatusCodes |
http://nictiz.nl/fhir/ConceptMap/VerificatieStatusCodelijst-to-ConditionVerificationStatus  | VerificatieStatusCodelijst to ConditionVerificationStatus |
https://fhir.nhs.uk/STU3/ConceptMap/CareConnect-AllergySeverity-1  | Concept Map - Allergy Severity |
https://fhir.nhs.uk/STU3/ConceptMap/CareConnect-AllergyVerificationStatus-1  | Concept Map - Allergy Verification Status |
https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECFixationTypeMap  | SPREC 3.0 Fixation Type Mapping |
https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECLongTermStorageMap  | SPREC 3.0 Long-Term Storage Mapping |
https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECPrimaryContainerMap  | SPREC 3.0 Primary Container Mapping |
https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECSampleTypeMap  | SPREC 3.0 Sample Type Mapping |
https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/ConceptMap/mii-cm-mtb-therapiestatusgrund-sct  | MII CM MTB Therapiestatusgrund SNOMED CT Mapping |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_ULB_Overview  | KBV_CM_MIO_ULB_Overview |
http://ig.ehealth4u.eu/fhir/ConceptMap/cyehr-cm-allergyreactionseverity-snomed2hl7fhir  | Cyprus EHR Concept Map: Allergy Reaction Severity - Snomed to HL7 FHIR |
http://ig.ehealth4u.eu/fhir/ConceptMap/cyehr-cm-allergytype-snomed2hl7fhir  | Cyprus EHR Concept Map: Allergy Type - Snomed to HL7 FHIR |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Bodysite_Hip_German  | Hüftlateralität |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Examination_Number_German  | Untersuchungsnummer U-Heft |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Foetal_Position_German  | Kindslage aus Sicht d. Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Gender_Birth_German  | Geschlecht SNOMED |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hearscreening_Method_German  | Hörscreenigmethode |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hearscreening_Result_German  | Hörscreeningbefund Lokalisation |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hip_History_German  | Hüftanamnese |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hip_Proceeding_German  | Hüfte - weiteres Vorgehen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hip_Screening_Method_German  | Hüftscreening Methode |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Newborn_Blood_Spot_Screening_Type_German  | Typ der Blutabnahme |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Percentile_Body_Measure_Loinc_German  | Perzentilkörpermaß LOINC |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Percentile_Body_Measure_Snomed_German  | Perzentilkörpermaß SNOMED |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Practitioner_Speciality_German  | Rolle des Behandelnden |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Pregnancy_History_German  | Schwangerschaftsanamnese |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Pulse_Oxymetry_Screening_Data_Absent_Reason_German  | Gründe zur Ablehnung des Pulsoxymetriescreenings |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Pulse_Oxymetry_Screening_Measurement_Type_German  | Typ der Pulsoxymetriemessung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_Apgar_Score_Identifier_German  | Apgar Score am Zeitpunkt |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_Apgar_Score_Value_German  | Apgar-Score Wert |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_U3_Birthmode_German  | Geburtsmodus |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_U3_Pulse_Oxymetry_Measurement_German  | Auffälligkeit Sauerstoffsättigung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Consultation_German  | U2 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Current_Child_History_German  | U2 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Family_History_German  | U2 - Familienanamnese |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Head_German  | U2 - Kopf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Mouth_Nose_German  | U2 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Musculoskeletal_System_German  | U2 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Skin_German  | U2 - Haut |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U3_Physical_Exam_Abdomen_Genitals_German  | U2, U3 - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U3_Physical_Exam_Ears_German  | U2, U3 - Ohren |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U3_Physical_Exam_Eyes_German  | U2, U3 - Augen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U4_Physical_Exam_Chest_Lung_Respiratory_Tract_German  | U2, U3, U4 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U6_Physical_Exam_Heart_Blood_Circulation_German  | U2, U3, U4, U5, U6 - Herz, Kreislauf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Consultation_German  | U3 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Current_Child_History_German  | U3 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Development_Assessment_German  | U3 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Family_History_German  | U3 - Familienanamnese |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Physical_Exam_Head_German  | U3 - Kopf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Physical_Exam_Musculoskeletal_System_German  | U3 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U4_Physical_Exam_Mouth_Nose_German  | U3, U4 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U4_Physical_Exam_Skin_German  | U3, U4 - Haut |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U9_Age_Appropriate_Development_German  | altersgemäße Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U9_Social_History_German  | U3-U9 - Sozialanamnese |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Consultation_German  | U4 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Current_Child_History_German  | U4 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Development_Assessment_German  | U4 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Physical_Exam_Abdomen_Genitals_German  | U4 - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Physical_Exam_Head_German  | U4 - Kopf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Physical_Exam_Musculoskeletal_System_German  | U4 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_U5_Physical_Exam_Eyes_German  | U4, U5 - Augen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Consultation_German  | U5 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Current_Child_History_German  | U5 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Development_Assessment_German  | U5 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Physical_Exam_Chest_Lung_Respiratory_Tract_German  | U5 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Physical_Exam_Mouth_Nose_German  | U5 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Physical_Exam_Musculoskeletal_System_German  | U5 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_U6_Physical_Exam_Abdomen_Genitals_German  | U5, U6 - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_U6_Physical_Exam_Head_German  | U5, U6 - Kopf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_U9_Physical_Exam_Skin_German  | U5, U6, U7, U7a, U8, U9 - Haut |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Consultation_German  | U6 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Current_Child_History_German  | U6 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Development_Assessment_German  | U6 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Physical_Exam_Eyes_German  | U6 - Augen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Physical_Exam_Mouth_Nose_German  | U6 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Physical_Exam_Musculoskeletal_System_German  | U6 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_U7_Physical_Exam_Chest_Lung_Respiratory_Tract_German  | U6, U7 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Consultation_German  | U7 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Current_Child_History_German  | U7 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Development_Assessment_German  | U7 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Physical_Exam_Eyes_German  | U7 - Augen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Physical_Exam_Mouth_Nose_German  | U7 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Physical_Exam_Musculoskeletal_System_German  | U7 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_U7a_Physical_Exam_Abdomen_Genitals_German  | U7, U7a - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_U9_Physical_Exam_Heart_Blood_Circulation_German  | U7, U7a, U8, U9 - Herz, Kreislauf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Consultation_German  | U7a - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Current_Child_History_German  | U7a - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Development_Assessment_German  | U7a - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Physical_Exam_Mouth_Nose_German  | U7a - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_U9_Physical_Exam_Eyes_German  | U7a, U8, U9 - Augen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_and_U9_Physical_Exam_Chest_Lung_Respiratory_Tract_German  | U7a, U9 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_and_U9_Physical_Exam_Musculoskeletal_System_German  | U7a, U9 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Consultation_German  | U8 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Current_Child_History_German  | U8 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Development_Assessment_German  | U8 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Abdomen_Genitals_German  | U8 - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Chest_Lung_Respiratory_Tract_German  | U8 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Ears_German  | U8 - Ohren |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Musculoskeletal_System_German  | U7a, U9 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_U9_Physical_Exam_Mouth_Nose_German  | U8, U9 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Consultation_German  | U9 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Current_Child_History_German  | U9 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Development_Assessment_German  | U9 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Physical_Exam_Abdomen_Genitals_German  | U9 - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_PC_PN_Examination_Number_German  | Untersuchungsnummer Teilnahmekarte |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_EMP_Overview  | KBV_CM_MIO_EMP_Overview |
http://hitstdio.ntunhs.edu.tw/fhir/ConceptMap/TWCDCVaccineCodeToQRCodeSctVaccinesCovid19  | TWCDC Vaccine Code to QRCode Sct Vaccines Covid-19 |
http://nictiz.nl/fhir/ConceptMap/DagdeelCodelijst-to-EventTiming  | DagdeelCodelijst to EventTiming |
http://nictiz.nl/fhir/ConceptMap/WeekdagCodelijst-to-DaysOfWeek  | WeekdagCodelijst to DaysOfWeek |
https://fhir.kbv.de/KBV_CM_MIO_CMR_U7a_Current_Child_History_German  | U7a - Aktuelle Anamnese des Kindes |
https://fhir.nhs.uk/ConceptMap/genomics-laterality-of-hearingloss  | Genomics Laterality of Hearing Loss |
https://fhir.nhs.uk/ConceptMap/genomics-condition-liquidtumourtype  | Genomics Condition Liquid Tumour Type |
https://fhir.nhs.uk/ConceptMap/genomics-condition-pancreatictumourtype  | Genomics Condition Pancreatic Tumour Type |
https://fhir.nhs.uk/ConceptMap/genomics-condition-pituitarytumourtype  | Genomics Condition Pituitary Tumour Type |
https://fhir.nhs.uk/ConceptMap/genomics-condition-solidtumourtype  | Genomics Condition Solid Tumour Type |
https://fhir.nhs.uk/ConceptMap/genomics-fetal-maternal-screening-genotype  | Genomics Fetal Maternal Screening Genotype |
https://fhir.nhs.uk/ConceptMap/genomics-patientpregnancytype  | Genomics Patient Pregnancy Type |
https://fhir.nhs.uk/ConceptMap/genomics-procedure-transfusiontype  | Genomics Procedure Transfusion Type |
https://fhir.nhs.uk/ConceptMap/genomics-risk-reason-for-specimen-specialhandling  | Genomics Risk Reason for Specimen Special Handling |
https://fhir.nhs.uk/ConceptMap/genomics-finalsample  | Genomics Final Sample |
https://fhir.nhs.uk/ConceptMap/genomics-primarysample  | Genomics Primary Sample |
https://fhir.nhs.uk/ConceptMap/genomics-samplepreparation  | Genomics Sample Preparation |
https://fhir.nhs.uk/ConceptMap/genomics-specimen-tumourcellularity  | Genomics Specimen Tumour Cellularity |
https://fhir.nhs.uk/ConceptMap/genomics-typeof-transplantprocedure  | Genomics Type of Transplant Procedure |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_ZAEB_Preventive_Check_Up_German  | KBV_CM_MIO_ZAEB_Preventive_Check_Up_German |
https://fhir.healthdata.be/ConceptMap/AllergyCategory-to-AllergyIntoleranceCategory  | AllergyCategory_to_AllergyIntoleranceCategory |
https://fhir.healthdata.be/ConceptMap/AllergyStatus-to-AllergyIntoleranceClinicalStatusCodes  | AllergyStatus_to_AllergyIntoleranceClinicalStatusCodes |
https://fhir.healthdata.be/ConceptMap/ContactType-to-ActEncounterCode  | ContactType to ActEncounterCode |
https://fhir.healthdata.be/ConceptMap/CriticalExtent-to-AllergyIntoleranceCriticality  | CriticalExtent_to_AllergyIntoleranceCriticality |
https://fhir.healthdata.be/ConceptMap/CriticalExtent-to-AllergyIntoleranceSeverity  | CriticalExtent_to_AllergyIntoleranceSeverity |
https://fhir.healthdata.be/ConceptMap/Gender-to-AdministrativeGender  | Gender_to_AdministrativeGender |
https://fhir.healthdata.be/ConceptMap/MedicationAdministrationStatus-to-MedicationAdministrationStatus  | MedicationAdministrationStatus_to_MedicationAdministrationStatusCodes |
https://fhir.healthdata.be/ConceptMap/MedicationStopType-to-MedicationStatementStatus  | MedicationStopType_to_MedicationStatementStatus |
https://fhir.healthdata.be/ConceptMap/NameUsage-to-HumanNameAssemblyOrder  | NameUsage_to_HumanNameAssemblyOrder |
https://fhir.healthdata.be/ConceptMap/ProblemStatus-to-ConditionClinicalStatusCodes  | ProblemStatus_to_ConditionClinicalStatusCodes |
https://fhir.healthdata.be/ConceptMap/ResultFlags-to-ObservationInterpretationCodes  | ResultFlags_to_ObservationInterpretationCodes |
https://fhir.healthdata.be/ConceptMap/TimeOfDay-to-EventTiming  | TimeOfDay_to_EventTiming |
https://fhir.healthdata.be/ConceptMap/TreatmentDecision-to-ConsentProvisionType  | TreatmentDecision to ConsentProvisionType |
https://fhir.healthdata.be/ConceptMap/VerificationStatus-to-ConditionVerificationStatus  | VerificationStatus_to_ConditionVerificationStatus |
https://fhir.healthdata.be/ConceptMap/WeekDay-to-DaysOfWeek  | WeekDay_to_DaysOfWeek |
http://hl7.org/fhir/uv/ips/ConceptMap/absence-to-snomed-uv-ips  | Absence of Information Mappings - IPS to SNOMED CT |
http://hl7.org/fhir/uv/ips/ConceptMap/severity-snomedct-uv-ips  | Severity Value Set Mappings - SNOMED CT to FHIR |
http://fhir.ch/ig/ch-epr-term/ConceptMap/DocumentEntryClassCodeToDocumentEntryTypeCode  | DocumentEntryClassCodeToDocumentEntryTypeCode |
http://fhir.ch/ig/ch-epr-term/ConceptMap/HCProfessionalHCProfessionSpecialisationMap  | HCProfessionalHCProfessionSpecialisationMap |
http://fhir.nottinghamshire.gov.uk/conceptmap/rockwood-clinical-frailty-scale  | Concept Map Rockwood Clinical Frailty Scale |
http://nictiz.nl/fhir/ConceptMap/MateVanKritiekZijnCodelijst-to-allergy-intolerance-criticality  | HCIM MateVanKritiekZijnCodelijst to allergy-intolerance-criticality |
http://nictiz.nl/fhir/ConceptMap/ProbleemStatusCodelijst-to-Condition-Clinical-Status-Codes  | HCIM ProbleemStatusCodelijst to Condition Clinical Status Codes |
http://nictiz.nl/fhir/ConceptMap/WaarschijnlijkheidCodelijst-to-reaction-event-certainty  | HCIM WaarschijnlijkheidCodelijst to reaction-event-certainty |
http://nictiz.nl/fhir/ConceptMap/AllergieCategorieCodelijst-to-allergy-intolerance-category  | HCIM AllergieCategorieCodelijst to allergy intolerance category |
http://nictiz.nl/fhir/ConceptMap/Condition-Clinical-Status-Codes-to-ProbleemStatusCodelijst  | HCIM ProbleemStatusCodelijst to Condition Clinical Status Codes |
http://nictiz.nl/fhir/ConceptMap/InterpretatieVlaggenCodelijst-to-observation-interpretation  | HCIM InterpretatieVlaggenCodelijst to Observation Interpretation Codes |
http://nictiz.nl/fhir/ConceptMap/OrderStatusCodelijst-to-RequestStatus  | HCIM OrderStatusCodelijst to RequestStatus |
http://nictiz.nl/fhir/ConceptMap/PositieCodelijst-to-LOINC  | HCIM PositieCodelijst to LOINC |
http://nictiz.nl/fhir/ConceptMap/WeekdagCodelijst-to-days-of-week  | HCIM WeekdagCodelijst-to-days-of-week |
https://mednet.swiss/fhir/ConceptMap/mni-obs-bloodGroup-toSnomed  | MedNet Interface (MNI) - Blood Group Observation SNOMED Mapping |
http://nictiz.nl/fhir/ConceptMap/CategorieCodelijst-to-AllergyIntoleranceCategory  | CategorieCodelijst to AllergyIntoleranceCategory |
http://nictiz.nl/fhir/ConceptMap/VerwachtRisicoBijBlootstelling-to-AllergyIntoleranceCriticality  | VerwachtRisicoBijBlootstelling to AllergyIntoleranceCriticality |
http://portal.esysta.com/fhir/ConceptMap/EvaluationItem  | Mapping of EvaluationItem to SNOMED CT |
http://portal.esysta.com/fhir/ConceptMap/EvaluationItemToSnomedCM  | Mapping of EvaluationItemCS to SNOMED CT |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Clinical_Course_German  | KBV_CM_MIO_TELE_Clinical_Course_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Procedure_And_Recommendations_German  | Weiteres Procedere und Empfehlung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Procedure_Category_Codes_SNOMEDCT_German  | KBV_CM_MIO_TELE_Procedure_Category_Codes_SNOMEDCT_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Procedure_Follow_Up_Codes_SNOMEDCT_German  | KBV_CM_MIO_TELE_Procedure_Follow_Up_Codes_SNOMEDCT_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Results_Type_German  | KBV_CM_MIO_TELE_Results_Type_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_SNOMED_CT_Drug_Therapy_Status_Codes_German  | KBV_CM_MIO_TELE_SNOMED_CT_Drug_Therapy_Status_Codes_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Type_Of_Medical_History_German  | KBV_CM_MIO_TELE_Type_Of_Medical_History_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_KHE_Overview  | KBV_CM_MIO_KHE_Overview |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_DIGA_Overview  | KBV_CM_MIO_DIGA_Overview |
http://nrces.in/ndhm/fhir/r4/StructureDefinition/MedicationRequest  | MedicationRequest |
https://fhir.hl7.org.uk/STU3/StructureDefinition/CareConnect-ACVPU-Observation-1  | CareConnect-ACVPU-Observation-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-ApplianceUseReview-Composition-1  | CareConnect-ITK-DM-ApplianceUseReview-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-DMIRS-Composition-1  | CareConnect-ITK-DM-DMIRS-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-EmergencySupply-Composition-1  | CareConnect-ITK-DM-EmergencySupply-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-Immunization-Composition-1  | CareConnect-ITK-DM-Immunization-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-MedicationReview-Composition-1  | CareConnect-ITK-DM-MedicationReview-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-NewMedicineService-Composition-1  | CareConnect-ITK-DM-NewMedicineService-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-ECD-Composition-1  | Electronic Discharge Composition |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-EDIS-Composition-1  | Electronic Discharge Composition |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-MH-Composition-1  | Mental Health Electronic Discharge Composition |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-OPL-Composition-1  | Outpatient Letter Composition |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-NEWS2-Observation-1  | CareConnect-NEWS2-Observation-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/NDOP-Consent-1  | NDOP-Consent-1.xml |
https://fhir.nhs.uk/STU3/StructureDefinition/eRS-ServiceSearchCriteria-Parameters-1  | eRS-ServiceSearchCriteria-Parameters-1 |
https://emiga.rki.de/fhir/case/StructureDefinition/CaseComposition  | Fall |
http://hl7.org/fhir/StructureDefinition/patient-adoptionInfo  | Patient Adoption Info |
http://ontariohealth.ca/fhir/StructureDefinition/ca-on-accdr-profile-AllergyIntolerance  | AllergyIntolerance Profile |
https://nrces.in/ndhm/fhir/r4/StructureDefinition/MedicationRequest  | MedicationRequest |
http://capable-project.eu/data/fhir/StructureDefinition/MedicationRequest_Profile  | MedicationRequest_Profile |
https://emiga.rki.de/fhir/outbreak/StructureDefinition/OutbreakComposition  | OutbreakComposition |
https://www.ehealth.fgov.be/standards/fhir/problem/ValueSet/ProblemDiseaseCourseVS  | Condition Disease Course Value Set |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-caracteristicas-margen-quirurgico-VS  | Set de Valores de Caracteristicas del Margen Quirurgico |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-categorias-pTNM-VS  | Set de Valores para Categorias pTNM |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-estructuras-anatomincas-VS  | Set de Valores Para los Sitios del Cuerpo |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-invasion-linfatica-VS  | Set de Valores para Invasión Linfática y Vascular |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-metodos-medicion-VS  | Set de Valores de los Metodos de Medición del Tumor |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-morfologico-VS  | Set de Valores de Snomed CT para Anomalías Morfológica |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-observaciones-biopsia-VS  | Set de Valores para Observaciones Biopsia |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-procedimientos-biopsias-VS  | Set de Valores Para Procedimientos |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-reporte-biopsia-vs  | Set de Valores de los Reportes de Biopsia |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-respuestas-infiltracion-perineural-vs  | Set de Valores Para Hallazgos de Infiltración Perineural |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-respuestas-infiltracion-peritumoral-vs  | Set de Valores Para Hallazgos de Infiltración Peritumoral |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-snomed-hallazgos-clinicos-VS  | ValueSet de Snomed CT para Hallazgos Clínicos con Mapeo a CIE-10 |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-tipo-especimen-vs  | Set de Valores de los Tipos de Especimen |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-tipo-procedimientos-biopsias-VS  | Set de Valores Para Tipo de Procedimientos |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-tnm-categoria-metastasis-distante-patologico-vs  | Set de Valores Categoría TNM Patológico Metastásico Distante |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-tnm-categoria-nodo-regional-patologico-vs  | Set de Valores Categoría TNM Patológico Nodos Regional |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-tnm-categoria-tumor-primario-patologico-vs  | Set de Valores Categoría TNM Patológico Tumor Primario |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-topografica-VS  | Set de Valores de Snomed CT para Topografía |
https://ranzcr.com/fhir/ValueSet/radiology-referral  | RANZCR Radiology Referral |
http://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType  | eHDSI Adverse Event Type |
http://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug  | eHDSI Allergen No Drug |
http://terminology.ehdsi.eu/ValueSet/eHDSIAnimalSpecies  | eHDSI Animal Species |
http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup  | eHDSI Blood Group |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite  | eHDSI Body Site |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodySiteLaterality  | eHDSI Body Site Laterality |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodyStructureLocation  | eHDSI Body Structure Location Qualifier |
http://terminology.ehdsi.eu/ValueSet/eHDSICodeProb  | eHDSI Code Prob |
http://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus  | eHDSI Current Pregnancy Status |
http://terminology.ehdsi.eu/ValueSet/eHDSILabSpecimenType  | eHDSI Laboratory Specimen Type |
http://terminology.ehdsi.eu/ValueSet/eHDSILabTechnique  | eHDSI Laboratory Technique |
http://terminology.ehdsi.eu/ValueSet/eHDSIMedicalDevice  | eHDSI Medical Device |
http://terminology.ehdsi.eu/ValueSet/eHDSIMicroorganism  | eHDSI Microorganism |
http://terminology.ehdsi.eu/ValueSet/eHDSIMorphologicAbnormality  | eHDSI Morphologic Abnormality |
http://terminology.ehdsi.eu/ValueSet/eHDSIOutcomeOfPregnancy  | eHDSI Outcome of Pregnancy |
http://terminology.ehdsi.eu/ValueSet/eHDSIPresenceAbsence  | eHDSI Presence Absence |
http://terminology.ehdsi.eu/ValueSet/eHDSIProcedure  | eHDSI Procedure |
http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy  | eHDSI Reaction Allergy |
http://terminology.ehdsi.eu/ValueSet/eHDSIResolutionOutcome  | eHDSI Resolution Outcome |
http://terminology.ehdsi.eu/ValueSet/eHDSISeverity  | eHDSI Severity |
http://terminology.ehdsi.eu/ValueSet/eHDSISocialHistory  | eHDSI Social History |
http://terminology.ehdsi.eu/ValueSet/eHDSIStatusCode  | eHDSI Status Code |
http://terminology.ehdsi.eu/ValueSet/eHDSIVaccine  | eHDSI Vaccine |
http://hl7.org/fhir/us/pco/ValueSet/goal-barrier-codes  | Goal Barrier Assessment Codes |
http://hl7.org/fhir/us/pco/ValueSet/pco-goal-barrier-types-example-vs  | Goal Barrier Types Example |
http://hl7.org/fhir/us/pco/ValueSet/what-matters-codes-example  | What Matters Codes Example |
http://hl7.org/fhir/uv/lab-report/ValueSet/laterality-uv-lab  | Body Structure Laterality |
http://hl7.org/fhir/uv/lab-report/ValueSet/siteQualifier-uv-lab  | Body Structure Qualifier |
http://hl7.org/fhir/uv/lab-report/ValueSet/specialty-uv-lab  | Laboratory Specialty |
http://hl7.org/fhir/uv/lab-report/ValueSet/speciesType-uv-lab  | Types of species |
http://hl7.org/fhir/uv/lab-report/ValueSet/specimenAdditive-uv-lab  | Specimen Additive |
http://hl7.org/fhir/uv/lab-report/ValueSet/specimenContainer-uv-lab  | Specimen Container |
http://hl7.org/fhir/uv/lab-report/ValueSet/specimenType-uv-lab  | Specimen Types |
http://hl7.org/fhir/uv/lab-report/ValueSet/technique-uv-lab  | Laboratory Techniques |
http://hl7.org/cda/us/eyecare/ValueSet/AidToVisionCodes  | Aid to Vision Codes |
http://hl7.org/cda/us/eyecare/ValueSet/DiagnosticAssessmentEyeTestCodes  | Diagnostic Assessment Eye Test Value Set |
http://hl7.org/cda/us/eyecare/ValueSet/EyecareTargetSiteCodes  | Eyecare Target Site Codes |
http://hl7.org/cda/us/eyecare/ValueSet/PosteriorSegmentObservationCodes  | Posterior Segment Observation Codes |
http://hl7.org/cda/us/eyecare/ValueSet/PosteriorSegmentOrganizerCodes  | Posterior Segment Organizer Codes |
http://hl7.org/cda/us/eyecare/ValueSet/RefractionMethodCodes  | Refraction Method Codes |
http://hl7.org/cda/us/eyecare/ValueSet/RefractionObservationCodes  | Refraction Observation Codes |
http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityMethodCodes  | Visual Acuity Method Codes |
http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityObservationCodes  | Visual Acuity Observation Codes |
http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityOrganizerCodes  | Visual Acuity Organizer Codes |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-bodysite  | Body Site |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-laterality  | Laterality |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-reaction-manifestation-code  | Reaction Manifestation Code |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-score  | Score Value Set |
https://fhir.infoway-inforoute.ca/ValueSet/encountertype  | Encounter Type |
https://fhir.infoway-inforoute.ca/ValueSet/ethnicitycode  | EthnicityCode |
https://fhir.virtually.healthcare/ValueSet/BARSReferralCode  | BARS Referral Code |
https://fhir.virtually.healthcare/ValueSet/PatientReferral  | Patient Referral |
https://fhir.virtually.healthcare/ValueSet/SmokingStatus  | Smoking Status |
https://fhir.virtually.healthcare/ValueSet/VHConditionCode  | VH Condition Code |
https://fhir.virtually.healthcare/ValueSet/VHImmunisationCode  | VH Immunisation Code |
https://fhir.virtually.healthcare/ValueSet/VHMedicationCode  | VH Medication Code |
https://fhir.virtually.healthcare/ValueSet/VHObservationCode  | VH Observation Code |
https://fhir.virtually.healthcare/ValueSet/VHObservationValueCode  | VH Observation Value Code |
https://fhir.virtually.healthcare/ValueSet/document-entry-class  | DocumentEntry Class |
https://fhir.virtually.healthcare/ValueSet/document-entry-type  | DocumentEntry Type |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-contributing-factor-vs  | AdverseEvent Contributing Factor |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-mitigating-action-vs  | AdverseEvent Mitigating Action |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-supporting-info  | AdverseEvent Supporting Information |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-type-vs  | AdverseEvent Type |
https://www.ehealth.fgov.be/standards/fhir/medication/ValueSet/medication-exposure-category-vs  | Medication exposure intent |
http://hl7.org/fhir/uv/shc-vaccination/ValueSet/lab-result-findings  | Lab result findings (SNOMED CT) |
http://hl7.org/fhir/uv/shc-vaccination/ValueSet/specimen-collection-supervision-status  | Specimen Collection Supervision Status |
https://www.ehealth.fgov.be/standards/fhir/mycarenet/ValueSet/be-vs-basic-laterality  | Basic Laterality |
https://www.ehealth.fgov.be/standards/fhir/mycarenet/ValueSet/be-vs-toothnumber-bodysite  | Tooth Number Body Site |
https://profiles.ihe.net/ITI/Scheduling/ValueSet/sct-services  | IHE ITI Scheduling Snomed CT Services |
https://profiles.ihe.net/ITI/Scheduling/ValueSet/specialty  | IHE ITI Scheduling Specialties |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-certifier-types-vs  | Certifier Types Value Set |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-contributory-tobacco-use-vs  | Contributory Tobacco Use ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-death-certification-event-max-vs  | Event Code for Death Certificate Composition - Max |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-death-certification-event-vs  | Event Code for Death Certificate Composition |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-manner-of-death-vs  | Manner of Death ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-method-of-disposition-vs  | Method of Disposition ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-place-of-death-vs  | Place of Death ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-transportation-incident-role-vs  | Transportation Incident Role ValueSet |
https://hl7chile.cl/fhir/ig/clcore/ValueSet/VSDiagnosticosSCT  | Diagnósticos SNOMED y Ausente o Desconocido |
https://hl7.cz/fhir/lab/ValueSet/cz-lab-clinically-relevant-time-VS  | ValueSet - Clinically Relevant Time |
https://hl7.cz/fhir/lab/ValueSet/cz-lab-container-types-VS  | Laboratory Container Types (CZ) |
https://hl7.cz/fhir/lab/ValueSet/cz-lab-speciality-types-VS  | Laboratory Speciality Types (CZ) |
https://hl7.cz/fhir/lab/ValueSet/cz-lab-technique-vs  | Laboratory Techniques |
http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-consentstatus  | Consent Status |
http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-legalrelation  | Legal Relation |
http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-personalrelation  | Personal Relation |
http://ns.electronichealth.net.au/fhir/ValueSet/apgarscoretypesnomedct-1  | Apgar Score Type SNOMED CT |
http://ns.electronichealth.net.au/fhir/ValueSet/birthcomplication-1  | Birth Complication |
http://ns.electronichealth.net.au/fhir/ValueSet/birthmethod-1  | Birth Method |
http://ns.electronichealth.net.au/fhir/ValueSet/birthpresentation-1  | Birth Presentation |
http://ns.electronichealth.net.au/fhir/ValueSet/congenitalabnormality-1  | Congenital Abnormality |
http://ns.electronichealth.net.au/fhir/ValueSet/emergency-contact-type-1  | Emergency Contact Type |
http://ns.electronichealth.net.au/fhir/ValueSet/labourinductionmethod-1  | Labour Induction Method |
http://ns.electronichealth.net.au/fhir/ValueSet/labouronsettype-1  | Labour Onset Type |
https://nzhts.digital.health.nz/fhir/ValueSet/vaping-status  | Vaping Status |
http://fhir.ch/ig/ch-term/ValueSet/ActivePharmaceuticalIngredient  | ActivePharmaceuticalIngredient |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceConditionValueSet  | CH AllergyIntolerance Condition |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceReactionManifestationValueSet  | CH AllergyIntolerance Reaction Manifestation |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceReactionSubstanceValueSet  | CH AllergyIntolerance Reaction Substance |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceValueSet  | CH AllergyIntolerance |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.classCode  | DocumentEntry.classCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.confidentialityCode  | DocumentEntry.confidentialityCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.healthcareFacilityTypeCode  | DocumentEntry.healthcareFacilityTypeCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.practiceSettingCode  | DocumentEntry.practiceSettingCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.typeCode  | DocumentEntry.typeCode |
http://fhir.ch/ig/ch-term/ValueSet/HCProfessional.hcProfession  | HCProfessional.hcProfession |
http://fhir.ch/ig/ch-term/ValueSet/SubmissionSet.contentTypeCode  | SubmissionSet.contentTypeCode |
http://fhir.ch/ig/ch-term/ValueSet/UnitCode  | UnitCode |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-ch-vaccination-plan-immunizations-vs  | CH VACD Swiss Vaccination Plan Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-recommendation-categories-vs  | CH VACD Recommendation Categories for Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs  | CH VACD Target disease and illnesses undergone for immunization |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-vaccines-snomedct-vs  | CH VACD Snomed CT for VaccineCode |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-vaccines-vs  | CH VACD Swissmedic code for VaccineCode |
http://fhir.ch/ig/ch-term/ValueSet/snomedct-concept-viraldiseases-vs  | Snomed CT Concept Viral Diseases |
http://fhir.ch/ig/ch-term/ValueSet/treatmentreason  | Treatment Reason |
http://hl7.org/fhir/uv/cqm/ValueSet/chronic-liver-disease-legacy-example  | Chronic Liver Disease Legacy Example |
http://hl7.eu/fhir/base-r5/ValueSet/siteLaterality-eu  | Body Structure Laterality |
http://hl7.eu/fhir/base-r5/ValueSet/siteQualifier-eu  | Body Structure Qualifier |
http://hl7.eu/fhir/base-r5/ValueSet/speciesType-eu  | Types of species |
http://fhir.ch/ig/ch-lab-order/ValueSet/MicrobiolProcedures  | Microbiological Procedure |
http://fhir.ch/ig/ch-lab-order/ValueSet/clinical-focus-vitamin-d  | Vitamin D all possible clinical contexts for test |
http://fhir.ch/ig/ch-lab-order/ValueSet/normal-contexts-vitamin-d  | Contexts for reimbursement of the vitamin D test |
http://fhir.ch/ig/ch-lab-order/ValueSet/reasons-for-order  | All Valid Reasons for Ordering a Lab Service |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-immunization-allergyintolerances-vs  | Allergies and Intolerance values for Immunization |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-medical-vs  | Swiss Medical Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-occupation-vs  | Swiss Occupation Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-preillness-vs  | Swiss Preillness Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-social-vs  | Swiss Social Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-verification-status-vs  | Verification Status Codes |
https://ncez.mzcr.cz/fhir/ValueSet/registering-provider-service-type-cz  | Registering Provider Service Type Cz |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-birth-attendant-titles-vr  | Value Set - Birth Attendants Titles Vital Records |
http://hl7.org/fhir/uv/livd/ValueSet/resultvalue-mappings-livd  | Result value mappings value set for LIVD |
https://fhir.hl7.at/elga/aps/r4/ValueSet/at-aps-immunization-vaccine-codes  | AT APS Immunitzation Vaccine Codes |
https://fhir.hl7.at/elga/aps/r4/ValueSet/at-aps-problems  | AT APS Problems |
http://bloodpressure.oemig.de/fhir/ValueSet/BodyPosition  | Body Position |
http://bloodpressure.oemig.de/fhir/ValueSet/MeasurementSetting  | Measurement Setting value set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-benign-uncertain-neoplasm-brain-cns-disorder-vs  | Benign Neoplasm of Brain and CNS Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-body-location-and-laterality-qualifier-vs  | Body Location and Laterality Qualifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-high-dose-rate-electronic-technique-vs  | Brachytherapy High Dose Rate Electronic Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-high-dose-rate-technique-vs  | Brachytherapy High Dose Rate Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-low-dose-rate-temporary-technique-vs  | Brachytherapy Low Dose Rate Temporary Radiation Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-modality-vs  | Brachytherapy Modality Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-permanent-seeds-technique-vs  | Brachytherapy Permanent Seeds Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-pulsed-dose-rate-technique-vs  | Brachytherapy Pulsed Dose Rate Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-radiopharmaceutical-technique-vs  | Brachytherapy Radiopharmaceutical Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-breslow-depth-stage-value-vs  | Breslow Depth Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-body-location-vs  | Cancer Body Location Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-disease-status-evidence-type-vs  | Cancer Disease Status Evidence Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-related-surgical-procedure-vs  | Cancer-Related Surgical Procedure Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-stage-type-vs  | Cancer Stage Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-stage-value-vs  | Cancer Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-method-vs  | Cancer Staging Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-prognostic-factor-type-vs  | Cancer Staging Prognostic Factors Types |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-prognostic-factor-value-vs  | Cancer Staging Prognostic Factors Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-carcinoma-in-situ-disorder-vs  | Carcinoma In-Situ Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-clark-level-value-vs  | Clark Level Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-clin-or-path-modifier-vs  | Clinical or Pathologic Modifier |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-condition-status-trend-max-vs  | Condition Status Trend Maximum Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-condition-status-trend-vs  | Condition Status Trend Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cytologic-evidence-malignancy-vs  | Cytologic Evidence of Malignancy Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-fab-classification-value-vs  | FAB Classification Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-figo-staging-method-vs  | FIGO Staging Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-gleason-grade-group-value-vs  | Gleason Grade Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-histologic-grade-vs  | Histologic Grade Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-histologic-grading-system-vs  | Histologic Grading System Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-histology-morphology-behavior-vs  | Histology Morphology Behavior Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-history-of-metastatic-malignant-neoplasm-vs  | History of Metastatic Malignant Neoplasm Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-hypereosinophilic-syndrome-disorder-vs  | Specific Diagnosis of Cancer Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-laterality-qualifier-vs  | Laterality Qualifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-stage-bulky-modifier-vs  | Lymphoma Stage Bulky Modifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-stage-value-modifier-vs  | Lymphoma Stage Value Modifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-stage-value-vs  | Lymphoma Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-staging-method-vs  | Lymphoma Staging System Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-melanoma-in-situ-disorder-vs  | Melanoma In-Situ Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-neuroblastoma-inss-value-vs  | International Neuroblastoma Staging System (INSS) for Neuroblastoma Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-normalization-basis-vs  | Normalization Basis Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-primary-malignant-neoplasm-disorder-vs  | Primary Malignant | http://sundhedsdatastyrelsen.dk/ValueSet/VS-knogler-muskler-bindevaev  | Knogler/Muskler/Bindevæv Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-konsultationsform  | Konsultationsform Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-kraeftsygdomme  | Kræftsygdomme Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-kredsloeb  | Kredsløb Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-nervesystemet  | Nervesystemet Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-oensket-ugedag  | ØnsketUgedag Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-omsorgsniveau  | Omsorgsniveau Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-operation-i-livmoderen  | OperationILivmoderen Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-paavirkningstype  | Påvirkningstype Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-partnerrelation  | Partnerrelation Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-partners-erhvervsmaessige-tilknytning  | PartnersErhvervsmæssigeTilknytning Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-resultat-type  | ResultatType Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-rygoperation  | Rygoperation Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-screening-aktualitet  | ScreeningAktualitet Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-screeningsstatus  | Screeningsstatus Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-screeningstype  | Screeningstype Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-tilstands-svaerhedsgrad  | TilstandsSværhedsgrad Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-tobaksrygning-under-graviditet  | TobaksrygningUnderGraviditet Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-type-rusmiddel-laegemiddel  | TypeRusmiddel/Lægemiddel Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-uddannelsesniveau  | Uddannelsesniveau Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-urinveje-koensorganer  | Urinveje/Kønsorganer Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-vandpibe-dagligt-lejlighedsvist  | VandpibeDagligt/Lejlighedsvist Value Set |
http://sundhedsdatastyrelsen.dk/ValueSet/VS-ydelse  | Ydelse Value Set |
https://euvabeco.net/vcds-ig/ValueSet/HealthProfession  | Health professions |
http://hl7.org/fhir/us/vdor/ValueSet/vdor-gun-owner-codes-vs  | VDOR Coding Manual Gun Owner Codes Value Set |
http://sundhedsdatastyrelsen.dk/terminologi/dk-ihe-healthcarefacilitytypecode-vs  | DK_IHE_HealthcareFacilityTypeCode_VS |
http://sundhedsdatastyrelsen.dk/terminologi/dk-ihe-practicesettingcode-vs  | DK_IHE_practiceSettingCode_VS |
http://ehealth.sundhed.dk/vs/activitydefinition-code  | Activity Definition Code |
http://ehealth.sundhed.dk/vs/clinicalimpression-finding-codes  | ClinicalImpression Finding Codes |
http://ehealth.sundhed.dk/vs/clinicalimpression-investigation-item-codes  | ClinicalImpression Investigation Item Codes |
http://ehealth.sundhed.dk/vs/device-types  | Device Types |
http://ehealth.sundhed.dk/vs/document-class  | Document Class |
http://ehealth.sundhed.dk/vs/facility-type-codes  | Facility Type Codes |
http://ehealth.sundhed.dk/vs/media-codes  | Media Codes |
http://ehealth.sundhed.dk/vs/questionnaire-types  | Questionnaire Types |
http://ehealth.sundhed.dk/vs/sor-organization-type  | SorOrganizationType |
http://ehealth.sundhed.dk/vs/sor-organization-specialty  | SorOrganizationSpecialty |
https://www.hl7.it/fhir/terminology/ValueSet/additivo-campione-it  | Additivo Campione |
https://www.hl7.it/fhir/terminology/ValueSet/campione-container-lab-it  | Container Campione |
https://www.hl7.it/fhir/terminology/ValueSet/results-microorganism-snomed-ct-ips-free-set  | Risultato osservazione codificato - microorganismo IPS di SNOMED CT |
https://www.hl7.it/fhir/terminology/ValueSet/results-observation-bloodgroup  | Risultato osservazione codificato - Gruppo Sanguigno IPS di SNOMED CT |
https://www.hl7.it/fhir/terminology/ValueSet/results-presence-absence-snomed-ct-ips-free-set  | Risultato osservazione codificato - presenza/assenza IPS di SNOMED CT |
https://www.hl7.it/fhir/terminology/ValueSet/tipo-campione-lab-it  | Tipo campione |
https://www.hl7.it/fhir/terminology/ValueSet/valueset-observation-value-bloodgroup  | Risultato osservazione codificato gruppo sanguigno |
https://www.hl7.it/fhir/terminology/ValueSet/valueset-observation-value-microorganism  | Risultato osservazione codificato microorganismi |
https://www.hl7.it/fhir/terminology/ValueSet/valueset-observation-value-presence-absence  | Risultato osservazione codificato presenza/assenza |
http://hl7.eu/fhir/base/ValueSet/siteLaterality-eu  | Body Structure Laterality |
http://hl7.eu/fhir/base/ValueSet/siteQualifier-eu  | Body Structure Qualifier |
http://hl7.eu/fhir/base/ValueSet/speciesType-eu  | Types of species |
http://terminology.hl7.org/ValueSet/device-kind  | FHIR Device Types |
http://terminology.hl7.org/ValueSet/edible-substance-type  | Types of Edible Substances |
http://terminology.hl7.org/ValueSet/gender-identity  | Gender Identity |
http://terminology.hl7.org/ValueSet/snomed-intl-gps  | SNOMED International Global Patient Set (GPS) |
http://terminology.hl7.org/ValueSet/v3-AllergyStatus  | Allergy Status |
http://terminology.hl7.org/ValueSet/v3-KnowledgeSubjectObservationValue  | KnowledgeSubjectObservationValue |
http://terminology.hl7.org/ValueSet/v3-KnowledgeSubtopicObservationValue  | KnowledgeSubtopicObservationValue |
http://terminology.hl7.org/ValueSet/v3-ObservationMeasureCountableItems  | ObservationMeasureCountableItems |
http://terminology.hl7.org/ValueSet/v3-immunizationForecastStatusObservationValue  | immunizationForecastStatusObservationValue |
http://hl7.org/fhir/us/davinci-ra/ValueSet/confidence-scale  | RA Confidence Scale |
https://fhir-ig.digital.health.nz/sdhr/ValueSet/sdhr-allergyintolerance-severity-valueset  | ValueSet for AllergyIntolerance Severity |
https://hi.iv.elga.gv.at/ValueSet/acetherapy  | ACE Therapie |
https://hi.iv.elga.gv.at/ValueSet/austritt  | Austritt |
https://hi.iv.elga.gv.at/ValueSet/comorbidities  | Komorbiditäten |
https://hi.iv.elga.gv.at/ValueSet/diagnosis  | Diagnose |
https://hi.iv.elga.gv.at/ValueSet/education  | Schulung und Beratung |
https://hi.iv.elga.gv.at/ValueSet/facilitytype  | Einrichtungsart |
https://hi.iv.elga.gv.at/ValueSet/ressourcen  | Ressourcen |
https://hi.iv.elga.gv.at/ValueSet/schulung  | Schulung |
https://hi.iv.elga.gv.at/ValueSet/symptoms  | Symptomatik |
https://hi.iv.elga.gv.at/ValueSet/targetdose  | Zieldosis |
https://hi.iv.elga.gv.at/ValueSet/therapie  | Therapie |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/AxillaSurgeryVS  | Axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ChemoTherapyTypeVS  | Type of chemotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationImpactVS  | Impact of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationTypeVS  | Type of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EducationLevelVS  | Education level of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EstrogenStatusVS  | Estrogen receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GermlineMutationVS  | Germline Mutation ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GradingVS  | Grading of tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HER2ReceptorStatusVS  | HER2 receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HistologicalTypeVS  | Histological type of the tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HormonalTherapyTypeVS  | Type of hormonal therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/InvolvedMarginsReoperationTypeVS  | Re-operation due to involved margins ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityNewCancerVS  | Laterality of new cancer ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityVS  | Laterality of breast cancer ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LocationRadiotherapyVS  | The location of radiotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/MenopausalStatusVS  | Menopausal status of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/PatientTreatPrefVS  | Patient treatment preference ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ProgesteroneStatusVS  | Progesterone receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecommendedTreatmentTypeVS  | Recommended treatment types ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecurrenceMethodVS  | Recurrence method ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationReasonVS  | Reasoncode of the re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationTypeVS  | Type of re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/SACQPatientComorbidityHistory  | SACQ Patient's comorbidity history ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMDistantMetastasesVS  | TNM Distant Metastases ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMPrimaryTumorVS  | TNM Primary Tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMRegionalNodesVS  | TNM Regional Nodes ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedAxillaSurgeryVS  | Targeted axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedTherapyVS  | Type of targeted therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TherapyIntentVS  | Intent of therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TreatmentTypeVS  | Type of treatments ValueSet |
http://hl7.org/fhir/us/dental-data-exchange/ValueSet/dental-observation-codes  | Dental Observation Codes |
http://hl7.org/fhir/us/dental-data-exchange/ValueSet/dental-reason-for-referral  | DentalReasonForReferral |
http://hl7.org/fhir/us/dental-data-exchange/ValueSet/oral-cavity-area  | Oral Cavity Area |
http://hl7.org/fhir/us/dental-data-exchange/ValueSet/tooth-identification-valueset  | Tooth Identification ValueSet |
https://fhir.nhs.uk/England/RAD/ValueSet/document-entry-class  | Document Entry Class |
https://fhir.nhs.uk/England/RAD/ValueSet/document-entry-type-imaging-report-report  | Document Entry Type Imaging Report |
https://fhir.nhs.uk/England/RAD/ValueSet/imaging-code-nicip  | ImagingCodeNICIP |
https://fhir.nhs.uk/England/RAD/ValueSet/modality  | Modality |
https://hl7.cz/fhir/ValueSet/cz-consent-category  | CZ Consent Category |
https://hl7.cz/fhir/ValueSet/cz-provision-code  | CZ Provision Code |
http://terminology.ehdsi.eu/ValueSet/eHDSIConditionPOA  | eHDSI Condition Present On Admission |
http://terminology.ehdsi.eu/ValueSet/eHDSITreatmentClass  | eHDSI Treatment Class |
http://medcomfhir.dk/ig/terminology/ValueSet/medcom-conditionlist-status-valueset  | MedComConditionListStatus |
http://hl7.org/fhir/uv/emedicinal-product-info/ValueSet/routeOfAdministration  | Route Of Administration |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Active.Advance.Directive.Finding.VS  | Active Advanced Healthcare Directives Findings Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Airbag.Type.VS  | Airbag Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Airway.Device.Confirmation.Method.VS  | Airway Device Confirmation Method Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Airway.Device.Type.VS  | Airway Device Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Barrier.To.Care.VS  | Barrier To Care Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Blood.Pressure.Measurement.Method.VS  | Blood Pressure Measurement Method Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Arrest.Etiology.VS  | Cardiac Arrest Etiology Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Arrest.Outcome.VS  | Cardiac Arrest Outcome Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Arrest.Witness.Role.VS  | Cardiac Arrest Witness Role Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Rhythm.Reading.VS  | Cardiac Rhythm Readings Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiopulmonary.Resuscitation.Type.VS  | Cardiopulmonary Resuscitation Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/ChiefComplaint.Anatomic.Location.VS  | ChiefComplaint Anatomic Location Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/ChiefComplaint.Organ.System.VS  | ChiefComplaint Organ System Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Collision.Object.VS  | Collision Object Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Complication.Subset.VS  | Complication Subset Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Destination.Prearrival.Activation.Type.VS  | Destination Prearrival Activation Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Device.Type.VS  | ECG Device Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Disaster.Type.VS  | Disaster Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/IHE.PCC.APGAR.VS  | IHE PCC mPSC APGAR Assessment Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/IHE.PCC.Facility.Ward.VS  | IHE PCC mPSC Facility Ward Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Length.Based.Weight.Class.VS  | Length Based Weight Class Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Level.Of.Responsiveness.AVPU.VS  | Level Of Responsiveness AVPU Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Location.In.Vehicle.VS  | Location In Vehicle Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Mechanism.Of.Injury.VS  | Mechanism Of Injury Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Medication.Administration.Device.VS  | Medication Administration Device Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Medication.Complication.VS  | Medication Complication Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/PSC.Location.Type.VS  | PSC Location Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Emergency.Event.Sub.List.VS  | Paramedicine Emergency Event Sub List Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Observation.Interpretation.VS  | Paramedicine Observation Interpretation Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Physical.Findings.of.Nervous.System.VS  | Physical Finding of Nervous System Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Physical.Findings.of.Respiratory.System.VS  | Physical Finding of Respiratory System Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Provider.Roles.VS  | Paramedicine Provider Roles Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Reason.For.Visit.VS  | Paramedicine Reason For Visit Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Vehicle.Type.VS  | Paramedicine Vehicle Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Pathient.Transfer.to.Ambulance.Method.VS  | Pathient Transfer to Ambulance_Method Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Abdomen.TargetSite.VS  | Physical Finding of Abdomen Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Abdomen.VS  | Physical Finding of Abdomen Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.TargetSite.VS  | Physical Finding of Back Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.VS  | Physical Finding of Back Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.and.Spine.VS  | Physical Finding of Back and Spine Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Chest.TargetSite.VS  | Physical Finding of Chest Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Chest.VS  | Physical Finding of Chest Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Extremities.TargetSite.VS  | Physical Finding of Extremities Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Extremities.VS  | Physical Finding of Extremities Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Eye.TargetSite.VS  | Physical Finding of Eye Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Eye.VS  | Physical Finding of Eye Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Face.VS  | Physical Finding of Face Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.GenitourinaryTract.VS  | Physical Finding of Genitourinary Tract Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Head.VS  | Physical Finding of Head Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Heart.VS  | Physical Finding of Heart Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Lung.TargetSite.VS  | Physical Finding of Lung Tartget Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Lung.VS  | Physical Finding of Lung Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Neck.VS  | Physical Finding of Neck Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pelvis.VS  | Physical Finding of Pelvis Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pelvis.and.Genitourinary.VS  | Physical Finding of Pelvis and Genitourinary Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pupil.TargetSite.VS  | Physical Finding of Back and Spine Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pupil.VS  | Physical Finding of Pupil Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Skin.VS  | Physical Finding of Skin Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Spine.TargetSite.VS  | Physical Finding of Spine Spine Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Protective.Equipment.VS  | Protective Equipment Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Pulse.Rhythm.VS  | Pulse Rhythm Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Reason.For.Visit.VS  | Reason For Visit Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Respiratory.Effort.VS  | Respiratory Effort Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Response.VS  | Paramedicine Treatment Response Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Safety.Equipment.VS  | Safety Equipment Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Stroke.Assessment.Interpretation.VS  | Stroke Assessment Interpretation Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Stroke.Scale.Type.VS  | Stroke Scale Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Substance.Use.Evidence.VS  | Substance Use Evidence Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Transport.Method.VS  | Transport Method Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Vehicle.Type.VS  | Vehicle Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Weight.Estimation.Tape.Values.VS  | Physical Finding of Pelvis and Genitourinary Value Set |
http://hl7.org/fhir/us/sdoh-clinicalcare/ValueSet/SDOHCC-ValueSetLOINCSNOMEDCT  | SDOHCC ValueSet LOINC SNOMEDCT |
http://hl7.org/fhir/uv/sdc/ValueSet/species  | Questionnaire Context Species |
http://hl7.org/fhir/uv/ips/ValueSet/allergies-intolerances-uv-ips  | Allergies & Intolerances - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-reaction-uv-ips  | Allergy Reaction - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/body-site-uv-ips  | Body Site - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/current-smoking-status-uv-ips  | Current Smoking Status - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medical-devices-uv-ips  | Medical Devices - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medication-example-uv-ips  | Medications - example (IPS) |
http://hl7.org/fhir/uv/ips/ValueSet/medication-uv-ips  | Medications - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medicine-active-substances-uv-ips  | Medicine Active Substances - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/pregnancy-status-uv-ips  | Pregnancy Status - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/problems-uv-ips  | Problems - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/procedures-uv-ips  | Procedures - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-coded-values-laboratory-pathology-uv-ips  | Results Coded Values Laboratory/Pathology - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-numobs-uv-ips  | Results Radiology Measurement Observation - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-txtobs-uv-ips  | Results Radiology Textual Observation - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-collection-method-uv-ips  | Results Specimen Collection Method - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-type-uv-ips  | Results Specimen Type - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/target-diseases-uv-ips  | Vaccine Target Diseases - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/vaccines-uv-ips  | Vaccines - IPS |
http://hl7.org/fhir/us/pacio-adi/ValueSet/ADIDocumentationTypeVS  | Documentation Types |
http://fhir.ch/ig/ch-epreg/ValueSet/blood-group  | CH EPREG VS: Blood Group |
http://fhir.ch/ig/ch-epreg/ValueSet/fetal-position  | CH EPREG VS: Fetal Position |
http://fhir.ch/ig/ch-epreg/ValueSet/parent  | CH EPREG VS: Parent |
http://hl7.org/fhir/uv/phenomics-exchange/ValueSet/Onset  | Onset ValueSet |
http://hl7.eu/fhir/imaging-r5/ValueSet/im-imaging-device-type  | Imaging Device Type |
http://hl7.eu/fhir/imaging-r5/ValueSet/im-procedure-type  | Imaging Procedure Type |
http://hl7.eu/fhir/imaging-r5/ValueSet/media-view  | Media View types - placeholder for cross-version extension |
http://hl7.eu/fhir/imaging-r5/ValueSet/periods-of-life-value-set  | Periods of Life |
http://fhir.health.gov.lk/ips/ValueSet/vs-follow-up-plan  | Follow-up plan |
http://fhir.health.gov.lk/ips/ValueSet/vs-medical-conditions  | Conditions |
http://fhir.health.gov.lk/ips/ValueSet/vs-reason-for-encounter  | Reason For Encounter |
http://fhir.health.gov.lk/ips/ValueSet/vs-risk-behaviour-physical-activity  | Physical Activity |
http://hl7.eu/fhir/laboratory/ValueSet/lab-laterality-eu-lab  | Body Structure Laterality |
http://hl7.eu/fhir/laboratory/ValueSet/lab-siteQualifier-eu-lab  | Body Structure Qualifier |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specialty-eu-lab  | Laboratory Specialty |
http://hl7.eu/fhir/laboratory/ValueSet/lab-speciesType-eu-vs  | Types of species |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenAdditive-eu-lab  | Specimen Additive |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenContainer-eu-lab  | Specimen Container |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenType-eu-lab  | Specimen Types |
http://hl7.eu/fhir/laboratory/ValueSet/lab-technique-eu-lab  | Laboratory Techniques |
http://hl7.org/fhir/us/central-cancer-registry-reporting/ValueSet/cancer-core-reportability-codes  | Cancer Core Reportability Codes |
https://hl7.fr/ig/fhir/medication/ValueSet/fr-treatment-intent  | French overall intention of the treatment |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-diabetes  | CVDRA Diabetes |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-percutaneous-coronary-intervention  | CVDRA Percutaneous Coronary Intervention |
https://nzhts.digital.health.nz/fhir/ValueSet/Smoking-status-code  | Smoking status |
https://nzhts.digital.health.nz/ns/ValueSet/health-service-type-refset-vs  | Health service type refset vs |
https://nzhts.digital.health.nz/fhir/ValueSet/air-status-reason-code  | AIR status reason code |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-coronary-artery-bypass-grafting  | CVDRA Coronary Artery Bypass Grafting |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-transient-ischaemic-attack  | CVDRA Transient Ischaemic Attack (TIA) |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-fh-premature-ischaemic-cvd  | CVDRA Family History Of Premature Ischaemic CVD |
https://nzhts.digital.health.nz/fhir/ValueSet/air-route-of-administration  | AIR route of administration |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-peripheral-vascular-disease  | CVDRA Peripheral Vascular Disease |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-renal-failure  | CVDRA Renal Failure |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-smoking-status  | CVDRA Smoking Status |
https://nzhts.digital.health.nz/ValueSet/cvdra-heart-failure  | CVDRA Heart failure |
https://nzhts.digital.health.nz/fhir/ValueSet/rheumatic-fever-care-team-participant-role  | Rheumatic fever care team participant role |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-ischaemic-stroke  | CVDRA Ischaemic Stroke |
https://nzhts.digital.health.nz/fhir/ValueSet/air-disease-covered-code  | AIR diseases covered code |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-AJCC-residual-tumour  | NZ AJCC latest edition residual tumour category clinical |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-AJCC8-residual-tumour-clincal  | NZ AJCC 8th edition residual tumour category clinical |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-AJCC8-residual-tumour  | NZ AJCC (8th edition) edition residual tumour category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-acute-leukaemia-cancer-type  | NZ cancer acute leukaemia cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-adrenal-topography  | NZ cancer adrenal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ajcc-staging-chapter  | NZ AJCC staging chapter |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ajcc-staging-manual-edition  | NZ AJCC cancer staging manual edition |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ann-arbor-lymphoma-stage  | NZ cancer Ann Arbor lymphoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-agressive-cancer-type  | NZ cancer aggressive B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-agressive-nhl-cancer-type  | NZ cancer aggressive non-Hodgkin B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-indolent-cancer-type  | NZ cancer indolent B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-indolent-nhl-cancer-type  | NZ cancer indolent non-Hodgkin B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-lymphoid-cancer-type  | NZ cancer B cell lymphoid cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-lymphoid-substream  | NZ cancer B cell lymphoid substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-lymphoma-cancer-type  | NZ cancer B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-basis-of-cancer-diagnosis  | NZ cancer basis of diagnosis |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bl-ipi-prognostic-score  | NZ cancer BL-IPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-cancer-type  | NZ cancer bone cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-other-topography  | NZ cancer bone other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-pelvis-topography  | NZ cancer bone pelvis topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-thoracic-topography  | NZ cancer bone thoracic topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-vertebral-column-topography  | NZ cancer bone vertebral column topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-ancillary-studies  | NZ cancer breast ancillary studies |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-clinical-behaviour-category  | NZ cancer breast clinical behaviour category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-clinical-presentation  | NZ cancer breast clinical presentation |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-mammogram-finding  | NZ cancer breast mammogram finding |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-non-nac-topography  | NZ cancer breast non-nipple-areola complex topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-procedure-image-guided-method  | NZ cancer breast procedure image guided method |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-radiology-type  | NZ cancer breast radiology type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-related-topography  | NZ cancer breast related topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-specimen-resection-procedure-type  | NZ cancer breast resection procedure type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-ultrasound-finding  | NZ cancer breast ultrasound finding |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-colorectal-topography-resection  | NZ cancer gastrointestinal colorectal resection topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-colorectal-topography-subtype-metastectomy  | NZ cancer colorectal metastectomy topography subtype |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-laboratory-test-method  | NZ cancer laboratory test method |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-ngs-pcr  | NZ cancer PCR OR NGS test method |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-procedure-specimen-gi-cr-diagnostic  | NZ cancer gastrointestinal diagnostic specimen collection procedure |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-procedure-specimen-gi-cr-resection-met  | NZ cancer gastrointestinal colorectal metastecomy resection specimen collection procedure |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-procedure-specimen-gi  | NZ cancer gastrointestinal specimen collection procedure |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-service  | NZ cancer service |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-stream  | NZ cancer stream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-topography-colonoscopy  | NZ cancer colonoscopy topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-clinical-impression-behaviour  | NZ cancer clinical impression of behaviour |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-clinical-scale  | NZ cancer clinical assessment scale |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-clockface-position  | NZ cancer clockface position |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-brain-topography  | NZ cancer central nervous system brain topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-cancer-type  | NZ cancer CNS cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-ipi-prognostic-score  | NZ cancer CNS-IPI for large B cell lymphoma prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-meninges-topography  | NZ cancer central nervous system meninges topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-nerve-topography  | NZ cancer central nervous system nerve topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-other-topography  | NZ cancer central nervous system other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-status-prognostic-score  | NZ cancer CNS status in acute lymphoblastic leukaemia lymphoma prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-topography  | NZ cancer central nervous system topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-cancer-type  | NZ cancer colorectal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-colon-perforation  | NZ perforation present in colon |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-obstruction-perforation  | NZ colorectal obstruction or perforation present in colon |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-obstruction  | NZ colorectal obstruction present |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-perforation  | NZ colorectal perforation present |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-referral-criteria-surveillance  | NZ cancer colorectal surveillance colonoscopy referral criteria |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-data-absent-reason  | NZ cancer data absent reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-diagnosis-clinical-status  | NZ cancer diagnosis clinical status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-document-type  | NZ cancer document type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eln-prognostic-score  | NZ cancer ELN standardised reporting for genetic alteration in AML prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-neuroendocrine-cancer-type  | NZ cancer endocrine and neuroendocrine cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-neuroendocrine-substream  | NZ cancer endocrine and neuroendocrine substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-neuroendocrine-topography  | NZ cancer endocrine and/or neuroendocrine topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-other-topography  | NZ cancer endocrine other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-topography  | NZ cancer endocrine topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-er-expression  | NZ cancer ER expression |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eutos-prognostic-score  | NZ cancer EUTOS for CML prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-excision-specimen-type  | NZ cancer excision specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-cancer-type  | NZ cancer eye and orbit cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-lacrimal-drainage-system-topography  | NZ cancer eye and orbit lacrimal drainage system topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-lacrimal-gland-topography  | NZ cancer eye and orbit lacrimal gland topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-optic-nerve-topography  | NZ cancer eye and orbit optic nerve topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-other-topography  | NZ cancer eye and orbit other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-uveal-tract-topography  | NZ cancer eye and orbit uveal tract topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-cervix-uteri-topography  | NZ cancer female genital cervix uteri topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-corpus-uteri-topography  | NZ cancer female genital corpus uteri topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-fallopian-tube-topography  | NZ cancer female genital fallopian tube topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-gestational-trophoblastic-topography  | NZ cancer female genital gestational trophoblastic disease topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-peritoneum-topography  | NZ cancer female genital peritoneum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-uterine-ligament-topography  | NZ cancer female genital uterine ligament topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-vulva-topography  | NZ cancer female genital vulva topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2001-gestational-stage  | NZ cancer FIGO 2001 gestational trophoblastic disease stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2009-endometrial-carcinoma-stage  | NZ cancer FIGO 2009 endometrial carcinoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2015-corpus-uteri-adenosarcoma-stage  | NZ cancer FIGO 2015 corpus uteri adenosarcoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2018-cervix-uteri-stage  | NZ cancer FIGO 2018 cervix uteri stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2021-vulva-stage  | NZ cancer FIGO 2021 vulva stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-flipi-prognostic-score  | NZ cancer FLIPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-follicular-lymphoma-grade  | NZ cancer follicular lymphoma grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-frozen-section-specimen-type  | NZ cancer frozen section specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gastro-cancer-type  | NZ cancer gastrointestinal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gastro-substream  | NZ cancer gastrointestinal substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-genitourinary-substream  | NZ cancer genitourinary substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-anus-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour anal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-appendix-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour appendix topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-colorectal-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour colorectal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-other-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-pancreas-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour pancreas topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-stomach-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour stomach topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-german-hodgkin-stage  | NZ cancer GHSG Hodgkin treatment stratification stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-colon-topography  | NZ cancer gastrointestinal colon topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-colorectal-topography  | NZ cancer gastrointestinal colorectal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-duodenum-topography  | NZ cancer gastrointestinal duodenum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-exocrine-pancreas-topography  | NZ cancer gastrointestinal exocrine pancreas topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-jejunum-ileum-topography  | NZ cancer gastrointestinal ileum and jejunum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-liver-topography  | NZ cancer gastrointestinal liver topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-oesophagus-topography  | NZ cancer gastrointestinal oesophagus topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-pancreas-topography  | NZ cancer gastrointestinal pancreas topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-rectum-topography  | NZ cancer gastrointestinal rectum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-stomach-topography  | NZ cancer gastrointestinal stomach topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-upper-topography  | NZ cancer upper gastrointestinal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grade  | NZ cancer grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grading-system  | NZ cancer grading system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haem-recurrence-type  | NZ cancer heamatology recurrence type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-stream  | NZ cancer haematology stream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-substream  | NZ cancer haematology substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-treatment-intent  | NZ cancer haematology treatment intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-cancer-type  | NZ cancer head and neck cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-hypopharynx-topography  | NZ cancer head and neck hypopharynx topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-larynx-topography  | NZ cancer head and neck larynx topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasal-paranasal-topography  | NZ cancer head and neck nasal cavity and paranasal sinus topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasal-topography  | NZ cancer head and neck nasal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasopharynx-topography  | NZ cancer head and neck nasopharynx topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-odontogenic-topography  | NZ cancer head and neck odontogenic topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-other-topography  | NZ cancer head and neck other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-salivary-gland-topography  | NZ cancer head and neck major salivary gland topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-substream  | NZ cancer head and neck substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-with-thyroid-topography  | NZ cancer head and neck with thyroid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-health-worker-role-path-radio-surg  | NZ cancer health worker role pathologist radiologist surgeon |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hep-pan-bil-other-topography  | NZ cancer other gastrointestinal hepatopancreaticobiliary topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hep-pan-bil-topography  | NZ cancer gastrointestinal hepatopancreaticobiliary topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-high-level-topography  | NZ cancer high level topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hl-ips-prognostic-score  | NZ cancer Hodgkin lymphoma International Prognostic Score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ipss-r-prognostic-score  | NZ cancer IPSS-R for MDS prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-mandatory  | NZ cancer laterality mandatory |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-optional  | NZ cancer laterality optional |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-or-side  | NZ cancer laterality or side |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-side-mandatory  | NZ cancer laterality or side mandatory |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-with-unknown  | NZ cancer laterality with unknown value |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality  | NZ cancer laterality |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lower-gastro-cancer-type  | NZ cancer lower gastrointestinal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lugano-lymphoma-stage  | NZ cancer Lugano staging classification for lymphoma |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lung-cancer-type  | NZ lung cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymph-node-specimen-type  | NZ cancer lymph node specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-breast  | NZ cancer breast lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-eye-orbit  | NZ cancer eye and orbit lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-cervix-uteri  | NZ cancer female genital cervix uteri lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-corpus-uteri  | NZ cancer female genital corpus uteri lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-vulva  | NZ cancer female genital vulva lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-anus  | NZ cancer gastrointestinal anus lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-colorectal  | NZ cancer gastrointestinal colorectal lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-stomach  | NZ cancer gastrointestinal stomach lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal  | NZ cancer gastrointestinal lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-head-neck  | NZ cancer head and neck lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-male-genital  | NZ cancer male genital lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-thorax-lung  | NZ cancer thorax lung lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-thorax  | NZ cancer thorax lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-kidney  | NZ cancer urinary and male genital kidney lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-penis  | NZ cancer urinary and male genital penis lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis-ureter  | NZ cancer urinary and male genital renal pelvis and ureter lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis  | NZ cancer urinary and male genital renal pelvis lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-testis  | NZ cancer urinary and male genital testis lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-urinary-bladder  | NZ cancer urinary and male genital urinary bladder lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital  | NZ cancer urinary and male genital lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary  | NZ cancer urinary system lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphoma-substream  | NZ cancer lymphoma substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-male-genital-sact-cancer-type  | NZ cancer male genital SACT cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-male-genital-topography  | NZ cancer male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-malt-ipi-prognostic-score  | NZ cancer MALT-IPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mastocytosis-cancer-type  | NZ cancer mastocytosis cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-md-anderson-residual-cancer-burden  | NZ cancer MD Anderson residual cancer burden |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mds-myeloproliferative-cancer-type  | NZ cancer myelodysplastic-myeloproliferative cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-melanoma-cancer-type  | NZ cancer melanoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-melanoma-cns-topography  | NZ cancer CNS melanoma topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-menopause-status  | NZ cancer menopause status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-midline-non-symmetrical-topography  | NZ cancer midline non-symmetrical topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-midline-topography  | NZ cancer midline topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mipi-prognostic-score  | NZ cancer MIPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mipss-70-v2-prognostic-score  | NZ cancer MIPSS 70+ v2.0 myelofibrosis prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-cns-cancer-type  | NZ cancer medical oncology cns cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-endocrine-cancer-type  | NZ cancer medical oncology endocrine cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-endocrine-neuroendocrine-cancer-type  | NZ medical oncology cancer endocrine and neuroendocrine cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-genitourinary-cancer-type  | NZ cancer medical oncology genitourinary cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-gynaecological-cancer-type  | NZ cancer medical oncology gynaecological cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-cancer-type  | NZ cancer medical oncology head and neck cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-other-cancer-type  | NZ cancer medical oncology other head and neck cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-other-topography  | NZ cancer medical oncology head and neck other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-male-genital-topography  | NZ cancer medical oncology male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-skin-melanoma-topography  | NZ cancer medical oncology skin and/or melanoma topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-skin-topography  | NZ cancer medical oncology skin topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-solid-tumour-cancer-type  | NZ cancer medical oncology solid tumour cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-solid-tumour-substream  | NZ cancer medical oncology solid tumour substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thoracic-cancer-type  | NZ cancer medical oncology thoracic cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thoracic-substream  | NZ cancer medicial oncology thoracic substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thorax-mesothelioma-topography  | NZ cancer thorax medical oncology mesothelioma topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thorax-topography  | NZ cancer thorax medical oncology topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-treatment-intent  | NZ cancer medical oncology treatment intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-urinary-male-genital-testicular-topography  | NZ cancer medical oncology urinary and male genital testicular topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-urinary-male-genital-topography  | NZ cancer medical oncology urinary and male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-who-brain-primary-histology  | NZ medical oncology WHO brain primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-myeloid-cancer-type  | NZ cancer myeloid proliferation and myeloid neoplasm cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nail-topography  | NZ cancer nail topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nasal-paranasal-cancer-type  | NZ cancer nasal cavity and paranasal sinus cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-benign-reactive-diagnosis  | NZ cancer national cervical screening programme benign and reactive diagnosis |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-excision-completeness  | NZ cancer national cervical screening programme completeness of excision |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-specimen-type  | NZ cancer national cervical screening programme specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-topography  | NZ cancer national cervical screening programme topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neoadjuvant-therapy-response-system  | NZ cancer neoadjuvant therapy response system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neoadjuvant-therapy-type-non-hormone  | NZ cancer neoadjuvant therapy administration type (non-hormone) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-breast-topography  | NZ cancer neuroendocrine tumour breast topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-male-genital-topography  | NZ cancer neuroendocrine tumour male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-urinary-topography  | NZ cancer neuroendocrine tumour urinary topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-gep-cancer-type  | NZ cancer neuroendocrine GEP cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-non-gep-cancer-type  | NZ cancer neuroendocrine non GEP cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-substream  | NZ cancer neuroendocrine substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-ajcc-staging-system  | NZ cancer non-AJCC staging system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-hodgkin-lymphoma-cancer-type  | NZ cancer non Hodgkin lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-prostate-genitourinary-cancer-type  | NZ cancer genitourinary (non prostate) cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-not-performed-reason  | NZ cancer not performed reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nottingham-grade  | NZ Nottingham Combined grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nuclear-grade  | NZ cancer nuclear grade of DCIS grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-observation  | NZ cancer observation code |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-parathryoid-topography  | NZ cancer parathryoid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-percist-1-cancer-burden  | NZ cancer PERCIST 1.0 cancer burden |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-performance-status  | NZ cancer performance status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pharynx-larynx-cancer-type  | NZ cancer pharynx and larynx and trachea cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pit-prognostic-score  | NZ cancer PIT prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pituitary-net-topography  | NZ cancer pituitary neuroendocrine tumour topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-polyp-morphology-specimen-type  | NZ cancer polyp morphology specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pos-neg-result  | NZ cancer positive negative result |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-presence-tumour-finding  | NZ cancer presence of tumour finding |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-procedure-status  | NZ cancer procedure status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-prognostic-scoring-system  | NZ cancer prognostic scoring system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-radiology-type  | NZ cancer radiology type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-rai-cll-stage  | NZ cancer Rai staging for CLL stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-recist-1-1-cancer-burden  | NZ cancer RECIST 1.1 cancer burden |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-recurrence-type  | NZ cancer recurrence type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-referral-criteria-procedure-assessment  | NZ cancer procedure referral criteria assessment |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-revised-mayo-amyloidosis-stage  | NZ cancer revised Mayo staging 2012 for AL (amyloidosis) stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-revised-multiple-myeloma-stage  | NZ cancer R-ISS for multiple myeloma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ro-beam-energy-type  | NZ cancer radiation oncology beam energy type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ro-planning-technique  | NZ cancer radiation oncology planning technique |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-aml-disease-response  | NZ SACT acute myeloid leukemia disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-amyloidosis-disease-response  | NZ SACT amyloidosis disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-substream  | NZ systemtic anti-cancer therapy substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-type  | NZ SACT cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cll-sll-disease-response  | NZ SACT chronic lymphocytic leukemia and small lymphocytic lymphoma disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cml-disease-response  | NZ SACT chronic myeloid leukemia disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-dose-form  | NZ SACT dose form |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-dose-unit  | NZ SACT dose unit |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-ecog-status  | NZ SACT ECOG status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-haem-disease-response  | NZ SACT haematology disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-heam-disease-response  | NZ SACT heamatology disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-mds-disease-response  | NZ SACT myelodysplastic syndrome disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-mo-disease-response  | NZ SACT medical oncology disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-non-small-lymphocytic-disease-response  | NZ SACT lymphoma (non small lymphocytic) disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-overall-discontinue-reason  | NZ SACT overall discontinue reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-patient-factor-discontinue-reason  | NZ SACT patient factor discontinue |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-pr-expression  | NZ SACT PR expression |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-toxicity-discontinue-reason  | NZ systemic anti-cancer therapy toxicity discontinue reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-side-mandatory  | NZ cancer side mandatory |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-side  | NZ cancer side |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-simple-performance-status  | NZ cancer simple performance status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-cancer-type  | NZ cancer skin cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-extremity-topography  | NZ cancer skin of extremity topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-head-neck-topography  | NZ cancer skin of head and neck topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-melanoma-substream  | NZ cancer skin and melanoma substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-topography  | NZ cancer skin topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-trunk-topography  | NZ cancer skin of trunk topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-abdomen-pelvis-topography  | NZ cancer soft tissue abdomen and pelvis topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-bone-cancer-type  | NZ cancer soft tissue and bone cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-bone-substream  | NZ cancer soft tissue and bone substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-extremity-topography  | NZ cancer soft tissue extremity topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-head-neck-topography  | NZ cancer soft tissue head and neck topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-skin-topography  | NZ cancer soft tissue skin topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-thoracic-topography  | NZ cancer soft tissue thoracic topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-non-ajcc-staging-system  | NZ cancer solid tumour non-AJCC staging system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-sact-cancer-type  | NZ cancer solid tumour SACT cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-staging-system  | NZ cancer solid tumour staging system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-substream  | NZ cancer solid tumour substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-category-excision-biopsy  | NZ cancer specimen category biopsy or excision |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-category  | NZ cancer specimen category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-colorectal-screening-colonoscopy-type  | NZ cancer colorectal screening colonoscopy specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-dimension-type  | NZ cancer specimen dimension type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-polyp-profile  | NZ cancer polyp profile type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-stage-classification  | NZ cancer stage classification |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-intent  | NZ surgical intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-margin-proximal-distal  | NZ cancer surgical margin qualifier proximal or distal |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-margin-type  | NZ cancer surgical margin type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-t-nk-cell-lymphoma-cancer-type  | NZ cancer T/NK cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-test-failure-reason  | NZ cancer test failure reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-test-inconclusive-reason  | NZ cancer test inconclusive reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thoracic-cancer-type  | NZ cancer thoracic cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-lung-lobe-topography  | NZ cancer thorax lung lobe topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-soft-tissue-topography  | NZ cancer thorax soft tissue topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-thymus-topography  | NZ cancer thorax thymus topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-topography  | NZ cancer thorax topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thryoid-topography  | NZ cancer thryoid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thyroid-topography  | NZ cancer thyroid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-b-lymphoma-stage  | NZ cancer revised TNM-B staging for cutaneous T cell lymphoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-clinical-stage-group  | NZ AJCC breast clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-cm  | NZ AJCC breast clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-ct  | NZ AJCC breast clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pathological-stage-group  | NZ AJCC breast pathological stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pn  | NZ AJCC breast pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pt  | NZ AJCC breast pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-stage-group  | NZ AJCC breast stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-clinical-stage-group  | NZ AJCC clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-cm  | NZ AJCC clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-gen-corpus-uteri-leiomyosarcoma-stage-group  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-cm  | NZ AJCC female genital cervix uteri clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-ct  | NZ AJCC female genital cervix uteri clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-pm  | NZ AJCC female genital cervix uteri pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-pt  | NZ AJCC female genital cervix uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-stage-group  | NZ AJCC female genital cervix uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-cn  | NZ AJCC female genital corpus uteri adenosarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-pt  | NZ AJCC female genital corpus uteri adenosarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-cn  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-ct  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-pt  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-stage-group  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-cm  | NZ AJCC female genital corpus uteri clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-cn  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-ct  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-pt  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pm  | NZ AJCC female genital corpus uteri pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pn  | NZ AJCC female genital corpus uteri pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pt  | NZ AJCC female genital corpus uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-stage-group  | NZ AJCC female genital corpus uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ct  | NZ AJCC female genital clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-gestational-pm  | NZ AJCC female genital gestational trophoblastic disease pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-gestational-stage-group  | NZ AJCC female genital gestational trophoblastic disease stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-cm  | NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-pt  | NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-pm  | NZ AJCC female genital pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-cn  | NZ AJCC female genital vagina clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pm  | NZ AJCC female genital vagina pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pn  | NZ AJCC female genital vagina pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pt  | NZ AJCC female genital vagina pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-stage-group  | NZ AJCC female genital vagina stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-ct  | NZ AJCC female genital vulva clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pm  | NZ AJCC female genital vulva pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pn  | NZ AJCC female genital vulva pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pt  | NZ AJCC female genital vulva pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-clinical-stage-group  | NZ AJCC gastrointestinal clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-cn  | NZ AJCC gastrointestinal clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-cm  | NZ AJCC gastrointestinal colon and rectum clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-cn  | NZ AJCC gastrointestinal colon and rectum clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-ct  | NZ AJCC gastrointestinal colon and rectum clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-pn  | NZ AJCC gastrointestinal colon and rectum pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-stage-group  | NZ AJCC gastrointestinal colon and rectum stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-pn  | NZ AJCC gastrointestinal pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-yp-stage-group  | NZ AJCC gastrointestinal pathological post therapy (neoadjuvant) stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-cm  | NZ AJCC gastrointestinal stromal | https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-upper-gastro-primary-histology  | NZ WHO upper gastrointestinal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-upper-gastro-site-histology  | NZ WHO upper gastrointestinal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urethra-primary-histology  | NZ WHO urethra primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urethra-site-histology  | NZ WHO urethra site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-histology  | NZ WHO urinary and male genital histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-kidney-germ-cell-histology  | NZ WHO urinary and male genital kidney germ cell histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-kidney-histology  | NZ WHO urinary and male genital kidney histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-neuroendocrine-histology  | NZ WHO urinary and male genital neuroendocrine histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-primary-histology  | NZ WHO urinary and male genital primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-prostate-histology  | NZ WHO urinary and male genital prostate histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testicular-adnexa-histology  | NZ WHO urinary and male genital testicular adnexa histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testis-germ-cell-histology  | NZ WHO urinary and male genital testis germ cell histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testis-histology  | NZ WHO urinary and male genital testis histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-system-site-histology  | NZ WHO urinary system site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-corpus-primary-histology  | NZ WHO uterine corpus primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-corpus-site-histology  | NZ WHO uterine corpus site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-ligament-site-histology  | NZ WHO uterine ligament site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-primary-histology  | NZ WHO uterine primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uveal-tract-site-histology  | NZ WHO uveal tract site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vagina-site-histology  | NZ WHO vagina site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vulva-primary-histology  | NZ WHO vulva primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vulva-site-histology  | NZ WHO vulva site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-aggressive-bcell-lymphoma-histology  | NZ WHO haematolymphoid aggressive cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-aggressive-nh-bcell-lymphoma-histology  | NZ WHO haematolymphoid aggressive non-Hodgkin B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-bone-histology  | NZ WHO bone histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-behaviour-free-histology  | NZ WHO breast behaviour free histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-benign-histology  | NZ WHO breast benign histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-haematolymphoid-histology  | NZ WHO breast haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-histology  | NZ WHO breast histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-nipple-histology  | NZ WHO breast tumour of nipple histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-choroid-plexus-histology  | NZ WHO central nervous system choroid plexus histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-cranial-paraspinal-nerve-histology  | NZ WHO central nervous system cranial and paraspinal nerve histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-embryonal-histology  | NZ WHO central nervous system embryonal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-germ-cell-histology  | NZ WHO central nervous system germ cell histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-glioma-glioneuronal-neuronal-histology  | NZ WHO central nervous system glioma and glioneuronal and neuronal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-haematolymphoid-histology  | NZ WHO central nervous system haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-pineal-histology  | NZ WHO central nervous system pineal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-sellar-region-histology  | NZ WHO central nervous system sellar region histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-differentiation-grade  | NZ WHO (5th edition) malignant differentiation grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-anal-canal-histology  | NZ WHO digestive system anal canal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-appendix-histology  | NZ WHO digestive system appendix histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-benign-histology  | NZ WHO digestive system benign tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-colon-rectum-hormone-histology  | NZ WHO digestive system colon and rectum hormone producing tumor histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-germ-tumour-histology  | NZ WHO digestive system germ cell tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-haematolymphoid-histology  | NZ WHO digestive system haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-liver-intrahepatic-bile-duct-histology  | NZ WHO digestive system liver and intrahepatic bile duct histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-mesenchymal-histology  | NZ WHO digestive system mesenchymal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-precursor-histology  | NZ WHO digestive system precursor tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-uncertain-histology  | NZ WHO digestive system uncertain behaviour tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-adrenal-histology  | NZ WHO endocrine and neuroendocrine adrenal gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-benign-histology  | NZ WHO endocrine and neuroendocrine benign histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-malignant-histology  | NZ WHO endocrine and neuroendocrine malignant histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-pituitary-histology  | NZ WHO endocrine and neuroendocrine pituitary gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-pituitary-net-histology  | NZ WHO pituitary neuroendocrine tumour primary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-thyroid-histology  | NZ WHO endocrine and neuroendocrine thyroid gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-uncertain-histology  | NZ WHO endocrine and neuroendocrine uncertain behaviour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-haematolymphoid-histology  | NZ WHO eye and orbit haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-histology  | NZ WHO eye and orbit histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-lacrimal-gland-histology  | NZ WHO eye and orbit lacrimal gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-optic-disc-nerve-histology  | NZ WHO eye and orbit optic disc and optic nerve histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-retina-neuroepithelium-histology  | NZ WHO eye and orbit retina and neuroepithelium histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-soft-tissue-bone-histology  | NZ WHO eye and orbit soft tissue and bone histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-uncertain-borderline-histology  | NZ WHO eye and orbit uncertain and borderline histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-germ-cell-histology  | NZ WHO female genital germ cell histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-haematolymphoid-histology  | NZ WHO female genital haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-neuroendocrine-histology  | NZ WHO female genital neuroendocrine histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-ovary-histology  | NZ WHO female genital ovary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-peritoneum-histology  | NZ WHO female genital peritoneum histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-vagina-histology  | NZ WHO female genital vagina histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-acute-leukaemia-amb-lineage-histology  | NZ WHO haematolymphoid acute leukaemia of mixed or ambiguous lineage histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-amyloidosis-histology  | NZ WHO haematolymphoid amyloidosis histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-b-cell-lymphoma-histology  | NZ WHO haematolymphoid B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-b-cell-reactive-lymphoma-histology  | NZ WHO haematolymphoid reactive B-cell rich lymphoid proliferations which mimic lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-bl-histology  | NZ WHO haematolymphoid Burkitt lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-castleman-disorder-histology  | NZ WHO haematolymphoid Castleman disease histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-cml-histology  | NZ WHO haematolymphoid chronic myeloid leukaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-cutaneous-t-cell-lymphoma-histology  | NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-et-histology  | NZ WHO haematolymphoid essential thrombocythaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-extranod-nk-t-cell-lymphoma-histology  | NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-histiocytic-histology  | NZ WHO haematolymphoid histiocytic dendritic cell neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-histology  | NZ WHO haematolymphoid tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-intest-nk-t-cell-lymphoid-histology  | NZ WHO classification of tumours (5th edition) haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-leukaemia-histology  | NZ WHO haematolymphoid leukaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-lymphoplasmacytic-lymphoma-histology  | NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mc-lymphoma-histology  | NZ WHO haematolymphoid mantle cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mds-histology  | NZ WHO haematolymphoid myelodysplastic syndrome histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mds-myeloproliferative-histology  | NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloid-lymphoid-gene-histology  | NZ WHO haematolymphoid myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloid-secondary-histology  | NZ WHO classification of tumours (5th edition) haematolymphoid secondary myeloid neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloproliferative-neoplasm-histology  | NZ WHO haematology chronic myeloproliferative neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-nhl-histology  | NZ WHO haematolymphoid non Hodgkin lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-peripheral-t-cell-lymphoma-histology  | NZ WHO haematolymphoid peripheral T cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-plasma-cell-histology  | NZ WHO haematolymphoid plasma cell neoplasms and other diseases with paraproteins histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-pv-histology  | NZ WHO haematolymphoid polycythaemia vera histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-benign-histology  | NZ WHO classification of tumours (5th edition) head and neck benign histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-ear-histology  | NZ WHO classification of tumours (5th edition) head and neck ear histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-haematolymphoid-histology  | NZ WHO classification of tumours (5th edition) head and neck haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-histology  | NZ WHO classification of tumours (5th edition) head and neck histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-malignant-histology  | NZ WHO classification of tumours (5th edition) head and neck malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-melanocytic-histology  | NZ WHO classification of tumours (5th edition) head and neck melanocytic histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-nasal-skull-histology  | NZ WHO classification of tumours (5th edition) head and neck nasal and paranasal and skull base histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-nasopharynx-histology  | NZ WHO classification of tumours (5th edition) head and neck nasopharynx histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-neck-lymph-histology  | NZ WHO classification of tumours (5th edition) head and neck tumour and tumour-like lesion of the neck and lymph node histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-odontogenic-maxfac-histology  | NZ WHO classification of tumours (5th edition) head and neck odontogenic and maxillofacial bone histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-oral-cavity-histology  | NZ WHO classification of tumours (5th edition) head and neck oral cavity and mobile tongue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-pharynx-larynx-histology  | NZ WHO classification of tumours (5th edition) head and neck hypopharynx and larynx and trachea and parapharyngeal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-precursor-histology  | NZ WHO classification of tumours (5th edition) head and neck precursor histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-salivary-histology  | NZ WHO classification of tumours (5th edition) head and neck salivary gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-soft-tissue-histology  | NZ WHO classification of tumours (5th edition) head and neck soft tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-histology-cll-histology  | NZ WHO haematolymphoid chronic lymphocytic leukaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-indolent-bcell-lymphoma-histology  | NZ WHO haematolymphoid indolent B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-indolent-nh-bcell-lymphoma-histology  | NZ WHO haematolymphoid indolent non-Hodgkin B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-low-high-diff-grade  | NZ WHO (5th edition) malignant low high (differentiation) grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-mature-tnk-cell-histology  | NZ WHO haematolymphoid mature T cell and natural killer cell neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-mature-tnk-leukaemia-histology  | NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-cns-histology  | NZ WHO classification of tumours (5th edition) CNS melanoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-histology  | NZ WHO classification of tumours (5th edition) melanoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-mucosal-histology  | NZ WHO classification of tumours (5th edition) mucosal melanoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-monoclonal-b-cell-lymphocytosis-histology  | NZ WHO haematolymphoid monoclonal B cell lymphocytosis histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-net-non-endo-organ-histology  | NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-neuroendo-pancreas-histology  | NZ WHO neuroendocrine pancreas histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-neuroendo-pancreas-net-histology  | NZ WHO neuroendocrine tumour pancreas primary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-orbit-histology  | NZ WHO orbit histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-heamatolymphoid-histology  | NZ WHO classification of tumours (5th edition) skin haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-histology  | NZ WHO classification of tumours (5th edition) skin histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-keratinocytic-epidermal-histology  | NZ WHO classification of tumours (5th edition) skin keratinocytic and epidermal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-merkel-histology  | NZ WHO classification of tumours (5th edition) Merkel cell carcinoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-precursor-histology  | NZ WHO classification of tumours (5th edition) skin precursor histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-skin-soft-tissue-histology  | NZ WHO classification of tumours (5th edition) skin soft tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-soft-tissue-bone-undiff-sarcoma-histology  | NZ WHO soft tissue and bone undifferentiated small round cell sarcoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-benign-histology  | NZ WHO thoracic benign histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-ectopic-thyroid-parathyroid-histology  | NZ WHO thoracic ectopic tumour of thyroid and parathyroid origin histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-germ-cell-mediastinum-histology  | NZ WHO thoracic mediastinum germ cell histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-haematolymphoid-mediastinum-histology  | NZ WHO thoracic mediastinum haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-heart-histology  | NZ WHO thoracic heart histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-neuroendocrine-grade  | NZ WHO (5th edition) thoracic neuroendocrine tumour grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-non-small-cell-lung-histology  | NZ WHO thoracic non small cell lung histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-pleura-pericardium-histology  | NZ WHO thoracic pleura and pericardium histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-precursor-histology  | NZ WHO thoracic precursor histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-thoracic-small-cell-lung-histology  | NZ WHO thoracic small cell lung histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-haematolymphoid-histology  | NZ WHO urinary and male genital haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-histology  | NZ WHO urinary and male genital histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-kidney-histology  | NZ WHO urinary and male genital kidney histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-prostate-histology  | NZ WHO urinary and male genital prostate histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-urinary-male-genital-testis-germ-cell-histology  | NZ WHO urinary and male genital testis germ cell histology (5th edition) |
http://hl7.org/fhir/ValueSet/condition-severity  | Condition/Diagnosis Severity |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-hypercholesterolaemia  | CVDRA Hypercholesterolaemia |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-angina  | CVDRA Angina |
http://hl7.org/fhir/uv/ips/ValueSet/medication-snomed-uv-ips  | Medications - SNOMED CT (IPS) |
https://nzhts.digital.health.nz/fhir/ValueSet/practitioner-role-code  | PractitionerRoleCode |
http://hl7.org/fhir/ValueSet/reason-medication-status-codes  | SNOMED CT Drug Therapy Status codes |
http://hl7.org/fhir/uv/ips/ValueSet/result-coded-value-pathology-uv-ips  | Results Coded Values Pathology - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-coded-values-laboratory-uv-ips  | Results Coded Values Laboratory - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-presence-absence-uv-ips  | Results Presence/Absence - IPS |
http://hl7.org/fhir/us/davinci-crd/ValueSet/serviceRequestCodes  | CRD Service Request Codes Value Set |
http://fhir.org/guides/hrsa/uds-plus/ValueSet/uds-plus-sex-codes  | Uds Plus Sex Codes |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/conditions-documenting-sleep-disordered-breathing  | Sleep disordered breathing |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/conditions-documenting-substance-misuse  | Conditions documenting substance misuse |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/conditions-likely-terminal-for-opioid-prescribing  | Conditions likely terminal for opioid prescribing |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/hospice-disposition  | Hospice Disposition |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/hospice-finding  | Hospice Finding |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/hospice-procedure  | Hospice Procedure |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/limited-life-expectancy-conditions  | Limited life expectancy conditions |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/office-visit  | Office Visit |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/opioid-counseling-procedure  | Opioid counseling procedure |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/opioid-misuse-assessment-procedure  | Opioid misuse assessment procedure |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/opioid-misuse-disorders  | Opioid misuse disorders |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/opioid-treatment-assessment-procedure  | Opioid treatment assessment procedure |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/pain-management-procedure  | Pain management procedure |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/pdmp-data-reviewed-finding  | PDMP data reviewed finding |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/pdmp-review-procedure  | PDMP review procedure |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/sickle-cell-diseases  | Sickle-cell diseases |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/substance-misuse-behavioral-counseling  | Substance misuse behavioral counseling |
http://fhir.org/guides/cdc/opioid-cds/ValueSet/therapies-indicating-end-of-life-care  | Therapies indicating end of life care |
http://who-umc.org/idmp/ValueSet/routeOfAdministration  | Route Of Administration |
http://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType  | Adverse Event Type |
http://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug  | Allergen No Drug |
http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup  | Blood Group |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite  | Body Site |
http://terminology.ehdsi.eu/ValueSet/eHDSICodeProb  | Problems |
http://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus  | Current Pregnancy Status |
http://terminology.ehdsi.eu/ValueSet/eHDSIProcedure  | Procedure |
http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy  | Reaction Allergy |
http://terminology.ehdsi.eu/ValueSet/eHDSISeverity  | Severity |
http://terminology.ehdsi.eu/ValueSet/eHDSISocialHistory  | eHDSI Social History |
http://terminology.ehdsi.eu/ValueSet/eHDSIVaccine  | Vaccine |
https://interoperabilidad.minsal.cl/fhir/ig/tei/ValueSet/TipoDeObservacion  | Tipo de Observación |
https://interoperabilidad.minsal.cl/fhir/ig/tei/ValueSet/VSServicioRequerido  | Servicio Requerido |
https://interoperabilidad.minsal.cl/fhir/ig/tei/ValueSet/VSTerminologiasDiag  | TerminologiasDiag |
https://nw-gmsa.github.io/LTW//ValueSet/document-entry-class  | DocumentEntry Class |
https://nw-gmsa.github.io/LTW//ValueSet/document-entry-type  | DocumentEntry Type |
https://nw-gmsa.github.io/LTW//ValueSet/ethnicity  | Ethnicity |
https://nw-gmsa.github.io/LTW//ValueSet/specimen-type  | Specimen Type |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-brachytherapy-applicator-type-vs  | Brachytherapy Applicator Type Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-brachytherapy-device-type-vs  | Brachytherapy Device Type Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-disease-progression-qualifier-vs  | Disease Progression Qualifier Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-image-guided-radiotherapy-modality-vs  | Image Guided Radiotherapy Modality Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-intrafraction-verification-procedure-vs  | Intrafraction Verification Procedure Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-intrafraction-verification-qualifier-vs  | Intrafraction Verification Procedure Qualifier Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-category-vs  | Radiotherapy Category Code Max Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-free-breathing-motion-mgmt-technique-vs  | Radiotherapy Free-Breathing Motion Management Technique Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-isotope-vs  | Radiotherapy Isotope Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-reason-for-revision-or-adaptation-vs  | Radiotherapy Reason for Revision or Adaptation Value Set |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-respiratory-motion-management-vs  | Radiotherapy Respiratory Motion Management Value Set |
https://www.ehealth.fgov.be/standards/fhir/pss/ValueSet/BacterialCodes  | Bacterial Codes |
https://www.ehealth.fgov.be/standards/fhir/pss/ValueSet/CandidaCodes  | Candida Codes |
https://www.ehealth.fgov.be/standards/fhir/pss/ValueSet/ChlamydiaCodes  | Chlamydia Codes |
https://www.ehealth.fgov.be/standards/fhir/pss/ValueSet/CompromisedImmuneSystemCodes  | CompromisedImmuneSystem Codes |
https://www.ehealth.fgov.be/standards/fhir/pss/ValueSet/GonokokCodes  | Gonokok Codes |
https://www.ehealth.fgov.be/standards/fhir/pss/ValueSet/MycoplasmaCodes  | Mycoplasma Codes |
https://www.ehealth.fgov.be/standards/fhir/pss/ValueSet/OncologyPatientCodes  | OncologyPatient Codes |
https://www.ehealth.fgov.be/standards/fhir/pss/ValueSet/OtherCodes  | Other Codes |
https://www.ehealth.fgov.be/standards/fhir/pss/ValueSet/PregnancyCodes  | Pregnancy Codes |
https://www.ehealth.fgov.be/standards/fhir/pss/ValueSet/TrichomonasCodes  | Trichomonas Codes |
http://hl7.org/fhir/us/breast-radiology/ValueSet/BreastAssessmentCategoryVS  | Breast Assessment Category ValueSet |
http://hl7.org/fhir/us/breast-radiology/ValueSet/CalcificationDistributionVS  | CalcificationDistribution ValueSet |
http://hl7.org/fhir/us/breast-radiology/ValueSet/ConsistentWithVS  | ConsistentWith ValueSet |
http://hl7.org/fhir/us/breast-radiology/ValueSet/NotPreviouslySeenVS  | NotPreviouslySeen ValueSet |
http://hl7.org/fhir/us/breast-radiology/ValueSet/PreviouslyDemonstratedByVS  | PreviouslyDemonstratedBy ValueSet |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-InfectPersPrecaution  | IVR Infection Transport Precaution Personnel |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-actRecovAid  | IVR Recovery Aid |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-actRespiOwner  | IVR Owner |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-ambulanceType  | IVR Ambulance Type |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-bedding  | IVR Transport Bedding |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-deathManner  | IVR Death Manner |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-diagType  | IVR Diagnosis Type |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-event  | IVR Event |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-eyeForm  | IVR Eye Form |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-findingsAirway  | IVR Findings Airway |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-formation  | IVR Formation |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-gcs-augenoeffnung  | IVR GCS Eye Opening |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-gcsMotoric  | IVR GCS Motoric Response |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-gcsVerbal  | IVR GCS Verbal Response |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-hospitalPriority  | IVR Hospital Priority |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-idSource  | IVR Identification Source |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-intensity  | IVR Intensity |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-laterality  | IVR Laterality |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-locationType  | IVR Location Type |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-offender  | IVR Offender |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-personRole  | IVR Person Role |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-preTreatType  | IVR Pretreatment Type |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-preTreatment  | IVR Pretreatment |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-pressureMethod  | IVR Blood Pressure Method |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-procAirType  | IVR Procedure Airway Type |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-pulesResult  | IVR Pulse Result |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-pulseMethod  | IVR Pulse Method |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-respirationObservation  | IVR Respiration Observation |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-result  | IVR Result |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-size  | IVR Size |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-symptom  | IVR Symptom |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-teamRole  | IVR Team Role |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-transDisinfection  | IVR Transport Unit Disinfection |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-urgency-adequate  | IVR Urgency Adequate |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-valType  | IVR Valuables Type |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-ventilation  | IVR Ventilation |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-violenceForm  | IVR Violence Form |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-violenceResult  | IVR Violence Result |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-woundTreat  | IVR Wound Treatment |
http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-yesNoUnknown  | IVR Yes/No/Unknown |
http://hl7.eu/fhir/hdr/ValueSet/admission-voluntary-status-vs  | Encounter Voluntary Status Value Set |
http://hl7.eu/fhir/hdr/ValueSet/allergy-intolerance-substances-eu-hdr  | Allergy Intolerance |
http://hl7.eu/fhir/hdr/ValueSet/condition-eu-hdr  | Condition Value Set |
http://hl7.eu/fhir/hdr/ValueSet/exposureAgent-eu-hdr  | Exposure of transmissible agents |
http://hl7.eu/fhir/hdr/ValueSet/hdr-encounter-type-eu-hdr  | In-patient Encounter Type Value Set |
http://hl7.eu/fhir/hdr/ValueSet/medical-devices-eu-hdr  | Medical Devices (SNOMED CT) |
http://hl7.eu/fhir/hdr/ValueSet/procedure-snomed-eu-hdr  | Procedure codes: Snomed CT |
http://hl7.eu/fhir/hdr/ValueSet/sdoh-obs-snomed-loinc-eu-hdr  | SDOH Observation codes |
https://www.ehealth.fgov.be/standards/fhir/core/ValueSet/be-vs-patient-relationship-type  | BeVSPatientRelationshipType |
http://hl7.org/fhir/us/birthdefectreporting/ValueSet/bdr-procedurelist  | Newborn Procedure List |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.10--20240802091633  | IPS Allergy or Intolerance Conditions |
http://hl7.org/fhir/ips/ValueSet/allergy-reaction-uv-ips  | IPS Allergy Reaction |
http://hl7.org/fhir/uv/ips/ValueSet/target-site-uv-ips  | IPS Body Site |
http://hl7.org/uv/ips/fhir/ValueSet/specimen-type  | IPS Specimen Type |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.57--20171212192725  | Laterality (qualifier) |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.58--20171212193352  | Topographical modifier (qualifier) |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-condition-uv-ips  | IPS Allergy or Intolerance Substances |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.66--20240802105026  | IPS Results Radiology Textual Observations |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.71--20240802094107  | IPS Medications Products |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.73--20240802094107  | IPS Problems |
http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.76--20240802105320  | IPS Results Specimen Collection Method |
https://hl7.cz/fhir/img/ValueSet/cz-laterality-codeList  | Laterality Codelist (CZ) |
https://github.com/HL7/intraproc-anesthesia/ValueSet/asagrade-vs  | ASA Grade |
http://fhir.ch/ig/ch-lab-report/ValueSet/ch-lab-bloodgroup-antibody-vs  | CH LAB-Report BloodGroup Antibody Result (SNOMED CT coded substances) |
http://fhir.ch/ig/ch-lab-report/ValueSet/ch-lab-bloodgroup-immuno-hematology-vs  | CH LAB-Report BloodGroup Immunohematology Tests (SNOMED CT coded procedures) |
http://hl7.org/fhir/us/registry-protocols/ValueSet/AbnormalElectrocardiacAssessment  | Abnormal Electrocardiac Assessment |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ArterialAccessSite  | Arterial Access Site |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CABG  | Coronary artery bypass grafting |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CABGType  | Coronary Artery Bypass Graft Type |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacArrest  | Cardiac Arrest |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacCTAResults  | Cardiac CTA Results |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacCatheter  | SNOMED Cardiac Catheters |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacInstabilityType  | Cardiac Instability Type |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacValves  | Cardiac Valves |
http://hl7.org/fhir/us/registry-protocols/ValueSet/CerebrovascularDisease  | Cerebrovascular Disease |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ChestPainSymptomAssessment  | Chest Pain Symptom Assessment |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ChronicLungDisease  | Chronic Lung Disease |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ConcomitantProceduresPerformedType  | Concomitant Procedures Performed Type |
http://hl7.org/fhir/us/registry-protocols/ValueSet/DiabetesMellitus  | Diabetes Mellitus |
http://hl7.org/fhir/us/registry-protocols/ValueSet/Dyslipidemia  | Dyslipidemia |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ElectrocardiacAbnormalityType  | Electrocardiac Abnormality Type |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ElectrocardiacAssessmentMethod  | Electrocardiac Assessment Method |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ElectrocardiacAssessmentResults  | Electrocardiac Assessment Results |
http://hl7.org/fhir/us/registry-protocols/ValueSet/FamilyPrematureCAD  | Family History of Premature CAD |
http://hl7.org/fhir/us/registry-protocols/ValueSet/GraftVesselCABGVessel  | Graft Vessel CABG Vessel |
http://hl7.org/fhir/us/registry-protocols/ValueSet/HeartFailure  | Heart Failure codes from SNOMED |
http://hl7.org/fhir/us/registry-protocols/ValueSet/HemodialysisOrPeritonealDialysis  | hemodialysis or peritoneal dialysis |
http://hl7.org/fhir/us/registry-protocols/ValueSet/Hypertension  | Hypertension |
http://hl7.org/fhir/us/registry-protocols/ValueSet/HypothermiaInduced  | Induced Hypothermia Codes |
http://hl7.org/fhir/us/registry-protocols/ValueSet/InterventionTypes  | Intervention Types |
http://hl7.org/fhir/us/registry-protocols/ValueSet/IntraAndPostEvents  | Cath PCI qualified list of Events |
http://hl7.org/fhir/us/registry-protocols/ValueSet/LesionSegmentNumber  | Lesion Segment Number |
http://hl7.org/fhir/us/registry-protocols/ValueSet/MyocardialInfarction  | Myocardial Infarction |
http://hl7.org/fhir/us/registry-protocols/ValueSet/NewYorkHeartAssociation  | New York Heart Association Assessment Scale |
http://hl7.org/fhir/us/registry-protocols/ValueSet/OrganDonor  | SNOMED Valueset of Organ Donor codes |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PCIIndications  | Percutaneous Coronary Intervention Indication |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PCIOperator  | PCI Operator SNOMED codes |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PackedRedBloodCells  | Packed Red Blood Ceels |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PercutaneousCoronaryIntervention  | PCI |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PeripheralArterialOcclusiveDisease  | Peripheral Arterial Occlusive Disease |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PriorCABG  | Prior History of Coronary Artery Bypass Graft |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PriorDiagnosticCoronaryAngiographyProcedureResults  | Prior Diagnostic Coronary Angiography Procedure Results |
http://hl7.org/fhir/us/registry-protocols/ValueSet/PriorMyocardialInfarction  | Prior Myocardial Infarction |
http://hl7.org/fhir/us/registry-protocols/ValueSet/SmokingStatus  | Smoking Status |
http://hl7.org/fhir/us/registry-protocols/ValueSet/StentType  | CathPCI List of Stent Types |
http://hl7.org/fhir/us/registry-protocols/ValueSet/TIMIFlow  | TIMI Flow |
http://hl7.org/fhir/us/registry-protocols/ValueSet/ValvularRegurgitation  | Valvular Regurgitation |
http://hl7.org/fhir/us/registry-protocols/ValueSet/VentricularSupport  | VentricularSupport |
http://hl7.org/fhir/us/registry-protocols/ValueSet/VentricularSupportDeviceType  | Ventricular Support Device Type |
http://hl7.org/fhir/us/registry-protocols/ValueSet/YesNo  | Yes or No |
http://example.org/fhir/ValueSet/sensitive-care-team-codes  | ValueSet - Sensitive CareTeam Codes |
http://example.org/fhir/ValueSet/sensitive-condition-codes  | ValueSet - Sensitive Condition Codes |
http://example.org/fhir/ValueSet/sensitive-medication-codes  | ValueSet - Sensitive Medication Codes |
http://example.org/fhir/ValueSet/sensitive-medication-request-codes  | ValueSet - Sensitive MedicationRequest Codes |
http://example.org/fhir/ValueSet/sensitive-observation-codes  | ValueSet - Sensitive Observation Codes |
http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-condition  | Caveat Condition |
http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-device  | Caveat Device |
http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-qualifier-value  | Qualifier Value |
http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-type  | Type of Caveat |
http://hl7.org/fhir/us/hai/ValueSet/nhsn-pathogen-ranking  | NHSNPathogenRanking |
http://hl7.org/fhir/us/cardx-htn/ValueSet/MeasSettingVS  | Measurement Setting value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/bodyPositionVS  | Body Position value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/bpMeasMethodVS  | Blood Pressure Measurement Method value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/bpmeasbodylocationprecoord  | Blood Pressure Measurement Body Location Precoordinated value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/exertionPhaseVS  | Exertion Phase value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/heartRateMeasBodyLocationPrecoordVS  | Heart Rate Measurement Body Location Precoordinated value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/heartRateMeasDeviceVS  | Heart Rate Measurement Device value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/heartRateMeasMethodVS  | Heart Rate Measurement Method value set |
http://hl7.org/fhir/us/cardx-htn/ValueSet/sleepStatusVS  | Sleep Status value set |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/condition-code-sct-tw  | SNOMED CT診斷代碼值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/health-professional-sct-tw  | SNOMED CT + 臺灣醫事司醫事人員類別值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/medical-department-sct-tw  | 對應至 SNOMED CT之就醫科別 + 診療科別值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/medication-path-sct-tw  | SNOMED CT + 臺灣健保署給藥途徑值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/serviceRequest-category  | 臺灣衛福部資訊處ServiceRequest類型值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/smoking-status-comprehensive-code  | SNOMED CT 吸菸狀態綜合評估值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/smoking-status-type-code  | SNOMED CT + LOINC 吸菸狀態種類向值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/snomed-pregnancy-status-code  | SNOMED CT + HL7 NullFlavor妊娠狀態值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/snomed-sexual-orientation-code  | SNOMED CT + HL7 NullFlavor 性傾向值集 |
https://fhir.north-west.england.nhs.uk/ValueSet/document-entry-class  | DocumentEntry Class |
https://fhir.north-west.england.nhs.uk/ValueSet/document-entry-type  | DocumentEntry Type |
https://fhir.north-west.england.nhs.uk/ValueSet/ethnicity  | Ethnicity |
https://fhir.north-west.england.nhs.uk/ValueSet/specimen-type  | Specimen Type |
http://hl7.org/fhir/uv/radiation-dose-summary/ValueSet/component-radiation-dose-summary-vs  | Radiation Dose Summary component type |
http://hl7.org/fhir/uv/radiation-dose-summary/ValueSet/procedure-reported-type-rds-vs  | Procedure Reported Type Value Set |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-apgar-timing  | APGAR Score Timing |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-birth-attendant-titles  | Birth Attendants Titles |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-birth-delivery-occurred  | Birth Delivery Occurred |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-delivery-routes  | Delivery Routes |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fertility-enhancing-drug-therapy-artificial-insem  | Fertility Enhancing Drug Therapy and Artificial Insemination Value Set |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-death-cause-or-condition  | Fetal Death Cause or Condition |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-death-time-points  | Fetal Death Time Points |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-presentations-max  | Fetal Presentations - Max |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-presentations  | Fetal Presentations |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-remains-disposition-method  | Fetal Remains Disposition Method |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-infections-during-pregnancy-live-birth  | Infections During Pregnancy Live Birth |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-newborn-congenital-anomalies  | Newborn Congenital Anomalies |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-obstetric-procedure-outcome  | Obstetric Procedure Outcome |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-performed-not-performed-planned  | Performed NotPerformed Planned |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/AxillaSurgeryVS  | Axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ChemoTherapyTypeVS  | Type of chemotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationImpactVS  | Impact of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationTypeVS  | Type of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EducationLevelVS  | Education level of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EstrogenStatusVS  | Estrogen receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GermlineMutationVS  | Germline Mutation ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GradingVS  | Grading of tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HER2ReceptorStatusVS  | HER2 receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HistologicalTypeVS  | Histological type of the tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HormonalTherapyTypeVS  | Type of hormonal therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/InvolvedMarginsReoperationTypeVS  | Re-operation due to involved margins ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityNewCancerVS  | Laterality of new cancer ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityVS  | Laterality of breast cancer ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LocationRadiotherapyVS  | The location of radiotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/MenopausalStatusVS  | Menopausal status of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/PatientTreatPrefVS  | Patient treatment preference ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ProgesteroneStatusVS  | Progesterone receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecommendedTreatmentTypeVS  | Recommended treatment types ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecurrenceMethodVS  | Recurrence method ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationReasonVS  | Reasoncode of the re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationTypeVS  | Type of re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/SACQPatientComorbidityHistory  | SACQ Patient's comorbidity history ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMDistantMetastasesVS  | TNM Distant Metastases ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMPrimaryTumorVS  | TNM Primary Tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMRegionalNodesVS  | TNM Regional Nodes ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedAxillaSurgeryVS  | Targeted axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedTherapyVS  | Type of targeted therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TherapyIntentVS  | Intent of therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TreatmentTypeVS  | Type of treatments ValueSet |
http://hl7.org/fhir/us/qicore/ValueSet/qicore-medication-dose-type  | QICore SNOMED CT Dosage Codes |
http://hl7.org/fhir/us/qicore/ValueSet/qicore-observation-body-position  | QICore Observation Body Position |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/document-type-vs  | Tipo de documento ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/newborn-congenital-anomalies-vs  | Tipos de doença congénita ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/newbornriskassessment-vs  | Tipos de risco para avaliação de recém-nascidos ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/puerperium-vs  | Tipos de outcome de puerpério ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/risco-gravidez-vs  | Risco de gravidez ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/tipo-gravidez-vs  | Tipo de gravidez ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/tipo-parto-vs  | Tipos de parto ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/transport-type-vs  | Tipos de transporte de recém-nascido ValueSet |
https://hl7.pt/fhir/NoticiaNascimento/ValueSet/vacinas-infancia-vs  | Vacinas ValueSet |
http://hl7.org/fhir/us/core/ValueSet/us-core-condition-code-current  | US Core Condition Codes Current |
http://hl7.org/fhir/us/core/ValueSet/us-core-condition-code  | US Core Condition Codes |
http://hl7.org/fhir/us/core/ValueSet/us-core-goal-description  | US Core Goal Codes |
http://hl7.org/fhir/us/core/ValueSet/us-core-procedure-code  | US Core Procedure Codes |
http://hl7.org/fhir/us/core/ValueSet/us-core-servicerequest-category  | US Core ServiceRequest Category Codes |
http://hl7.org/fhir/us/mihr/ValueSet/hypertensive-disorders-pregnancy-SNOMED  | ValueSet – Hypertensive Disorders of Pregnancy SNOMED CT |
https://hl7.cz/fhir/img-order/ValueSet/cz-imaging-procedure-vs  | CZ Imaging Procedure |
http://hl7.org/fhir/us/covid19library/ValueSet/close-contact-setting-vs  | Close Contact Setting Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid-19-disease-severity-value-set  | COVID-19 Disease Severity Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid-19-severity-value-set  | COVID-19 Signs and Symptoms Severity Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid-19-snomed-diagnosis-vs  | COVID-19 SNOMED CT Diagnosis Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-det-notdet-eq-inc-vs  | Detected, Not Detected, Inconclusive Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-det-notdet-vs  | Detected, Not-detected value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-eqvs  | Positive/Negative Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-ind-vs  | COVID19 Positive, Negative, Indeterminate value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-inv-incl-vs  | COVID19 Positive, Negative, Invalid, Inconclusive value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-inv-vs  | COVID19 Positive Negative Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-susp-inv-vs  | COVID19 Positive Negative Suspected Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-vs  | Positive, Negative value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-react-nonreact-borderline-inv-value-set  | Reactive, Non-reactive, Borderline, Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-react-nonreact-inv-vs  | COVID19 Reactive, Non-reactive, Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-react-nonreact-vs  | COVID19 Reactive Non-reactive value set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-reporting-priority-vs  | Reporting Priorities Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-signs-1nd-symptoms-value-set  | COVID-19 Signs and Symptoms Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-cardiovascular-condition-value-set  | COVID-19 cardiovascular underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-gastrointestinal-hepatic-condition-value-set  | COVID-19 gastrointestinal or hepatic underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-immune-condition-value-set  | COVID-19 immune underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-immunocompromised-condition-value-set  | COVID-19 immunocompromised underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-medical-condition-vs  | COVID-19 Underlying Medical Condition Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-metabolic-condition-value-set  | COVID-19 metabolic underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-neurolgic-condition-value-set  | COVID-19 neurologic underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-renal-condition-value-set  | COVID-19 renal underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-respiratory-condition-value-set  | COVID-19 respiratory underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-uncategorized-condition-value-set  | COVID-19 uncategorized underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/covid91-underlying-hemoglobinopathy-condition-value-set  | COVID-19 hemoglobinopathy underlying condition reference set |
http://hl7.org/fhir/us/covid19library/ValueSet/det-notdet-equivocal-invalid-vs  | Detected, Not-detected, Equivocal, Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/det-notdet-inconclusive-invalid-vs  | Detected, Not-detected, Inconclusive, Invalid value set |
http://hl7.org/fhir/us/covid19library/ValueSet/detected-not-detected-value-set  | Detected, Not-detected Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/fluAB-SARSCoV2-SARSCoV-value-set  | Influenza A, Influenza B, SARS CoV 2, and SARS CoV value set |
http://hl7.org/fhir/us/covid19library/ValueSet/fluAB-SARSCoV2-value-set  | Influenza A, Influenza B, and SARS CoV2 value set |
http://hl7.org/fhir/us/covid19library/ValueSet/pregnancy-status-value-set  | Pregnancy Status Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/present-absent-unknown-vs  | Present, Absent, Unknown Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/reactive-non-reactive-value-set  | Reactive - Non-reactive value set |
http://hl7.org/fhir/us/covid19library/ValueSet/smoking-status-value-set  | Smoking Status Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/state-codes-vs  | State Codes Value Set |
http://hl7.org/fhir/us/covid19library/ValueSet/yes-no-vs  | Yes/No Value Set |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIAdverseEventType  | Adverse Event Type |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIAllergenNoDrug  | Allergen No Drug |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIBloodGroup  | Blood Group |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSICodeProb  | Problems |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSICurrentPregnancyStatus  | Current Pregnancy Status |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIProcedure  | Procedure |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIReactionAllergy  | Reaction Allergy |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSISeverity  | Severity |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSISocialHistory  | eHDSI Social History |
http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIVaccine  | Vaccine |
https://paho.org/fhir/ops-esavi/ValueSet/CodigoMedicamentoVS  | Codigo Medicamento |
https://paho.org/fhir/ops-esavi/ValueSet/FormaFarmaceuticaVS  | Identificación Formas Farmacéuticas |
https://paho.org/fhir/ops-esavi/ValueSet/ViaAdminMedicamentoVS  | Vías de Administración de Medicamentos |
http://hl7.org/fhir/us/health-care-surveys-reporting/ValueSet/2.16.840.1.113762.1.4.1099.27  | Care Team Member Function (SNOMEDCT) |
http://hl7.org/fhir/us/cimi-labs/ValueSet/abnml-int-numeric-nom-value-set  | Abnormal Interpretation Numeric Nominal value set |
http://hl7.org/fhir/us/cimi-labs/ValueSet/abnormal-interpretation-value-set  | Abnmormal Interpretation value set |
http://hl7.org/fhir/us/cimi-labs/ValueSet/lab-result-code-value-set  | Lab Result Code value set |
http://hl7.org/fhir/us/cimi-labs/ValueSet/null-flavor-value-set  | Null Flavor value set |
http://hl7.org/fhir/us/cimi-labs/ValueSet/ordinal-value-code-value-set  | Ordinal Value Code value set |
http://hl7.se/fhir/ig/base/ValueSet/SEBaseAddressPersonVS  | SE ValueSet for official address types |
http://hl7.se/fhir/ig/base/ValueSet/SEBaseSKRYrkeSpecialtyVS  | SKR ValueSet for clinical specialties |
http://hl7.se/fhir/ig/base/ValueSet/SEBaseSKRYrkeVS  | SKR ValueSet for occupations |
http://hl7.eu/fhir/ig/pcsp/ValueSet/grade-test-vs  | Grade: follow up |
http://hl7.eu/fhir/ig/pcsp/ValueSet/laterality-qualifier-lrub-vs  | Laterality Qualifier Value Set |
http://hl7.eu/fhir/ig/pcsp/ValueSet/mcode-body-location-qualifier-vs  | Body Location Qualifier Value Set |
http://hl7.eu/fhir/ig/pcsp/ValueSet/mcode-cancer-staging-system-vs  | Cancer Staging System Value Set |
http://hl7.eu/fhir/ig/pcsp/ValueSet/morphologicAbnormality-eu-vs  | Morphologically abnormal structure |
http://hl7.eu/fhir/ig/pcsp/ValueSet/otherInfos-condition-vs  | Other Infors Condition |
http://hl7.eu/fhir/ig/pcsp/ValueSet/relapse-type-vs  | Relapse type (Local/Distant/Combined) |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-Gvhd-type-eu-pcsp  | Gvhd condition |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-ProstheticProcedureType-eu-pcsp  | Prosthetic Surgical Procedure Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-action-eu-pcsp  | Surgical Actions |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-affectedOrgan-eu-pcsp  | Affected Organs (surgery) |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-amputationProcedureType-eu-pcsp  | Amputation Surgical Procedure Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-calcest-eu-pcsp  | Calculated|Estimated |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-colostomyProcedureType-eu-pcsp  | Colostomy Surgical Procedure Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-fromToPosteriorAnterior-eu-pcsp  | Body Location Qualifier Value Set |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-gastrostomyProcedureType-eu-pcsp  | Gastrostomy Surgical Procedure Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-hereditary-eu-pcsp  | Hereditary Predispositions or Disease |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-isotopes-eu-pcsp  | Radiotherapy Isotopes |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-radiotherapyDoseType-eu-pcsp  | Radiotherapy Dose Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-radiotherapyType-eu-pcsp  | Radiotherapy Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sacrifiedOrgan-eu-pcsp  | Sacrified Organs (surgery) |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sct-prophylaxis-cathegory-eu-pcsp  | SCT Prophylaxis Cathegory |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sct-prophylaxis-type-eu-pcsp  | SCT Prophylaxis Type |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sct-type-eu-pcsp  | Stem Cell Transplantation type |
http://hmb.org/working/ValueSet/menstrual-regularity-findings  | Menstrual Regularity Findings |
http://hl7.org/fhir/uv/termchangeset/ValueSet/case-significance-vs  | Case Significance Value Set |
http://hl7.org/fhir/uv/termchangeset/ValueSet/defining-relationship-type-vs  | Defining Relationship Type Value Set |
http://hl7.org/fhir/uv/termchangeset/ValueSet/designation-acceptability-vs  | Designation Acceptability Value Set |
http://hl7.org/fhir/uv/termchangeset/ValueSet/dialect-vs  | Dialect Value Set |
http://hl7.org/fhir/uv/termchangeset/ValueSet/el-profile-set-operator-vs  | EL Profile Set Operator Value Set |
http://hl7.org/fhir/ValueSet/animal-breeds  | animal breeds |
http://hl7.org/fhir/ValueSet/animal-species  | animal species |
http://hl7.org/fhir/ValueSet/barrier  | Barrier |
http://hl7.org/fhir/ValueSet/condition-cause  | Condition Cause Codes |
http://hl7.org/fhir/ValueSet/condition-course  | Condition Course Codes |
http://hl7.org/fhir/ValueSet/condition-predecessor  | Condition Predecessor Codes |
http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclass  | DataElement SDC Object Class |
http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclassproperty  | DataElement SDC Object Class Property |
http://hl7.org/fhir/ValueSet/feeding-device  | Feeding Device Codes Value Set |
http://hl7.org/fhir/ValueSet/focal-subject  | Focal Subject Codes |
http://hl7.org/fhir/ValueSet/protective-factor  | Protective Factor |
http://hl7.org/fhir/ValueSet/specimen-additive-substance  | Specimen Additive Substance Codes |
http://fhir.ch/ig/ch-ig/ValueSet/ch-ig-example-sct  | CH IG Example SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10  | Non essential Hypertension SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.124  | Alcohol Brief Intervention and Counseling |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.511  | Ambulatory Blood Pressure Monitoring (ABPM) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.2  | Systolic blood pressure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.15  | Hospice care ambulatory |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.418  | Physical Activity Recommendations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.420  | Weight Reduction Recommendations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1195.111  | BMI Follow Up Plan SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.24  | Alcohol Abuse Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4012  | Hypertension |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.104.12.1016  | Hypertension |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.195.12.1003  | Counseling for Nutrition |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.422  | Tobacco User |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.590  | End Stage Renal Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.378  | Pregnancy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.509  | Tobacco Use Cessation Counseling |
http://fhir.org/guides/ohsuhypertensionig/ValueSet/conditions-related-to-antihypertensives  | Conditions Adversely Related to Antihypertensives |
http://hl7.org/fhir/uv/genomics-reporting/ValueSet/genetic-therapeutic-implications-vs  | Genetic Therapeutic Implications |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/bodyLandmarkDescriptionVS  | BodyLandmarkDescriptionvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/bodyLocationOrientationVS  | BodyLocationOrientationvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/bodyLocationQualifierVS  | BodyLocationQualifiervalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/bodySideVS  | BodySidevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/clockFacePositionVS  | ClockFacePositionValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/courseVS  | Coursevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/episodeVS  | Episodevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/periwoundConditionVS  | ReriwoundConditionvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/presentAbsentVS  | PresentAbsentValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/pressureUlcerAssociationVS  | PressureUlcerAssociationvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/qualitativeWoundDepthVS  | QualitativeWoundDepthvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/recurrenceVS  | Recurrencevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/surfaceOrientationVS  | SurfaceOrientationvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/trendVS  | Trendvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/underlyingAnatomicalStructureVS  | UnderlyingAnatomicalStructurevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundAnatomicLocationVS  | WoundAnatomicLocationvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundAssessmentInterpretationVS  | WoundAssessmentInterpretationvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundBedAppearanceVS  | WoundBedAppearanceValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundBedColorVS  | Wound Bed Color value set |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundEdgeColorVS  | WoundEdgeColorValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundEdgeDescriptionVS  | WoundEdgeDescriptionValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundExudateAmountDescriptionVS  | WoundExudateAmountDescriptionValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundExudateAppearanceVS  | WoundExudateAppearanceValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundExudateColorVS  | WoundExudateColorValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundExudateOdorVS  | WoundExudateOdorValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundGradationVS  | WoundGradationValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundInternalItemOrBodyStructureVisibleVS  | WoundInternalItemOrBodyStructureVisiblevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundMeasurementDeviceVS  | WoundMeasurementDeviceValueSet |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundShapeVS  | Wound Shape value set |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundTypeEtiologyVS  | WoundTypeEtiologyvalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/woundTypeVS  | CIMIWoundTypevalueset |
http://hl7.org/fhir/us/lower-extremity-skin-wound-assessment/ValueSet/yesNoVS  | YesNoValueSet |
http://fhir.hl7.nl/zorgviewer/ValueSet/ACPTreatmentCodelist  | ACP behandelingen waardelijst |
http://fhir.hl7.nl/zorgviewer/ValueSet/ProbleemNaamCodelist  | Zorgviewer probleem naam waardelijst |
http://fhir.hl7.nl/zorgviewer/ValueSet/SubjectRoleCodelist  | Subject rol (beroepen) waardelijst |
http://fhir.hl7.nl/zorgviewer/ValueSet/VerrichtingTypeCodelist  | Zorgviewer verrichting type waardelijst |
http://hl7.org/fhir/us/reportofilltraveler/ValueSet/InfectiousDiseaseVS  | Infectious Disease VS |
https://open-health-manager.github.io/standard-patient-health-record-ig/ValueSet/pcd-sleep-observation-code  | Patient contributed data: sleep observation code |
https://open-health-manager.github.io/standard-patient-health-record-ig/ValueSet/pcd-sleep-observation-value  | Patient contributed data: sleep stage value |
http://profiles.ihe.net/PCC/RIPT/ValueSet/RIPT.Medical.Necessity.VS  | Medical_Necessity_VS |
http://profiles.ihe.net/PCC/RIPT/ValueSet/RIPT.Reason.for.Interfacility.Transport.VS  | Reason_for_Interfacility_Transport_VS |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-body-position  | Body Position value set |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-bp-meas-body-location  | Blood Pressure Measurement Body Location Precoordinated value set |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-bp-meas-method  | Blood Pressure Measurement Method value set |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-bp-method  | FR Core ValueSet BP measurement method |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-heartrate-body-location  | Heart Rate Measurement Body Location Precoordinated value set |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-heartrate-measurement-method  | Heart Rate Measurement Method value set |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-height-body-position  | FR Core ValueSet BodyPosition |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-height-meas-method  | Height Length Measurement Method value set |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-respiratory-rate-meas-method  | Respiratory Rate Measurement Method value set |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-spo2-body-location  | Oxygen Saturation Body Location value set |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vsbody-temp-meas-body-location  | Body Temperature Measurement Body Location value set |
http://hl7.org/fhir/uv/saner/ValueSet/AllCOVID19RiskFactors  | All COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/COPDCOVID19RiskFactors  | COPD COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/COVID19Antibody  | COVID-19 Antibody |
http://hl7.org/fhir/uv/saner/ValueSet/COVID19Complications  | COVID-19 Complications |
http://hl7.org/fhir/uv/saner/ValueSet/COVID19DXSNOMED  | COVID-19 SNOMED |
http://hl7.org/fhir/uv/saner/ValueSet/COVID19Exposures  | COVID-19 Exposures |
http://hl7.org/fhir/uv/saner/ValueSet/COVID19Organism  | COVID-19 Organism |
http://hl7.org/fhir/uv/saner/ValueSet/CardiovascularCOVID19RiskFactors  | Cardiovascular COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/ConfirmedCOVID19Diagnoses  | Confirmed COVID-19 Diagnosis Values |
http://hl7.org/fhir/uv/saner/ValueSet/DiabetesCOVID19RiskFactors  | Diabetes COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/EventContext  | Event Context |
http://hl7.org/fhir/uv/saner/ValueSet/HypertensionCOVID19RiskFactors  | Hypertension COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/IsolationPrecautions  | COVID-19 Isolation Precautions |
http://hl7.org/fhir/uv/saner/ValueSet/KidneyDiseaseCOVID19RiskFactors  | Kidney Disease COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/NegativeResults  | COVID-19 Not Detected |
http://hl7.org/fhir/uv/saner/ValueSet/NeoplasticCOVID19RiskFactors  | Neoplastic COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/ObesityCOVID19RiskFactors  | Obesity COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/PositiveResults  | COVID-19 Detected |
http://hl7.org/fhir/uv/saner/ValueSet/PregnancyCOVID19RiskFactors  | Pregnancy COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/Remdesivir  | Remdesivir |
http://hl7.org/fhir/uv/saner/ValueSet/SickleCellCOVID19RiskFactors  | Sickle Cell COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/SuspectedCOVID19Diagnoses  | Suspected COVID19 Diagnoses |
http://hl7.org/fhir/uv/saner/ValueSet/SuspectedOrConfirmedCOVID19Diagnoses  | Suspected Or Diagnosed COVID-19 |
http://hl7.org/fhir/uv/saner/ValueSet/TobaccoCOVID19RiskFactors  | Tobacco COVID-19 Risk Factors |
http://hl7.org/fhir/uv/saner/ValueSet/VentilatorDevices  | Ventilator Devices |
http://hl7.org/fhir/uv/saner/ValueSet/VentilatorProcedures  | Ventilator Procedures |
https://nhicore.nhi.gov.tw/ci/ValueSet/body-site  | SNOMEDCT-健保重大傷病-身體部位值集 |
https://fhir.nw-gmsa.nhs.uk/ValueSet/document-entry-class  | DocumentEntry Class |
https://fhir.nw-gmsa.nhs.uk/ValueSet/document-entry-type  | DocumentEntry Type |
https://fhir.nw-gmsa.nhs.uk/ValueSet/ethnicity  | Ethnicity |
https://fhir.nw-gmsa.nhs.uk/ValueSet/specimen-type  | Specimen Type |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Advance.Directives.VS  | Advance Directives |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Antepartum.Education.VS  | Antepartum Education |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Antepartum.Family.History.and.Genetic.Screening.VS  | Antepartum Family History and Genetic Screening |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Antepartum.History.of.Infection.VS  | Antepartum History of Infection |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Antepartum.History.of.Past.Illness.VS  | Antepartum History of Past Illness |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Antepartum.Review.of.Systems.Menstrual.History.VS  | Antepartum Review of Systems Menstrual History |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Edema.VS  | Edema observation |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Fetal.Movement.VS  | Fetal Movement |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Fetal.Presentation.VS  | Fetal Presentation |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Presence.In.Urine.VS  | Presence In Urine |
https://profiles.ihe.net/PCC/mAPS/ValueSet/Smoking.Status.VS  | Smoking Status |
http://fkcfhir.org/fhir/ValueSet/fmc-allergy-code-vs  | Fresenius Allergy Code Value Set |
http://fkcfhir.org/fhir/ValueSet/fmc-sexual-orientation-vs  | Fresenius Sexual Orientation Value Set |
https://gematik.de/fhir/isik/ValueSet/ConditionDiagnosisSeverity  | ConditionDiagnosisSeverity |
https://gematik.de/fhir/isik/ValueSet/DiagnosesSCT  | DiagnosesSCT |
https://gematik.de/fhir/isik/ValueSet/EncounterReasonCodes  | EncounterReasonCodes |
https://gematik.de/fhir/isik/ValueSet/ISiKKernTempSctVS  | ISiK Kerntemperatur SnomedCT ValueSet |
https://gematik.de/fhir/isik/ValueSet/ISiKTerminPriority  | ISiKTerminPriority |
https://gematik.de/fhir/isik/ValueSet/ProzedurenCodesSCT  | ProzedurenCodesSCT |
https://gematik.de/fhir/isik/ValueSet/ProzedurenKategorieSCT  | ProzedurenKategorieSCT |
https://gematik.de/fhir/isik/ValueSet/SctRouteOfAdministration  | SctRouteOfAdministration |
https://gematik.de/fhir/isik/ValueSet/vs-mii-icu-bodysite-observation-blutdruck  | VS MII ICU BodySite Observation Blutdruck |
https://gematik.de/fhir/isik/ValueSet/vs-mii-icu-bodysite-observation-monitoring-und-vitaldaten  | VS MII ICU BodySite Observation Monitoring und Vitaldaten |
https://gematik.de/fhir/isik/ValueSet/vs-mii-icu-code-monitoring-und-vitaldaten-snomed  | VS MII ICU Code Monitoring und Vitaldaten [sct] |
https://gematik.de/fhir/isik/ValueSet/vs-mii-icu-method-observation-blutdruck  | VS MII ICU Method Observation Blutdruck |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-aviditaet-snomedct  | MII VS Mikrobio Aviditaet [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-eucast-snomedct  | MII VS Mikrobio EUCAST [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-kultur-methode-snomedct  | MII VS Mikrobio Kultur Methode[SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-mikroskopiemethoden-snomedct  | MII VS Mikrobio Mikroskopiemethoden [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-morphologie-snomedct  | MII VS Mikrobio Morphologie [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-mre-klasse-snomedct  | MII VS Mikrobio MRE Klasse [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-organismen-snomedct  | MII VS Mikrobio Organismen [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-positiv-negativ-snomedct  | MII VS Mikrobio Positiv Negativ [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-qualitative-labor-ergebnisse-snomedct  | MII VS Mikrobio Qualitative Labor Ergebnisse [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-voraussichtliche-empfindlichkeit-snomedct  | MII VS Mikrobio Voraussichtliche Empfindlichkeit [SNOMED CT] |
https://fhir.infoway-inforoute.ca/ValueSet/medicationreasoncode  | Medication Reason Code |
http://ontariohealth.ca/fhir/ehr/ValueSet/medication-repeat-pattern  | Medication Repeat Pattern |
https://fhir.infoway-inforoute.ca/ValueSet/pharmaceuticalbiologicproductandsubstancecode  | PharmaceuticalBiologicProductAndSubstanceCode |
http://ontariohealth.ca/fhir/ehr/ValueSet/practitioner-specialty  | Practitioner Specialty EHR |
https://fhir.infoway-inforoute.ca/ValueSet/prescribedquantityunit  | Prescribed Quantity Unit |
https://fhir.infoway-inforoute.ca/ValueSet/prescriptiondosequantityunit  | PrescriptionDoseQuantityUnit |
http://ontariohealth.ca/fhir/ehr/ValueSet/procedure-body-part  | Procedure Body Part EHR |
http://ontariohealth.ca/fhir/ehr/ValueSet/procedure-contrast-used  | Procedure Contrast Used EHR |
http://ontariohealth.ca/fhir/ehr/ValueSet/procedure-laterality  | Procedure Laterality EHR |
http://ontariohealth.ca/fhir/ehr/ValueSet/procedure-specialty  | Procedure Specialty EHR |
http://ontariohealth.ca/fhir/ehr/ValueSet/procedure-type-sct  | Procedure Type SNOMED CT EHR |
https://fhir.infoway-inforoute.ca/ValueSet/routeofadministration  | Route Of Administration |
https://gematik.de/fhir/epa-medication/ValueSet/epa-plan-composition-code-vs  | EPA Plan Composition Code ValueSet |
https://gematik.de/fhir/epa-medication/ValueSet/epa-plan-observation-list-code-vs  | EPA Observation List Code ValueSet |
https://fhir.kbv.de/ValueSet/KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Urgency  | KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Urgency |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_DPE_Declaration_Type  | Art der Erklärung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Implant  | Medizinprodukt |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Person_Institution  | BAI_ART |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Procedure  | Prozedur SNOMEDCT |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Reaction_Allergy  | Manifestation |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Runaway_Risk  | Weglaufgefährdung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Allergy_Substance  | Allergie Substanz |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_NFD_Communication_Disorder  | Kommunikationsstörung |
http://ehealthontario.ca/fhir/ValueSet/delivery-method  | DeliveryMethod |
http://ehealthontario.ca/fhir/ValueSet/facet  | Facet |
http://ehealthontario.ca/fhir/ValueSet/healthcareservice-categories  | HealthcareServiceCategories |
http://ontariohealth.ca/fhir/ValueSet/qualified-expertise-role-type  | QualifiedExpertiseRoleType |
http://kl.dk/fhir/common/caresocial/ValueSet/KLComplicationCodesSCT  | KLComplicationCodesSCT |
http://kl.dk/fhir/common/caresocial/ValueSet/KLEvaluationTypeCodesSCT  | KLEvaluationTypeCodesSCT |
http://kl.dk/fhir/common/caresocial/ValueSet/KLObservationCodes  | KLObservationCodes |
https://fhir.cohesiondata.com/clinemr/ValueSet/procedure-cohesion-category  | 中醫處置值集 |
https://fhir.cohesiondata.com/clinemr/ValueSet/treatment-region-sct-tw  | SNOMED CT + 臺灣診療部位值集 |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundgrund  | Wundgrund (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundrand  | Wundrand |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundumgebung  | Wundumgebung |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundlokalisation  | Lokalisation der Wunde (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Schmerzassessmentskalen  | Scores für Schmerzen |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundschmerz  | Wundbezogener Schmerz (VAS, SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Exsudatmenge  | Exsudatmenge (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Exsudatfarbe  | Exsudatfarbe (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Wundart  | Wundarten (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/WundVerband  | Wundverband (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Ernaehrungsstatus  | Ernährungsstatus |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Hilfsmittel  | Wundbezogene Hilfsmittel - Auswahl (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Immunstatus  | Status Immunsystem (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Bewusstseinslevel_qualitativ  | Bewusstseinslevel - qualitativ (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Bewusstseinslevel_quantitativ  | Bewusstseinslevel - quantitativ (SNOMED) |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/EducationCode  | Edukation Code |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/Laterality  | PosiThera - Laterality |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/ProcedureCategory  | Maßnahme - Kategorie |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/allergy-code  | Allergie Code |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/contentVerbalAssessment  | PosiThera - Inhalte verbaler Angaben |
http://hs-osnabrueck.de/fhir/eWundbericht/ValueSet/LowerLegBodyStructure  | Location of Ulcer |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-collection-method-snomed-ct  | MII VS Patho Collection Method [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-container-type-snomed-ct  | MII VS Patho Container Type [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-media-modality-snomed-ct  | MII VS Patho Media Modality [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-problem-list-snomed-ct  | MII VS Patho Problem List [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-processing-procedure-snomed-ct  | MII VS Patho Processing Procedure [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/ValueSet/mii-vs-patho-service-request-snomed-ct  | MII VS Patho Service Request [SNOMED CT] |
https://fhir.stichting-nice.nl/ValueSet/NICE-AdmitSource  | NICE-AdmitSource |
https://fhir.stichting-nice.nl/fhir/ValueSet/NICE-ConditionCodeList  | NICE-ConditionCodeList |
https://fhir.stichting-nice.nl/ValueSet/NICE-DischargeDisposition  | NICE-DischargeDisposition |
https://fhir.stichting-nice.nl/ValueSet/NICE-GeneralMeasurementCodeList  | NICE-GeneralMeasurementCodeList |
https://fhir.stichting-nice.nl/fhir/ValueSet/NICE-HospitalTypeCodelist  | NICE-HospitalTypeCodelist |
https://fhir.stichting-nice.nl/fhir/ValueSet/NICE-ProcedureCodeList  | NICE-ProcedureCodeList |
https://fhir.stichting-nice.nl/ValueSet/NICE-TreatmentCodelist  | NICE-TreatmentCodelist |
https://fhir.ee/ValueSet/guardian-status  | Guardian Status |
https://fhir.ee/ValueSet/person-relationship  | Person Relationship |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Allergy_Substance_SNOMED_CT  | Allergie Substanz SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Apgar_Score_Identifier_SNOMED_CT  | Apgar Score SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Apgar_Score_Value  | Apgar Score Wert |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Body_Weight_Method_SNOMED_CT  | Körpergewicht Methode Datenerhebung SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Device_SNOMED_CT  | Gerät SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Diagnosis_SNOMED_CT  | Diagnose SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Dose_Form_SNOMED_CT  | Darreichungsform SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Drug_Therapy_Status_Codes_SNOMED_CT  | Medikation Therapie Statuscodes SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Glucose_Concentration_Interpretation  | Glukosespiegel Interpretation |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Glucose_Concentration_Method_SNOMED_CT  | Glukosespiegel Methode SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Glucose_Concentration_SNOMED_CT  | Glukosespiegel SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Head_Circumference_BodySite_SNOMED_CT  | Head Circumference BodySite SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Medication_Type  | Arzneimittel/Rezeptur |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Nursing_Professions  | Pflegefachberufe SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_PRN_Medication_Reason_SNOMED_CT  | Bedarfsmedikation Bedingung SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Pain_Scale_SNOMED_CT  | Schmerzskala SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Practitioner_Speciality_SNOMED_CT  | Behandelnder SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Pregnancy_Status_Method_SNOMED_CT  | Schwangerschaftsstatus Methode SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Procedure_Categories_SNOMED_CT  | Prozeduren Kategorie SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Procedure_SNOMED_CT  | Prozedur SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Reaction_Allergy  | Manifestation SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Route_of_Administration_SNOMED_CT  | Verabreichungsweg SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Stage_Life  | Stage Life SNOMED CT® |
http://ehealthontario.ca/fhir/ValueSet/ppr-qualified-expertise-role-type  | QualifiedExpertiseRoleType |
http://ehealthontario.ca/fhir/ValueSet/service-category-eServices  | Service Category-eServices |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Apgar_Score_Identifier_Snomed  | KBV_VS_Base_Apgar_Score_Identifier_Snomed |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Body_Height_Snomed  | Koerpergroesse |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Body_Weight_Method_Snomed  | Koerpergroesse |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Body_Weight_Snomed  | Koerpergroesse |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Diagnose_Snomed_CT  | SNOMED CT Diagnosen |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Head_Circumference_BodySite_Snomed  | Körperstelle Kopfumfang |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Head_Circumference_Snomed  | KBV_VS_Base_Head_Circumference_Snomed |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Practitioner_Speciality_Addendum  | Rolle des Behandelnden |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Body_Temp_Snomed  | KBV_VS_Base_Body_Temp_Snomed |
https://fhir.kbv.de/ValueSet/KBV_VS_Base_Heart_Rate_Snomed  | KBV_VS_Base_Heart_Rate_Snomed |
http://hl7.org/fhir/uv/sdc/ValueSet/species  | Questionnaire Context Species |
https://demis.rki.de/fhir/ValueSet/answerSetAcuteHBVD  | Anwort akute Infektion aufgrund wessen bei Hepatitis B |
https://demis.rki.de/fhir/ValueSet/answerSetAcuteHCVD  | Anwort akute Infektion aufgrund wessen bei Hepatitis C |
https://demis.rki.de/fhir/ValueSet/answerSetCauseDiagnosisMYTD  | Anwort Anlass der Diagnose bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetCoinfectionHDVD  | Anwort Koinfektion mit Hepatitis B bei Hepatitis D |
https://demis.rki.de/fhir/ValueSet/answerSetConservationCLOD  | Antwort zur Art der Lebensmittelkonservierung bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetConsumptionCLOD  | Antwort zum Ort des Verzehrs bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetDiagnosisCJKD  | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)" |
https://demis.rki.de/fhir/ValueSet/answerSetFoodCLOD  | Antwort zum verzehrten Lebensmittel bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetFormBAND  | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Milzbrand" |
https://demis.rki.de/fhir/ValueSet/answerSetFormCDFD  | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Clostridioides-difficile-Erkrankung, schwere Verlaufsform" |
https://demis.rki.de/fhir/ValueSet/answerSetFormCJKD  | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)" |
https://demis.rki.de/fhir/ValueSet/answerSetFormCLOD  | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Botulismus" |
https://demis.rki.de/fhir/ValueSet/answerSetFormCORD  | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Diphtherie" |
https://demis.rki.de/fhir/ValueSet/answerSetFormMYBD  | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Tuberkulose, bei Behandlungsabbruch" |
https://demis.rki.de/fhir/ValueSet/answerSetFormYPSD  | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Pest" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionAnimalWhereHUSD  | Anwort Tierkontakt wo bei Hämolytisch-urämisches Syndrom (HUS) |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionEnvironmentSettingCVDD  | Antwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionEnvironmentSettingMYTD  | Antwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Tuberkulose" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathCJKD  | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Creutzfeldt-Jakob-Krankheit (CJK)" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHAVD  | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis A" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHBVD  | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis B" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHCVD  | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis C" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHEVD  | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis E" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHUSD  | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathIZVD  | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Zoonotische Influenza" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathMPXD  | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Mpox" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathOPXD  | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Orthopocken, andere" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathWhoHUSD  | Antwortmöglichkeiten zur Angabe der Person, bei der sich infiziert wurde, bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalHEVD  | Antwort zu Tierkontakt bei Hepatitis E |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalHUSD  | Antwort zu Tierkontakt bei Hämolytisch-urämisches Syndrom (HUS) |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalRBVD  | Antwort zu Tierkontakt bei Tollwut |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalTTVD  | Antwort zu Tierkontakt bei Tollwutexpositionsverdacht |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskCVDD  | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskIZVD  | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Zoonotische Influenza" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskJobHEVD  | Antwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hepatitis E" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskJobHTVD  | Antwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hantavirus-Erkrankung, hämorrhagischer Verlauf" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskNEID  | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Meningokokken, invasive Erkrankung" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskOtherHEVD  | Antwort zu Sonstiger Kontakt bei Hepatitis E |
https://demis.rki.de/fhir/ValueSet/answerSetLocationLymphNodeSwellingMPXD  | Anwort Lokalisation der Lymphknotenschwellung bei Mpox |
https://demis.rki.de/fhir/ValueSet/answerSetLocationMucosalLesionsMPXD  | Anwort Lokalisation der Schleimhautläsionen bei Mpox |
https://demis.rki.de/fhir/ValueSet/answerSetLocationSkinLesionsMPXD  | Anwort Lokalisation der Hautläsionen bei Mpox |
https://demis.rki.de/fhir/ValueSet/answerSetMajorSiteMYTD  | Anwort hauptsächlich betroffenes Organ bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetManufacturingCLOD  | Antwort zur Art der Lebensmittelherstellung bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetMethodCDFD  | Antwortmöglichkeiten für die Angabe der Nachweismethode der Clostridioides-difficile-Erkrankung, schwere Verlaufsform |
https://demis.rki.de/fhir/ValueSet/answerSetMinorSiteMYTD  | Anwort weiteres betroffenes Organ bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetPathogenHFAD  | Antwortmöglichkeiten zur Angabe des Erregers bei dem Meldetatbestand "Hämorrhagisches Fieber" |
https://demis.rki.de/fhir/ValueSet/answerSetResultOfPrevTreatmentMYTD  | Anwort Ergebnis der Vorbehandlung bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetResultOfTreatmentMYTD  | Anwort Behandlungsergebnis bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetStadiumHBVD  | Anwort Stadium der Infektion bei Hepatitis B |
https://demis.rki.de/fhir/ValueSet/answerSetStadiumHCVD  | Anwort Stadium der Infektion bei Hepatitis C |
https://demis.rki.de/fhir/ValueSet/answerSetTransmissionKindHBVD  | Antwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis B |
https://demis.rki.de/fhir/ValueSet/answerSetTransmissionKindHCVD  | Antwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis C |
https://demis.rki.de/fhir/ValueSet/answerSetTrimester  | Antwort zum Trimester |
https://demis.rki.de/fhir/ValueSet/diagnosisHXXD  | Antwortmöglichkeiten für die Angabe einer Diagnose bei dem Meldetatbestand "Akute Virushepatitis" |
https://demis.rki.de/fhir/ValueSet/diagnosisSXXD  | Antwortmöglichkeiten für die Angabe einer Diagnose bei dem Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
https://demis.rki.de/fhir/ValueSet/evidenceBAND  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Milzbrand" |
https://demis.rki.de/fhir/ValueSet/evidenceBPSD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Keuchhusten" |
https://demis.rki.de/fhir/ValueSet/evidenceCLOD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Botulismus" |
https://demis.rki.de/fhir/ValueSet/evidenceCORD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Diphtherie" |
https://demis.rki.de/fhir/ValueSet/evidenceCVDD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
https://demis.rki.de/fhir/ValueSet/evidenceCVDDv1  | Coronavirus-Krankheit-2019 (COVID-19) -Symptom und -Manifestation Version 1 |
https://demis.rki.de/fhir/ValueSet/evidenceDEND  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Denguefieber" |
https://demis.rki.de/fhir/ValueSet/evidenceEBVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Ebolafieber" |
https://demis.rki.de/fhir/ValueSet/evidenceGFVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Gelbfieber" |
https://demis.rki.de/fhir/ValueSet/evidenceHAVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis A" |
https://demis.rki.de/fhir/ValueSet/evidenceHBVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis B" |
https://demis.rki.de/fhir/ValueSet/evidenceHCVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis C" |
https://demis.rki.de/fhir/ValueSet/evidenceHDVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis D" |
https://demis.rki.de/fhir/ValueSet/evidenceHEVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis E" |
https://demis.rki.de/fhir/ValueSet/evidenceHFAD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hämorrhagisches Fieber" |
https://demis.rki.de/fhir/ValueSet/evidenceHTVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hantavirus-Erkrankung, hämorrhagischer Verlauf" |
https://demis.rki.de/fhir/ValueSet/evidenceHUSD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
https://demis.rki.de/fhir/ValueSet/evidenceHXXD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Akute Virushepatitis" |
https://demis.rki.de/fhir/ValueSet/evidenceIZVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Zoonotische Influenza" |
https://demis.rki.de/fhir/ValueSet/evidenceLSVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Lassafieber" |
https://demis.rki.de/fhir/ValueSet/evidenceMBVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Marburgfieber" |
https://demis.rki.de/fhir/ValueSet/evidenceMPVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Mumps" |
https://demis.rki.de/fhir/ValueSet/evidenceMPXD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Mpox" |
https://demis.rki.de/fhir/ValueSet/evidenceMSVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Masern" |
https://demis.rki.de/fhir/ValueSet/evidenceNEID  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Meningokokken, invasive Erkrankung" |
https://demis.rki.de/fhir/ValueSet/evidenceOPXD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Orthopocken, andere" |
https://demis.rki.de/fhir/ValueSet/evidencePKVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Pocken" |
https://demis.rki.de/fhir/ValueSet/evidencePOVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Poliomyelitis" |
https://demis.rki.de/fhir/ValueSet/evidenceRBVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Tollwut" |
https://demis.rki.de/fhir/ValueSet/evidenceRUND  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Röteln, konnatal" |
https://demis.rki.de/fhir/ValueSet/evidenceRUVD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Röteln, postnatal" |
https://demis.rki.de/fhir/ValueSet/evidenceSPAD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Paratyphus" |
https://demis.rki.de/fhir/ValueSet/evidenceSSPD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Subakute sklerosierende Panenzephalitis (SSPE)" |
https://demis.rki.de/fhir/ValueSet/evidenceSTYD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Typhus" |
https://demis.rki.de/fhir/ValueSet/evidenceSXXD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
https://demis.rki.de/fhir/ValueSet/evidenceVCHD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Cholera" |
https://demis.rki.de/fhir/ValueSet/evidenceVZWD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Windpocken" |
https://demis.rki.de/fhir/ValueSet/evidenceVZZD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Herpes Zoster" |
https://demis.rki.de/fhir/ValueSet/evidenceYPSD  | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Pest" |
https://demis.rki.de/fhir/ValueSet/vaccineBAND  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Milzbrand" |
https://demis.rki.de/fhir/ValueSet/vaccineBPSD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Keuchhusten" |
https://demis.rki.de/fhir/ValueSet/vaccineCDFD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Clostridioides-difficile-Erkrankung, schwere Verlaufsform" |
https://demis.rki.de/fhir/ValueSet/vaccineCORD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Diphtherie" |
https://demis.rki.de/fhir/ValueSet/vaccineCVDD-SNOMED  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" als SNOMED-Code |
https://demis.rki.de/fhir/ValueSet/vaccineDEND  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Denguefieber" |
https://demis.rki.de/fhir/ValueSet/vaccineEBVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Ebolafieber" |
https://demis.rki.de/fhir/ValueSet/vaccineGFVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Gelbfieber" |
https://demis.rki.de/fhir/ValueSet/vaccineHAVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis A" |
https://demis.rki.de/fhir/ValueSet/vaccineHBVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis B" |
https://demis.rki.de/fhir/ValueSet/vaccineHDVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis D" |
https://demis.rki.de/fhir/ValueSet/vaccineHEVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis E" |
https://demis.rki.de/fhir/ValueSet/vaccineHXXD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Akute Virushepatitis" |
https://demis.rki.de/fhir/ValueSet/vaccineIZVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Zoonotische Influenza" |
https://demis.rki.de/fhir/ValueSet/vaccineMPVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mumps" |
https://demis.rki.de/fhir/ValueSet/vaccineMPXD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mpox" |
https://demis.rki.de/fhir/ValueSet/vaccineMSVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Masern" |
https://demis.rki.de/fhir/ValueSet/vaccineMYTD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tuberkulose" |
https://demis.rki.de/fhir/ValueSet/vaccineNEID  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Meningokokken, invasive Erkrankung" |
https://demis.rki.de/fhir/ValueSet/vaccinePKVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Pocken" |
https://demis.rki.de/fhir/ValueSet/vaccinePOVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Poliomyelitis" |
https://demis.rki.de/fhir/ValueSet/vaccineRBVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwut" |
https://demis.rki.de/fhir/ValueSet/vaccineRUVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Röteln, postnatal" |
https://demis.rki.de/fhir/ValueSet/vaccineSSPD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Subakute sklerosierende Panenzephalitis (SSPE)" |
https://demis.rki.de/fhir/ValueSet/vaccineSTYD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Typhus" |
https://demis.rki.de/fhir/ValueSet/vaccineSXXD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
https://demis.rki.de/fhir/ValueSet/vaccineTTVD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwutexpositionsverdacht" |
https://demis.rki.de/fhir/ValueSet/vaccineVCHD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Cholera" |
https://demis.rki.de/fhir/ValueSet/vaccineVZWD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Windpocken" |
https://demis.rki.de/fhir/ValueSet/vaccineVZZD  | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Herpes Zoster" |
http://fhir.laniado.org.il/ValueSet/demog-alert-code  | Demog Alert Code |
http://fhir.laniado.org.il/ValueSet/encounter-department-type  | Encounter Department Type |
http://fhir.hie.moh.gov.my/ValueSet/adverse-event-event-my-core  | ValueSetAdverseEventEvent (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/allergy-manifestation-my-core  | value-set-allergy-manifestation-my-core |
http://fhir.hie.moh.gov.my/ValueSet/allergy-negation-my-core  | ValueSetAllergyNegation (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/child-identification-type-my-core  | ValueSetChildIdentificationType (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/developmental-milestone-my-core  | ValueSetDevelopmentalMilestone (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/glucose-level-my-core  | ValueSetGlucoseLevel(MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/observation-glucose-my-core  | ValueSetObservationGlucose (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/observation-social-history-my-core  | ValueSetObservationSocialHistory (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/procedure-category-my-core  | ValueSetProcedureCategory (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/procedure-code-my-core  | ValueSetProcedureCode (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/side-my-core  | ValueSetSide (MY Core) |
http://fhir.hie.moh.gov.my/ValueSet/site-my-core  | ValueSetSite (MY Core) |
https://gematik.de/fhir/isik/v3/Basismodul/ValueSet/DiagnosesSCT  | DiagnosesSCT |
https://gematik.de/fhir/isik/v3/Basismodul/ValueSet/ProzedurenCodesSCT  | ProzedurenCodesSCT |
https://gematik.de/fhir/isik/v3/Basismodul/ValueSet/ProzedurenKategorieSCT  | ProzedurenKategorieSCT |
https://www.medizininformatik-initiative.de/fhir/ext/modul-bildgebung/ValueSet/mii-vs-bildgebung-diagnostic-report-coding  | MII VS Bildgebung DiagnosticReport Coding |
https://www.medizininformatik-initiative.de/fhir/ext/modul-bildgebung/ValueSet/mii-vs-bildgebung-service-request-coding  | MII VS Bildgebung ServiceRequest Coding |
https://www.medizininformatik-initiative.de/fhir/ext/modul-bildgebung/ValueSet/mii-vs-bildgebung-service-request-reason  | MII VS Bildgebung ServiceRequest Reason |
https://www.ehealth.fgov.be/standards/fhir/public-health/ValueSet/BeVSPopulationScreeningFollowUpAdvice  | Population Screening Follow-up Advice Value Set |
https://www.ehealth.fgov.be/standards/fhir/public-health/ValueSet/be-populationscreening-result-vs  | PopulationScreening Result Value Set |
https://www.ehealth.fgov.be/standards/fhir/public-health/ValueSet/be-vs-populationscreening-type  | Population Screening Type Value Set |
https://www.ehealth.fgov.be/standards/fhir/public-health/ValueSet/be-vspopulationscreening-body-site-location  | PopulationScreening Body Site Value Set |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.42.11.3--20241004140515  | StatusCategorieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.42.11.2--20241003115148  | VerrichtingCategorieCodelijst |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-cd-common-chronic-disease-name-sct-local  | NFDI4Health CD Common Chronic Disease Name [SNOMED CT, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-ne-device-nci-snomedct-local  | NFDI4Health NE Device [NCI, SNOMED CT, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-ne-portion-size-snomedct-local  | NFDI4Health NE Portion Size [SNOMED CT, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-ne-reference-period-unit-sct  | NFDI4Health NE Portion Size [SNOMED CT] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-role-name-type-snomed  | NFDI4Health VS MDS Role Name Type [SNOMED] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-assessments-sct-nci  | NFDI4Health VS MDS Study Assessments [SCT, NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-centers-snomedct-local  | NFDI4Health VS MDS Study Centers [SNOMED CT, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-data-sharing-plan-ds-sct-nci  | NFDI4Health VS MDS Study Data Sharing Plan Datashield [SCT, NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-diseases-generally-icd-sct  | NFDI4Health VS MDS Study Groups Of Diseases Generally [ICD 10, SCT] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-ds-biosamples-sct-nci  | NFDI4Health VS MDS Study Data Sources Biosamples [SCT, NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-eligibility-gender-snomedct-local  | NFDI4Health VS MDS Study Eligibility Criteria Genders [local, SNOMED CT] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-recruitment-register-nci-sct-local  | NFDI4Health VS MDS Study Recruitment Register [NCI, SCT, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-subject-snomedct  | NFDI4Health VS MDS Study Subject [SNOMED CT] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-use-rights-label-spdx-smomed-local  | NFDI4Health VS MDS Use Rights Label [SPDX, SNOMED, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-yes-no-not-applicable-snomedct  | NFDI4Health VS MDS Yes, No, Not Applicable [SNOMED CT] |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_LAB_Body_Site  | Körperstelle |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_LAB_Device_Type  | Gerät |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_LAB_ELGA_Specimen_Type_SNOMED  | ELGA Probenart SNOMED |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_LAB_Specimen_Collection_Method  | Probenentnahme-Methode |
http://fhir.smart4health.eu/ValueSet/s4h-back-pain-location  | S4hBackPainLocation |
http://ontariohealth.ca/fhir/ValueSet/language-use  | Language Use |
http://ontariohealth.ca/fhir/ValueSet/personal-income-source  | Personal Income Source |
http://ontariohealth.ca/fhir/ValueSet/pre-existing-conditions  | Pre-existing Conditions |
http://ontariohealth.ca/fhir/ValueSet/service-termination-reason  | Service Termination Reason |
http://ontariohealth.ca/fhir/ValueSet/mha/citizenshipStatus  | Citizenship Status |
http://ontariohealth.ca/fhir/ValueSet/sdohObservationCode  | SDOH Observation Code |
http://ontariohealth.ca/fhir/ValueSet/employment-status  | Employment Status |
http://ontariohealth.ca/fhir/ValueSet/highest-level-of-education-attained  | Highest Level of Education Attained |
http://ontariohealth.ca/fhir/ValueSet/sexual-orientation  | Sexual Orientation |
http://fhir.de/ValueSet/EkgAbleitungenVS  | SNOMED CT codes der EKG Ableitungen |
http://fhir.de/ValueSet/VitalSignDE-Atemfrequenz-SNOMED-CT  | VitalSignDE_Atemfrequenz_SNOMED_CT |
http://fhir.de/ValueSet/VitalSignDE-Herzfrequenz-SNOMED-CT  | VitalSignDE_Herzfrequenz_SNOMED_CT |
http://fhir.de/ValueSet/VitalSignDE-Koerpergewicht-SNOMED-CT  | VitalSignDE_Koerpergewicht_SNOMED_CT |
http://fhir.de/ValueSet/VitalSignDE-Koerpergroesse-SNOMED-CT  | VitalSignDE_Koerpergroesse_SNOMED_CT |
http://fhir.de/ValueSet/VitalSignDE-Koerpertemperatur-SNOMED-CT  | VitalSignDE_Koerpertemperatur_SNOMED_CT |
http://fhir.de/ValueSet/VitalSignDE-Kopfumfang-SNOMED-CT  | VitalSignDE_Kopfumfang_SNOMED_CT |
http://fhir.de/ValueSet/VitalSignDE-Sauerstoffsaettigung-SNOMED-CT  | VitalSignDE_Sauerstoffsaettigung_SNOMED_CT |
http://fhir.de/ValueSet/lebensphase-de  | LebensphaseDe ValueSet |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_Snomed  | Art der Immunreaktion SCT2 |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_Tuberculin  | Tuberkulin-Test |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_Vaccination_Lab_Titer_Immunity  | Titer Immunität |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_Vaccination_Practitioner_Speciality_Addendum  | KBV_VS_MIO_Vaccination_Practitioner_Speciality_Addendum |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_Vaccination_Prior_Disease  | VaccinationrelevantDisease |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_Vaccination_Source_of_Information  | Source_of_Information |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_Vaccination_TargetDisease  | TargetDisease |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_Vaccination_Vaccine_Brucella  | Vaccine_Brucella |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_Vaccination_Vaccine_Immunoglobulin_List  | Immunglobulin |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_Vaccination_Vaccine_List  | Vaccine |
https://gematik.de/fhir/ISiK/ValueSet/DiagnosesSCT  | DiagnosesSCT |
https://gematik.de/fhir/ISiK/ValueSet/ProzedurenCodesSCT  | ProzedurenCodesSCT |
https://gematik.de/fhir/ISiK/ValueSet/ProzedurenKategorieSCT  | ProzedurenKategorieSCT |
http://hl7.org/fhir/us/breastcancer/ValueSet/cimi-context-DeltaFlagVS  | BC DeltaFlagVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/cimi-context-PresenceContextVS  | BC PresenceContextVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/cimi-element-AnatomicalLocationVS  | BC AnatomicalLocationVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-BreastCancerDetectionVS  | BC BreastCancerDetectionVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-BreastCarcinomaHistologicTypeVS  | BC BreastCarcinomaHistologicTypeVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-BreastLymphNodeGroupVS  | BC BreastLymphNodeGroupVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-BreastSiteVS  | BC BreastSiteVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-BreastSpecimenCollectionMethodVS  | BC BreastSpecimenCollectionMethodVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-BreastSpecimenTypeVS  | BC BreastSpecimenTypeVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-DCISNuclearGradeVS  | BC DCISNuclearGradeVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-HER2FISHMethodVS  | BC HER2FISHMethodVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-Ki-67NuclearAntigenVS  | BC Ki-67NuclearAntigenVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-LymphNodeClinicalMethodVS  | BC LymphNodeClinicalMethodVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-LymphNodeInvolvementVS  | BC LymphNodeInvolvementVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-LymphNodeMobilityVS  | BC LymphNodeMobilityVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-LymphNodeSamplingMethodVS  | BC LymphNodeSamplingMethodVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-MorphologyBehaviorVS  | BC MorphologyBehaviorVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-StainingIntensityVS  | BC StainingIntensityVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-TumorMarginDescriptionVS  | BC TumorMarginDescriptionVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/shr-core-ClockDirectionVS  | BC ClockDirectionVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/shr-core-PositiveNegativeEquivocalIndeterminateVS  | BC PositiveNegativeEquivocalIndeterminateVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/shr-core-PositiveNegativeIndeterminateVS  | BC PositiveNegativeIndeterminateVS ValueSet |
http://hl7.org/fhir/us/breastcancer/ValueSet/shr-core-PositiveNegativeVS  | BC PositiveNegativeVS ValueSet |
http://nictiz.nl/fhir/ValueSet/HCIMLegalSituationCategory  | HCIM LegalSituation Category |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.6.4--20200901000000  | RedenVanToepassenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.6.1--20200901000000  | SoortInterventieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.6.2--20200901000000  | SoortInterventieWvggzCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.6.3--20200901000000  | SoortInterventieWzdCodelijst |
https://acticore.com/fhir/ValueSet/ActicoreTherapieTyp  | Acticore Therapie-Typen |
http://ontariohealth.ca/fhir/ValueSet/anaesthesia-type  | Anaesthesia Type |
http://ontariohealth.ca/fhir/ValueSet/hospital-service  | Hospital Service |
http://example.org/fhir/ValueSet/lateralizable-body-structure-vs  | Lateralizable Body Structure |
http://ontariohealth.ca/fhir/ValueSet/observation-types  | Observation Types |
http://ontariohealth.ca/fhir/ValueSet/procedure-complication  | Procedure Complication |
http://ontariohealth.ca/fhir/ValueSet/Race  | Race |
https://fhir.infoway-inforoute.ca/ValueSet/prescriptiondrugform  | PrescriptionDrugForm |
http://ontariohealth.ca/fhir/ValueSet/GenderIdentity  | Gender Identity |
http://ontariohealth.ca/fhir/ValueSet/IndigenousIdentity  | Indigenous Identity |
http://snomed.info/sct?fhir_vs=refset/723264001  | SNOMED CT Reference Set 723264001 |
https://fhir.nottinghamshire.gov.uk/STU3/valueset/SHD-ReferralRequestType  | SHD-ReferralRequestType |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.254--20200406100640  | a terme datum obv (23) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.355--20220117102535  | AanUitKleden_GZ |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.265--20210525145536  | Aanvang Probleem |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.285--20200616133418  | Ademhaling |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.214--20160125115042  | Specificatie van de afwijking van placenta en/of vliezen en/of navelstreng (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.19--20141222113040  | AmniotomieMoment |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.31--20140922095444  | Anemie (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.28--20140919141340  | Auto-immuun aandoening (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.2.2.1--20200901000000  | BehandelingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.317--20210322154057  | BeleidProfessioneelOnderzoek 3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.14.1--20200901000000  | BepalingsMethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.341--20210225105013  | BetrokkenheidKinderarts |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.260--20200407134908  | Bevinding_Hart |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.323--20201124142938  | Bevindingen borsten 3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.264--20200409090337  | Beweging |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.309--20210128112703  | Blood Group Antibodies 3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.11--20140814133240  | Cardiovasculaire aandoeningen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.175--20130422173433  | Cervical dilatation |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.175--20201210140135  | Cervical dilatation |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.158--20120317000000  | Cervix Effacement |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.158--20201210134951  | Cervix Effacement |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.198--20161026164418  | ChromosomaleAfwijkingen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.230--20170201162016  | Compleetheid vliezen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.160--20120317000000  | Completeness placenta |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.310--20210201115558  | ConclusieProfessioneelOnderzoek 3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.294--20200129150958  | ConclusieUterusContracties |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.315--20210222102852  | Conditie Sfincter (3.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.368--20220210155748  | Conditie Perineum Observatie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.354--20220110114406  | Conditie VrouwelijkeGeslachtsorganen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.192--20140122110447  | Conditie perineum (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.301--20200901151615  | Conditie perineum (3.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.196--20191010091229  | Congenitale afwijking |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.284--20200610131200  | ContactSoort |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.324--20201124152403  | Controle benen 3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.322--20201124115905  | Controle borsten 3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.279--20191118174055  | ControleNavelstomp |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.290--20200622000000  | Controle perineum |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.295--20200129154254  | DeceleratiesCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.357--20220117103812  | Douchen_GZ |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.321--20210412154013  | Echelon_3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.251--20181119182547  | Ernst van de aandoening |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.351--20211214145747  | Eten_GZ |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.297--20200129155847  | FIGO_ScoreCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.10--20201117115600  | Fase Perinatale Sterfte (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.15.1--20171231000000  | FecesContinentieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.207--20201112144120  | Leven voelen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.296--20200129155035  | FoetaleHartslagVariabiliteit |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.298--20200129160647  | FoetaleMonitoringMethode |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.299--20200129162827  | FoetaleMonitoringMoment |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.227--20170201134622  | Foliumzuur gebruik |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.235--20170203161446  | Frequentie hartslag |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.226--20161216162923  | Fundusstand (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.246--20191028105919  | Fundusstand Kraamzorg |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.313--20210210164932  | Geboorte Placenta 3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.37--20141020151252  | Groei afwijkend |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.16--20140814134544  | Gynaecologische aandoeningen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.236--20170203161659  | Hartactie op basis van |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.159--20120317000000  | Hodge Planes |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.159--20210621112616  | Hodge Planes |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.274--20200512160326  | Huilgedrag baby |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.36--20141020145518  | Hypertensieve aandoening |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.223--20161202162349  | IUVD methode |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.320--20201112155937  | Indaling (3.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.204--20141021114554  | Infectie (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.15--20140814134341  | Infectieziekten |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.291--20200129144103  | IntensiteitUterusContracties |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.15.2.1--20200901000000  | IntentieBehandelingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.189--20140120142052  | Interventie begin baring (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.26--20140919115814  | Intra-uteriene behandeling (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.266--20200414155952  | KeuzeTest |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.20--20210222094051  | KleurVruchtwater |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.20.7.2--20200901000000  | LateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.188--20140102000000  | Ligging |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.177--20131224000000  | LiggingBijGeboorte22 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.287--20200619144804  | Lochia |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.205--20141027141746  | Longaandoening |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.29--20140919144015  | Maag Darm Lever aandoening (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.282--20200526172902  | MeetMethode_GZ |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.258--20200406134703  | Methode_1e_trimester_SEO |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.226--20180816141641  | MicroorganismeCongInfectCodelijst_LNR |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.249--20191205111425  | MicroorganismeSepsisMeningCodelijst_LNR |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.353--20211214152957  | Mobiliteit_GZ |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.231--20170201164126  | Navelstreng vaten |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.14--20140814134140  | Neurologische aandoeningen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.337--20201207162228  | ObservatieKind_Abdomen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.339--20201208105521  | ObservatieKind_Extremiteiten |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.335--20201203120002  | ObservatieKind_Genitalia |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.326--20201201113630  | ObservatieKind_Hoofd-Hals |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.305--20200921120509  | ObservatieKind_Huid |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.340--20201208121209  | ObservatieKind_Neurologie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.338--20201208102213  | ObservatieKind_Rug |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.328--20201201152903  | ObservatieKind_Thorax |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.27--20140919131821  | Oncologische aandoening (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.229--20181012134434  | Ondersteuning_Ontslag_Huis |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.255--20200406115120  | Onderzoektype |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.283--20200101130352  | OnsetCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.265--20200409144953  | Ontlasting zuigeling |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.369--20220214141440  | Opname Indicatie Kind (3.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.322--20210506140617  | OrgaansysteemFoetus |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.17--20140814134642  | Orthopedische afwijkingen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.272--20190925122834  | Ostium |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.20--20161123204523  | Overige interventies |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.195--20140102000000  | Partus stadium |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.202--20161123213413  | Pediatrische verwijsindicatie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.342--20210225121553  | PlacentaCompleet (3.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.209--20141128125356  | Placentalokalisatie (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.213--20160425122048  | Positie portio (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.34--20191218092252  | Postpartum complicatie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.34--20210413094135  | Postpartum complicatie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.172--20130320000000  | Presentation of fetus |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.172--20201210141721  | Presentation of fetus |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.3--20171231000000  | ProbleemNaamCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.337--20210628164200  | ProbleemNaam_AcuteOverdracht |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.328--20210520161536  | ProbleemNaam_Congenitale Afwijking Obstetrie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.298--20200824133956  | ProbleemNaam CongenitaleAfwijking Pediatrie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.299--20200824154514  | ProbleemNaam CongenitaleAfwijking Kraam |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.327--20210518144535  | ProbleemNaam_Geboortetrauma (Kraam) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.326--20210518125239  | ProbleemNaam_Geboortetrauma (Obstetrie) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.296--20200811105755  | ProbleemNaam_Geboortetrauma (Pediatrie) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.313--20201027113825  | ProbleemNaam_Hb-pathie (3.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.319--20210323153828  | ProbleemNaam_HuidBaby |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.358--20220117155944  | ProbleemNaam_InfectiesGezin |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.304--20200213111855  | ProbleemNaam_KindspecifiekMaternaal |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.289--20200127101358  | ProbleemNaam_Maternaal |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.325--20210518104806  | ProbleemNaam_Probleem Kind (Kraam) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.324--20210518101158  | ProbleemNaam_Probleem Kind (Obstetrie) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.295--20200810122858  | ProbleemNaam_Problematiek Kind (Pediatrie) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.231--20220120134819  | ProbleemNaam_Zintuigen (Neonatologie) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.302--20200211092928  | ProbleemNaam_Zwangerschap |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20210329100741  | ProbleemTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.12--20191009125104  | Problematiek kind |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.153--20120829000000  | Categorie Reden overdracht |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.234--20170203161304  | Regelmaat hartslag |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.292--20200129145703  | RegelmatigheidUterusActiviteit |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.219--20161124113309  | Indicatie secundaire sectio |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.220--20180228115805  | SC Indicatie - primaire sectio |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.370--20220221143159  | SchedelCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.13--20140814134002  | Schildklieraandoeningen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.323--20210506154515  | Sonomarkers 3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.284--20200103125137  | SpugenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.174--20151019205620  | Stand |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20171231000000  | TabakGebruikStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.350--20211214144904  | ToiletGebruik_GZ |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.352--20211214151241  | Transfer_GZ |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.356--20220117103400  | TrappenLopen_GZ |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.310--20201006145809  | TweelingzwangerschapType |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.18--20140814143051  | Type operatie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.182--20200811153819  | TypePartus |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.19--20140814144207  | Type stollingsprobleem |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.221--20161201112008  | Type verwijzing |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.348--20211101122336  | TypeVerwijzing_3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.21--20160108110123  | Type vrouwelijke genitale verminking |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.275--20200513143542  | Type Biologische Relatie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.250--20181119171538  | Type anticonceptie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.349--20211214143820  | UiterlijkeVerzorging_GZ |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.14.1--20171231000000  | UrineContinentieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.291--20200623135655  | Urine baby |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.30--20200114155725  | Urogenitale aandoening (2.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.293--20200129150222  | UterusActiviteitMethode |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.181--20140102000000  | VaginaleKunstverlossing22 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.253--20200401105232  | Verdenking Afwijking Hersenen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.283--20200527093520  | Verdenking Afwijking Wervelkolom Ruggemerg |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.359--20220131105223  | Verdenking Afwijking Aangezicht |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.363--20220131112406  | Verdenking Afwijking Buikwand |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.362--20220131111328  | Verdenking Afwijking Diafragma |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.367--20220131120004  | Verdenking Afwijking Extremiteiten |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.364--20220131113252  | Verdenking Afwijking MaagDarm |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.360--20220131110025  | Verdenking Afwijking Nek/Huid |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.365--20220131114808  | Verdenking Afwijking NierenBlaasUrogenitalis |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.366--20220131115327  | Verdenking_Afwijking_SkeletSpierstelsel |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.361--20220131110815  | Verdenking Afwijking ThoraxLuchtwegen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.1.1--20171231000000  | VerrichtingAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.1.3--20171231000000  | VerrichtingLateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.1.4--20171231000000  | VerrichtingMethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.375--20220321094419  | VerrichtingTypeGeboortezorgCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.333--20210615102522  | VerrichtingType_ChirurgischeIngrepen_3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.288--20200123134654  | VerrichtingType_Kindspecifiek |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.303--20200213102349  | VerrichtingType_Maternaal |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.329--20210525162006  | VerrichtingType_ProblematiekKind |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.307--20200226094046  | VerrichtingType_Zwangerschap |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.173--20201210140520  | Vliezen |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.249--20181119171103  | Vloeien |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.331--20210607115708  | VoedingSoort_GZ |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.319--20201112122448  | VoorgenomenPlaatsBaring (3.2) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.228--20170201140644  | Voorgenomen voeding |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.191--20140121165337  | Vruchtwater |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.178--20131230000000  | WerkelijkePlaatsBaring22 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.321--20201117110614  | Werkelijke plaats baring 3.2 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.308--20210126165826  | WijzeBeginBaring_32 |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.248--20181119170402  | Wond |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.5--20171231000000  | WondRandCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.11.374--20220316115154  | ZorgVoorKindOnzekerheid |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.292--20200623140138  | ZorgVoorKindVaardigheid |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.308--20201006103803  | ZorgverlenerType (3.2) |
http://nictiz.nl/fhir/ValueSet/bc-BirthObservation-code  | bc-BirthObservation-code |
http://nictiz.nl/fhir/ValueSet/bc-ChildObservation-code  | bc-ChildObservation-code |
http://nictiz.nl/fhir/ValueSet/bc-DeliveryObservation-code  | bc-DeliveryObservation-code |
http://nictiz.nl/fhir/ValueSet/bc-FetusObservation-code  | bc-FetusObservation-code |
http://nictiz.nl/fhir/ValueSet/bc-MaternalObservation-code  | bc-MaternalObservation-code |
http://nictiz.nl/fhir/ValueSet/bc-PregnancyObservation-code  | bc-PregnancyObservation-code |
http://nictiz.nl/fhir/ValueSet/bc-ProcedureObservation-code  | bc-ProcedureObservation-code |
http://ehealthontario.ca/fhir/ValueSet/dhdr-medication-repeat-pattern  | Medication Repeat Pattern |
https://fhir.ee/ValueSet/ee-clinical-specialty  | Clinical Specialty |
https://fhir.ee/ValueSet/ee-person-relationship  | Person Relationship |
http://fhir.kl.dk/term/ValueSet/KLComplicationCodesSCT  | KLKomplikationskoderSCT |
http://fhir.kl.dk/term/ValueSet/KLEvaluationTypeCodesSCT  | KLVurderingTypekoderSCT |
http://fhir.kl.dk/term/ValueSet/KLObservationCodes  | KLObservationskoder |
http://ehealthontario.ca/fhir/ValueSet/anatomicalsite  | Anatomical Site |
http://ehealthontario.ca/fhir/ValueSet/disease  | Disease Code |
http://ehealthontario.ca/fhir/ValueSet/generic  | Vaccine Generic Code |
http://ehealthontario.ca/fhir/ValueSet/repsource  | Immunization Reporting Source |
http://ehealthontario.ca/fhir/ValueSet/routeofadmin  | Route Of Administration |
http://ehealthontario.ca/fhir/ValueSet/tradename  | Vaccine Tradename Code |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-boston-bowel-preparation-scale  | Colonoscopy Report Boston Bowel Preparation Scale |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-complication  | Colonoscopy Report Complications |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-complication-consequence  | Colonoscopy Report Complication Consequences |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-current-medication  | Colonoscopy Report Current Medication |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-followup  | Colonoscopy Report Follow Up |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-medication  | Colonoscopy Report Medication |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-medication-krg  | KRG Medication |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-method-tissue-removal-biopsy  | Colonoscopy Report Tissue Removal Method |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-normal-abnormal  | Colonoscopy Report Normal/Abnormal |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-paris-polyp-classification  | Colonoscopy Report Colonoscopy Paris Polyp Classification |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-relevant-conditions  | Colonoscopy Report Relevant Conditions |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-sedation-level  | Colonoscopy Report Sedation Level |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-segment-lesion  | Colonoscopy Report Segment Lesion |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-segment-reached  | Colonoscopy Report Segment Lesion |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-type  | Colonoscopy Type |
http://ehelse.no/fhir/ValueSet/no-coloscopy-segment-reached  | Colonoscopy Report Segment Reached |
http://ehelse.no/fhir/ValueSet/no-procedure-performer-function  | Conoloscopy Report Performer Function |
http://ehelse.no/fhir/valueset/no-colonoscopy-procedure-reason-gastronet  | Colonoscopy Report Indication |
http://fhir.ch/ig/ch-emed-epr/ValueSet/ch-emed-epr-amount-quantity-unit-code  | Amount Quantity Unit Codes |
https://fake-acme.org/fhir/ca/ValueSet/EaseOfRespirationVS  | Ease of Respiration Value Set |
https://imri.cgh.org.tw/imri/ValueSet/anesthesia-sct  | SNOMED CT Anesthesia值集 |
https://imri.cgh.org.tw/imri/ValueSet/mcode-cancer-stage-type  | mCode Cancer Stage Type值集 |
https://imri.cgh.org.tw/imri/ValueSet/mcode-cancer-stage  | mCode Cancer Stage值集 |
https://imri.cgh.org.tw/imri/ValueSet/physical-examination-sct  | SNOMED CT Physical Examination值集 |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_AB0_System  | AB0-System |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_AB0_System_First_Examination_After_Childbirth  | AB0-System des Kindes im Wochenbett |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Biometrics_I  | Biometrie I |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Biometrics_II_III  | Biometrie II und III |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Birth_Mode  | Geburtsmodus |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Breastfeeding_Behavior  | Stillverhalten der Mutter |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Catalogue_A  | Anamneseerhebung bei Erstuntersuchung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Child_Position  | Kindslage |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Counselling  | Beratung von Schwangeren |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Direct_Coombstest  | Direkter Coombstest |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Examination_Interpretation  | Interpretation der Messergebnisse hinsichtlich der Immunität |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Examination_Result_Qualitative  | Qualitative Beurteilung der Messergebnisse |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Examination_Snomed  | Laboruntersuchungen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Findings_Required_Control  | Kontrollbedürftige Befunde |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_General_Information  | Allgemeine Angaben zum Fötus beim ersten Ultraschallscreening |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Heart_Sounds_Child  | Herztöne des Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Immunization_Status  | Nachweise der prophylaktischen Impfungen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Localisation_Placenta  | Lokalisation/Struktur der Plazenta |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Morphology  | Morphologie |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Other_Ultrasound_Studies  | Weitere Ultraschalluntersuchungen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Practitioner_Function_Addendum  | Funktionen/Rollen des Behandelnden Ergänzung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Pregnancy_Information  | Angaben zur Schwangerschaft beim Ultraschallscreening |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Rhesus_System  | Rhesus-System |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Rhesus_System_Fetus  | Rhesus-System des Fötus |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_Special_Findings  | Befundkatalog Besondere Befunde |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_oGTT_Diagnosistest  | Oraler Glucosetoleranztest (oGTT) Diagnosetest |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_MR_oGTT_Pretest  | Oraler Glucosetoleranztest (oGTT) Vortest |
http://hl7.org/fhir/ValueSet/substance-codes  | SNOMED CT Substance Codes |
https://fhir.ee/ValueSet/clinical-specialty  | Clinical Specialty |
https://fhir.ee/ValueSet/eestkoste-liik  | Eestkoste liik |
https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/ValueSet/mii-vs-molgen-familiaere-linie  | MII VS MolGen Familiäre Linie |
https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/ValueSet/mii-vs-molgen-family-member-snomed  | MII VS MolGen Family Member SNOMED |
https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/ValueSet/mii-vs-molgen-verwandtschaftsgrad  | MII VS Mol Gen Verwandtschaftsgrad |
https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/ValueSet/mii-vs-molgen-verwandtschaftsverhaeltnis  | MII VS MolGen Verwandtschaftsverhaeltnis |
http://fhir.hie.moh.gov.id/ValueSet/adverse-event-event-id-core  | ValueSetAdverseEventEvent (ID Core) |
http://fhir.hie.moh.gov.id/ValueSet/allergy-manifestation-id-core  | value-set-allergy-manifestation-id-core |
http://fhir.hie.moh.gov.id/ValueSet/allergy-negation-id-core  | ValueSetAllergyNegation (ID Core) |
http://fhir.hie.moh.gov.id/ValueSet/child-identification-type-id-core  | ValueSetChildIdentificationType (ID Core) |
http://fhir.hie.moh.gov.id/ValueSet/glucose-level-id-core  | ValueSetGlucoseLevel(ID Core) |
http://fhir.hie.moh.gov.id/ValueSet/observation-glucose-id-core  | ValueSetObservationGlucose (ID Core) |
http://fhir.hie.moh.gov.id/ValueSet/observation-social-history-id-core  | ValueSetObservationSocialHistory (ID Core) |
http://smart.who.int/ddcc/ValueSet/LabTestPathogenCovid19SnomedValueSet  | Lab Test - Pathogen - COVID-19 - SNOMED CT |
http://smart.who.int/ddcc/ValueSet/LabTestQualitativeResultSnomedValueSet  | Lab Test - Qualitative Result - SNOMED CT |
http://smart.who.int/ddcc/ValueSet/VaccineCovid19SnomedValueSet  | Vaccine - COVID-19 - SNOMED CT |
https://fhir.healthdata.be/ValueSet/HDBP0037-Microorganism  | HDBP0037-Microorganism |
https://fhir.healthdata.be/ValueSet/HDBP0037-ResultFlags  | HDBP0037-ResultFlags |
https://fhir.healthdata.be/ValueSet/HDBP0037-SpecimenMaterial  | HDBP0037-SpecimenMaterial |
https://fhir.healthdata.be/ValueSet/HDBP0037-TestMethod  | HDBP0037-TestMethod |
https://fhir.healthdata.be/ValueSet/HDBP0037-TestResult  | HDBP0037-TestResult |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.131.11.2--20220301153357  | VaccinatieAanleidingWaardelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.131.11.3--20220301175614  | ZiekteWaarTegenGevaccineerdWordtWaardelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.131.11.4--20220301181306  | VaccinatieIndicatieWaardelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.131.11.6--20240417113339  | ProductCodeSNOMEDCTCodeLijst |
http://fhir.de/onkologie/ValueSet/ecog-performance-status-snomed  | ValueSet ECOG Performance Status SNOMED |
http://fhir.de/onkologie/ValueSet/histopathologisches-grading-snomed  | ValueSet Histopathologisches Grading SNOMED |
http://fhir.de/onkologie/ValueSet/morphologie-snomed  | ValueSet Morphologie SNOMED |
http://fhir.de/onkologie/ValueSet/topographie-snomed  | ValueSet Topographie SNOMED |
http://fhir.de/onkologie/ValueSet/treatment-intent-vs  | Treatment Intent Value Set |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Ucni/ValueSet/ClasseAsaMaitre  | ClasseAsaMaitre |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/ColoscopieAnterieureEndo  | ColoscopieAnterieureEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/ColoscopieTypeEndo  | ColoscopieTypeEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/ComplicationEndo  | ComplicationEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/EchelleBostonEndo  | EchelleBostonEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/PractitionerRole  | EndoPractitionerRole |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/IndicationColoscopieEndo  | IndicationColoscopieEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/InstrumentColoscopieEndo  | InstrumentColoscopieEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/IntervenantEndoscopiste  | IntervenantEndoscopiste |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/IntervenantProcedureEndo  | IntervenantProcedureEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/IntervenantResident  | IntervenantResident |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/InterventionNonPlanifieeEndo  | InterventionNonPlanifieeEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/LienUsagerEndo  | LienUsagerEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/MedicamentEndo  | MedicamentEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/MedicationUniteMesureEndo  | MedicationUniteMesureEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/ModalitePriseMedicationEndo  | ModalitePriseMedicationEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/MorphologiePolypeEndo  | MorphologiePolypeEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/ObservationStructureEndo  | ObservationStructureEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/OrigineDemandeEndo  | OrigineDemandeEndo |
http://hl7.org/fhir/ValueSet/practitioner-role  | Practitioner role |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/PreparationColiqueEndo  | PreparationColiqueEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/ProcedureTypeEndo  | ProcedureTypeEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/RecommandationEndo  | RecommandationEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/ReferentEndo  | ReferentEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/RetroflexionEndo  | RetroflexionEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/SpecimenStatutEndo  | SpecimenStatutEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/StatutObservationEndo  | StatutObservationEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/StructureCorporelleEndo  | StructureCorporelleEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/SuiviPriseChargeEndo  | SuiviPriseChargeEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/TaillePolypeEndo  | TaillePolypeEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/TypeObservationEndo  | TypeObservationEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/VoieAdministrationEndo  | VoieAdministrationEndo |
http://hl7.org/fhir/ValueSet/c80-practice-codes  | PracticeSettingCode |
https://mos.esante.gouv.fr/NOS/JDV_J148-ReferenceRangeAppliesTo-CISIS/FHIR/JDV-J148-ReferenceRangeAppliesTo-CISIS  | JDV_J148-ReferenceRangeAppliesTo-CISIS |
https://mos.esante.gouv.fr/NOS/JDV_J149-BodySiteBP-ENS/FHIR/JDV-J149-BodySiteBP-ENS  | JDV_J149-BodySiteBP-ENS |
https://mos.esante.gouv.fr/NOS/JDV_J161-Lateralite-CISIS/FHIR/JDV-J161-Lateralite-CISIS  | JDV_J161-Lateralite-CISIS |
https://mos.esante.gouv.fr/NOS/JDV_J276-SNOMED-UPNOS/FHIR/JDV-J276-SNOMED-UPNOS  | JDV_J276-SNOMED-UPNOS |
http://moh.gov.vn/fhir/core/ValueSet/snomedCT-additional-dosage-instruction  | ValueSet dành cho Các chỉ dẫn dùng thuốc (bổ sung) (SNOMED CT) |
http://moh.gov.vn/fhir/core/ValueSet/snomedCT-anatomical-body-structure  | ValueSet dành cho Vị trí cơ thể theo giải phẫu học (SNOMED CT) |
http://moh.gov.vn/fhir/core/ValueSet/snomedCT-clinical-finding  | ValueSet dành cho Các thông tin thăm, khám lâm sàng (SNOMED CT) |
http://moh.gov.vn/fhir/core/ValueSet/snomedCT-dosage-administration-route  | ValueSet dành cho Đường dùng thuốc (SNOMED CT) |
http://moh.gov.vn/fhir/core/ValueSet/vn-core-condition-code  | ValueSet dành cho Mã bệnh tật |
http://moh.gov.vn/fhir/core/ValueSet/vn-core-occupation  | ValueSet dành cho Thông tin nghề nghiệp |
http://moh.gov.vn/fhir/core/ValueSet/vn-medication-code  | ValueSet dành cho Mã dược phẩm |
http://moh.gov.vn/fhir/core/ValueSet/vn-core-observation-smokingstatus  | ValueSet dành cho Tình trạng hút thuốc lá (SNOMED CT) |
http://moh.gov.vn/fhir/core/ValueSet/vn-procedure-code  | ValueSet dành cho Mã dịch vụ kỹ thuật |
http://moh.gov.vn/fhir/core/ValueSet/vaccine-code  | ValueSet dành cho Vaccine Code |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-bodysite-observation-beatmung  | VS MII ICU BodySite Observation Beatmung |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-bodysite-observation-blutdruck  | VS MII ICU BodySite Observation Blutdruck |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-bodysite-observation-extrakorporale-verfahren  | VS MII ICU BodySite Observation extrakorporale Verfahren |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-bodysite-observation-monitoring-und-vitaldaten  | VS MII ICU BodySite Observation Monitoring und Vitaldaten |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-category-procedure-beatmung-snomed  | VS MII ICU Category Procedure Beatmung [SNOMED] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-code-extrakorporale-verfahren  | VS MII ICU Code extrakorporale Verfahren |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-code-monitoring-und-vitaldaten-snomed  | VS MII ICU Code Monitoring und Vitaldaten [SNOMED] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-code-observation-beatmung-snomed  | VS MII ICU Code Observation Beatmung [SNOMED] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-code-observation-bilanzen-snomed  | VS MII ICU Code Observation Bilanzen [SNOMED] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-code-observation-extrakorporale-verfahren-snomed  | VS MII ICU Code Observation extrakorporale Verfahren [SNOMED] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-code-procedure-beatmung-snomed  | VS MII ICU Code Procedure Beatmung [SNOMED] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-devicemetric-extrakorporale-verfahren  | VS MII ICU Category Procedure Beatmung [SNOMED] |
https://www.medizininformatik-initiative.de/fhir/ext/modul-icu/ValueSet/vs-mii-icu-method-observation-blutdruck  | VS MII ICU Method Observation Blutdruck |
https://fhir.nexuzhealth.com/standards/fhir/ValueSet/nxh-vs-act-procedure-code  | NxhVSActProcedureCode |
https://fhir.nexuzhealth.com/standards/fhir/ValueSet/nxh-vs-snomed  | NxhVSSnomed |
https://fhir.nexuzhealth.com/standards/fhir/ValueSet/nxh-vs-body-sites  | NxhVSBodySites |
https://fhir.nexuzhealth.com/standards/fhir/ValueSet/nxh-vs-nxh-vs-care-observation-code  | NxhVSCareObservationCodes |
http://ontariohealth.ca/fhir/ValueSet/addiction-substance-use  | Addiction-Substance Use |
http://ontariohealth.ca/fhir/ValueSet/alcohol-anti-craving-medication  | Alcohol Anti-Craving Medication |
http://ontariohealth.ca/fhir/ValueSet/alcohol-anti-craving-medication-enrollment  | Alcohol Anti-Craving Medication Enrollment |
http://ontariohealth.ca/fhir/ValueSet/mha-disability-status  | Disability Status |
http://ontariohealth.ca/fhir/ValueSet/mha-disability-type  | Disability Type |
http://ontariohealth.ca/fhir/ValueSet/mha-organization-admission-discharge-reason  | Discharge Reason |
http://ontariohealth.ca/fhir/ValueSet/gambling-problem-identified  | Gambling Problem Identified |
http://ontariohealth.ca/fhir/ValueSet/gender-identity  | Gender Identity |
http://ontariohealth.ca/fhir/ValueSet/hcn-issuing-authority  | HCN Issuing Authority |
http://ontariohealth.ca/fhir/ValueSet/opioid-agonist-medication-enrollment  | Opioid Agonist Medication Enrollment |
http://ontariohealth.ca/fhir/ValueSet/symptoms-of-clinical-concern  | Symptoms Of Clinical Concern |
http://ontariohealth.ca/fhir/ValueSet/mha-race  | Race |
http://ontariohealth.ca/fhir/ValueSet/religion-and-spiritual-affiliation  | ReligionAndSpiritualAffiliation |
http://ontariohealth.ca/fhir/ValueSet/transgender-identity  | Transgender Identity |
http://ontariohealth.ca/fhir/ValueSet/housing-status  | Housing Status |
https://twidir.cdc.gov.tw/twidir/ValueSet/snomedct-methodtype-values  | SNOMED CT檢驗檢查方法種類值集 |
https://simplifier.net/myhw/ValueSet/Condition-KCD-8  | myhw-fhir-condition-kcd-8 |
http://interopsante.org/fhir/valueset/fr-bp-measurement-method  | Bp-measurement-method |
https://fhir.nhs.uk/ValueSet/covid-19-detection-of-antibody  | COVID-19 SNOMED CT Detection Of Antibody |
https://fhir.nhs.uk/ValueSet/covid-19-detection-of-antigen  | COVID-19 SNOMED CT Detection Of Antigen |
https://fhir.nhs.uk/ValueSet/covid-19-detection-of-virus  | COVID-19 SNOMED CT Detection of Virus |
https://fhir.nhs.uk/ValueSet/covid-19-snomed-test-vs  | COVID-19 SNOMED CT Tests Value Set |
https://www.medizininformatik-initiative.de/fhir/core/modul-diagnose/ValueSet/mii-vs-diagnose-bodystructure-snomed  | MII VS Diagnose BodyStructure SNOMED |
https://www.medizininformatik-initiative.de/fhir/core/modul-diagnose/ValueSet/diagnoses-sct  | MII VS Diagnose Diagnose-Codes SNOMED |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-EmergencyCareDischargeStatus-1  | Care Connect Emergency Care Discharge Status |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-EncounterType-1  | Care Connect Encounter Type |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ListCode-1  | Care Connect List Code |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ReligiousAffiliation-1  | Care Connect Religious Affiliation |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-SourceOfReferral-1  | Care Connect Source of Referral |
https://fhir.nhs.uk/STU3/ValueSet/UEC-ConditionCode-1  | UEC Condition Code |
https://fhir.nhs.uk/STU3/ValueSet/UEC-ObservationCode-1  | UEC Observation Code |
https://hl7chile.cl/fhir/ig/CoreCL/ValueSet/VSDiagnosticosSCT  | Diagnósticos SNOMED y Ausente o Desconocido |
https://termgit.elga.gv.at/ValueSet/eimpf-medikationartanwendung  | eImpf_MedikationArtAnwendung |
https://termgit.elga.gv.at/ValueSet/elga-medicaldevices  | ELGA_MedicalDevices |
https://gematik.de/fhir/dipag/ValueSet/DiPagVerkehrsmittel  | Digitale PatientenrechnungVerkehrsmittel |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20150401000000  | AfnameprocedureCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20150401000000  | AllergieCategorieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.5.5--20150401000000  | DagdeelCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.4--20150401000000  | MateVanKritiekZijnCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.6--20150401000000  | MonstermateriaalCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.21--20160617112039  | RedenMedicatieafspraak |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.1--20150401000000  | ResultaatTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.3.11.2--20150401000000  | SpecifiekeStofCodeLijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20150401000000  | SymptoomCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.4--20150401000000  | TestmethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.3.11.1--20150401000000  | VeroorzakendeStofCodeLijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.8--20150401000000  | WaarschijnlijkheidCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.5.4--20150401000000  | WeekdagenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.12--20150401000000  | WijzeVanBlootstellingCodelijst |
https://fhir.nhs.uk/STU3/ValueSet/CareConnect-AllergyCertainty-1  | Care Connect Allergy Certainty |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-AllergyCode-1  | Care Connect Allergy Code |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-AllergyExposureRoute-1  | Care Connect Allergy Exposure Route |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-AllergyManifestation-1  | Care Connect Allergy Manifestation |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-AllergySeverity-1  | Care Connect Allergy Severity |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-BodySite-1  | Care Connect Body Site |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-CareSettingType-1  | Care Connect Care Setting Type |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-CompositionSectionCode-1  | Care Connect Composition Section Code |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ConditionCode-1  | Care Connect Condition Code |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ConditionEpisodeSnCT-1  | Care Connect Condition Episode SnCT |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-DocumentType-1  | Care Connect Document Type |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-FindingCode-1  | Care Connect Finding Code |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ImmunizationExplanationReason-2  | Care Connect Immunization Explanation Reason |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ManufacturedMaterialSnCT-1  | Care Connect Manufactured Material SnCT |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-MedicationCode-1  | Care Connect Medication Code |
https://fhir.nhs.uk/STU3/ValueSet/CareConnect-MedicationDosageMethod-1  | Care Connect Medication Dosage Method |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-MedicationDosageRoute-1  | Care Connect Medication Dosage Route |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-MedicationForm-1  | Care Connect Medication Form |
https://fhir.nhs.uk/STU3/ValueSet/CareConnect-MedicationSupplyType-1  | Care Connect Medication Supply Type |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ProcedureCode-1  | Care Connect Procedure Code |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ReasonImmunizationNotAdministered-1  | Care Connect Reason Immunization Not Administered |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ReportCodeSnCT-1  | Care Connect Report Code SnCT |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-SpecimenBodySite-1  | Care Connect Specimen Body Site |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-SpecimenType-1  | Care Connect Specimen Type |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-VaccinationProcedure-1  | Care Connect Vaccination Procedure |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-VaccineCode-1  | Care Connect Vaccine Code |
https://fhir.nhs.uk/STU3/ValueSet/CarePlanType-1  | Care Plan Type |
https://fhir.nhs.uk/STU3/ValueSet/CareSettingType-1  | Care Setting Type |
https://fhir.nhs.uk/STU3/ValueSet/DCH-AABRHearingTest-Outcome-1  | DCH AABR Hearing Test Outcome |
https://fhir.nhs.uk/STU3/ValueSet/DCH-AOAEHearingTest-Outcome-1  | DCH AOAE Hearing Test Outcome |
https://fhir.nhs.uk/STU3/ValueSet/DCH-APGARScoreObservation-1  | DCH APGAR Score Observation |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ASQ3AssessmentToolType-1  | DCH ASQ 3 Assessment Tool Type |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ASQSEAssessmentToolType-1  | DCH ASQ SE Assessment Tool Type |
https://fhir.nhs.uk/STU3/ValueSet/DCH-AdmissionReason-1  | DCH-AdmissionReason-1 |
https://fhir.nhs.uk/STU3/ValueSet/DCH-AlcoholUse-1  | DCH Alcohol Use |
https://fhir.nhs.uk/STU3/ValueSet/DCH-AssessmentScale-1  | DCH Assessment Scale |
https://fhir.nhs.uk/STU3/ValueSet/DCH-AttemptedDeliveryType-1  | DCH Attempted Delivery Type |
https://fhir.nhs.uk/STU3/ValueSet/DCH-BloodSpotOutcome-1  | DCH Blood Spot Outcome |
https://fhir.nhs.uk/STU3/ValueSet/DCH-BloodSpotOutcomeCFSnCT-1  | DCH Blood Spot Outcome CF SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-BloodSpotOutcomeCHTSnCT-1  | DCH Blood Spot Outcome CHT SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-BloodSpotOutcomeGA1SnCT-1  | DCH Blood Spot Outcome GA1 SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-BloodSpotOutcomeHCUSnCT-1  | DCH Blood Spot Outcome HCU SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-BloodSpotOutcomeIVASnCT-1  | DCH Blood Spot Outcome IVA SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-BloodSpotOutcomeMCADDSnCT-1  | DCH Blood Spot Outcome MCADD SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-BloodSpotOutcomeMSUDSnCT-1  | DCH Blood Spot Outcome MSUD SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-BloodSpotOutcomePKUSnCT-1  | DCH Blood Spot Outcome PKU SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-BloodSpotOutcomeSCDSnCT-1  | DCH Blood Spot Outcome SCD SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ClinicalRiskFactorSnCT-1  | DCH Clinical Risk Factor SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-DevelopmentalSkill-1  | DCH Developmental Skill |
https://fhir.nhs.uk/STU3/ValueSet/DCH-DevelopmentalSkillObservation-1  | DCH Developmental Skill Observation |
https://fhir.nhs.uk/STU3/ValueSet/DCH-Diagnosis-Condition-1  | DCH Diagnosis Condition |
https://fhir.nhs.uk/STU3/ValueSet/DCH-DischargeDestinationEmergencyCare-1  | DCH Discharge Destination Emergency Care |
https://fhir.nhs.uk/STU3/ValueSet/DCH-DrugOrSubstanceUse-1  | DCH Drug Or Substance Use |
https://fhir.nhs.uk/STU3/ValueSet/DCH-EducationalAssessmentOutcome-1  | DCH Educational Assessment Outcome |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ExaminationFindingOutcome-1  | DCH Examination Finding Outcome |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ExaminationFindingProcedure-1  | DCH Examination Finding Procedure |
https://fhir.nhs.uk/STU3/ValueSet/DCH-FamilyHistory-1  | DCH Family History |
https://fhir.nhs.uk/STU3/ValueSet/DCH-FeedingMethod-1  | DCH Feeding Method |
https://fhir.nhs.uk/STU3/ValueSet/DCH-FinalDeliveryType-1  | DCH Final Delivery Type |
https://fhir.nhs.uk/STU3/ValueSet/DCH-HeadCircumferenceSnCT-1  | DCH Head Circumference SnCT |
https://fhir.nhs.uk/STU3/ValueSet/DCH-HearingScreeningOutcome-1  | DCH Hearing Screening Outcome |
https://fhir.nhs.uk/STU3/ValueSet/DCH-HouseholdAlcoholStatus-1  | DCH Household Alcohol Status |
https://fhir.nhs.uk/STU3/ValueSet/DCH-HouseholdSmokingStatus-1  | DCH Household Smoking Status |
https://fhir.nhs.uk/STU3/ValueSet/DCH-HouseholdSubstanceStatus-1  | DCH Household Substance Status |
https://fhir.nhs.uk/STU3/ValueSet/DCH-IdenticalTwinIndicator-1  | DCH Identical Twin Indicator |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ImmunisationRoute-1  | DCH Immunisation Route |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ImmunisationSite-1  | DCH Immunisation Site |
https://fhir.nhs.uk/STU3/ValueSet/DCH-IndividualRequirement-Cognitive-1  | DCH Individual Requirement - Cognitive |
https://fhir.nhs.uk/STU3/ValueSet/DCH-IndividualRequirement-CommunicationMethod-1  | DCH Individual Requirement - Communication Method |
https://fhir.nhs.uk/STU3/ValueSet/DCH-IndividualRequirement-CommunicationProfessional-1  | DCH Individual Requirement - Communication Professional |
https://fhir.nhs.uk/STU3/ValueSet/DCH-IndividualRequirement-CommunicationSupport-1  | DCH Individual Requirement - Communication Support |
https://fhir.nhs.uk/STU3/ValueSet/DCH-IndividualRequirement-ContactMethod-1  | DCH Individual Requirement - Contact Method |
https://fhir.nhs.uk/STU3/ValueSet/DCH-IndividualRequirement-GPOptOutIndicator-1  | DCH Individual Requirement - GP Opt Out Indicator |
https://fhir.nhs.uk/STU3/ValueSet/DCH-IndividualRequirement-InformationFormat-1  | DCH Individual Requirement - Information Format |
https://fhir.nhs.uk/STU3/ValueSet/DCH-IndividualRequirement-MobilityNeed-1  | DCH Individual Requirement - Mobility Need |
https://fhir.nhs.uk/STU3/ValueSet/DCH-InformationOrAdviceGiven-1  | DCH Information Or Advice Given |
https://fhir.nhs.uk/STU3/ValueSet/DCH-MaternalProblemsInPregnancy-FamilyHistory-1  | DCH Maternal Problems In Pregnancy Family History |
https://fhir.nhs.uk/STU3/ValueSet/DCH-NCMPWithdrawalReason-1  | DCH NCMP Withdrawal Reason |
https://fhir.nhs.uk/STU3/ValueSet/DCH-Occupation-1  | DCH Employment Status |
https://fhir.nhs.uk/STU3/ValueSet/DCH-OutcomeStatusEyes-1  | DCH Outcome Status Eyes |
https://fhir.nhs.uk/STU3/ValueSet/DCH-OutcomeStatusHeart-1  | DCH Outcome Status Heart |
https://fhir.nhs.uk/STU3/ValueSet/DCH-OutcomeStatusHips-1  | DCH Outcome Status Hips |
https://fhir.nhs.uk/STU3/ValueSet/DCH-OutcomeStatusTestes-1  | DCH Outcome Status Testes |
https://fhir.nhs.uk/STU3/ValueSet/DCH-PersonSmokingStatus-1  | DCH Person Smoking Status |
https://fhir.nhs.uk/STU3/ValueSet/DCH-PhysicalProblemAtBirth-1  | DCH Physical Problem At Birth |
https://fhir.nhs.uk/STU3/ValueSet/DCH-PresentingComplaintEmergencyCare-1  | DCH Presenting Complaint Emergency Care |
https://fhir.nhs.uk/STU3/ValueSet/DCH-Problem-Condition-1  | DCH Problem Condition |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ProblemDuringDelivery-1  | DCH Problem During Delivery |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ProcedureEmergencyCare-1  | DCH Procedure Emergency Care |
https://fhir.nhs.uk/STU3/ValueSet/DCH-PutToBreastIndicator-1  | DCH Put To Breast Indicator |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ReasonForReferral-1  | DCH Reason For Referral |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ReasonNotAdminsitered-1  | DCH Reason Not Adminsitered |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ReferralSourceEmergencyCare-1  | DCH Referral Source Emergency Care |
https://fhir.nhs.uk/STU3/ValueSet/DCH-SafeguardingObservationCode-1  | DCH Safeguarding Observation Code |
https://fhir.nhs.uk/STU3/ValueSet/DCH-ServiceReferredTo-1  | DCH Service Referred To |
https://fhir.nhs.uk/STU3/ValueSet/DCH-SourceOfReferral-1  | DCH Source of Referral |
https://fhir.nhs.uk/STU3/ValueSet/DCH-SpecialEducationalNeed-1  | DCH Special Educational Need |
https://fhir.nhs.uk/STU3/ValueSet/DCH-Weight-1  | DCH Weight |
https://fhir.nhs.uk/STU3/ValueSet/DD4C-AssessmentScaleSimpleReferenceSetSnCT-1  | DD4C Assessment Scale Simple Reference Set |
https://fhir.nhs.uk/STU3/ValueSet/DD4C-LastingPowerAttorney-Code-1  | DD4C Lasting Power Attorney Code |
https://fhir.nhs.uk/STU3/ValueSet/DeviceType-1  | Device Type |
https://fhir.nhs.uk/STU3/ValueSet/DocumentType-1  | Document Type |
https://fhir.nhs.uk/STU3/ValueSet/EOL-AdvanceDecisionToRefuseTreatment-1  | EOL Advance Decision to Refuse Treatment |
https://fhir.nhs.uk/STU3/ValueSet/EOL-AwareOfDecisionSnCT-1  | EOL Prognosis Awareness SnCT |
https://fhir.nhs.uk/STU3/ValueSet/EOL-CPRStatus-Code-1  | EOL CPR Status Code |
https://fhir.nhs.uk/STU3/ValueSet/EOL-ConsentDecisionSnCT-1  | EOL Consent Decision SnCT |
https://fhir.nhs.uk/STU3/ValueSet/EOL-FunctionalStatusType-Code-1  | EOL Functional Status Type Code |
https://fhir.nhs.uk/STU3/ValueSet/EOL-IssueOfAnticipatoryMedicines-1  | EOL Issue of Anticipatory Medicines |
https://fhir.nhs.uk/STU3/ValueSet/EOL-PreferredPlaceDeath-Code-1  | EOL Preferred Place Death Code |
https://fhir.nhs.uk/STU3/ValueSet/EOL-Prognosis-Code-1  | EOL Prognosis Code |
https://fhir.nhs.uk/STU3/ValueSet/EOL-Register-Code-1  | End of Life Register Flag Code |
https://fhir.nhs.uk/STU3/ValueSet/ITK-ADRT-1  | ITK Advance Decision to Refuse Treatment |
https://fhir.nhs.uk/STU3/ValueSet/ITK-AccessibleInformation-1  | ITK Accessible Information |
https://fhir.nhs.uk/STU3/ValueSet/ITK-AllergyFlagCode-1  | Allergy Flag Code |
https://fhir.nhs.uk/STU3/ValueSet/ITK-Cognition-1  | ITK Cognition |
https://fhir.nhs.uk/STU3/ValueSet/ITK-FamilyHistoryIllness-1  | ITK Family History Illness |
https://fhir.nhs.uk/STU3/ValueSet/ITK-LPoA-1  | ITK Lasting Power of Attorney |
https://fhir.nhs.uk/STU3/ValueSet/ITK-Mobility-1  | ITK Mobility |
https://fhir.nhs.uk/STU3/ValueSet/ITK-OccupationalHistory-1  | ITK Occupational History |
https://fhir.nhs.uk/STU3/ValueSet/NIPE-Outcome-1  | NIPE Outcome |
https://fhir.nhs.uk/STU3/ValueSet/NRL-PracticeSetting-1  | NRL Practice Setting |
https://fhir.nhs.uk/STU3/ValueSet/NRL-RecordClass-1  | NRL Record Class |
https://fhir.nhs.uk/STU3/ValueSet/NRL-RecordType-1  | NRL Record Type |
https://fhir.nhs.uk/STU3/ValueSet/NRLS-RecordType-1  | NRLS Record Type |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-AccessibleInformationCommunicationProfessional-1  | AccessibleInformation - Communication Professional |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-AccessibleInformationCommunicationSupport-1  | Accessible Information - Communication Support |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-AccessibleInformationSpecificContactMethod-1  | Accessible Information - Specific Contact Method |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-AccessibleInformationSpecificInformationFormat-1  | Accessible Information - Specific Information Format |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-AdditionalCommunicationSupport-1  | Additional Communication Support |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-AdditionalSupport-1  | Additional Support |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-BespokeReasonableAdjustment-1  | Bespoke Reasonable Adjustment |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-CommunityLanguageSupport-1  | Community Language Support |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-EnvironmentAdjustment-1  | Environment Adjustment |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-FlagCode-1  | Reasonable Adjustments Record Flag Code |
https://fhir.nhs.uk/STU3/ValueSet/RARecord-IndividualCareRequirement-1  | Individual Care Requirement |
https://fhir.nhs.uk/STU3/ValueSet/ReasonForReferralSnCT-1  | Reason For Referral SnCT |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.9--20220610000000  | ContainerTypeCodelijst |
http://fhir.health.gov.il/ValueSet/diagnostic-conclusion-code  | Diagnostic Conclusion Codes |
http://fhir.health.gov.il/ValueSet/il-core-allergy-intolerance-code  | IL Core Allergy Intolerance Code |
http://fhir.health.gov.il/ValueSet/il-core-allergy-intolerance-end-reason  | IL Core Condition End Reason |
http://fhir.health.gov.il/ValueSet/il-core-body-position  | IL Core Body Position |
http://fhir.health.gov.il/ValueSet/il-core-common-units-of-measure  | IL Core Units Of Measure Codes |
http://fhir.health.gov.il/ValueSet/il-core-condition-category  | IL Core Condition Category Codes |
http://fhir.health.gov.il/ValueSet/il-core-condition-code  | IL Core Condition Code |
http://fhir.health.gov.il/ValueSet/il-core-doctor-to-doctor  | IL Core Doctor To Doctor Codes |
http://fhir.health.gov.il/ValueSet/il-core-manifestation  | IL Core Condition Codes |
http://fhir.health.gov.il/ValueSet/il-core-medication-code  | ILCore Medication Code |
http://fhir.health.gov.il/ValueSet/il-core-medication-dose-form  | IL Core Medication Dose Form |
http://fhir.health.gov.il/ValueSet/il-core-medication-statement-code  | ILCore Medication statement Code |
http://fhir.health.gov.il/ValueSet/il-core-observation-code  | IL Core Observation Codes |
http://fhir.health.gov.il/ValueSet/il-core-observation-value  | IL Core Observation Value Codes |
http://fhir.health.gov.il/ValueSet/il-core-procedure-code  | IL Core procedure Codes |
http://fhir.health.gov.il/ValueSet/il-core-route-code  | IL Core Route Code |
http://fhir.health.gov.il/ValueSet/il-core-service-category  | IL Core ServiceCategory |
http://fhir.health.gov.il/ValueSet/il-core-service-type  | IL Core Service type |
http://fhir.health.gov.il/ValueSet/il-core-specimen-type  | IL Core Specimen type |
http://fhir.health.gov.il/ValueSet/il-core-substance  | IL Core Substance Codes |
http://fhir.health.gov.il/ValueSet/il-core-units-of-measure  | IL Core Units Of Measure Codes |
http://fhir.health.gov.il/ValueSet/il-core-virtual-type  | IL Core Virtual encounter Type Codes |
http://fhir.health.gov.il/ValueSet/immunization-body-site  | Immunization Observation Body Site list |
http://fhir.health.gov.il/ValueSet/immunization-side-effect  | Immunization side-effect codes |
http://fhir.health.gov.il/ValueSet/organization-type  | Organization Type |
http://fhir.health.gov.il/ValueSet/reason-not-done  | statusReason codes for Immunization profile |
http://fhir.health.gov.il/ValueSet/target-disease  | Target Disease Codes |
http://fhir.health.gov.il/ValueSet/vaccine-code  | Vaccine Codes |
https://demis.rki.de/fhir/ValueSet/answerSetABVP  | AnswerSet für Arboviren (sonstige) |
https://demis.rki.de/fhir/ValueSet/answerSetACBP  | AnswerSet für Acinetobacter spp. bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
https://demis.rki.de/fhir/ValueSet/answerSetADEP  | AnswerSet für Adenoviren; Meldepflicht bei akuter Infektion für Nachweise aus allen Körpermaterialien |
https://demis.rki.de/fhir/ValueSet/answerSetADVP  | AnswerSet für Adenoviren; Meldepflicht nur für den direkten Nachweis im Konjunktivalabstrich |
https://demis.rki.de/fhir/ValueSet/answerSetASTP  | AnswerSet für Astroviren |
https://demis.rki.de/fhir/ValueSet/answerSetBANP  | AnswerSet für Bacillus anthracis |
https://demis.rki.de/fhir/ValueSet/answerSetBOBP  | AnswerSet für (Lyme-) Borreliose, Borrelia burgdorferi |
https://demis.rki.de/fhir/ValueSet/answerSetBORP  | AnswerSet für Borrelia recurrentis |
https://demis.rki.de/fhir/ValueSet/answerSetBOVP  | AnswerSet für humanpathogene Bornaviren; Meldepflicht nur für den direkten Nachweis |
https://demis.rki.de/fhir/ValueSet/answerSetBPSP  | AnswerSet für Bordetella pertussis, Bordetella parapertussis |
https://demis.rki.de/fhir/ValueSet/answerSetBRUP  | AnswerSet für Brucella sp. |
https://demis.rki.de/fhir/ValueSet/answerSetCAMP  | AnswerSet für Campylobacter spp. (darmpathogen) |
https://demis.rki.de/fhir/ValueSet/answerSetCAUP  | AnswerSet für Candida auris; Meldepflicht nur für den direkten Nachweis |
https://demis.rki.de/fhir/ValueSet/answerSetCHLP  | AnswerSet für Chlamydia psittaci |
https://demis.rki.de/fhir/ValueSet/answerSetCKVP  | AnswerSet für Chikungunya-Virus |
https://demis.rki.de/fhir/ValueSet/answerSetCLOP  | AnswerSet für Clostridium botulinum oder Toxinnachweis |
https://demis.rki.de/fhir/ValueSet/answerSetCLTP  | AnswerSet für Tetanus, Clostridium tetani |
https://demis.rki.de/fhir/ValueSet/answerSetCORP  | AnswerSet für Corynebacterium spp. (Toxin bildend) |
https://demis.rki.de/fhir/ValueSet/answerSetCOXP  | AnswerSet für Coxiella burnetii |
https://demis.rki.de/fhir/ValueSet/answerSetCRYP  | AnswerSet für humanpathogene Cryptosporidium sp. |
https://demis.rki.de/fhir/ValueSet/answerSetCVDP  | AnswerSet für Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) |
https://demis.rki.de/fhir/ValueSet/answerSetCVSP  | AnswerSet für Severe-Acute-Respiratory-Syndrome-Coronavirus (SARS-CoV) |
https://demis.rki.de/fhir/ValueSet/answerSetCYMP  | AnswerSet für Cytomegalie, Cytomegalievirus |
https://demis.rki.de/fhir/ValueSet/answerSetDENP  | AnswerSet für Denguevirus |
https://demis.rki.de/fhir/ValueSet/answerSetEAHP  | AnswerSet für Amoebiasis, Entamoeba histolytica |
https://demis.rki.de/fhir/ValueSet/answerSetEBCP  | AnswerSet für Enterobacterales bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
https://demis.rki.de/fhir/ValueSet/answerSetEBVP  | AnswerSet für Ebolavirus |
https://demis.rki.de/fhir/ValueSet/answerSetECOP  | AnswerSet für Escherichia coli (sonstige darmpathogene Stämme) |
https://demis.rki.de/fhir/ValueSet/answerSetEHCP  | AnswerSet für E. coli (enterohämorrhagische Stämme) (EHEC) |
https://demis.rki.de/fhir/ValueSet/answerSetETVP  | AnswerSet für Enteroviren |
https://demis.rki.de/fhir/ValueSet/answerSetFRTP  | AnswerSet für Francisella tularensis |
https://demis.rki.de/fhir/ValueSet/answerSetFSVP  | AnswerSet für FSME-Virus |
https://demis.rki.de/fhir/ValueSet/answerSetGBSP  | AnswerSet für Gruppe-B-Streptokokken (GBS); Meldepflicht nur für den direkten Nachweis bei Schwangeren und Neugeborenen |
https://demis.rki.de/fhir/ValueSet/answerSetGFVP  | AnswerSet für Gelbfiebervirus |
https://demis.rki.de/fhir/ValueSet/answerSetGILP  | AnswerSet für Giardia lamblia |
https://demis.rki.de/fhir/ValueSet/answerSetHAVP  | AnswerSet für Hepatitis-A-Virus |
https://demis.rki.de/fhir/ValueSet/answerSetHBVP  | AnswerSet für Hepatitis-B-Virus; Meldepflicht für alle Nachweise |
https://demis.rki.de/fhir/ValueSet/answerSetHCVP  | AnswerSet für Hepatitis-C-Virus; Meldepflicht für alle Nachweise |
https://demis.rki.de/fhir/ValueSet/answerSetHDVP  | AnswerSet für Hepatitis-D-Virus; Meldepflicht für alle Nachweise |
https://demis.rki.de/fhir/ValueSet/answerSetHEVP  | AnswerSet für Hepatitis-E-Virus |
https://demis.rki.de/fhir/ValueSet/answerSetHFAP  | AnswerSet für Andere Erreger hämorrhagischer Fieber |
https://demis.rki.de/fhir/ValueSet/answerSetHFMP  | AnswerSet für Hand-Fuß-Mund-Krankheit |
https://demis.rki.de/fhir/ValueSet/answerSetHINP  | AnswerSet für Haemophilus influenzae; Meldepflicht nur für den direkten Nachweis aus Liquor oder Blut |
https://demis.rki.de/fhir/ValueSet/answerSetHTVP  | AnswerSet für Hantavirus |
https://demis.rki.de/fhir/ValueSet/answerSetINVP  | AnswerSet für Influenzavirus; Meldepflicht nur für den direkten Nachweis |
https://demis.rki.de/fhir/ValueSet/answerSetLEGP  | AnswerSet für Legionella sp. |
https://demis.rki.de/fhir/ValueSet/answerSetLEPP  | AnswerSet für humanpathogene Leptospira sp. |
https://demis.rki.de/fhir/ValueSet/answerSetLISP  | AnswerSet für Listeria monocytogenes; Meldepflicht nur für den direkten Nachweis aus Blut, Liquor oder anderen normalerweise sterilen Substraten sowie aus Abstrichen von Neugeborenen |
https://demis.rki.de/fhir/ValueSet/answerSetLSVP  | AnswerSet für Lassavirus |
https://demis.rki.de/fhir/ValueSet/answerSetMBVP  | AnswerSet für Marburgvirus |
https://demis.rki.de/fhir/ValueSet/answerSetMPMP  | AnswerSet für Mycoplasmen |
https://demis.rki.de/fhir/ValueSet/answerSetMPVP  | AnswerSet für Mumpsvirus |
https://demis.rki.de/fhir/ValueSet/answerSetMPXP  | AnswerSet für Orthopockenviren (Mpoxvirus) |
https://demis.rki.de/fhir/ValueSet/answerSetMRAP  | AnswerSet für Staphylococcus aureus (Methicillin-resistente Stämme); Meldepflicht nur für den Nachweis aus Blut oder Liquor |
https://demis.rki.de/fhir/ValueSet/answerSetMRSP  | AnswerSet für Middle-East-Respiratory-Syndrome-Coronavirus (MERS-CoV) |
https://demis.rki.de/fhir/ValueSet/answerSetMSVP  | AnswerSet für Masernvirus |
https://demis.rki.de/fhir/ValueSet/answerSetMYLP  | AnswerSet für Mycobacterium leprae |
https://demis.rki.de/fhir/ValueSet/answerSetMYTP  | AnswerSet für Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis; Meldepflicht für den direkten Erregernachweis sowie nachfolgend für das Ergebnis der Resistenzbestimmung; vorab auch für den Nachweis säurefester Stäbchen im Sputum |
https://demis.rki.de/fhir/ValueSet/answerSetNEIP  | AnswerSet für Neisseria meningitidis; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, hämorrhagischen Hautinfiltraten oder anderen normalerweise sterilen Substraten |
https://demis.rki.de/fhir/ValueSet/answerSetNOVP  | AnswerSet für Norovirus |
https://demis.rki.de/fhir/ValueSet/answerSetOPXP  | AnswerSet für Orthopockenviren (sonstige Orthopockenviren) |
https://demis.rki.de/fhir/ValueSet/answerSetPINP  | AnswerSet für Parainfluenzavirus |
https://demis.rki.de/fhir/ValueSet/answerSetPKVP  | AnswerSet für Orthopockenviren (Variolavirus) |
https://demis.rki.de/fhir/ValueSet/answerSetPLAP  | AnswerSet für Plasmodium spp. (Malaria) |
https://demis.rki.de/fhir/ValueSet/answerSetPOVP  | AnswerSet für Poliovirus |
https://demis.rki.de/fhir/ValueSet/answerSetPVBP  | AnswerSet für Ringelröteln, Parvovirus B 19 |
https://demis.rki.de/fhir/ValueSet/answerSetRBVP  | AnswerSet für Rabiesvirus |
https://demis.rki.de/fhir/ValueSet/answerSetRICP  | AnswerSet für Rickettsia prowazekii |
https://demis.rki.de/fhir/ValueSet/answerSetRSVP  | AnswerSet für Respiratorisches-Synzytial-Virus |
https://demis.rki.de/fhir/ValueSet/answerSetRTVP  | AnswerSet für Rotavirus |
https://demis.rki.de/fhir/ValueSet/answerSetRUVP  | AnswerSet für Rubellavirus |
https://demis.rki.de/fhir/ValueSet/answerSetSALP  | AnswerSet für Salmonella (sonstige) |
https://demis.rki.de/fhir/ValueSet/answerSetSHIP  | AnswerSet für Shigella sp. |
https://demis.rki.de/fhir/ValueSet/answerSetSPAP  | AnswerSet für Salmonella Paratyphi; Meldepflicht für alle direkten Nachweise |
https://demis.rki.de/fhir/ValueSet/answerSetSPNP  | AnswerSet für Streptococcus pneumoniae; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, Gelenkpunktat oder anderen normalerweise sterilen Substraten |
https://demis.rki.de/fhir/ValueSet/answerSetSPYP  | AnswerSet für Scharlach, Beta-hämolysierenden Streptokokken der Gruppe A |
https://demis.rki.de/fhir/ValueSet/answerSetSTYP  | AnswerSet für Salmonella Typhi; Meldepflicht für alle direkten Nachweise |
https://demis.rki.de/fhir/ValueSet/answerSetTRIP  | AnswerSet für Trichinella spiralis |
https://demis.rki.de/fhir/ValueSet/answerSetVCHP  | AnswerSet für Vibrio spp. (humanpathogen); soweit ausschließlich eine Ohrinfektion vorliegt nur bei Vibrio cholerae |
https://demis.rki.de/fhir/ValueSet/answerSetVZVP  | AnswerSet für Varizella-Zoster-Virus |
https://demis.rki.de/fhir/ValueSet/answerSetWNVP  | AnswerSet für West-Nil-Virus |
https://demis.rki.de/fhir/ValueSet/answerSetYENP  | AnswerSet für Yersinia spp. (darmpathogen) |
https://demis.rki.de/fhir/ValueSet/answerSetYPSP  | AnswerSet für Yersinia pestis |
https://demis.rki.de/fhir/ValueSet/answerSetZKVP  | AnswerSet für Zika-Virus |
https://demis.rki.de/fhir/ValueSet/materialABVP  | Material für Arboviren (sonstige) |
https://demis.rki.de/fhir/ValueSet/materialACBP  | Material für Acinetobacter spp. bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
https://demis.rki.de/fhir/ValueSet/materialADEP  | Material für Adenoviren; Meldepflicht bei akuter Infektion für Nachweise aus allen Körpermaterialien |
https://demis.rki.de/fhir/ValueSet/materialADVP  | Material für Adenoviren; Meldepflicht nur für den direkten Nachweis im Konjunktivalabstrich |
https://demis.rki.de/fhir/ValueSet/materialASTP  | Material für Astroviren |
https://demis.rki.de/fhir/ValueSet/materialBANP  | Material für Bacillus anthracis |
https://demis.rki.de/fhir/ValueSet/materialBOBP  | Material für (Lyme-) Borreliose, Borrelia burgdorferi |
https://demis.rki.de/fhir/ValueSet/materialBORP  | Material für Borrelia recurrentis |
https://demis.rki.de/fhir/ValueSet/materialBOVP  | Material für humanpathogene Bornaviren; Meldepflicht nur für den direkten Nachweis |
https://demis.rki.de/fhir/ValueSet/materialBPSP  | Material für Bordetella pertussis, Bordetella parapertussis |
https://demis.rki.de/fhir/ValueSet/materialBRUP  | Material für Brucella sp. |
https://demis.rki.de/fhir/ValueSet/materialCAMP  | Material für Campylobacter spp. (darmpathogen) |
https://demis.rki.de/fhir/ValueSet/materialCAUP  | Material für Candida auris; Meldepflicht nur für den direkten Nachweis |
https://demis.rki.de/fhir/ValueSet/materialCHLP  | Material für Chlamydia psittaci |
https://demis.rki.de/fhir/ValueSet/materialCKVP  | Material für Chikungunya-Virus |
https://demis.rki.de/fhir/ValueSet/materialCLOP  | Material für Clostridium botulinum oder Toxinnachweis |
https://demis.rki.de/fhir/ValueSet/materialCLTP  | Material für Tetanus, Clostridium tetani |
https://demis.rki.de/fhir/ValueSet/materialCORP  | Material für Corynebacterium spp. (Toxin bildend) |
https://demis.rki.de/fhir/ValueSet/materialCOXP  | Material für Coxiella burnetii |
https://demis.rki.de/fhir/ValueSet/materialCRYP  | Material für humanpathogene Cryptosporidium sp. |
https://demis.rki.de/fhir/ValueSet/materialCVDP  | Material für Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) |
https://demis.rki.de/fhir/ValueSet/materialCVSP  | Material für Severe-Acute-Respiratory-Syndrome-Coronavirus (SARS-CoV) |
https://demis.rki.de/fhir/ValueSet/materialCYMP  | Material für Cytomegalie, Cytomegalievirus |
https://demis.rki.de/fhir/ValueSet/materialDENP  | Material für Denguevirus |
https://demis.rki.de/fhir/ValueSet/materialEAHP  | Material für Amoebiasis, Entamoeba histolytica |
https://demis.rki.de/fhir/ValueSet/materialEBCP  | Material für Enterobacterales bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
https://demis.rki.de/fhir/ValueSet/materialEBVP  | Material für Ebolavirus |
https://demis.rki.de/fhir/ValueSet/materialECOP  | Material für Escherichia coli (sonstige darmpathogene Stämme) |
https://demis.rki.de/fhir/ValueSet/materialEHCP  | Material für E. coli (enterohämorrhagische Stämme) (EHEC) |
https://demis.rki.de/fhir/ValueSet/materialETVP  | Material für Enteroviren |
https://demis.rki.de/fhir/ValueSet/materialFRTP  | Material für Francisella tularensis |
https://demis.rki.de/fhir/ValueSet/materialFSVP  | Material für FSME-Virus |
https://demis.rki.de/fhir/ValueSet/materialGBSP  | Material für Gruppe-B-Streptokokken (GBS); Meldepflicht nur für den direkten Nachweis bei Schwangeren und Neugeborenen |
https://demis.rki.de/fhir/ValueSet/materialGFVP  | Material für Gelbfiebervirus |
https://demis.rki.de/fhir/ValueSet/materialGILP  | Material für Giardia lamblia |
https://demis.rki.de/fhir/ValueSet/materialHAVP  | Material für Hepatitis-A-Virus |
https://demis.rki.de/fhir/ValueSet/materialHBVP  | Material für Hepatitis-B-Virus; Meldepflicht für alle Nachweise |
https://demis.rki.de/fhir/ValueSet/materialHCVP  | Material für Hepatitis-C-Virus; Meldepflicht für alle Nachweise |
https://demis.rki.de/fhir/ValueSet/materialHDVP  | Material für Hepatitis-D-Virus; Meldepflicht für alle Nachweise |
https://demis.rki.de/fhir/ValueSet/materialHEVP  | Material für Hepatitis-E-Virus |
https://demis.rki.de/fhir/ValueSet/materialHFAP  | Material für Andere Erreger hämorrhagischer Fieber |
https://demis.rki.de/fhir/ValueSet/materialHFMP  | Material für Hand-Fuß-Mund-Krankheit |
https://demis.rki.de/fhir/ValueSet/materialHINP  | Material für Haemophilus influenzae; Meldepflicht nur für den direkten Nachweis aus Liquor oder Blut |
https://demis.rki.de/fhir/ValueSet/materialHTVP  | Material für Hantavirus |
https://demis.rki.de/fhir/ValueSet/materialINVP  | Material für Influenzavirus; Meldepflicht nur für den direkten Nachweis |
https://demis.rki.de/fhir/ValueSet/materialLEGP  | Material für Legionella sp. |
https://demis.rki.de/fhir/ValueSet/materialLEPP  | Material für humanpathogene Leptospira sp. |
https://demis.rki.de/fhir/ValueSet/materialLISP  | Material für Listeria monocytogenes; Meldepflicht nur für den direkten Nachweis aus Blut, Liquor oder anderen normalerweise sterilen Substraten sowie aus Abstrichen von Neugeborenen |
https://demis.rki.de/fhir/ValueSet/materialLSVP  | Material für Lassavirus |
https://demis.rki.de/fhir/ValueSet/materialMBVP  | Material für Marburgvirus |
https://demis.rki.de/fhir/ValueSet/materialMPMP  | Material für Mycoplasmen |
https://demis.rki.de/fhir/ValueSet/materialMPVP  | Material für Mumpsvirus |
https://demis.rki.de/fhir/ValueSet/materialMPXP  | Material für Orthopockenviren (Mpoxvirus) |
https://demis.rki.de/fhir/ValueSet/materialMRAP  | Material für Staphylococcus aureus (Methicillin-resistente Stämme); Meldepflicht nur für den Nachweis aus Blut oder Liquor |
https://demis.rki.de/fhir/ValueSet/materialMRSP  | Material für Middle-East-Respiratory-Syndrome-Coronavirus (MERS-CoV) |
https://demis.rki.de/fhir/ValueSet/materialMSVP  | Material für Masernvirus |
https://demis.rki.de/fhir/ValueSet/materialMYLP  | Material für Mycobacterium leprae |
https://demis.rki.de/fhir/ValueSet/materialMYTP  | Material für Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis; Meldepflicht für den direkten Erregernachweis sowie nachfolgend für das Ergebnis der Resistenzbestimmung; vorab auch für den Nachweis säurefester Stäbchen im Sputum |
https://demis.rki.de/fhir/ValueSet/materialNEIP  | Material für Neisseria meningitidis; Meldepflicht nur für den dire | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3108.html  | NM/PETProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3110.html  | NuclearCardiologyProtocol |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3111.html  | NuclearCardiologyRadiopharmaceutical |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3113.html  | PerfusionDefectType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3115.html  | StressImagingQualityIssue |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3116.html  | NMExtracardiacFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3118.html  | LevelofRisk |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3119.html  | LVFunction |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3120.html  | PerfusionFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3121.html  | PerfusionMorphology |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3122.html  | VentricularEnlargement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3200.html  | StressTestProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3201.html  | IndicationsforStressTest |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3202.html  | ChestPain |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3203.html  | ExerciserDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3204.html  | StressAgent |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3205.html  | IndicationsforPharmacologicalStressTest |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3206.html  | NoninvasiveCardiacImagingProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3207.html  | StressTestProcedurePhase |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3208.html  | ExerciseECGSummaryCode |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3209.html  | StressImagingSummaryCode |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3210.html  | SpeedofResponse |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3211.html  | BPResponse |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3213.html  | StressHemodynamicFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3215.html  | PerfusionFindingMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3220.html  | StressSymptom |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3221.html  | StressTestTerminationReason |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3230.html  | ECGFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3231.html  | STSegmentFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3232.html  | STSegmentLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3233.html  | STSegmentMorphology |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3234.html  | EctopicBeatMorphology |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3235.html  | PerfusionComparisonFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3236.html  | ToleranceComparisonFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3237.html  | WallMotionComparisonFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3238.html  | StressScoringScale |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3241.html  | HemodynamicMeasurementTechnique |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3250.html  | CatheterizationProcedurePhase |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3254.html  | ElectrophysiologyProcedurePhase |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3261.html  | StressProtocol |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3262.html  | ECGPatientStateValue |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3271.html  | HemodynamicPhysiologicalChallenge |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3337.html  | HemodynamicAnnotation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3403.html  | PercutaneousEntry |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3405.html  | ProcedureActionValue |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3411.html  | IntracoronaryDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3413.html  | AdverseOutcome |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3414.html  | ProcedureUrgency |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3416.html  | RespirationRhythm |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3422.html  | DeviceUseAction |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3423.html  | NumericDeviceCharacteristic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3425.html  | InterventionParameter |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3428.html  | CardiovascularImagingProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3429.html  | CatheterizationDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3440.html  | PeripheralPulseLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3441.html  | PatientAssessment |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3442.html  | PeripheralPulseMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3451.html  | CalibrationObject |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3462.html  | ChamberIdentification |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3463.html  | VentricleIdentification |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3466.html  | PlaneIdentification |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3472.html  | CardiacContractionPhase |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3480.html  | IVUSProcedurePhase |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3481.html  | IVUSDistanceMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3482.html  | IVUSAreaMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3483.html  | IVUSLongitudinalMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3485.html  | IVUSVolumeMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3487.html  | IntravascularVolumetricRegion |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3488.html  | Min/Max/Mean |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3489.html  | CalciumDistribution |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3491.html  | IVUSLesionMorphology |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3492.html  | VascularDissectionClassification |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3494.html  | IVUSNonMorphologicalFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3495.html  | IVUSPlaqueComposition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3496.html  | IVUSFiducialPoint |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3497.html  | IVUSArterialMorphology |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3515.html  | SpecimenCollection |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3520.html  | BloodSourceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3531.html  | OxygenAdministration |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3553.html  | CirculatorySupport |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3554.html  | Ventilation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3555.html  | Pacing |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3560.html  | BloodPressureMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3600.html  | RelativeTime |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3602.html  | HemodynamicPatientState |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3604.html  | ArterialLesionLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3606.html  | ArterialSourceLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3607.html  | VenousSourceLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3608.html  | AtrialSourceLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3609.html  | VentricularSourceLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3610.html  | GradientSourceLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3611.html  | PressureMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3614.html  | NonmitralValveArea |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3615.html  | ValveArea |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3616.html  | HemodynamicPeriodMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3617.html  | ValveFlow |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3619.html  | HemodynamicResistanceMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3620.html  | HemodynamicRatio |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3621.html  | FractionalFlowReserve |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3627.html  | MeasurementType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3628.html  | CardiacOutputMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3629.html  | ProcedureIntent |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3630.html  | CardiovascularAnatomicLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3640.html  | Hypertension |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3641.html  | HemodynamicAssessment |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3642.html  | DegreeFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3651.html  | HemodynamicMeasurementPhase |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3670.html  | ECGProcedureType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3671.html  | ReasonforECGStudy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3676.html  | LeadMeasurementTechnique |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3677.html  | SummaryCodesECG |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3700.html  | CathDiagnosis |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3701.html  | CardiacValve/Tract |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3703.html  | WallMotion |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3704.html  | MyocardiumWallMorphologyFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3705.html  | ChamberSize |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3706.html  | OverallContractility |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3707.html  | VSDDescription |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3710.html  | CoronaryDominance |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3711.html  | ValvularAbnormality |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3712.html  | VesselDescriptor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3713.html  | TIMIFlowCharacteristic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3714.html  | Thrombus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3715.html  | LesionMargin |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3716.html  | Severity |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3717.html  | LeftVentricleMyocardialWall17SegmentModel |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3718.html  | MyocardialWallSegmentsinProjection |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3719.html  | CanadianClinicalClassification |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3721.html  | CardiovascularSurgery |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3722.html  | DiabeticTherapy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3723.html  | MIType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3724.html  | SmokingHistory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3726.html  | CoronaryInterventionIndication |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3727.html  | CatheterizationIndication |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3728.html  | CathFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3729.html  | AdmissionStatus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3736.html  | NYHAClassification |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3739.html  | CathProcedureType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3740.html  | ThrombolyticAdministration |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3741.html  | LabVisitMedicationAdministration |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3742.html  | PCIMedicationAdministration |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3743.html  | Clopidogrel/TiclopidineAdministration |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3744.html  | EFTestingMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3745.html  | CalculationMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3746.html  | PercutaneousEntrySite |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3754.html  | VascularComplication |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3755.html  | CathComplication |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3756.html  | CardiacPatientRiskFactor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3757.html  | CardiacDiagnosticProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3758.html  | CardiovascularFamilyHistory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3760.html  | HypertensionTherapy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3761.html  | AntilipemicAgent |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3762.html  | AntiarrhythmicAgent |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3764.html  | MyocardialInfarctionTherapy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3769.html  | ConcernType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3770.html  | ProblemStatus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3772.html  | HealthStatus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3773.html  | UseStatus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3774.html  | SocialHistory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3777.html  | CardiovascularImplant |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3778.html  | Stage |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3779.html  | ImplantedDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3781.html  | LeftVentricleMyocardialWall18SegmentModel |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3782.html  | LeftVentricleBasalWall6Segments |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3783.html  | LeftVentricleMidlevelWall6Segments |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3784.html  | LeftVentricleApicalWall4Segments |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3785.html  | LeftVentricleApicalWall6Segments |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3802.html  | PlaqueStructure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3805.html  | StenosisType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3806.html  | StenosisShape |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3808.html  | AneurysmType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3809.html  | AssociatedCondition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3810.html  | VascularMorphology |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3813.html  | StentFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3814.html  | StentComposition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3815.html  | SourceofVascularFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3817.html  | VascularSclerosisType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3820.html  | NoninvasiveVascularProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3823.html  | RespiratoryStatus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3826.html  | HeartRhythm |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3827.html  | VesselSegment |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3829.html  | PulmonaryArtery |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3831.html  | StenosisLength |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3832.html  | StenosisGrade |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3835.html  | CardiacVolumeMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3837.html  | FiducialFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3838.html  | DiameterDerivation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3839.html  | CoronaryVein |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3840.html  | PulmonaryVein |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3843.html  | MyocardialSubsegment |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3850.html  | ContrastBolusSubstance |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4.html  | AnatomicRegion |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4005.html  | PartialViewSectionforMammography |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4009.html  | DXAnatomyImaged |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4010.html  | DXView |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4011.html  | DXViewModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4012.html  | ProjectionEponymousName |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4013.html  | AnatomicRegionforMammography |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4014.html  | ViewforMammography |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4015.html  | ViewModifierforMammography |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4016.html  | AnatomicRegionforIntraoralRadiography |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4017.html  | AnatomicRegionModifierforIntraoralRadiography |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4018.html  | PrimaryAnatomicStructureforIntraoralRadiography(PermanentDentitionDesignationofTeeth) |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4019.html  | PrimaryAnatomicStructureforIntraoralRadiography(DeciduousDentitionDesignationofTeeth) |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4020.html  | PETRadionuclide |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4021.html  | PETRadiopharmaceutical |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4025.html  | PrimaryAnatomicStructureforIntraoralRadiography(SupernumeraryDentitionDesignationofTeeth) |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4026.html  | PrimaryAnatomicStructureforIntraoralandCraniofacialRadiographyTeeth |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4028.html  | CraniofacialAnatomicRegion |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4029.html  | DermatologyAnatomicSite |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4030.html  | CT,MRandPETAnatomyImaged |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4031.html  | CommonAnatomicRegion |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4032.html  | MRSpectroscopyMetabolite |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4033.html  | MRProtonSpectroscopyMetabolite |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4040.html  | EndoscopyAnatomicRegion |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4042.html  | XA/XRFAnatomyImaged |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4050.html  | DrugorContrastAgentCharacteristic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4051.html  | GeneralDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4052.html  | PhantomDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4061.html  | HeadandNeckPrimaryAnatomicStructure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4062.html  | VLView |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4063.html  | VLDentalView |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4064.html  | VLViewModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4065.html  | VLDentalViewModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4066.html  | OrthognathicFunctionalCondition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4067.html  | OrthodonticFindingbyInspection |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4068.html  | OrthodonticObservableEntity |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4069.html  | DentalOcclusion |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4070.html  | OrthodonticTreatmentProgress |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4071.html  | GeneralPhotographyDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4072.html  | DevicesforthePurposeofDentalPhotography |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4200.html  | OphthalmicImagingAgent |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4201.html  | PatientEyeMovementCommand |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4202.html  | OphthalmicPhotographyAcquisitionDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4203.html  | OphthalmicPhotographyIllumination |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4204.html  | OphthalmicFilter |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4205.html  | OphthalmicLens |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4206.html  | OphthalmicChannelDescription |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4207.html  | OphthalmicImagePosition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4208.html  | MydriaticAgent |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4209.html  | OphthalmicAnatomicStructureImaged |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4210.html  | OphthalmicTomographyAcquisitionDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4211.html  | OphthalmicOCTAnatomicStructureImaged |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4214.html  | OphthalmicHorizontalDirection |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4215.html  | OphthalmicVerticalDirection |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4216.html  | OphthalmicVisualAcuityType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4220.html  | VisualFixationQualityDuringAcquisition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4221.html  | VisualFixationQualityProblem |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4222.html  | OphthalmicMacularGridProblem |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4231.html  | LensStatus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4232.html  | VitreousStatus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4233.html  | OphthalmicAxialLengthMeasurementsSegmentName |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4234.html  | RefractiveSurgeryType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4237.html  | LensConstantType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4238.html  | RefractiveErrorType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4253.html  | VisualFieldStaticPerimetryFixationStrategy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4254.html  | VisualFieldStaticPerimetryTestAnalysisResult |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4255.html  | VisualFieldIlluminationColor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4256.html  | VisualFieldProcedureModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4266.html  | OphthalmicAnatomicStructureReferencePoint |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4273.html  | RetinalSegmentationSurface |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4275.html  | AnteriorEyeSegmentationSurface |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4402.html  | HistoryofMalignantMelanoma |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4403.html  | HistoryofMelanomainSitu |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4404.html  | HistoryofNonMelanomaSkinCancer |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4405.html  | SkinDisorder |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4406.html  | PatientReportedLesionCharacteristic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4408.html  | LesionVisualFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4409.html  | SkinProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4410.html  | TopicalTreatment |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4411.html  | LesionColor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4412.html  | SpecimenStainforConfocalMicroscopy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_5.html  | TransducerApproach |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_501.html  | VolumetricViewDescription |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_502.html  | VolumetricViewModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6.html  | TransducerOrientation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_60.html  | ImagingAgentAdministrationAdverseEvent |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6000.html  | OverallBreastComposition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6001.html  | OverallBreastCompositionfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6002.html  | ChangeSinceLastMammogramorPriorSurgery |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6003.html  | ChangeSinceLastMammogramorPriorSurgeryfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6004.html  | MammographyShapeCharacteristic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6005.html  | ShapeCharacteristicfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6006.html  | MammographyMarginCharacteristic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6007.html  | MarginCharacteristicfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6008.html  | DensityModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6009.html  | DensityModifierfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_601.html  | BiosafetyLevel |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6010.html  | MammographyCalcificationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6011.html  | CalcificationTypefromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6012.html  | CalcificationDistributionModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6013.html  | CalcificationDistributionModifierfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6014.html  | MammographySingleImageFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6015.html  | SingleImageFindingfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6016.html  | MammographyCompositeFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6017.html  | CompositeFeaturefromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6018.html  | ClockfaceLocationorRegion |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6019.html  | ClockfaceLocationorRegionfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_602.html  | BiosafetyControlReason |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6020.html  | QuadrantLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6021.html  | QuadrantLocationfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6022.html  | Side |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6023.html  | SidefromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6024.html  | Depth |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6025.html  | DepthfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6026.html  | MammographyAssessment |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6027.html  | AssessmentfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6028.html  | MammographyRecommendedFollowup |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6029.html  | RecommendedFollowupfromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_603.html  | AnimalRoomType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6030.html  | MammographyPathologyCode |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6031.html  | BenignPathologyCodefromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6032.html  | HighRiskLesionPathologyCodefromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6033.html  | MalignantPathologyCodefromBIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6037.html  | MammographyQuantitativeTemporalDifferenceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6038.html  | MammographyQualitativeTemporalDifferenceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6039.html  | NippleCharacteristic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6040.html  | NonlesionObjectType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6043.html  | MammographyCADAnalysisType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6050.html  | BreastProcedureReported |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6051.html  | BreastProcedureReason |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6052.html  | BreastImagingReportSectionTitle |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6053.html  | BreastImagingReportElement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6054.html  | BreastImagingFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6055.html  | BreastClinicalFindingorIndicatedProblem |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6056.html  | AssociatedFindingforBreast |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6057.html  | DuctographyFindingforBreast |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6058.html  | ProcedureModifiersforBreast |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6059.html  | BreastImplantType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_606.html  | AnimalShelterType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6060.html  | BreastBiopsyTechnique |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6061.html  | BreastImagingProcedureModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6062.html  | InterventionalProcedureComplication |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6063.html  | InterventionalProcedureResult |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6064.html  | UltrasoundFindingforBreast |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6065.html  | InstrumentApproach |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6067.html  | FluidColor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6069.html  | NottinghamCombinedHistologicGrade |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6070.html  | BloomRichardsonHistologicGrade |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6071.html  | HistologicGradingMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6072.html  | BreastImplantFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6080.html  | GynecologicalHormone |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6081.html  | BreastCancerRiskFactor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6082.html  | GynecologicalProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6083.html  | ProceduresforBreast |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6084.html  | MammoplastyProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6085.html  | TherapiesforBreast |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6086.html  | MenopausalPhase |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6087.html  | GeneralRiskFactor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6088.html  | OBGYNMaternalRiskFactor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6089.html  | Substance |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_609.html  | AnimalFeedingMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6091.html  | RelativeFrequencyofEventValue |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6092.html  | Usage/ExposureQualitativeConcept |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6096.html  | PregnancyStatus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6097.html  | SideofFamily |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6099.html  | RacialGroup |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_610.html  | WaterType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6100.html  | ChestComponentCategory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6102.html  | ChestFindingorFeatureModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6103.html  | AbnormalLinesFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6104.html  | AbnormalOpacityFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6105.html  | AbnormalLucencyFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6107.html  | WidthDescriptor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6108.html  | ChestAnatomicStructureAbnormalDistribution |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6109.html  | RadiographicAnatomyFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_611.html  | AnesthesiaCategoryCodeTypeforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6110.html  | LungAnatomyFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6111.html  | BronchovascularAnatomyFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6112.html  | PleuraAnatomyFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6113.html  | MediastinumAnatomyFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6114.html  | OsseousAnatomyFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6115.html  | OsseousAnatomyModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6116.html  | MuscularAnatomy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6117.html  | VascularAnatomy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6118.html  | SizeDescriptor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6119.html  | ChestBorderShape |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_612.html  | AnesthesiaCategoryCodeTypefromAnesthesiaQualityInitiative |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6120.html  | ChestBorderDefinition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6121.html  | ChestOrientationDescriptor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6122.html  | ChestContentDescriptor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6124.html  | LocationinChest |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6125.html  | GeneralChestLocation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6126.html  | LocationinLung |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6127.html  | SegmentLocationinLung |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6128.html  | ChestDistributionDescriptor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6129.html  | ChestSiteInvolvement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_613.html  | AnesthesiaInductionCodeTypeforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6130.html  | SeverityDescriptor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6132.html  | ChestCalcificationDescriptor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6133.html  | ChestQuantitativeTemporalDifferenceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6134.html  | ChestQualitativeTemporalDifferenceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6137.html  | CADAnalysisType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6138.html  | ChestNonlesionObjectType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6139.html  | NonlesionModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_614.html  | AnesthesiaInductionCodeTypefromAnesthesiaQualityInitiative |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6140.html  | CalculationMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6142.html  | CalculatedValue |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6146.html  | TimePointType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6148.html  | MediastinumFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6149.html  | MediastinumAnatomy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_615.html  | AnesthesiaMaintenanceCodeTypeforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6159.html  | MalignancyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_616.html  | AnesthesiaMaintenanceCodeTypefromAnesthesiaQualityInitiative |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6160.html  | BreastPrimaryTumorAssessmentFromAJCC |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6161.html  | PathologicalRegionalLymphNodeAssessmentforBreast |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6162.html  | AssessmentofMetastasisforBreast |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6163.html  | MenstrualCyclePhase |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6165.html  | BreastLinearMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6166.html  | CADGeometrySecondaryGraphicalRepresentation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_617.html  | AirwayManagementMethodCodeTypeforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6170.html  | LobeofLung |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6171.html  | ZoneofLung |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_618.html  | AirwayManagementMethodCodeTypefromAnesthesiaQualityInitiative |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_619.html  | AirwayManagementSubMethodCodeTypeforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_620.html  | AirwayManagementSubMethodCodeTypefromAnesthesiaQualityInitiative |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6201.html  | ColonFindingorFeature |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6202.html  | ColonFindingorFeatureModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6203.html  | ColonNonlesionObjectType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6204.html  | AnatomicNoncolonFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6205.html  | ClockfaceLocationforColon |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6206.html  | RecumbentPatientOrientationforColon |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6207.html  | ColonQuantitativeTemporalDifferenceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6209.html  | ColonMorphologyDescriptor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_621.html  | MedicationTypeforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6210.html  | LocationinIntestinalTract |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6211.html  | ColonCADMaterialDescription |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6212.html  | CalculatedValueforColonFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_622.html  | MedicationTypeCodeTypefromAnesthesiaQualityInitiative |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_623.html  | MedicationforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_624.html  | InhalationalAnesthesiaAgentforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_625.html  | InjectableAnesthesiaAgentforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_626.html  | PremedicationAgentforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_627.html  | NeuromuscularBlockingAgentforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_629.html  | CarrierGasesforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_630.html  | LocalAnestheticsforSmallAnimalAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6300.html  | ProstateAnatomy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6301.html  | ProstateSectorAnatomyfromPIRADSv2 |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6302.html  | ProstateSectorAnatomyfromEuropeanConcensus16Sector(Minimal)Model |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6303.html  | ProstateSectorAnatomyfromEuropeanConcensus27Sector(Optimal)Model |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6304.html  | ProstateSectorAnatomyfromPIRADSv2.1 |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_631.html  | ProcedurePhaseRequiringAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6312.html  | CrosssectionalScanPlaneOrientation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6313.html  | HistoryofProstateDisease |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6319.html  | AbdominalInterventionType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_632.html  | SurgicalProcedurePhaseRequiringAnesthesia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6320.html  | AbdominopelvicIntervention |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6321.html  | ProstateCancerDiagnosticProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6322.html  | ProstateCancerFamilyHistory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6323.html  | ProstateCancerTherapy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6327.html  | ProstateImagingIndication |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6333.html  | mpMRIAssessmentType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6334.html  | mpMRIAssessmentTypefromPIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6335.html  | mpMRIAssessmentValue |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6336.html  | MRIAbnormality |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6337.html  | mpMRIProstateAbnormalityfromPIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6338.html  | mpMRIBenignProstateAbnormalityfromPIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6339.html  | MRIShapeCharacteristic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_634.html  | AnimalHandlingPhase |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6340.html  | ProstateMRIShapeCharacteristicfromPIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6341.html  | MRIMarginCharacteristic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6342.html  | ProstateMRIMarginCharacteristicfromPIRADS® |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6347.html  | ProstateMRIExtraprostaticFinding |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6348.html  | ProstateMRIAssessmentofExtraprostaticAnatomicSite |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_635.html  | HeatingMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6350.html  | EndorectalCoilFillSubstance |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_636.html  | TemperatureSensorDeviceComponentTypeforSmallAnimalProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_637.html  | ExogenousSubstanceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_638.html  | ExogenousSubstance |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_639.html  | TumorGraftHistologicType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_64.html  | ImagingAgentAdministrationPatientState |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6401.html  | NonlesionObjectTypePhysicalObject |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6402.html  | NonlesionObjectTypeSubstance |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6403.html  | NonlesionObjectTypeTissue |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6404.html  | ChestNonlesionObjectTypePhysicalObject |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_6405.html  | ChestNonlesionObjectTypeTissue |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_641.html  | Virus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_642.html  | Cytokine |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_643.html  | Toxin |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_644.html  | ExogenousSubstanceAdministrationSite |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_645.html  | ExogenousSubstanceOriginTissue |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_646.html  | PreclinicalSmallAnimalImagingProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_65.html  | ImagingAgentAdministrationPremedication |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_66.html  | ImagingAgentAdministrationMedication |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_67.html  | ImagingAgentAdministrationCompletionStatus |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_68.html  | ImagingAgentAdministrationPharmaceuticalPresentationUnit |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_69.html  | ImagingAgentAdministrationConsumable |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7.html  | UltrasoundBeamPath |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_70.html  | Flush |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7000.html  | DiagnosticImagingReportDocumentTitle |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7002.html  | DiagnosticImagingReportElement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7026.html  | RadiotherapeuticDoseMeasurementDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7027.html  | SegmentedRadiotherapeuticDoseMeasurementDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7030.html  | InstitutionalDepartment/Unit/Service |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7039.html  | PediatricSizeCategory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7040.html  | BroselowLutenPediatricSizeCategory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7064.html  | ModelUsage |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7101.html  | BrainAtlasFiducial |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7110.html  | FiducialCategory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7111.html  | Fiducial |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7112.html  | RadiotherapyFiducial |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7140.html  | BrainStructureforVolumetricMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7150.html  | SegmentationPropertyCategory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7151.html  | SegmentationPropertyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7152.html  | CardiacStructureSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7153.html  | CNSSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7154.html  | AbdominalSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7155.html  | ThoracicSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7156.html  | VascularSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7157.html  | DeviceSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7158.html  | ArtifactSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7159.html  | LesionSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7160.html  | PelvicOrganSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7161.html  | PhysiologySegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7163.html  | BreastSegmentationTypes |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7165.html  | AbstractSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7166.html  | CommonTissueSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7167.html  | PeripheralNervousSystemSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7168.html  | BrainLesionSegmentationTypeWithNecrosis |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7169.html  | BrainLesionSegmentationTypeWithoutNecrosis |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7170.html  | CouinaudLiverSegment |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7171.html  | LiverSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7180.html  | AbstractMultidimensionalImageModelComponentSemantic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7186.html  | AbstractMultidimensionalImageModelQualitativeDimensionSampleSemantic |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7191.html  | TissueSegmentationPropertyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7192.html  | AnatomicalStructureSegmentationPropertyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7193.html  | PhysicalObjectSegmentationPropertyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7194.html  | MorphologicallyAbnormalStructureSegmentationPropertyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7195.html  | FunctionSegmentationPropertyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7196.html  | SpatialandRelationalConceptSegmentationPropertyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7197.html  | BodySubstanceSegmentationPropertyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7198.html  | SubstanceSegmentationPropertyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7199.html  | AnatomicallyLocalizedLesionSegmentationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7230.html  | AutomationofMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7300.html  | ImplantMaterial |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7301.html  | InterventionType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7302.html  | ImplantTemplateViewOrientation |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7304.html  | ImplantTargetAnatomy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7307.html  | ImplantComponentType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7308.html  | HumanHipImplantComponentType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7309.html  | HumanTraumaImplantComponentType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7310.html  | ImplantFixationMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_74.html  | ImagingAgentAdministrationConsumableCatheterType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7450.html  | PersonRole |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7451.html  | FamilyMember |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7452.html  | OrganizationalRole |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7453.html  | PerformingRole |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7454.html  | AnimalTaxonomicRankValue |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7458.html  | PersonGenderIdentity |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7464.html  | GeneralRegionofInterestMeasurementModifier |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7465.html  | MeasurementDerivedFromMultipleROIMeasurements |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7469.html  | GenericIntensityandSizeMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7470.html  | LinearMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7471.html  | AreaMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7472.html  | VolumeMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7480.html  | Breed |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7482.html  | DXAnatomyImagedforAnimal |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7483.html  | CommonAnatomicRegionsforAnimal |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7484.html  | DXViewforAnimal |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7486.html  | MixedBreed |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_75.html  | LowHighorEqual |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7550.html  | AngleMeasurement |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_76.html  | PremedicationType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7600.html  | LymphNodeAnatomicSite |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7601.html  | HeadandNeckCancerAnatomicSite |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7602.html  | VertebralAnatomicStructure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7603.html  | Vertebra |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7604.html  | IntervertebralDisc |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7701.html  | FiberTractInBrainstem |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7702.html  | ProjectionandThalamicFiber |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7703.html  | AssociationFiber |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7704.html  | LimbicSystemTract |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7705.html  | CommissuralFiber |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7706.html  | CranialNerve |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7707.html  | SpinalCordFiber |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7710.html  | TractographyAnatomicSite |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8.html  | AngiographicInterventionalDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8101.html  | ContainerType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8102.html  | ContainerComponentType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8103.html  | AnatomicPathologySpecimenType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8104.html  | BreastTissueSpecimenType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8109.html  | SpecimenCollectionProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8110.html  | SpecimenSamplingProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8111.html  | SpecimenPreparationProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8112.html  | SpecimenStain |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8113.html  | SpecimenPreparationStep |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8114.html  | SpecimenFixative |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8115.html  | SpecimenEmbeddingMedia |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8121.html  | MicroscopyLensType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8122.html  | MicroscopyIlluminatorandSensorColor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8124.html  | MicroscopyFilter |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8125.html  | MicroscopyIlluminatorType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8130.html  | StainingProtocol |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8131.html  | PathologyImagingProtocol |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8134.html  | AnatomicStructure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8135.html  | MicroscopyAnnotationPropertyType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8136.html  | MicroscopyMeasurementType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9.html  | ImageGuidedTherapeuticProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9000.html  | PhysicalQuantityDescriptor |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_91.html  | FunctionalConditionPresentDuringAcquisition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_92.html  | JointPositionDuringAcquisition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9268.html  | PatientPositionAcquisitionDevices |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9271.html  | RTImagePatientPositionAcquisitionDevices |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9272.html  | RTROIImageAcquisitionContext |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_93.html  | JointPositioningMethod |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9300.html  | ProcedureDiscontinuationReason |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9301.html  | ModalityPPSDiscontinuationReason |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_94.html  | PhysicalForceAppliedDuringAcquisition |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9501.html  | PrescriptionAnatomyCategory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9502.html  | RTSegmentAnnotationCategory |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9505.html  | FixationorPositioningDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9513.html  | FixationDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9514.html  | AnatomicalStructureforRadiotherapy |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9515.html  | RTPatientSupportDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9516.html  | RadiotherapyBolusDeviceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9517.html  | RadiotherapyBlockDeviceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9520.html  | SegmentedRTAccessoryDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9525.html  | RadiationTherapyParticle |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9526.html  | IonTherapyParticle |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9527.html  | TeletherapyIsotope |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9528.html  | BrachytherapyIsotope |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9534.html  | RadiotherapyTarget |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9536.html  | RadiotherapyPrescribingandSegmentingPersonRole |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9541.html  | BeamLimitingDeviceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9545.html  | FixedBeamLimitingDeviceType |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9555.html  | RadiotherapyTreatmentPlanningPersonRole |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9562.html  | RadiotherapyTreatmentDeliveryPersonRole |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9572.html  | PatientShieldingDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9573.html  | PatientTreatmentPreparationDevice |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9577.html  | PatientTreatmentPreparationProcedure |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9579.html  | RTSegmentMaterial |
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9580.html  | RTSegmentationPropertyCategory |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Advance_Directive_Status  | Information Persönliche Erklärung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Allergies  | Vorliegen Allergien |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Assessment_Scales  | Assessment |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Behavior_Finding  | Auffälliges Verhalten |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Bladder_Continence_Status  | Harnkontinenz differenzierte Einschätzung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Bowel_Continence_Status  | Stuhlkontinenz differenzierte Einschätzung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Cognitive_Awareness  | Bewusstseinslage |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Constraint_Control_Seclusion  | Freiheitsentziehende Maßnahmen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Diagnosis_ICNP  | Pflegeproblem/Pflegediagnose ICNP |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Disability  | Einschränkung Funktionen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Disability_Degree_Presence_Status  | Grad Behinderung vorhanden |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Evacuation_Bladder_Content  | Art der Harnableitung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Evacuation_Intestinal_Contents  | Art der Stuhlableitung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Food_Administration_Form  | Kostdarreichungsform |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Food_Type  | Kostform |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Health_Care_Proxy_Type  | Art der Erklärung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Information_Legal_Guardian  | Information gesetzliche Betreuung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Information_Medication  | Information Einnahme Medikamente |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Interventions_ICNP  | Pflegerische Maßnahmen ICNP |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Isolation_Necessity  | Isolation Notwendig |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Isolation_Type  | Isolation Art |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Living_Condition  | Wohnverhältnis |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Medical_Device  | Medizinprodukt |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Medical_Product_Information  | Information Medizinprodukt |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Nutrition  | Ernährung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Nutritional_Information  | Hinweis Ernährung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Orientation_Person  | Orientierung Person |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Orientation_Place  | Orientierung Ort |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Orientation_Situation  | Orientierung Situation |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Orientation_Time  | Orientierung Zeit |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Pain_Symptom  | Schmerzsymptomatik |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Payment_Exemption  | Zuzahlungsbefreiung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Presence_Respiratory_Support  | Vorliegen Atmungsunterstützung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Problem_Presence  | Vorliegen Problem |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Relatives_Involvement  | Pflege durch Angehörige |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Relatives_Notification_Status  | Benachrichtigung von An- und Zugehörigen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Respiratory_Access  | Art der Luftleitung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Result_Qualitative  | Ergebnis Qualitativ |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Risk  | Risiko |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Risk_Presence  | Vorliegen von Risiken |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Type_Of_Facility  | Typ der Einrichtung |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-cypdisunitintakeresult  | Cyprus EHR Value Set: CYPDIS Unit Intake Result |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsiadverseeventtype  | Cyprus EHR Value Set: eHDSI Adverse Event Type |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsiallergennodrug  | Cyprus EHR Value Set: eHDSI Allergen No Drug |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsibloodgroup  | Cyprus EHR Value Set: eHDSI Blood Group |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsicodeprob  | Cyprus EHR Value Set: eHDSI Code Prob |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsimedicaldevice  | Cyprus EHR Value Set: eHDSI Medical Device |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsiprocedure  | Cyprus EHR Value Set: eHDSI Procedure |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsireactionallergy  | Cyprus EHR Value Set: eHDSI Reaction Allergy |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsiresolutionoutcome  | Cyprus EHR Value Set: eHDSI Resolution Outcome |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsiseverity  | Cyprus EHR Value Set: eHDSI Severity |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsisocialhistory  | Cyprus EHR Value Set: eHDSI Social History |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsistatuscode  | Cyprus EHR Value Set: eHDSI Status Code |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsivaccine  | Cyprys EHR Value Set: eHDSI Vaccine |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-nursingcategories  | Cyprus EHR Value Set: Nursing Categories |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-contactpersonlevel  | Cyprus EHR Value Set: Contact Person Level |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-diet  | Cyprus EHR Value Set: Diet |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-drugormedicationtype  | Cyprus EHR Value Set: Drug Or Medication Type |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-drugusestatus  | Cyprus EHR Value Set: Drug Use Status |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-findingrelatedtosleep  | Cyprus EHR Value Set: Finding Related To Sleep |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-respiratoryrhythm  | Cyprus EHR Value Set: Respiratory Rhythm |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-tobaccotype  | Cyprus EHR Value Set: Tobacco Type |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-heartrhythm  | Cyprus EHR Value Set: Heart Rhythm |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-alcoholstatus  | Cyprus EHR Value Set: Alcohol Status |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-alcoholtypes  | Cyprus EHR Value Set: Alcohol Types |
https://fhir.nhs.uk/STU3/ValueSet/CareConnect-AllergyManifestation-1  | Care Connect Allergy Manifestation |
http://terminology.hl7.org/ValueSet/device-kind  | FHIR Device Types |
http://terminology.hl7.org/ValueSet/edible-substance-type  | Types of Edible Substances |
http://terminology.hl7.org/ValueSet/gender-identity  | Gender Identity |
http://terminology.hl7.org/ValueSet/snomed-intl-gps  | SNOMED International Global Patient Set (GPS) |
http://terminology.hl7.org/ValueSet/v3-AllergyStatus  | Allergy Status |
http://terminology.hl7.org/ValueSet/v3-KnowledgeSubjectObservationValue  | KnowledgeSubjectObservationValue |
http://terminology.hl7.org/ValueSet/v3-KnowledgeSubtopicObservationValue  | KnowledgeSubtopicObservationValue |
http://terminology.hl7.org/ValueSet/v3-ObservationMeasureCountableItems  | ObservationMeasureCountableItems |
http://terminology.hl7.org/ValueSet/v3-immunizationForecastStatusObservationValue  | immunizationForecastStatusObservationValue |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.10  | Seizure or Serious Neurologic Dysfunction (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.100  | Third Degree Perineal Laceration (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.101  | Fourth Degree Perineal Laceration (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.102  | Ruptured Uterus (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.103  | Unplanned Hysterectomy (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.105  | Unplanned Operation (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.106  | Attempted Forceps Procedure (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.107  | Attempted Vacuum Procedure (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.108  | Fetal Presentation at Birth- Breech (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.109  | Fetal Presentation at Birth- Cephalic (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.11  | Newborn Given Surfactant Replacement (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.110  | Fetal Presentation at Birth- Other (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.111  | Route and Method of Delivery - Spontaneous (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.112  | Route and Method of Delivery - Forceps (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.113  | Route and Method of Delivery - Vacuum (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.114  | Route and Method of Delivery - Cesarean (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.115  | Route Method of Delivery - Trial of Labor (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.116  | Route and Method of Delivery - Scheduled C (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.119  | Problem Status Active (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.125  | Cervical Cerclage (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.127  | External Cephalic Version (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.128  | Tocolysis (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.129  | Premature Rupture (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.130  | Precipitous Labor (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.131  | Prolonged Labor (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.136  | Prepregnancy Diabetes (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.137  | Gestational Diabetes (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.138  | Prepregnancy Hypertension (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.139  | Gestational Hypertension (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.14  | Delivery (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.140  | Eclampsia (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.141  | Preterm Birth (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.142  | Poor Pregnancy Outcome History (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.143  | Infertility Treatment (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.145  | Artificial or Intrauterine Insemination (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.146  | Assistive Reproductive Technology (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.147  | Listeria (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.149  | Neonatal Death (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.15  | Physician (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.150  | Hysterotomy Hysterectomy (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.153  | Fetal Autopsy (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.154  | Karyotype Determination (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.16  | Doctor of Osteopathic Medicine (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.166  | Group B Streptococcus (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.167  | Cytomegalovirus (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.168  | Parvovirus (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.169  | Toxoplasmosis (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.176  | Transferred for Maternal Medical or Fetal Indicat |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.178  | Antibiotic Administration Procedure (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.188  | ICU Care (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.189  | Cleft Palate Alone (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.190  | Transfer to Facility (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.192  | Birth Place Hospital (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.193  | Birth Place Home Intended (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.194  | Birth Place Home Unintended (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.196  | Birth Place Freestanding Birthing Center (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.197  | Birth Place Clinic Office (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.198  | NICU Care (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.22  | Augmentation of Labor - Procedure (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.24  | Chorioamnionitis During Labor (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.25  | Fever Greater Than 100.4 (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.27  | Epidural Anesthesia - Procedure (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.29  | Spinal Anesthesia - Procedure (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.30  | Fetal Intolerance of Labor (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.31  | In-utero Resuscitation (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.32  | Further Fetal Assessment (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.33  | Operative Delivery (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.34  | Induction of Labor (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.35  | Spontaneous Onset of Labor (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.36  | Meconium Staining (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.37  | Non-vertex presentation in active phase of (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.39  | Immature Fetus (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.40  | Inflammation Indication (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.41  | Breastfed Infant (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.53  | Anencephaly of the Newborn (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.54  | Cyanotic Congenital Heart Disease (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.55  | Congenital Diaphragmatic Hernia (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.56  | Karyotype Confirmed (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.57  | Suspected Chromosomal Disorder (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.58  | Cleft Lip with or without Cleft Palate (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.6  | Neonatal Sepsis (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.60  | Cleft Lip without Cleft Palate (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.61  | Down Syndrome (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.62  | Gastroschisis of the Newborn (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.63  | Hypospadias (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.65  | Meningomyelocele/Spina Bifida - Newborn (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.66  | Omphalocele of the Newborn (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.9  | Significant Birth Injury (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.93  | Chlamydia (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.95  | Pregnant (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.96  | Hepatitis B (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.97  | Hepatitis C (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.98  | Syphilis (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.99  | Transfusion Whole Blood or Packed Red Bld (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.11  | JCIH-EHDI Hearing Loss Risk Factors |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.12  | JCIH-EHDI Hearing Loss Risk Factors - Procedures |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.14  | JCIH-EHDI Newborn Hearing Loss Diagnosis |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.15  | JCIH-EHDI Reason for no Hearing Loss Diagnosis |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.16  | JCIH-EHDI Newborn Hearing Loss Referrals |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.17  | JCIH-EHDI Newborn Hearing Procedure |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.20  | JCIH-EHDI Procedure Declined |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.7  | JCIH-EHDI Reason for no Follow-up - Patient Reason |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.1  | Autopsy Performed (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.13  | Family History (HW) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.14  | Mother Breastfeeding (HW) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.19  | Associated Conditions (HW) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.2  | Autopsy Not Performed (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.6  | Death Certification (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.7  | Interventions (HW) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.8  | Dietary Behavior (HW) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.9  | Physical Activity Behavior (HW) |
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.75  | Joint Commission Medical Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.11222.4.11.5025  | Original Specimen Type Modifier PHLIP |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9  | Substance Other Than Clinical Drug (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98  | Route of Administration |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2  | Advance Directive Type Value Set |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.1  | Amniotic Fluid Conditions (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.10  | Type of Twin (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.11  | Twin Placenta (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.12  | Umbilical Cord Complication (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.13  | Infant Fetal Complications (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.14  | Placental Measurement (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.2  | Cord Insertion Type (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.3  | Hospital Care-Setting (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.4  | Maternal Exposures (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.5  | Intended Newborn Feeding Type (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.6  | Placenta Type (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.7  | Placental Conditions (HL7) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.34  | Patient Education |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.38  | Current Smoking Status (NAACCR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.41  | Tobacco Use |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.49  | Residence and Accommodation Type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.60  | Priority Level (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.13.277  | Birth Defect Diagnosis |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.22  | Laterality (NAACCR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.26  | Radiation Rx and Boost Radiation SNOMEDCT (NAACCR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.29  | NAACCR SNOMEDCT Cancer Reportability List |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.2  | Allergy/Adverse Event Type Value Set |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.8  | Problem Severity |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.2  | Problem Type Value Set |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.4  | Problem Value Set |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.19  | Medication Type Value Set |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.9  | Body Site Value Set |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.21  | Medication Vehicle Value Set |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.60  | Social History Type Value Set |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.68  | Problem Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1007  | Major Site of Disease (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1009  | Microorganism |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1010  | Microscopic Exam Culture Site (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1013  | Missing Lab Result Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1014  | Modifier or Qualifier |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1018  | Non Paint Lead Source |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1019  | Non-paint lead source - hobby related |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1022  | Occupation Risk Category (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1026  | Pregnancy Trimester |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1027  | Previous Vaccine History |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1032  | Rash Distribution (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1033  | Rash Location First Noted (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1035  | Reason Therapy Stopped (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1036  | Referral Status (CRA) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1037  | Risk Category |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1051  | Substance Treatment Refusal Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1052  | Transmission Setting (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1056  | Vaccination Location (CRA) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1057  | Vaccine Contraindications |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1060  | Abnormal Chest X-ray Condition Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1067  | Body Substance |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1068  | Event |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1069  | Material |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1074  | Animal |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1075  | Physical Object |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1076  | Situation with Explicit Context |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1109  | Procedure by Site (SNOMED) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3017  | Lab Test Result (PHLIP Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3024  | Blood Contact Frequency (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3025  | Case Confirmation Method |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3026  | Case Detection Method |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3027  | Case Transmission Mode |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3028  | Contact Type (Hepatitis A) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3029  | Contact Type (Hepatitis B and C) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3033  | Number Of Sex Partners (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3034  | Outbreak Type (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3036  | Reporting Source Type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3037  | Tattoo Obtained From (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3038  | Vaccine Dose Number (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3044  | Microbiology strain |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3045  | Microorganism (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3048  | Lab Test Interpretation |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3049  | Lab Test Result Qualitative |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3058  | Cancer Type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3059  | Clinical Syndrome (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3060  | Immunosuppressed Condition |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3062  | Transplant Organ |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3063  | Virus Type (Arboviral Disease) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3066  | Bat Species (Animal Rabies) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3068  | Animal Species (Animal Rabies) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3069  | Yes No Unknown Not Done |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3071  | Pregnancy Outcome (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3072  | Animal Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3073  | Botulinum Toxin Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3075  | Cholera Risk Factor (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3076  | Cholera Sequelae (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3077  | Cholera Signs Symptoms (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3078  | Cyclosporiasis Signs Symptoms (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3079  | Day Care Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3080  | Eosin Units (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3081  | Fetal Neonatal Infection Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3082  | Fetal Neonatal Specimen Type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3085  | Fresh Berries (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3086  | Fresh Herbs (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3087  | Fresh Produce (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3088  | Information Source |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3090  | Lettuce Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3091  | Maternal Infection (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3092  | Meat Purchase Info (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3094  | Other Related Cases |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3095  | Outbreak Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3096  | Pork Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3097  | Present Absent Unknown Not Examined |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3098  | Recreational Water (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3099  | Seafood Purchase Info (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3101  | Skin Exposure (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3107  | Travel Mode |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3108  | Travel Purpose |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3110  | Trichinellosis Signs Symptoms (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3111  | Typhoid Signs Symptoms (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3112  | Underlying Conditions |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3113  | Water Salinity (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3116  | Notifiable Condition (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3118  | Medication Treatment (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3119  | Acute Convalescent IgG Difference (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3120  | Antibiotic Received (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3121  | Birth Attendees (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3122  | Birth Location (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3123  | Birth Outcome (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3124  | Body Region (Tetanus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3126  | Genotype (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3127  | Genotype (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3128  | Immunization Information Source (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3129  | Injury Occurred Environment (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3130  | Injury Type (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3131  | Lab Result (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3132  | Lab Result (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3134  | No Case Reason (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3135  | Non-Live Birth Outcome (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3140  | Specimen Source (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3141  | Specimen Source (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3142  | Test Method EIA IgM |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3143  | Tetanus Type (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3144  | Treatment Outcome Tetanus (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3145  | Vaccine Doses Received (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3146  | Vaccine Doses Received (Tetanus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3148  | PCR Specimen Source (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3149  | Lab Test Method (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3160  | Microscopic Exam Type (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3161  | Primary Reason For Evaluation (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3162  | Risk Factors (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3163  | Immigration Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3164  | Sputum Culture Conversion Not Documented Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3167  | Therapy Extended Reason (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3203  | Treatment status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3204  | Non-Laboratory Intervention and Procedure |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3209  | Exposure Location |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3210  | Contact Type (Hepatitis B) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3211  | Material exposure type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3212  | Signs and Symptoms (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3213  | Signs and Symptoms (Acute Hepatitis B) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3214  | Signs and Symptoms (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3215  | Signs and Symptoms (Tularemia) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3220  | Disease Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3221  | Disease Type (Acute Hepatitis B) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3222  | Disease Type (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3223  | Disease Type (Tularemia) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3225  | Blood or body fluid exposure frequency |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3226  | Blood or body fluid exposure related procedure |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3228  | Sociobehavioral risk factor |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3230  | Disease Type (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3231  | Disease Type (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3232  | HIV Status (PHCR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3240  | Flu Signs and Symptoms |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3242  | Risk Factor (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3243  | Lab Test Finding (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3246  | Specimen (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3251  | Lab Test Procedure (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3252  | Lab Test Interpretation (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3253  | Obesity Severity (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3254  | Employment Status (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3255  | Case Contact Signs and Symptoms (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3256  | Time Frame (Daily Weekly) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3257  | Surveillance Method (Novel Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3258  | Change Pattern |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3259  | Age Group (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3261  | Death Location (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3262  | Lab Test Procedure (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3263  | Lab Test Interpretation (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3264  | Sterile Specimen (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3265  | Positive Negative Unknown |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3266  | Microorganism (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3267  | Non-Sterile Specimen (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3268  | Acute Illness Complications (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3269  | Underlying Conditions (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3271  | Therapy Prior Illness Onset (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3272  | Therapy After Illness Onset (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3275  | Relationship (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3282  | Specimen Collection Method |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3285  | Anatomical Entity (Body Site) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3288  | Vaccination Contraindication (IIS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3289  | Vaccination Reaction and Adverse Event (IIS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3293  | Evidence Of Immunity (IIS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3301  | Lab Test Interpretation (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3302  | Lab Test Procedure (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3303  | Specimen Source (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3304  | Parotitis Laterality (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3305  | Type of Deafness (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3306  | Lab Test Procedure (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3307  | Specimen Source (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3308  | Complications (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3310  | Medication Missed (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3312  | Medication Treatment (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3313  | Species (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3314  | Specimen Type (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3317  | Antimicrobial Susceptibility Test Method (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3318  | Bacterial Infection Syndrome (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3319  | Oxacillin Interpretation (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3320  | Serotype Method (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3321  | Sterile Specimen (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3322  | Underlying Conditions (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3336  | Susceptibility Result (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3359  | Evaluation Finding |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3407  | Case Class Status (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3409  | Transmission Setting (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3410  | Vaccine Not Given Reasons (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3411  | Body Region Tetanus (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3412  | Injury Occurred Environment (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3413  | Injury Type (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3414  | Birth Attendees (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3417  | Contact Type Hepatitis A (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3418  | Sexual Preference (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3419  | Lab Test Result Lyme (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3420  | Microorganism (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3421  | Bacterial Infection Syndrome (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3422  | Associated Conditions (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3425  | Geographic Region (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3432  | Serogroup (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3435  | Serotype (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3501  | Bacterial Infectious Disease |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3502  | Infectious Disease |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3503  | Pneumonia Disease |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3587  | Flu Activity Code |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3594  | Campylobacter Organism |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4000  | Lab Result (Amebiasis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4001  | Lab Result (Anaplasma) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4002  | Lab Result (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4003  | Lab Result (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4004  | Lab Result (Arenavirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4005  | Lab Result (Babesiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4006  | Lab Result (Bartonellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4007  | Lab Result (Blastomycosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4008  | Lab Result (Botulism) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4009  | Lab Result (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4010  | Lab Result (California serogroup virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4011  | Lab Result (Campylobacteriosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4012  | Lab Result (Chagas) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4013  | Lab Result (Chancroid) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4014  | Lab Result (Chlamydia trachomatis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4015  | Lab Result (Cholera) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4016  | Lab Result (Clostridium perfringens) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4017  | Lab Result (Clostridium perfringens Epsilon Toxin) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4018  | Lab Result (Coccidioidomycosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4019  | Lab Result (Colorado Tick Fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4020  | Lab Result (Creutzfeldt-Jakob disease) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4021  | Lab Result (Cryptococcosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4022  | Lab Result (Cryptosporidiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4023  | Lab Result (Cyclosporiasis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4024  | Lab Result (Cysticercosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4025  | Lab Result (Dengue) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4026  | Lab Result (Diphtheria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4027  | Lab Result (Eastern equine encephalitis virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4028  | Lab Result (Ebolavirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4029  | Lab Result (E. coli STEC) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4030  | Lab Result (Ehrlichia chaffeensis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4031  | Lab Result (Ehrlichia ewingii) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4032  | Lab Result (Ehrlichiosis Anaplasmosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4033  | Lab Result (Genital Warts) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4034  | Lab Result (Giardiasis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4035  | Lab Result (Glanders) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4036  | Lab Result (Gonorrhea) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4037  | Lab Result (Granuloma Inguinale) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4038  | Lab Result (Haemophilus influenzae) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4039  | Lab Result (Hansen's Disease) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4040  | Lab Result (Hantavirus Pulmonary Syndrome) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4041  | Lab Result (Hendra virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4042  | Lab Result (Hepatitis A) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4043  | Lab Result (Hepatitis B) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4044  | Lab Result (Hepatitis C) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4045  | Lab Result (Hepatitis D) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4046  | Lab Result (Hepatitis E) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4047  | Lab Result (Herpes Simplex) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4048  | Lab Result (Histoplasmosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4049  | Lab Result (HIV) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4050  | Lab Result (Influenza A virus, H1N1 2009 strain) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4051  | Lab Result (Jamestown Canyon virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4052  | Lab Result (Legionellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4053  | Lab Result (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4054  | Lab Result (Listeriosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4055  | Lab Result (Lyme disease) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4056  | Lab Result (Lymphogranuloma Venereum) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4057  | Lab Result (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4058  | Lab Result (Marburgvirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4059  | Lab Result (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4060  | Lab Result (Melioidosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4061  | Lab Result (Meningococcal Disease) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4062  | Lab Result (Monkeypox Orthopox) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4063  | Lab Result (MRSA) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4064  | Lab Result (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4065  | Lab Result (Nipah Virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4066  | Lab Result (Nongonococcal Urethritis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4067  | Lab Result (Nontuberculous Mycobacteria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4068  | Lab Result (Norovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4069  | Lab Result RCMT (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4070  | Lab Result (Plague) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4071  | Lab Result (Polio) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4072  | Lab Result (Powassan virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4073  | Lab Result (Prion Disease) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4074  | Lab Result (Psittacosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4075  | Lab Result (Q Fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4076  | Lab Result (Rabies) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4077  | Lab Result (Relapsing Fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4078  | Lab Result (Respiratory Syncytial Virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4079  | Lab Result (Rickettsial infection, other) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4080  | Lab Result (Rift Valley Fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4081  | Lab Result (Rotavirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4082  | Lab Result RCMT (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4083  | Lab Result (Salmonellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4084  | Lab Result (SARS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4085  | Lab Result (Shigella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4086  | Lab Result (Smallpox) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4087  | Lab Result (Spotted fever rickettsiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4088  | Lab Result (Staphylococcus aureus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4089  | Lab Result (Staphylococcus aureus enterotoxin B) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4090  | Lab Result (Staphylococcus aureus food poisoning) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4091  | Lab Result (Staphylococcal TSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4092  | Lab Result (St. Louis encephalitis virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4093  | Lab Result (Streptococcus pneumoniae) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4094  | Lab Result (Streptococcal TSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4095  | Lab Result (Streptococcus, group A) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4096  | Lab Result (Streptococcus, group B) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4097  | Lab Result (Syphilis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4098  | Lab Result (Tetanus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4099  | Lab Result (Toxoplasmosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4100  | Lab Result (Trichinellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4101  | Lab Result (Tuberculosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4102  | Lab Result (Tularemia) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4103  | Lab Result (Typhoid Fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4104  | Lab Result (Typhus group rickettsiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4105  | Lab Result (Vaccinia) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4106  | Lab Result (Vancomycin resistant Enterococcus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4107  | Lab Result (Varicella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4108  | Lab Result (Vesicular Stomatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4109  | Lab Result (Vibriosis, non-cholera) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4110  | Lab Result (Viral Hemorrhagic Fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4111  | Lab Result (VISA) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4112  | Lab Result (VRSA) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4113  | Lab Result (Western equine encephalitis virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4114  | Lab Result (West Nile virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4115  | Lab Result (Yellow Fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4116  | Lab Result (Yersiniosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4275  | Lab Result (Cancer Morphology) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4276  | Lab Result (Pesticide) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5001  | Specimen Type PHLIP |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5004  | Specimen Reject Reason (SCT) (PHLIP) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5013  | Suspected Agent (PHLIP Sal) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5021  | Original Specimen Source Site PHLIP (PLT212) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5022  | Original Specimen Source Site Modifier PHLIP |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5023  | Original Specimen Collection Method PHLIP |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5024  | Original Specimen Type PHLIP |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5026  | Lab Test Result PHLIP Salmonella |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5028  | Method Detail (PHLIP) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6001  | Certifier Types (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6002  | Manner of Death (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6004  | Contributory Tobacco Use (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6005  | Transportation Relationships (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6027  | Smoking Status (PI) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6054  | Lab Test Result (Reportable Conditions) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6070  | Infections During Pregnancy - Live Birth (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6071  | Gonorrhea (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6072  | Trachoma (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7103  | VPD Laboratory Coded Observation |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7104  | VPD Specimen Type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7105  | VPD Specimen Collection Method |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7106  | VPD Specimen Source Body Site |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7108  | VPD Specimen Condition |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7110  | VPD Specimen Reject Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7111  | Birth Attendant Titles (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7112  | Fetal Death Time Points (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7113  | Fetal Presentations (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7115  | Karyotype Suspected Chromosomal Disorder (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7116  | Karyotype Down Syndrome (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7117  | Labor and Delivery Characteristics (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7118  | Delivery Routes (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7119  | Maternal Morbidities (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7121  | Newborn Abnormal Conditions (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7122  | Newborn Congenital Anomalies (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7123  | Onset Labor (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7124  | Birth or Delivery Occurred (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7126  | Pregnancy Risk Factors (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7135  | Infections During Pregnancy Fetal Death (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7136  | Obstetric Procedures (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7137  | Autopsy Examination (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7138  | Histological Placental Examination (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7140  | Autopsy Planned (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7142  | Non-Vertex Presentation (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7143  | Steroids For Fetal Lung Maturation (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7153  | Estimated Time of Death No Labor Ongoing (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7154  | Fetal Presentation at Birth- Unknown (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7156  | Assisted Ventilation (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7165  | Previous Cesarean (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7167  | Case Transmission Mode (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7168  | Notifiable Event Disease Condition (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7170  | Specimen Site (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7171  | Salmonella Serogroup (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7172  | Shigella Serogroup (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7173  | Campylobacter Species (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7174  | Campylobacter Nonculture Test Type (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7175  | E. coli Culture Isolate Id Serotype (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7177  | E. coli Shiga Toxin Test Type (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7178  | E. coli Shiga Toxin (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7179  | Vibrio Culture Species (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7180  | Vibrio Serotype (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7181  | Vibrio Biotype (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7182  | Vibrio Cholera Toxin Test Type (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7183  | Listeria Culture Species (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7189  | Specimen Source (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7192  | HIV Status (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7194  | Drugs Used (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7195  | Clinician Observed Lesions (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7199  | Detection Method (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7200  | Lab Results (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7203  | Quantitative Syphilis Test Result (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7206  | Lab Test Result Qualitative (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7212  | Certifier Titles (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7216  | Place of Death (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7217  | Lab Test Reactivity (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7218  | Syphilis Clinical Stage (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7219  | Syphilis Surveillance Stage (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7220  | Pregnancy Treatment Stage (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7223  | Birth Status (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7224  | Darkfield DFA Result (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7225  | Signs Symptoms (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7227  | VDRL Test Result (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7228  | CSF WBC Protein Result (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7229  | Syphilis Treatment Infant (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7234  | Qual Lab Result Positive (Reportable Conditions) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7235  | Qual Lab Result Negative (Reportable Conditions) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7236  | Qual Lab Result Inconc (Reportable Conditions) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7244  | History of Disease as Evidence Of Immunity (IIS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7245  | Serological Evidence Of Immunity (IIS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7247  | Symptoms (EVD Triage) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7250  | Observation Identifiers (EVD Triage) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7256  | Morphologic Abnormalities of Neoplasms |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7257  | Abdominal Pain (CDS - EHR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7258  | Weakness (CDS - EHR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7259  | Fever (CDS - EHR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7260  | Headache (CDS - EHR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7261  | Hemorrhage (CDS - EHR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7262  | Muscle Pain (CDS - EHR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7263  | Vomiting (CDS - EHR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7264  | Diarrhea (CDS - EHR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7269  | Reason for Missing Test (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7270  | Lab Test Result Interpretation (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7273  | Death Pronouncement Finding (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7274  | Death Pronouncement Procedure (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7277  | Transport Mode to Hospital (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7282  | Complications (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7283  | Signs and Symptoms (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7284  | Signs and Symptoms (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7285  | Complications (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7329  | Type of Testing at CDC (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7332  | Setting of Further Spread |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7333  | Timing of Maternal Treatment (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7334  | Lab Test Interpretation (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7343  | Lab Result (Chikungunya virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7344  | Lab Result (Crimean-Congo hemorrhagic fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7345  | Lab Result (Guanarito hemorrhagic fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7346  | Lab Result (Junin hemorrhagic fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7347  | Lab Result (Lassa fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7348  | Lab Result (Lujo virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7349  | Lab Result (Machupo hemorrhagic fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7350  | Lab Result (Sabia virus hemorrhagic fever) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7351  | Lab Test Performed Modifier (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7357  | Hysterectomy (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7358  | Hysterotomy (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7359  | Point of Origin (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7361  | Disposition OPD (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7362  | Follow-up Attempt Outcome (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7365  | Priority (Type) of Admission or Visit (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7369  | Present on Admission (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7379  | Methods of Disposition (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7402  | Patient Residence (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7403  | Injury or Poisoning (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7405  | Co-morbid Conditions (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7419  | Provider ED (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7422  | Fetal Death Cause or Condition (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7423  | Pregnancy Resulting From Fertility Enhancing Drugs |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7431  | Surfactant Replacement Therapy (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7432  | Asthma (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7433  | Condition Control (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7437  | Disposition ED (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7439  | Episode of Care (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7440  | Hospital Discharge Status (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7441  | Neurological Manifestation (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7449  | Qualitative Lab Result (RCMT) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7450  | Vaccine Event Information Source (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7451  | Type of Testing at CDC (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7453  | Body Region(s) of Rash |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7454  | Character of Lesions |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7458  | Transmission Mode (Zika) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7459  | Signs Symptoms (Zika) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7460  | Signs Symptoms (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7462  | Prenatal Diagnostic Procedures |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7463  | Specimen Type (Zika) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7464  | Insect Repellant |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7465  | Vector (Zika) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7466  | Complications (Zika) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7467  | Drug Disease Interaction (Dengue) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7468  | Length of Gestation in Weeks |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7469  | Microcephaly Causes |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7470  | Head Circumference Findings |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7473  | Diagnostic Lab Test Findings (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7474  | Type of Complication (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7476  | Positive Negative Equivocal Not Done |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7477  | Positive Negative 4 Fold Rise Not Done |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7478  | Serotype (Dengue) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7479  | Lab Result (Zika virus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7481  | Signs Symptoms (Dengue) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7482  | Signs Symptoms (Chikungunya) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7487  | Reason for Hospitalization (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7488  | Specimen Type (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7489  | Transmission Mode (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7490  | Clinical Syndrome - Secondary (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7491  | Pregnancy Complications (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7492  | Newborn Complications (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7494  | Pregnancy Outcome |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7495  | Serotype (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7516  | Data Elements (NND Hep A Acute) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7517  | Data Elements (NND Hep B Acute) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7519  | Data Elements (NND Hep B Chronic) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7520  | Data Elements (NND Hep C Acute) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7521  | Data Elements (NND Hep C Chronic) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7523  | Data Elements (NND Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7524  | Data Elements (NND STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7526  | Method of Delivery VaginalSpon Finding (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7527  | Method of Delivery Cesarean Finding (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7528  | Method of Delivery Vaginal Forceps Finding (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7529  | Method of Delivery Vaginal Vacuum Finding (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7530  | Scheduled Cesarean Finding (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7531  | Induction of Labor Finding (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7532  | Augmentation of Labor Finding (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7538  | Type of Complication (Babesiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7540  | Blood Product |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7541  | Clinical Manifestations (Babesiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7543  | Lab Result (Hantavirus Infection) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7544  | Outdoor Activities |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7551  | Test Result Coded Qualitative |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7552  | Organism Identified AST (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7553  | Specimen Type AST (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7554  | Specimen Collection Site AST (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7556  | Susceptibility Test Method (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7557  | Susceptibility Test Interpretation (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.756  | Gender Identity |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7563  | Sexual Orientation |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7585  | Fetal Remains Disposition Method (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7596  | Adverse Event Severity (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7604  | Route Method of Delivery SpontaneousProcedure (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7607  | Type of Testing at CDC |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7608  | Type Of Complication (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7609  | Sexual Orientation (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7610  | Gender Identity (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7614  | Case Appraisal (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7615  | Pre-Pregnancy SerologicalTestInterp (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7616  | Specimen From Mother Or Infant (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7617  | Organism (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7621  | Signs and Symptoms (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7622  | Positive Negative Not Done |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7626  | Test Result (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7627  | Specimen Collection Source (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7633  | Day Care Setting (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7636  | Medical History (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7643  | Vibrio Species (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7644  | Vibrio Cholera Serotype (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7645  | Vibrio Cholera Biotype (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7647  | Typhoid Paratyphoid Serotype (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7648  | Yes No Not Tested (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7649  | Signs and Symptoms (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7650  | Type Of Complication (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7651  | Previous Case Diagnosed By (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7653  | Specimen Type (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7655  | PCR Specimen Source (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7656  | Specimen Source (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7657  | Specimen Type (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7659  | Type of Testing at CDC(Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7660  | Type of Complication (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7662  | Signs and Symptoms (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7663  | Data Elements (NND Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7664  | Data Elements (NND Babesiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7665  | Data Elements (NND Varicella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7666  | Signs and Symptoms (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7670  | Meat Purchase Info (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7674  | Lab Test Interpretation (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7675  | Specimen type (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7676  | Strain Type (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7677  | Form Status (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7678  | Discharge Location (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7679  | Pregnancy Status (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7680  | Fetal Outcome (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7681  | Underlying Condition (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7682  | Smoking Status (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7683  | Substance Abuse (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7684  | Mode of Delivery (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7686  | Microorganism (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7689  | Vaccination Information Source (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7690  | GAS Risk Factor (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7692  | Rehab Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7693  | Antibiotic Received (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7695  | Antibiotic Reason (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7696  | Detection Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7697  | Birth Location (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7698  | Gestational Age Determination (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7699  | Susceptibility Data NA (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7700  | AR Agent (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7701  | AR Test Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7702  | ATI Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7703  | MIC Operator (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7704  | Susceptibility Interpretation (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7706  | Sequelae (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7707  | Blood Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7708  | Rupture Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7709  | Delivery Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7710  | Medication Pre-Treatment (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7711  | Contact Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7714  | Legionella Diagnosis (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7715  | Legionella Exposure (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7716  | Definitely Possibly No (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7717  | Legionella Exposure Setting (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7718  | Healthcare Exposure Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7720  | Water Source (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7723  | Signs and Symptoms (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7724  | Personal Protective Equipment (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7725  | Respiratory Protective Equipment (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7726  | Glove Material (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7727  | Titer Test Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7728  | Bird Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7729  | Establishment Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7730  | Residence Location (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7731  | Insurance Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7732  | Infection Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7734  | Lab Test Interpretation (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7735  | SPN/IPD Serotype (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7736  | Serotype Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7737  | Legionellosis Serogroup (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7738  | Isolate Not Available (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7744  | Lab Test Interpretation (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7745  | Type of Radiology Study |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7746  | Result of Radiology Study (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7747  | Diabetes Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7748  | Epidemiological Risk Factors (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7749  | Smoking Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7750  | Diagnosis Type (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7752  | Strength of Link (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7753  | Directionality of Link (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7754  | Treatment Administration Type (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7756  | Reason LTBI Not Started (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7757  | Reason LTBI Treatment Stopped (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7758  | Adverse Event Severity (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7761  | Susceptibility Test Interpretation (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7762  | Susceptibility Test Method (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7764  | Molecular Test Results (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7765  | Molecular Indel (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7767  | Reason Not Treated with RIPE (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7769  | Final Treatment Outcome (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7770  | Length of Time Drug Taken (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7772  | Side Effect of Treatment (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7773  | Serogroup Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7774  | Specimen Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7778  | Specimen Site (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7779  | Condition Status (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7782  | Deli Meats (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7783  | Deli Salads (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7784  | Diet Type (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7786  | Food (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7787  | Food Allergy (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7788  | Food Freshness (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7789  | Fruit (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7792  | Illness (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7795  | Medical History (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7797  | Birth Location (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7798  | Pregnancy Outcome (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7801  | Signs and Symptoms (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7802  | Specimen Type (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7804  | Patient Outcome (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7805  | Yes No None (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7806  | Assisted Living Exposure Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7808  | N. meningitidis Serogroup (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7809  | H. influenzae Serotype (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7810  | Provider Information Source (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7813  | Specimen Source (CP-CRE) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7814  | Genotypic Test Result (CP-CRE) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7816  | Data Elements (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7817  | Type of Dairy Product (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7818  | General Condition Status (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7820  | Born in the United States (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7823  | Lab Test Interpretation (Legionellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7825  | Gene Name (CP-CRE) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7826  | Specimen Source Site (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7832  | Clinical Manifestation (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7833  | Complications (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7836  | Organism (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7837  | Coinfection Type (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7838  | Specimen Type (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7840  | Clinical Manifestations (Lyme) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7841  | Specimen Type (Lyme) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7843  | Organism (Lyme) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7845  | Serotype Master (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7846  | Lab Test Interpretation Master (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7848  | Exposure Setting Master (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7849  | Usual Occupation and Industry (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7850  | Organism (CP-CRE) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7862  | Test Result (CP-CRE) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7864  | Specimen Source (C. auris) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7866  | Lab Test Method (MDRO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7867  | Test Result (C. auris) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7869  | Specimen Collection Setting Type (C. auris) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7870  | Type of Co-infection (C. auris) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7874  | Poison Control Center Record (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7876  | Intent of Exposure (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7877  | Extreme Weather Type (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7878  | Exposure Source (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7879  | Treatment Type (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7884  | Exposure Site Category (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7885  | Public Site of Exposure (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7886  | Treatment Location (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7887  | Underlying Conditions (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7888  | Signs and Symptoms (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7891  | Data Reporting Source (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7892  | Lab Result (Candida auris) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7895  | Lab Result Carbapenem Resistant Enterobacteriace |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7896  | Residential Site of Exposure (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7902  | GC specimen quality (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7903  | GC beta-lactamase result (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7911  | Clinical sample or isolate (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7912  | Candida auris culture result (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7913  | Candida auris PCR result (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7914  | Acinetobacter culture result (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7915  | Carbapenemase phenotypic result (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7916  | CPO phenotypic method (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7917  | CPO PCR method (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7918  | CPO AST method (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7919  | CPO PCR result (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7921  | Specimen type (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7922  | Microorganism (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7923  | Medication Treatment (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7924  | Mother Infant Indicator (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7925  | Type of Complication (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7926  | Number of Cigarettes Smoked per Day (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7927  | Dose Unit (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7928  | Lab Test Result Qualitative (Syphilis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7929  | Medication Route (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7930  | Route of Administration (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7931  | Medication Frequency Unit (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7934  | Microorganism (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7936  | Contact Type (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7939  | Residence Type (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7940  | Healthcare Occupation (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7941  | Job Setting (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7942  | Exposure Setting (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7944  | Signs and Symptoms (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7945  | Clinical Finding (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7946  | Animal Type (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7947  | Risk Factor (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7949  | Treatment Type (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7951  | Reason for Test (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7953  | Critical Infrastructure Sector (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7955  | Location of Initial Diagnosis (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7956  | Type of Leprosy (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7958  | Hospital Procedure (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7959  | Underlying Condition(s) (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7960  | Disease Outcome Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7961  | Medication (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7962  | Contact Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7963  | Medication Administered (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7965  | Sick Animal Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7966  | Rodent Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7967  | Animal Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7968  | Clinical Manifestations (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7969  | Specimen Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7970  | Disease Stage (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7971  | Animal Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7973  | Diagnostic Test Finding (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7974  | Specimen Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7975  | Specimen Source Site (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7976  | Test Titer Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7977  | Brucella Exposure (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7978  | Exposure Risk (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7980  | Patient Case Status (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7981  | Animal Ownership (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7982  | Vaccine Exposure (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7983  | Time of Day (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7984  | Hospital Procedure (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7985  | Actual Route of Administration (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7987  | Country of Product Acquisition (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7988  | Location Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7989  | Clinical Outcome (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7990  | Specimen Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7991  | Procedure Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7992  | Public TransportationType (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7995  | Diet Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7996  | Post-exposure or Treatment (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7997  | Treatment Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7998  | Severe Weather Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7999  | Animal Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8000  | Test Results Anthrax |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8001  | Time of Day (CDC) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8002  | Reason Medication Not Completed (BSP) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8003  | Smoking Status (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8004  | Test Results (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8005  | Antimicrobials (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8006  | Contact Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8007  | Clinical Manifestations (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8008  | Clinical Manifestations (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8009  | Exposure Location (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8010  | Organism Name (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8011  | Activity Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8012  | Activity Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8013  | Exposure Source (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8015  | Food Product Consumed (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8016  | Fresh Water or Mud Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8017  | Exposure Source (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8019  | Alcohol Use Frequency (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8020  | Anthrax Vaccine Exposure (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8021  | Total Doses of Vaccine (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8030  | Lab Test (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8035  | Subject of Medication Received (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8037  | Test Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8038  | Specimen Source Site (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8039  | Test Results (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8040  | Pregnancy Outcome (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8041  | Lab Test Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8042  | Test Result (Hepatitis A) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8043  | HBeAg Test Result (Hepatitis B Perinatal) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8044  | Infant Nucleic Acid Test Result (Hepatitis C) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8045  | Infant HCV Antigen Test Result (Hepatitis C) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8046  | Mother Nucleic Acid Test Result (Perinatal Hep) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8047  | Common-Source Outbreak (Hepatitis A) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8048  | Common-Source Outbreak (Hepatitis B) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8049  | Common-Source Outbreak (Hepatitis C) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8050  | Other Case Hepatitides (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8051  | Patient Epidemiological Risk Factors (Hepatitis A) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8052  | Patient Epidemiological Risk Factors (Hepatitis B) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8053  | Patient Epidemiological Risk Factors (Hepatitis C) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8055  | Source of Laboratory Test (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8056  | HBsAg Test Result (Hepatitis B Perinatal) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8057  | Infant Anti-HCVTest Result (Hepatitis C Perinatal) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8059  | Signs and Symptoms (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8060  | Test Result (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8061  | HBV DNA Test Result (Hepatitis B Perinatal) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8062  | Gender Identity (USCDI) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8063  | Sexual Orientation (USCDI) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8064  | Travel Purpose (CDC) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.834  | Allergen |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.909  | Disease |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.928  | True False (TF) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.929  | Positive Negative Unknown Not Done |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.930  | Chest XRay Result |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.931  | Vaccine Not Given Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.941  | Susceptibility Result |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.946  | Specimen |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.950  | Passed Failed Unknown |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.959  | Additional Site of Disease (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.967  | Body site |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.968  | Case Classification Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.969  | Case investigation closure reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.970  | Case Investigation Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.972  | Case Verification (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.981  | Diagnosed Pneumonia By (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.982  | Directly Observed Therapy (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.984  | Dwelling Type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.985  | Employment Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.988  | Countermeasure Encounter Purpose |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.991  | Environmental Investigation Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.994  | General Condition Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.995  | Health Care Practice Type (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.996  | History Source (CRA) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.997  | HIV Diagnosis Based On |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.998  | HIV Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.3.20  | Specimen Source Site (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/6.1.4.1.19376.1.7.3.1.1.13.8.64  | Limb Reduction Defect (NCHS) |
http://hl7.org/fhir/ValueSet/condition-severity  | Condition/Diagnosis Severity |
http://hl7.org/fhir/ValueSet/device-action  | Procedure Device Action Codes |
http://hl7.org/fhir/ValueSet/device-kind  | FHIR Device Types |
http://hl7.org/fhir/ValueSet/c80-facilitycodes  | Facility Type Code Value Set |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.32  | Gender Identity |
http://hl7.org/fhir/ValueSet/performer-role  | Procedure Performer Role Codes |
http://hl7.org/fhir/ValueSet/procedure-category  | Procedure Category Codes (SNOMED CT) |
http://hl7.org/fhir/ValueSet/procedure-followup  | Procedure Follow up Codes (SNOMED CT) |
http://hl7.org/fhir/ValueSet/procedure-not-performed-reason  | Procedure Not Performed Reason (SNOMED-CT) |
http://hl7.org/fhir/ValueSet/procedure-outcome  | Procedure Outcome Codes (SNOMED CT) |
http://hl7.org/fhir/ValueSet/referencerange-appliesto  | Observation Reference Range Applies To Codes |
http://hl7.org/fhir/ValueSet/servicerequest-orderdetail  | Service Request Order Details Codes |
http://hl7.org/fhir/us/core/ValueSet/us-core-encounter-type  | US Core Encounter Type |
http://hl7.org/fhir/us/core/ValueSet/us-core-servicerequest-category  | US Core ServiceRequest Category Codes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Bodysite_Hip  | Hüftlateralität |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Examination_Number  | Untersuchungsnummer U-Heft |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Foetal_Position  | Kindslage aus Sicht d. Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Gender_Birth  | Geschlecht |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hearscreening_Method  | Hörscreenigmethode |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hearscreening_Result  | Hörscreeningbefund Lokalisation |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hip_History  | Hüftanamnese |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hip_Proceeding  | Hüfte - weiteres Vorgehen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hip_Screening_Method  | Hüftscreening Methode |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Newborn_Blood_Spot_Screening_Type  | Typ der Blutabnahme |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Percentile_Body_Measure_Snomed  | Perzentilkörpermaß SNOMED |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Practitioner_Speciality  | Rolle des Behandelnden |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Pregnancy_History  | Schwangerschaftsanamnese |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Pulse_Oxymetry_Screening_Data_Absent_Reason  | Gründe zur Ablehnung des Pulsoxymetriescreenings |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Pulse_Oxymetry_Screening_Measurement_Type  | Typ der Pulsoxymetriemessung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_Apgar_Score_Identifier  | Apgar Score am Zeitpunkt |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_Apgar_Score_Value  | Apgar-Score Wert |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_U3_Birthmode  | Geburtsmodus |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_U3_Pulse_Oxymetry_Measurement  | Auffälligkeit Sauerstoffsättigung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Consultation  | U2 - Beratung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Current_Child_History  | U2 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Family_History  | U2 - Familienanamnese |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Head  | U2 - Kopf |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Mouth_Nose  | U2 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Musculoskeletal_System  | U2 - Bewegungsapparat |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Skin  | U2 - Haut |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Abdomen_Genitals  | U2, U3 - Abdomen, Genitale |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Ears  | U2, U3 - Ohren |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Eyes  | U2, U3 - Augen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U4_Physical_Exam_Chest_Lung_Respiratory_Tract  | U2, U3, U4 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U6_Physical_Exam_Heart_Blood_Circulation  | U2, U3, U4, U5, U6 - Herz, Kreislauf |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Consultation  | U3 - Beratung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Current_Child_History  | U3 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Development_Assessment  | U3 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Family_History  | U3 - Familienanamnese |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Physical_Exam_Head  | U3 - Kopf |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Physical_Exam_Musculoskeletal_System  | U3 - Bewegungsapparat |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U4_Physical_Exam_Mouth_Nose  | U3, U4 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U4_Physical_Exam_Skin  | U3, U4 - Haut |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U9_Age_Appropriate_Development  | Altersgemäße Entwicklung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U9_Social_History  | U3-U9 - Sozialanamnese |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Consultation  | U4 - Beratung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Current_Child_History  | U4 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Development_Assessment  | U4 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Physical_Exam_Abdomen_Genitals  | U4 - Abdomen, Genitale |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Physical_Exam_Head  | U4 - Kopf |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Physical_Exam_Musculoskeletal_System  | U4 - Bewegungsapparat |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_U5_Physical_Exam_Eyes  | U4, U5 - Augen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Consultation  | U5 - Beratung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Current_Child_History  | U5 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Development_Assessment  | U5 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Physical_Exam_Chest_Lung_Respiratory_Tract  | U5 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Physical_Exam_Mouth_Nose  | U5 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Physical_Exam_Musculoskeletal_System  | U5 - Bewegungsapparat |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_U6_Physical_Exam_Abdomen_Genitals  | U5, U6 - Abdomen, Genitale |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_U6_Physical_Exam_Head  | U5, U6 - Kopf |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_U9_Physical_Exam_Skin  | U5, U6, U7, U7a, U8, U9 - Haut |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Consultation  | U6 - Beratung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Current_Child_History  | U6 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Development_Assessment  | U6 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Physical_Exam_Eyes  | U6 - Augen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Physical_Exam_Mouth_Nose  | U6 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Physical_Exam_Musculoskeletal_System  | U6 - Bewegungsapparat |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_U7_Physical_Exam_Chest_Lung_Respiratory_Tract  | U6, U7 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Consultation  | U7 - Beratung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Current_Child_History  | U7 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Development_Assessment  | U7 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Physical_Exam_Eyes  | U7 - Augen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Physical_Exam_Mouth_Nose  | U7 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Physical_Exam_Musculoskeletal_System  | U7 - Bewegungsapparat |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_U7a_Physical_Exam_Abdomen_Genitals  | U7, U7a - Abdomen, Genitale |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_U9_Physical_Exam_Heart_Blood_Circulation  | U7, U7a, U8, U9 - Herz, Kreislauf |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Consultation  | U7a - Beratung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Current_Child_History  | U7a - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Development_Assessment  | U7a - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Physical_Exam_Mouth_Nose  | U7a - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_U9_Physical_Exam_Eyes  | U7a, U8, U9 - Augen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_and_U9_Physical_Exam_Chest_Lung_Respiratory_Tract  | U7a, U9 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_and_U9_Physical_Exam_Musculoskeletal_System  | U7a, U9 - Bewegungsapparat |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Consultation  | U8 - Beratung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Current_Child_History  | U8 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Development_Assessment  | U8 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Abdomen_Genitals  | U8 - Abdomen, Genitale |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Chest_Lung_Respiratory_Tract  | U8 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Ears  | U8 - Ohren |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Musculoskeletal_System  | U8 - Bewegungsapparat |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_U9_Physical_Exam_Mouth_Nose  | U8, U9 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Consultation  | U9 - Beratung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Current_Child_History  | U9 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Development_Assessment  | U9 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Physical_Exam_Abdomen_Genitals  | U9 - Abdomen, Genitale |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_PC_PN_Examination_Number  | Untersuchungsnummer Teilnahmekarte |
https://tgateway.infoway-inforoute.ca/vs/practitionerspecialty  | PractitionerSpecialtywithFrench |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ClasseAsa  | ClasseAsa |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ClassificationDeParis  | ClassificationDeParis |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Complications  | Complications |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ConsentementReponse  | ConsentementReponse |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/EchelleBostonScore  | EchelleBostonScore |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/InaptConsentementPar  | InaptConsentementPar |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IndicationsEndoscopie  | IndicationEndoscopie |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/InstrumentsUtilises  | InstrumentsUtilises |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IntervenantEndoscopiste  | IntervenantEndoscopiste |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IntervenantProcedure  | IntervenantProcedure |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IntervenantResident  | IntervenantResident |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/LienUsagerEndo  | LienUsagerEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ListeMedicamentsEndo  | ListeMedicamentsEndo |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/MethodesAdministration  | MethodesAdministration |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Observations  | Observations |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/PrecisionProvenanceExterne  | PrecisionProvenanceExterne |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/PreparationColiqueLaxatifs  | PreparationColiqueLaxatifs |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ProceduresEffectuees  | ProceduresEffectuees |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ProceduresType  | ProceduresType |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ProceduresTypeSpecimentEnvoye  | ProceduresTypeSpecimenEnvoye |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Recommandations  | Recommandations |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/RetroflexionEffectuee  | RetroflexionEffectuee |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/StatutObservation  | StatutObservation |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/StructuresCorporelles  | StructuresCorporelles |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/SuiviPriseCharge  | SuiviPriseCharge |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/TaillesPolype  | TaillesPolype |
https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/TypeObservation  | TypeObservation |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-condition-gps-uv-ips  | Allergy intolerance substance condition (GPS) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-reaction-gps-uv-ips  | Allergy Reaction (GPS) - IPS |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Dose_Form_SNOMED_CT  | Darreichungsform SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Drug_Therapy_Status_SNOMED_CT  | Medikation Statusgrund |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-allergic-disposition-sct  | Allergic Disposition SCT |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-assessment-scales  | Assessment Scales |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-assessment  | Assessment |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-body-positioning-snomed  | Body Positioning SNOMED CT |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-drugs  | Drugs |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-observations  | Observations |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-procedures  | Procedures |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-radiologic-finding-sct  | Radiologic Finding SCT |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-substances-snomed  | Substances SNOMED CT |
https://gematik.de/fhir/erg/ValueSet/ERGVerkehrsmittel  | ERGVerkehrsmittel |
http://hitstdio.ntunhs.edu.tw/fhir/ValueSet/covid-19-diseases  | COVID-19 Diseases |
http://hitstdio.ntunhs.edu.tw/fhir/ValueSet/covid-19-lab-result  | COVID-19 Lab Result |
http://hitstdio.ntunhs.edu.tw/fhir/ValueSet/covid-19-sample-origin  | COVID-19 Sample Origin |
http://hitstdio.ntunhs.edu.tw/fhir/ValueSet/sct-vaccines-covid-19  | SNOMED CT Vaccine List (COVID-19) |
http://hitstdio.ntunhs.edu.tw/fhir/ValueSet/vaccines-covid-19  | Vaccine List (COVID-19) |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-diagnosis-use  | Diagnosis Use |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-diagnostic-report-type  | Diagnostic Report Type |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-medicine-codes  | Medicine Codes |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-practitioner-role  | Practitioner Role |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-route-of-administration  | Route Of Administration |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-specimen-types  | Specimen Types |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-vaccine-codes  | Vaccine Codes |
https://www.ehealth.fgov.be/standards/fhir/allergy/ValueSet/be-causativeagent  | BeCausativeAgent |
https://www.ehealth.fgov.be/standards/fhir/allergy/ValueSet/be-exposureroute  | BeExposureRoute |
https://www.ehealth.fgov.be/standards/fhir/allergy/ValueSet/be-noallergy  | BeNoAllergy |
https://www.ehealth.fgov.be/standards/fhir/allergy/ValueSet/be-riskmanifestation  | BeRiskManifestation |
https://www.ehealth.fgov.be/standards/fhir/allergy/ValueSet/be-vs-allergyintolerance-type  | BeVSAllergyIntoleranceType |
http://ontariohealth.ca/fhir/ValueSet/mi-category-type  | Medical Imaging Category Type |
http://ontariohealth.ca/fhir/ValueSet/mi-procedure-bodypart-sct  | Medical Imaging Procedure Body Part. |
http://ontariohealth.ca/fhir/ValueSet/mi-procedure-contrast-used  | Medical Imaging Procedure Contrast Used |
http://ontariohealth.ca/fhir/ValueSet/mi-procedure-laterality-sct  | Medical Imaging Procedure Laterality - SNOMED CT |
http://ontariohealth.ca/fhir/ValueSet/mi-procedure-specialty  | Medical Imaging Procedure Specialty |
http://ontariohealth.ca/fhir/ValueSet/mi-procedure-type-sct  | Medical Imaging SNOMED CT Procedure Type |
https://standards.digital.health.nz/fhir/ValueSet/cancer-type-code  | Cancer type |
https://standards.digital.health.nz/fhir/ValueSet/sact-administration-site-code  | Administration location |
https://standards.digital.health.nz/fhir/ValueSet/sact-location-medication-collection-code  | Medication collection location |
https://standards.digital.health.nz/fhir/ValueSet/sact-support-factor-code  | Support Factors |
https://standards.digital.health.nz/fhir/ValueSet/sact-support-factor-value-code  | Possible values for Support Factors |
https://standards.digital.health.nz/fhir/ValueSet/sact-treatment-intent-code  | Treatment intent |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.3--20200901000000  | DagdeelCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.47--20240131165054  | MedicatieToedieningRedenVanAfwijkenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.55--20230119145802  | MedicatiegebruikStopTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.53--20220323181942  | PrikPlakLocatieCodeLijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.42--20221114132525  | RedenWijzigen-StakenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.54--20221114181621  | RedenWijzigen-StakenWDSCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.43--20221115122002  | RedenWijzigen-StoppenGebruikCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.50--20221216102010  | StopTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.49--20221115120643  | Toedieningsafspraak-RedenWijzigen-StakenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.2--20200901000000  | WeekdagCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.48--20230112155455  | WisselendDoseerschemaStopTypeCodelijst |
https://www.ehealth.fgov.be/standards/fhir/vaccination/ValueSet/be-vs-vaccination-bodysite  | BeVSVaccinationBodySite |
https://www.ehealth.fgov.be/standards/fhir/vaccination/ValueSet/be-vs-vaccination-reason-code  | BeVSVaccinationReasonCode |
https://www.ehealth.fgov.be/standards/fhir/vaccination/ValueSet/be-vs-vaccine-code  | BeVSVaccineCode |
http://fhir.org/guides/argonaut/ValueSet/device-kind  | Argonaut Device Types |
http://fhir.org/guides/argonaut/ValueSet/observation-ccdasmokingstatus  | Smoking Status |
http://fhir.org/guides/argonaut/ValueSet/observation-value-codes  | Observation Value Codes (SNOMED-CT) |
http://fhir.org/guides/argonaut/ValueSet/procedure-type  | Argonaut ProcedureType |
http://fhir.org/guides/argonaut/ValueSet/provider-role  | Care Team Provider Roles |
http://fhir.org/guides/argonaut/ValueSet/substance-sct  | DAF SNOMED CT Substances Other Than Clinical Drugs |
http://fhir.org/guides/argonaut/ValueSet/substance  | Argonaut Substance-Reactant for Intolerance and Negation Codes |
https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-causativeagent  | BeCausativeAgent |
https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-exposureroute  | BeExposureRoute |
https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-noallergy  | BeNoAllergy |
https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-riskmanifestation  | BeRiskManifestation |
https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-vs-score  | Score Value Set |
https://www.alberta.ca/fhir/ValueSet/referral-reason-code  | ReferralReasonCode |
https://plsp.dk/fhir/ValueSet/Laterality2  | Health Hub Dk Core Laterality |
http://fhir.infoway-inforoute.ca/io/CA-CSD/ValueSet/delivery-method  | Delivery Method |
http://aehrc.github.io/genclipr-fhir-ig/ValueSet/AbnormalClinicalFindings  | Abnormal Clinical Findings Value Set |
http://aehrc.github.io/genclipr-fhir-ig/ValueSet/BiologicalSexes  | Biological Sexes Value Set |
http://aehrc.github.io/genclipr-fhir-ig/ValueSet/Lateralities  | Lateralities Value Set |
http://aehrc.github.io/genclipr-fhir-ig/ValueSet/PresenceValues  | Presence Value Set |
http://aehrc.github.io/genclipr-fhir-ig/ValueSet/Severities  | Severity Value Set |
http://aehrc.github.io/genclipr-fhir-ig/ValueSet/TestInterpretationValues  | Test Interpretation Value Set |
http://terminology.ehdsi.eu/ValueSet/eHDSIAnimalSpecies  | eHDSI Animal Species |
http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup  | eHDSI Blood Group |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite  | eHDSI Body Site |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodySiteLaterality  | eHDSI Body Site Laterality |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodyStructureLocation  | eHDSI Body Structure Location Qualifier |
http://terminology.ehdsi.eu/ValueSet/eHDSILabSpecimenType  | eHDSI Laboratory Specimen Type |
http://terminology.ehdsi.eu/ValueSet/eHDSILabTechnique  | eHDSI Laboratory Technique |
http://terminology.ehdsi.eu/ValueSet/eHDSIMedicalDevice  | eHDSI Medical Device |
http://terminology.ehdsi.eu/ValueSet/eHDSIMicroorganism  | eHDSI Microorganism |
http://terminology.ehdsi.eu/ValueSet/eHDSIMorphologicAbnormality  | eHDSI Morphologic Abnormality |
http://terminology.ehdsi.eu/ValueSet/eHDSIPresenceAbsence  | eHDSI Presence Absence |
http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy  | eHDSI Reaction Allergy |
https://demis.rki.de/fhir/ars/ValueSet/abnahmeortKoerperstelleSNOMED  | Abnahmeort |
https://demis.rki.de/fhir/ars/ValueSet/abnahmeortMorphologischeAnomalieSNOMED  | Abnahmeort morphologische Anomalien |
https://demis.rki.de/fhir/ars/ValueSet/anforderungChlamydienSentinelSNOMED  | Untersuchungsanlass Chlamydien-Sentinel |
https://demis.rki.de/fhir/ars/ValueSet/anforderungMasernSentinelSNOMED  | Untersuchungsanlass Masern-Sentinel |
https://demis.rki.de/fhir/ars/ValueSet/anforderungSNOMED  | Untersuchungsanlass Diagnose oder Screening |
https://demis.rki.de/fhir/ars/ValueSet/antwortNominalSNOMED  | Ergebnis der Laboruntersuchung Nominal |
https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenBakSNOMED  | Ergebnis der Laboruntersuchung BAK |
https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenBeschreibungMikroskopieSNOMED  | Ergebnis der Laboruntersuchung Mikroskopie |
https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenMykSNOMED  | Ergebnis der Laboruntersuchung MYK |
https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenParSNOMED  | Ergebnis der Laboruntersuchung PAR |
https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenVirSNOMED  | Ergebnis der Laboruntersuchung VIR |
https://demis.rki.de/fhir/ars/ValueSet/antwortResistenzklassifikationSNOMED  | Ergebnis der Laboruntersuchung MRE |
https://demis.rki.de/fhir/ars/ValueSet/interpretationSNOMED  | Angabe der Interpretation mit SNOMED CT qualifier values |
https://demis.rki.de/fhir/ars/ValueSet/materialSNOMED  | Probenmaterial |
https://demis.rki.de/fhir/ars/ValueSet/methodeSNOMED  | Testmethoden |
http://www.egde.no/ValueSet/care-team-role-vs  | Care Team role |
http://www.egde.no/ValueSet/consent-vs  | Consent codes from Loinc and Snomed-ct |
http://www.egde.no/ValueSet/organization-type-vs  | Organization type |
http://capable-project.eu/data/fhir/ValueSet/body-parts  | Body parts |
http://capable-project.eu/data/fhir/ValueSet/ctcae-symptom-grades  | CTCAE symptom grades |
http://capable-project.eu/data/fhir/ValueSet/capsules  | Capsule list |
http://capable-project.eu/data/fhir/ValueSet/hobbies  | Hobbies |
http://capable-project.eu/data/fhir/ValueSet/list-codes  | List codes |
http://capable-project.eu/data/fhir/ValueSet/medication-performer-type  | Medication performer types |
http://capable-project.eu/data/fhir/ValueSet/melanoma-types  | Types of melanoma |
http://capable-project.eu/data/fhir/ValueSet/patient-goals  | Patient goals |
http://capable-project.eu/data/fhir/ValueSet/prescription-type  | Prescription types |
http://capable-project.eu/data/fhir/ValueSet/symptom-codes  | Symptom codes |
http://capable-project.eu/data/fhir/ValueSet/visit-types  | Visit types |
http://capable-project.eu/data/fhir/ValueSet/who-score  | WHO score |
https://fhir.infoway-inforoute.ca/ValueSet/allergicconditioncode  | Allergic Condition Code |
https://fhir.infoway-inforoute.ca/ValueSet/allergyintolerancestatuscode  | Allergy/Intolerance Status Code |
https://fhir.infoway-inforoute.ca/ValueSet/drugormedicamentsubstancecode  | Drug Or Medicament Substance Code |
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-klassifikation-typ  | MII VS Onkologie TNM Klassifikation Typ |
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-m-kategorie  | MII VS Onkologie TNM M Kategorie |
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-n-kategorie  | MII VS Onkologie TNM N Kategorie |
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-t-kategorie  | MII VS Onkologie TNM T Kategorie |
http://fhir.ch/ig/swissnoso/ValueSet/swissnoso-germ  | Swissnoso Germ |
https://terms.sil-th.org/core/ValueSet/vs-43file-refer-care-procedure  | 43File: รหัสแสดงการให้การดูแลหรือปฐมพยาบาลผู้ป่วยขณะส่งต่อผู้ป่วย |
https://terms.sil-th.org/core/ValueSet/vs-meta-child-development-observations  | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับพัฒนาการเด็ก |
https://terms.sil-th.org/core/ValueSet/vs-meta-lab-observations  | Metadata: รหัสการตรวจทางห้องปฏิบัติการบางส่วน |
https://terms.sil-th.org/core/ValueSet/vs-meta-ncd-observations  | Metadata: รหัสการตรวจหรือบริการคัดกรองโรค NCD |
https://terms.sil-th.org/core/ValueSet/vs-meta-neonate-observations  | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับทารกแรกคลอด |
https://terms.sil-th.org/core/ValueSet/vs-meta-physical-observations  | Metadata: รหัสการตรวจร่างกาย |
https://terms.sil-th.org/core/ValueSet/vs-meta-pregnancy-observations  | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับการตั้งครรภ์ |
https://terms.sil-th.org/core/ValueSet/vs-snomed-blood-abo  | SNOMED CT Blood Group - ABO |
https://terms.sil-th.org/core/ValueSet/vs-snomed-blood-rh  | SNOMED CT Blood Group - Rh |
https://terms.sil-th.org/core/ValueSet/vs-snomed-bloodgroup  | SNOMED CT Blood Group |
https://terms.sil-th.org/core/ValueSet/vs-snomed-int  | SNOMED-CT International Release |
http://roche.com/fhir/iop/ValueSet/device-kind  | device-kind |
http://roche.com/fhir/iop/ValueSet/device-settings-codes  | device-settings-codes |
http://roche.com/fhir/iop/ValueSet/observation-codes  | observation-codes |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ZAEB_Preventive_Check_Up_Type  | KBV_VS_MIO_ZAEB_Preventive_Check_Up_Type |
https://fhir.healthdata.be/ValueSet/AdministrationAgreementStopType  | AdministrationAgreementStopType |
https://fhir.healthdata.be/ValueSet/AdministrationDevice  | AdministrationDevice |
https://fhir.healthdata.be/ValueSet/AlcoholUseStatus  | AlcoholUseStatus |
https://fhir.healthdata.be/ValueSet/AlertName  | AlertName |
https://fhir.healthdata.be/ValueSet/AllergyCategory  | AllergyCategory |
https://fhir.healthdata.be/ValueSet/AllergyStatus  | AllergyStatus |
https://fhir.healthdata.be/ValueSet/AsNeededCriterium  | AsNeededCriterium |
https://fhir.healthdata.be/ValueSet/BathingOneself  | BathingOneself |
https://fhir.healthdata.be/ValueSet/BodyPartToBeBathed  | BodyPartToBeBathed |
https://fhir.healthdata.be/ValueSet/BodyPartToBeDressed  | BodyPartToBeDressed |
https://fhir.healthdata.be/ValueSet/BurnwoundDepth  | BurnwoundDepth |
https://fhir.healthdata.be/ValueSet/BurnwoundLaterality  | BurnwoundLaterality |
https://fhir.healthdata.be/ValueSet/CausativeAgent  | CausativeAgent |
https://fhir.healthdata.be/ValueSet/ChangingPosition  | ChangingPosition |
https://fhir.healthdata.be/ValueSet/ClimbingStairs  | ClimbingStairs |
https://fhir.healthdata.be/ValueSet/Clothing  | Clothing |
https://fhir.healthdata.be/ValueSet/CollectionMethod  | CollectionMethod |
https://fhir.healthdata.be/ValueSet/CommunicationDetails  | CommunicationDetails |
https://fhir.healthdata.be/ValueSet/ConditionsDuringMeasurement  | ConditionsDuringMeasurement |
https://fhir.healthdata.be/ValueSet/ContactType  | ContactType |
https://fhir.healthdata.be/ValueSet/ContainerType  | ContainerType |
https://fhir.healthdata.be/ValueSet/CriticalExtent  | CriticalExtent |
https://fhir.healthdata.be/ValueSet/CuffType  | CuffType |
https://fhir.healthdata.be/ValueSet/DASMethod  | DASMethod |
https://fhir.healthdata.be/ValueSet/DeathIndicator  | DeathIndicator |
https://fhir.healthdata.be/ValueSet/DecubitusCategory  | DecubitusCategory |
https://fhir.healthdata.be/ValueSet/DefecationColor  | DefecationColor |
https://fhir.healthdata.be/ValueSet/DentalHygiene  | DentalHygiene |
https://fhir.healthdata.be/ValueSet/DepartmentSpecialty  | DepartmentSpecialty |
https://fhir.healthdata.be/ValueSet/Depth  | Depth |
https://fhir.healthdata.be/ValueSet/Destination  | Destination |
https://fhir.healthdata.be/ValueSet/DevelopmentCognition  | DevelopmentCognition |
https://fhir.healthdata.be/ValueSet/DevelopmentLinguistics  | DevelopmentLinguistics |
https://fhir.healthdata.be/ValueSet/DevelopmentLocomotion  | DevelopmentLocomotion |
https://fhir.healthdata.be/ValueSet/DevelopmentSocialChild  | DevelopmentSocialChild |
https://fhir.healthdata.be/ValueSet/DeviatingBreathingPattern  | DeviatingBreathingPattern |
https://fhir.healthdata.be/ValueSet/DeviceAnatomicalLocation  | DeviceAnatomicalLocation |
https://fhir.healthdata.be/ValueSet/DiastolicEndpoint  | DiastolicEndpoint |
https://fhir.healthdata.be/ValueSet/DressingOneself  | DressingOneself |
https://fhir.healthdata.be/ValueSet/Drinking  | Drinking |
https://fhir.healthdata.be/ValueSet/DrinkingLimitations  | DrinkingLimitations |
https://fhir.healthdata.be/ValueSet/DrugUseStatus  | DrugUseStatus |
https://fhir.healthdata.be/ValueSet/Eating  | Eating |
https://fhir.healthdata.be/ValueSet/EatingLimitations  | EatingLimitations |
https://fhir.healthdata.be/ValueSet/EstimatingMethod  | EstimatingMethod |
https://fhir.healthdata.be/ValueSet/FamilyComposition  | FamilyComposition |
https://fhir.healthdata.be/ValueSet/FamilyCompositionChild  | FamilyCompositionChild |
https://fhir.healthdata.be/ValueSet/FecalContinence  | FecalContinence |
https://fhir.healthdata.be/ValueSet/FeedingMethod  | FeedingMethod |
https://fhir.healthdata.be/ValueSet/FeedingTubeType  | FeedingTubeType |
https://fhir.healthdata.be/ValueSet/FeedingType  | FeedingType |
https://fhir.healthdata.be/ValueSet/FrequencyQualifier  | FrequencyQualifier |
https://fhir.healthdata.be/ValueSet/Gender  | Gender |
https://fhir.healthdata.be/ValueSet/Grooming  | Grooming |
https://fhir.healthdata.be/ValueSet/HeadCircumferenceMeasuringMethod  | HeadCircumferenceMeasuringMethod |
https://fhir.healthdata.be/ValueSet/HealthProfessionalRole  | HealthProfessionalRole |
https://fhir.healthdata.be/ValueSet/HearingAidType  | HearingAidType |
https://fhir.healthdata.be/ValueSet/HearingFunction  | HearingFunction |
https://fhir.healthdata.be/ValueSet/HeartRateMeasurementMethod  | HeartRateMeasurementMethod |
https://fhir.healthdata.be/ValueSet/HeartbeatRegularity  | HeartbeatRegularity |
https://fhir.healthdata.be/ValueSet/HomeAccessibility  | HomeAccessibility |
https://fhir.healthdata.be/ValueSet/HomeAdaption  | HomeAdaption |
https://fhir.healthdata.be/ValueSet/IndependentMedicationUse  | IndependentMedicationUse |
https://fhir.healthdata.be/ValueSet/InfusionCatheterType  | InfusionCatheterType |
https://fhir.healthdata.be/ValueSet/InterpretationHeartRate  | InterpretationHeartRate |
https://fhir.healthdata.be/ValueSet/InterpretationMethod  | InterpretationMethod |
https://fhir.healthdata.be/ValueSet/Intervention  | Intervention |
https://fhir.healthdata.be/ValueSet/Laterality  | Laterality |
https://fhir.healthdata.be/ValueSet/LifeStance  | LifeStance |
https://fhir.healthdata.be/ValueSet/Location  | Location |
https://fhir.healthdata.be/ValueSet/LumenLocation  | LumenLocation |
https://fhir.healthdata.be/ValueSet/MaintainingPosition  | MaintainingPosition |
https://fhir.healthdata.be/ValueSet/MaritalStatus  | MaritalStatus |
https://fhir.healthdata.be/ValueSet/MeasuringLocation  | MeasuringLocation |
https://fhir.healthdata.be/ValueSet/MeasuringMethod  | MeasuringMethod |
https://fhir.healthdata.be/ValueSet/MeasuringPosition  | MeasuringPosition |
https://fhir.healthdata.be/ValueSet/MedicationAdministrationReasonForDeviation  | MedicationAdministrationReasonForDeviation |
https://fhir.healthdata.be/ValueSet/MedicationAdministrationStatus  | MedicationAdministrationStatus |
https://fhir.healthdata.be/ValueSet/MedicationAgreementAdditionalInformation  | MedicationAgreementAdditionalInformation |
https://fhir.healthdata.be/ValueSet/MedicationReason  | MedicationReason |
https://fhir.healthdata.be/ValueSet/MedicationStopType  | MedicationStopType |
https://fhir.healthdata.be/ValueSet/MenstrualCare  | MenstrualCare |
https://fhir.healthdata.be/ValueSet/Microorganism  | Microorganism |
https://fhir.healthdata.be/ValueSet/Morphology  | Morphology |
https://fhir.healthdata.be/ValueSet/MultipleBirthIndicator  | MultipleBirthIndicator |
https://fhir.healthdata.be/ValueSet/Municipality  | Municipality |
https://fhir.healthdata.be/ValueSet/NameUsage  | NameUsage |
https://fhir.healthdata.be/ValueSet/Origin  | Origin |
https://fhir.healthdata.be/ValueSet/PainCourse  | PainCourse |
https://fhir.healthdata.be/ValueSet/PainPattern  | PainPattern |
https://fhir.healthdata.be/ValueSet/PainType  | PainType |
https://fhir.healthdata.be/ValueSet/PerformNursingActivity  | PerformNursingActivity |
https://fhir.healthdata.be/ValueSet/PharmaceuticalForm  | PharmaceuticalForm |
https://fhir.healthdata.be/ValueSet/PlaceOfResidence  | PlaceOfResidence |
https://fhir.healthdata.be/ValueSet/Position  | Position |
https://fhir.healthdata.be/ValueSet/Postcode  | Postcode |
https://fhir.healthdata.be/ValueSet/ProblemName  | ProblemName |
https://fhir.healthdata.be/ValueSet/ProblemStatus  | ProblemStatus |
https://fhir.healthdata.be/ValueSet/ProblemType  | ProblemType |
https://fhir.healthdata.be/ValueSet/ProcedureMethod  | ProcedureMethod |
https://fhir.healthdata.be/ValueSet/ProcedureType  | ProcedureType |
https://fhir.healthdata.be/ValueSet/ProductCode  | ProductCode |
https://fhir.healthdata.be/ValueSet/ProductType  | ProductType |
https://fhir.healthdata.be/ValueSet/ProthesisType  | ProthesisType |
https://fhir.healthdata.be/ValueSet/PulseRegularity  | PulseRegularity |
https://fhir.healthdata.be/ValueSet/ReasonForUse  | ReasonForUse |
https://fhir.healthdata.be/ValueSet/RefractionMeasurementMethod  | RefractionMeasurementMethod |
https://fhir.healthdata.be/ValueSet/Relationship  | Relationship |
https://fhir.healthdata.be/ValueSet/ResultFlags  | ResultFlags |
https://fhir.healthdata.be/ValueSet/ResultType  | ResultType |
https://fhir.healthdata.be/ValueSet/Rhythm  | Rhythm |
https://fhir.healthdata.be/ValueSet/Role  | Role |
https://fhir.healthdata.be/ValueSet/RouteOfAdministration  | RouteOfAdministration |
https://fhir.healthdata.be/ValueSet/RouteOfExposure  | RouteOfExposure |
https://fhir.healthdata.be/ValueSet/RouteOfMedicationAdministration  | RouteOfMedicationAdministration |
https://fhir.healthdata.be/ValueSet/SOAPLineHeader  | SOAPLineHeader |
https://fhir.healthdata.be/ValueSet/SmokingStatus  | SmokingStatus |
https://fhir.healthdata.be/ValueSet/SpecimenMaterial  | SpecimenMaterial |
https://fhir.healthdata.be/ValueSet/SpecimenSource  | SpecimenSource |
https://fhir.healthdata.be/ValueSet/StatusName  | StatusName |
https://fhir.healthdata.be/ValueSet/StatusValue  | StatusValue |
https://fhir.healthdata.be/ValueSet/StomaType  | StomaType |
https://fhir.healthdata.be/ValueSet/SubstanceCode  | SubstanceCode |
https://fhir.healthdata.be/ValueSet/Symptom  | Symptom |
https://fhir.healthdata.be/ValueSet/TemperatureType  | TemperatureType |
https://fhir.healthdata.be/ValueSet/TestMethod  | TestMethod |
https://fhir.healthdata.be/ValueSet/TextResultType  | TextResultType |
https://fhir.healthdata.be/ValueSet/TimeOfDay  | TimeOfDay |
https://fhir.healthdata.be/ValueSet/ToiletTrainednessFeces  | ToiletTrainednessFeces |
https://fhir.healthdata.be/ValueSet/ToiletTrainednessUrine  | ToiletTrainednessUrine |
https://fhir.healthdata.be/ValueSet/ToiletUse  | ToiletUse |
https://fhir.healthdata.be/ValueSet/Transfer  | Transfer |
https://fhir.healthdata.be/ValueSet/Treatment  | Treatment |
https://fhir.healthdata.be/ValueSet/TreatmentDecision  | TreatmentDecision |
https://fhir.healthdata.be/ValueSet/TypeOfDisorder  | TypeOfDisorder |
https://fhir.healthdata.be/ValueSet/TypeOfDrugOrMedication  | TypeOfDrugOrMedication |
https://fhir.healthdata.be/ValueSet/TypeOfHelp  | TypeOfHelp |
https://fhir.healthdata.be/ValueSet/TypeOfHome  | TypeOfHome |
https://fhir.healthdata.be/ValueSet/TypeOfIntervention  | TypeOfIntervention |
https://fhir.healthdata.be/ValueSet/TypeOfLivingWill  | TypeOfLivingWill |
https://fhir.healthdata.be/ValueSet/TypeOfSmokingOrTobacco  | TypeOfSmokingOrTobacco |
https://fhir.healthdata.be/ValueSet/UrineCatheterType  | UrineCatheterType |
https://fhir.healthdata.be/ValueSet/UrineContinence  | UrineContinence |
https://fhir.healthdata.be/ValueSet/VaccineProduct  | VaccineProduct |
https://fhir.healthdata.be/ValueSet/VerificationStatus  | VerificationStatus |
https://fhir.healthdata.be/ValueSet/VisualAcuityMeasurementDevice  | VisualAcuityMeasurementDevice |
https://fhir.healthdata.be/ValueSet/VisualAcuityType  | VisualAcuityType |
https://fhir.healthdata.be/ValueSet/VisualAidType  | VisualAidType |
https://fhir.healthdata.be/ValueSet/VisualFunction  | VisualFunction |
https://fhir.healthdata.be/ValueSet/Walking  | Walking |
https://fhir.healthdata.be/ValueSet/WeekDay  | WeekDay |
https://fhir.healthdata.be/ValueSet/WoundDrainType  | WoundDrainType |
https://fhir.healthdata.be/ValueSet/WoundEdge  | WoundEdge |
https://fhir.healthdata.be/ValueSet/WoundType  | WoundType |
https://roche.com/fhir/iop/ValueSet/device-kind  | DeviceKind |
https://roche.com/fhir/iop/ValueSet/device-settings-codes  | DeviceSettingsCodes |
https://roche.com/fhir/iop/ValueSet/observation-codes  | ObservationCodes |
https://roche.com/fhir/iop/ValueSet/SNOMED-CT  | SNOMEDCT |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-alcohol-drinking-status  | Alcohol Drinking Status |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-benefit-type  | Benefit Type |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-benefitcategory  | Benefit Category |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-care-team-qualification  | Care Team Qualification |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-care-team-role  | Care Team Role |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-claim-type  | Claim Type |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-coverage-type  | Coverage Type |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-diagnostic-type  | Diagnostic Type |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-diet-type  | Diet Type |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-encounter-type  | EncounterTypes |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-general-assessment  | General Assessment |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-general-well-being  | General Wellbeing |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-lifestyle  | Lifestyle |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-mental-status  | Mental Status |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-productorservice  | ProductorService |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-tobacco-chewing-status  | Tobacco Chewing Status |
https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-tobacco-smoking-status  | Tobacco Smoking Status |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/blood-gas-analysis-combined  | Blood Gas Analysis Combined |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/diseases-combined  | Diseases Combined |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/procedures-combined  | Procedures Combined |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/apheresis-procedures  | Apheresis-Procedures |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/cardiovascular-diseases  | Cardiovascular-Diseases |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-kidney-diseases  | Chronic Kidney Diseases |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-liver-diseases  | Chronic-Liver-Diseases |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-lung-diseases  | Chronic Lung Diseases |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-neurological-mental-diseases  | Chronic Neurological Mental Diseases |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/complications-covid-19  | Complications of Covid-19 |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/condition-severity  | Condition Severity |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/detected-not-detected-inconclusive  | Detected Not-detected Inconclusive |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/diabetes-mellitus-diseases  | Diabetes Mellitus Diseases |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/dialysis-procedures  | Dialysis Procedures |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/discharge-disposition  | Discharge Disposition |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/ethnic-groups  | Ethnic Groups |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/gastrointestinal-ulcers  | Gastrointestinal Ulcers |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/human-immunodeficiency-virus-infections  | Human Immunodeficiency Virus Infections |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/known-exposure  | Known Exposure to SARS-CoV-2 |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/malignant-neoplastic-diseases  | Malignant Neoplastic Diseases |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/organs-for-transplant  | Organs for Transplantation |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pharmacological-therapy-snomed  | Drug Therapy SNOMED |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pregnancy-status  | Pregnancy Status |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/radiology-findings  | Radiology Findings |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/radiology-procedures  | Radiology Procedures |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/respiratory-therapies-devices  | Respiratory Therapy Devices |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/respiratory-therapies  | Respiratory Therapies |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/resuscitation-status  | Do-Not-Resuscitate-Order |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/rheumatological-immunological-diseases  | Rheumatological Immunological Diseases |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/sars-cov-2-symptoms  | SARS-CoV-2-Symptoms |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/stage-at-diagnosis  | Stage at Diagnosis |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/therapeutic-intent  | Therapeutic Intent |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/vaccines-snomed  | Vaccines SNOMED |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/verification-status  | ConditionVerificationStatus SNOMED |
https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/yes-no-unknown-other-na  | Yes-No-Unknown-Other-Na |
https://emiga.rki.de/fhir/ValueSet/YesNoNullFlavor  | Ja, Nein, Nicht ermittelbar, Nicht erhoben Antworten |
http://fhir.dgmc.health.gov.il/ValueSet/body-site-laterlity  | Body Site Laterality |
http://fhir.kl.dk/ffinst/ValueSet/BodyTemperatureSCTObservables  | TemperatureSCTObservables |
http://fhir.kl.dk/ffinst/ValueSet/BodyheightSCTobservables  | BodyheightSCTobservables |
http://fhir.kl.dk/ffinst/ValueSet/BodyweightSCTobservables  | BodyweightSCTobservables |
http://fhir.kl.dk/ffinst/ValueSet/ConsciousnessSCTFindings  | ConsciousnessSCTFindings |
http://fhir.kl.dk/ffinst/ValueSet/DiastolicBloodPressureSCTObservables  | DiastolicBloodPressureSCTObservables |
http://fhir.kl.dk/ffinst/ValueSet/EQ5DSCTfindingsActivity  | EQ5DSCTfindingsActivity |
http://fhir.kl.dk/ffinst/ValueSet/EQ5DSCTfindingsAnxiety  | EQ5DSCTfindingsAnxiety |
http://fhir.kl.dk/ffinst/ValueSet/EQ5DSCTfindingsHygiene  | EQ5DSCTfindingsHygiene |
http://fhir.kl.dk/ffinst/ValueSet/EQ5DSCTfindingsMobility  | EQ5DSCTfindingsMobility |
http://fhir.kl.dk/ffinst/ValueSet/EQ5DSCTfindingsPain  | EQ5DSCTfindingsPain |
http://fhir.kl.dk/ffinst/ValueSet/HeartRateSCTobservables  | HeartRateSCTobservables |
http://fhir.kl.dk/ffinst/ValueSet/OxygenSaturationSCTobservables  | OxygenSaturationSCTobservables |
http://fhir.kl.dk/ffinst/ValueSet/RespirationRateSCTObservables  | RespirationRateSCTObservables |
http://fhir.kl.dk/ffinst/ValueSet/SCTUrinStix  | SCTUrinStix |
http://fhir.kl.dk/ffinst/ValueSet/SystolicBloodPressureSCTObservables  | SystolicBloodPressureSCTObservables |
http://fhir.kl.dk/ffinst/ValueSet/TechniqesSCTCodes  | TechniqesSCTCodes |
http://fhir.kl.dk/ffinst/ValueSet/VRSSCTfindingsPain  | VRSSCTfindingsPain |
http://fhir.kl.dk/ffinst/ValueSet/WHO5SCTfindingsActive3  | WHO5SCTfindingsActive3 |
http://fhir.kl.dk/ffinst/ValueSet/WHO5SCTfindingsCalm2  | WHO5SCTfindingsCalm2 |
http://fhir.kl.dk/ffinst/ValueSet/WHO5SCTfindingsHappy1  | WHO5SCTfindingsHappy1 |
http://fhir.kl.dk/ffinst/ValueSet/WHO5SCTfindingsInterest5  | WHO5SCTfindingsInterest5 |
http://fhir.kl.dk/ffinst/ValueSet/WHO5SCTfindingsRested4  | WHO5SCTfindingsRested4 |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-condition-uv-ips  | Allergy intolerance substance condition - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/core-problem-finding-situation-event-gps-uv-ips  | CORE Problem List Finding/Situation/Event (GPS) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medical-devices-uv-ips  | Medical Devices - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medication-example-uv-ips  | Medications (example) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medication-snomed-uv-ips  | Medications (SNOMED CT) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medicine-active-substances-uv-ips  | Medicine Active Substances - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/procedures-uv-ips  | Procedures - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/result-coded-value-pathology-gps-uv-ips  | Results Coded Values Pathology (GPS) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-laboratory-blood-abo-rh-grp-gps-uv-ips  | Results Laboratory ABO+RH Group (GPS) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-laboratory-presence-absence-gps-uv-ips  | Results Laboratory Presence/Absence (GPS) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-organism-gps-uv-ips  | Results Organism (GPS) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-numobs-gps-dicom-uv-ips  | Results Radiology Measurement Observation (GPS-DICOM) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-txtobs-gps-dicom-loinc-uv-ips  | Results Radiology Textual Observations (GPS-DICOM-LOINC) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-collection-method-gps-uv-ips  | Results Specimen Collection Method (GPS) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-type-gps-uv-ips  | Results Specimen Type (GPS) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/snomed-intl-gps  | SNOMED International Global Patient Set (GPS) |
http://hl7.org/fhir/uv/ips/ValueSet/target-site-uv-ips  | Target Site - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/targetDiseases-gps-uv-ips  | Vaccine Target Diseases (GPS) - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/targetDiseases-uv-ips  | Vaccine Target Diseases - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/vaccines-gps-uv-ips  | Vaccines (GPS) - IPS |
https://fhir.nhs.uk/ValueSet/NHSDigital-CareSettingType  | NHSDigital-CareSettingType |
https://fhir.nhs.uk/ValueSet/NHSDigital-ImmunizationExplanationReason  | NHS Digital Immunization Explanation Reason |
https://fhir.nhs.uk/ValueSet/NHSDigital-VaccinationProcedure  | Interim version of UK Core Vaccination Procedure. |
https://fhir.nhs.uk/ValueSet/NHSDigital-MedicationDispense-Code  | Digital Medicine MedicationDispense Code |
https://fhir.nhs.uk/ValueSet/NHSDigital-MedicationRequest-Code  | Digital Medicine MedicationRequest Code |
https://fhir.nhs.uk/ValueSet/NHSDigital-MedicationCode  | NHS Digital Medication Code |
https://fhir.nhs.uk/ValueSet/NHSDigital-ReasonImmunizationNotAdministered  | NHSDigital Reason Immunization Not Administered |
https://fhir.nhs.uk/ValueSet/NHSDigital-VaccineCode  | NHS Digital Vaccine Code |
https://fhir.nhs.uk/ValueSet/NHSDigital-action-code  | NHSDigital Action Code |
https://fhir.nhs.uk/ValueSet/NHSDigital-ServiceRequest-category  | ServiceRequestCategory |
https://fhir.nhs.uk/ValueSet/DocumentCategory  | NHSEnglandDocumentCategory |
https://fhir.nhs.uk/ValueSet/Document-Type  | NHSEnglandDocumentType |
https://fhir.nhs.uk/ValueSet/covid-19-snomed-procedure-code-vs  | COVID-19 SNOMED CT Procedure Code Value Set |
https://www.medizininformatik-initiative.de/fhir/core/modul-prozedur/ValueSet/procedures-intend  | MII VS Prozedur Durchführungsabsicht [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/core/modul-prozedur/ValueSet/procedures-category-sct  | MII VS Prozedur OPS Kategorien [SNOMED CT] |
https://www.medizininformatik-initiative.de/fhir/core/modul-prozedur/ValueSet/procedures-sct  | MII VS Prozedur Prozeduren [SNOMED CT] |
https://demis.rki.de/fhir/ValueSet/answerSetLaboratoryTest-SNOMED  | SNOMED-AnswerSet für Labortest |
https://demis.rki.de/fhir/ValueSet/answerSetNCVP  | AnswerSet für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 |
https://demis.rki.de/fhir/ValueSet/answerSetResistance-SNOMED  | SNOMED-AnswerSet für Resistenz |
https://demis.rki.de/fhir/ValueSet/answerSetWBKP  | AnswerSet für Krankheitserreger unter Berücksichtigung der Art der Krankheitserreger und der Häufigkeit ihres Nachweises wenn Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit bestehen |
https://demis.rki.de/fhir/ValueSet/interpretation-SNOMED  | SNOMED-Interpretation des Testergebnisses |
https://demis.rki.de/fhir/ValueSet/materialNCVP  | Material für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 |
https://demis.rki.de/fhir/ValueSet/reasonForTesting  | Untersuchungsgrund |
http://fhir.ch/ig/ch-epr-term/ValueSet/DocumentEntry.classCode  | DocumentEntry.classCode |
http://fhir.ch/ig/ch-epr-term/ValueSet/DocumentEntry.confidentialityCode  | DocumentEntry.confidentialityCode |
http://fhir.ch/ig/ch-epr-term/ValueSet/DocumentEntry.healthcareFacilityTypeCode  | DocumentEntry.healthcareFacilityTypeCode |
http://fhir.ch/ig/ch-epr-term/ValueSet/DocumentEntry.practiceSettingCode  | DocumentEntry.practiceSettingCode |
http://fhir.ch/ig/ch-epr-term/ValueSet/DocumentEntry.typeCode  | DocumentEntry.typeCode |
http://fhir.ch/ig/ch-epr-term/ValueSet/HCProfessional.hcProfession  | HCProfessional.hcProfession |
http://fhir.ch/ig/ch-epr-term/ValueSet/SubmissionSet.contentTypeCode  | SubmissionSet.contentTypeCode |
https://sil-th-group-a.org/valueset/screening-tests  | Lung Cancer Screening Tests |
https://sil-th-group-a.org/valueset/lung-cancer-condition  | lung-cancer-condition |
http://fhir.nottinghamshire.gov.uk/valueset/preferred-place-of-death  | Preferred place of death |
http://ontariohealth.ca/fhir/ValueSet/practitioner-specialty  | PractitionerSpecialty |
http://ontariohealth.ca/fhir/ValueSet/service-category-eServices  | Service Category-eServices |
http://ontariohealth.ca/fhir/ValueSet/service-type-ocean  | Service Type OCEAN |
http://ontariohealth.ca/fhir/ValueSet/wait-time-service-type  | WaitTime Service Type |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-product-gps-uv-ips  | Allergy-intolerance substance-product - GPS - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-product-snomed-extended-uv-ips  | Allergy intolerance substance product - SNOMED CT extended - IPS |
http://hl7.org/fhir/ValueSet/covid-19-cond  | COVID-19 related Condition codes |
http://terminology.hl7.org/ValueSet/snomed-intl-ips  | SNOMED CT® International Patient Set (IPS) |
https://medipee.com/fhir/uroli-export/ValueSet/HighMediumLowVS  | SCT: High - Medium - Low |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20150401000000  | AlcoholGebruikStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20150401000000  | AlertNaamCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.2.1--20150401000000  | BehandelingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.2--20150401000000  | DiastolischEindpuntCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20150401000000  | DrugGebruikStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20150401000000  | DrugsOfGeneesmiddelSoortCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.2.4--20150401000000  | GeverifieerdBijCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.3.2--20150401000000  | HartslagMeetMethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.3.1--20150401000000  | HartslagRegelmatigheidCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.5--20150401000000  | HoudingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.1.2--20150401000000  | HulpmiddelAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.4--20150401000000  | MeetLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.1--20150401000000  | MeetmethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.16.1.2--20150401000000  | OrderStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.16.1.2--20171231000000  | OrderStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.3--20150401000000  | ProbleemNaamCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20150401000000  | ProbleemTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.6.2--20171231000000  | RedenMedicatieafspraakCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2--20171231000000  | RedenWijzigenOfStoppenGebruikCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20150401000000  | SoortTabakGebruikCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.4--20150401000000  | StatusNaamSnomedCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.8--20150401000000  | StatusWaardeSnomedCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20150401000000  | TabakGebruikStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20150401000000  | TekstUitslagTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20150401000000  | TemperatuurTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.1.1--20150401000000  | VerrichtingAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20171231000000  | AfnameprocedureCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.5.3--20171231000000  | AfwijkendAdemhalingspatroonCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20171231000000  | AlcoholGebruikStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20171231000000  | AlertNaamCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20171231000000  | AllergieCategorieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.2.1.1--20171231000000  | BehandelingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.15.1.3--20171231000000  | BestemmingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.4.2--20171231000000  | BrandwondAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.4.4--20171231000000  | BrandwondLateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.4.3--20171231000000  | BrandwondSoortCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.9--20171231000000  | ContainerTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.3--20171231000000  | DagdeelCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.1.2--20171231000000  | DecubitusAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.1.1--20171231000000  | DecubitusCategorieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.1.3--20171231000000  | DecubitusWondLateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.15.5--20171231000000  | DefecatieKleurCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.2--20171231000000  | DiastolischEindpuntCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.5.2--20171231000000  | DiepteCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.4.1--20171231000000  | DieptegraadCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.8.2--20171231000000  | DrinkBeperkingenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.8.1--20171231000000  | DrinkenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20171231000000  | DrugsGebruikStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20171231000000  | DrugsOfGeneesmiddelSoortCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.7.2--20171231000000  | EetBeperkingenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.6--20171231000000  | ErnstCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.7.1--20171231000000  | EtenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.2.1.4--20171231000000  | GeverifieerdBijCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.13.1--20171231000000  | GezinssamenstellingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.16.1--20171231000000  | GezinssamenstellingKindCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.3.2--20171231000000  | HartslagMeetMethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.3.1--20171231000000  | HartslagRegelmatigheidCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.15.1.2--20171231000000  | HerkomstCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.17.1--20171231000000  | HoorFunctieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.17.2--20171231000000  | HorenHulpmiddelTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.5--20171231000000  | HoudingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.3.4--20171231000000  | HoudingHandhavenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.3.1--20171231000000  | HoudingVeranderenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.3.2--20171231000000  | HuidAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.3.3--20171231000000  | HuidLateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.1.2--20171231000000  | HulpmiddelAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.2.1--20171231000000  | InfuuskatheterTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.7--20171231000000  | InterpretatieVlaggenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.2.4--20171231000000  | InterventieSnomedCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.12--20171231000000  | LateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20171231000000  | LevensovertuigingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.17.3--20171231000000  | LocatieGehoorapparaatCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.3.9--20171231000000  | LopenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.2.2--20171231000000  | LumenLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.4--20171231000000  | MateVanKritiekZijnCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.1.4--20171231000000  | MedischHulpmiddelLateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.4--20171231000000  | MeetLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.1--20171231000000  | MeetmethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.3.4--20171231000000  | MeetmethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.3.2--20171231000000  | MetingNaamCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.10--20171231000000  | MicroorganismeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.11--20171231000000  | MonsterAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.6--20171231000000  | MonstermateriaalCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.13--20171231000000  | MorfologieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.3.3--20171231000000  | OnderzoekCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.3--20171231000000  | OntwikkelingMotoriekCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.4--20171231000000  | OntwikkelingSociaalCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.5--20171231000000  | OntwikkelingTaalCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.6--20171231000000  | OntwikkelingVerstandelijkCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.9.2--20171231000000  | PijnAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.9.3--20171231000000  | PijnLateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.7.1--20171231000000  | PolsRegelmatigheidCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.5--20171231000000  | ProbleemAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.6--20171231000000  | ProbleemLateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.2--20171231000000  | ProbleemStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20171231000000  | ProbleemTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.1.1--20171231000000  | ProductTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.13.2--20171231000000  | ProtheseTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.1--20171231000000  | ResultaatTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.5.1--20171231000000  | RitmeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.29.4--20171231000000  | SNAQrcHulpBijEtenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.14.1--20171231000000  | SchedelomvangMeetmethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.3.1--20171231000000  | SondeTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.3.1--20171231000000  | SoortAandoeningCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.3.2.1--20171231000000  | SoortHulpCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.3.3--20171231000000  | SoortInterventieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20171231000000  | SoortTabakGebruikCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.16--20171231000000  | SpecifiekeStofAllergeneStoffenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.4--20171231000000  | StatusNaamSnomedCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.8--20171231000000  | StatusWaardeSnomedCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.2.2--20171231000000  | StomaAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.2.3--20171231000000  | StomaLateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20171231000000  | StomaTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20171231000000  | SymptoomCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.11.2--20171231000000  | TeKledenLichaamsdeelCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.10.2--20171231000000  | TeWassenLichaamsdeelCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20171231000000  | TekstUitslagTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20171231000000  | TemperatuurTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.4--20171231000000  | TestmethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.5.4--20171231000000  | ToedieningHulpmiddelCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.22.4--20171231000000  | ToiletgebruikCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.3.12--20171231000000  | TraplopenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.33.1--20171231000000  | UiterlijkeVerzorgingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.3.7--20171231000000  | UitvoerenTransferCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.14.2--20171231000000  | UrineKatheterTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.4--20171231000000  | VerificatieStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.17--20171231000000  | VeroorzakendeStofAllergeneStoffenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.34.1--20171231000000  | VerrichtenVPKHandelingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.1.2--20171231000000  | VerrichtingTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.13.1--20171231000000  | VerzorgenTandenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.16.1--20171231000000  | VisueleFunctieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.31.2--20171231000000  | VoedingMethodeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.31.1--20171231000000  | VoedingSoortCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.2--20171231000000  | WeekdagCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.12--20171231000000  | WijzeVanBlootstellingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.6--20171231000000  | WondAnatomischeLocatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.7--20171231000000  | WondDrainTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.8--20171231000000  | WondLateraliteitCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.4--20171231000000  | WondSoortCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.35.1--20171231000000  | ZelfstandigMedicatiegebruikCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.11.1--20171231000000  | ZichKledenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.10.1--20171231000000  | ZichWassenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.16.2--20171231000000  | ZienHulpmiddelTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.2--20171231000000  | ZindelijkheidFecesCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.1--20171231000000  | ZindelijkheidUrineCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.22.3--20171231000000  | ZorgBijMenstruatieCodelijst |
http://hl7.org/fhir/ValueSet/animal-breeds  | animal breeds |
http://hl7.org/fhir/ValueSet/animal-species  | animal species |
http://hl7.org/fhir/ValueSet/barrier  | Barrier |
http://hl7.org/fhir/ValueSet/condition-cause  | Condition Cause Codes |
http://hl7.org/fhir/ValueSet/condition-course  | Condition Course Codes |
http://hl7.org/fhir/ValueSet/condition-predecessor  | Condition Predecessor Codes |
http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclass  | DataElement SDC Object Class |
http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclassproperty  | DataElement SDC Object Class Property |
http://hl7.org/fhir/ValueSet/feeding-device  | Feeding Device Codes Value Set |
http://hl7.org/fhir/ValueSet/focal-subject  | Focal Subject Codes |
http://hl7.org/fhir/ValueSet/protective-factor  | Protective Factor |
http://hl7.org/fhir/ValueSet/specimen-additive-substance  | Specimen Additive Substance Codes |
http://medmij.nl/fhir/ValueSet/DentalCare-ASAScore  | DentalCare - ASA Score |
http://medmij.nl/fhir/ValueSet/DentalCare-OralHygieneFinding  | DentalCare - Oral Hygiene Finding |
http://hdp.fhir.health.gov.il/ValueSet/il-hdp-condition-code  | ILHDP Condition Code |
https://mednet.swiss/fhir/ValueSet/mni-obs-bloodGroup  | MedNet Interface (MNI) - Blood Group Observation ValueSet |
https://mednet.swiss/fhir/ValueSet/mni-serviceRequestCode  | MedNet Interface (MNI) - ServiceRequest Code ValueSet |
http://hl7.org/fhir/ValueSet/body-site  | SNOMED CT Body Structures |
http://omi.de/fhir/registry/ValueSet/device-property-type-valueset  | Device Property Type ValueSet |
http://omi.de/fhir/registry/ValueSet/type-code-value-set  | Type Code Value Set |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.7--20211028090253  | CategorieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.31--20231207101023  | DiagnoseNaamCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.19--20231120131658  | ErnstCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.41--20240910090504  | StartRedenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.34--20240501114150  | SymptoomErnstCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.35--20240501114333  | SymptoomNaamCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.16--20231120123250  | VerwachtRisicoBijBlootstellingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.14--20231120120019  | WijzeVanVaststellenCodelijst |
http://portal.esysta.com/fhir/ValueSet/BloodGlucoseMarkVS  | BloodGlucoseMarkVS |
http://portal.esysta.com/fhir/ValueSet/BloodGlucoseUnit  | BloodGlucoseUnit |
http://portal.esysta.com/fhir/ValueSet/CarbohydrateUnit  | CarbohydrateUnit |
http://portal.esysta.com/fhir/ValueSet/CarbohydrateUnitSettingVS  | CarbohydrateUnitSettingVS |
http://portal.esysta.com/fhir/ValueSet/CarbohydrateUnitVS  | CarbohydrateUnitVS |
http://portal.esysta.com/fhir/ValueSet/DiabetesType  | DiabetesType |
http://portal.esysta.com/fhir/ValueSet/DiabetesTypeVS  | DiabetesTypeVS |
http://portal.esysta.com/fhir/ValueSet/DiaryEventVS  | DiaryEventVS |
http://portal.esysta.com/fhir/ValueSet/EsystaEvaluationColorVS  | EsystaEvaluationColorVS |
http://portal.esysta.com/fhir/ValueSet/EvaluationColor  | EvaluationColor |
http://portal.esysta.com/fhir/ValueSet/EvaluationColorVS  | EvaluationColorVS |
http://portal.esysta.com/fhir/ValueSet/InsulinPenMarkerColor  | InsulinPenMarkerColor |
http://portal.esysta.com/fhir/ValueSet/InsulinPenMarkerColorVS  | InsulinPenMarkerColorVS |
http://portal.esysta.com/fhir/ValueSet/InsulinType  | InsulinType |
http://portal.esysta.com/fhir/ValueSet/InsulinTypeVS  | InsulinTypeVS |
http://portal.esysta.com/fhir/ValueSet/MedicalFindingStageVS  | MedicalFindingStageVS |
http://portal.esysta.com/fhir/ValueSet/MedicalFindingsVS  | MedicalFindingsVS |
https://gematik.de/fhir/terminology/ValueSet/epa-xds-event-code-vs  | IHE XDS Event Code ValueSet für ePA |
https://gematik.de/fhir/terminology/ValueSet/ti-medication-snomed-ct-vs  | TI Arzneimittel SNOMED CT ValueSet |
https://gematik.de/fhir/terminology/ValueSet/ti-medication-type-pharmaceutical-product-vs  | TI Medication Type ValueSet for a Pharmaceutical Product |
https://gematik.de/fhir/terminology/ValueSet/ti-medication-type-product-vs  | TI Medication Type ValueSet for PZN-Medication |
https://gematik.de/fhir/terminology/ValueSet/ti-medication-type-vs  | TI Medication Type ValueSet |
https://gematik.de/fhir/terminology/ValueSet/ti-medicine-form-snomed-ct-vs  | Value Set Darreichungsform SNOMED CT |
https://gematik.de/fhir/terminology/ValueSet/ti-substance-snomed-ct-vs  | TI Substance SNOMED CT ValueSet |
https://www.ehealth.fgov.be/standards/fhir/patientwill/ValueSet/be-vs-patientwill-scope  | BeVSPatientWillScope |
https://demis.rki.de/fhir/igs/ValueSet/sequencingReason  | Grund der Sequenzierung |
https://demis.rki.de/fhir/igs/ValueSet/uploadStatus  | Status des Sequenz-Uploads |
http://fhir.kl.dk/children/ValueSet/BodyheightSCTobservablesChildren  | HøjdeObservationskoderSCT |
http://hl7.org/fhir/us/sdcde/ValueSet/dataelement-sdccode  | DataElement SDC Concept |
https://furore.com/data/fhir/ValueSet/EducationLevelVS  | Education level of patient ValueSet |
https://furore.com/data/fhir/ValueSet/ProcedureIntentVS  | Procedure Intent Value Set |
http://hl7.it/fhir/lab-report/ValueSet/additivo-campione-it  | Additivo Campione |
http://hl7.it/fhir/lab-report/ValueSet/campione-container-lab-it  | Container Campione |
http://hl7.it/fhir/lab-report/ValueSet/results-microorganism-snomed-ct-ips-free-set  | Risultato osservazione codificato - microorganismo IPS di SNOMED CT |
http://hl7.it/fhir/lab-report/ValueSet/results-observation-bloodgroup  | Risultato osservazione codificato - Gruppo Sanguigno IPS di SNOMED CT |
http://hl7.it/fhir/lab-report/ValueSet/results-presence-absence-snomed-ct-ips-free-set  | Risultato osservazione codificato - presenza/assenza IPS di SNOMED CT |
http://hl7.it/fhir/lab-report/ValueSet/tipo-campione-lab-it  | Tipo campione |
http://hl7.it/fhir/lab-report/ValueSet/valueset-observation-value-bloodgroup  | Risultato osservazione codificato gruppo sanguigno |
http://hl7.it/fhir/lab-report/ValueSet/valueset-observation-value-microorganism  | Risultato osservazione codificato microorganismi |
http://hl7.it/fhir/lab-report/ValueSet/valueset-observation-value-presence-absence  | Risultato osservazione codificato presenza/assenza |
https://tstifhir.azurehealthcareapis.com/ValueSet/adultcheck-code  | 成人預防保健疾病史代碼集值 |
https://tstifhir.azurehealthcareapis.com/ValueSet/adultcheck-lifecode  | 成人預防保健生活史代碼集值 |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Clinical_Course  | Verlauf |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Procedure_And_Recommendations  | Weiteres Procedere und Empfehlung |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Results_Type  | Befundtyp |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_SNOMED_CT_Drug_Therapy_Status_Codes  | Medikation Therapie Statuscodes SNOMED CT® |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Type_Of_Medical_History  | Art der Anamnese |
http://fhir.data4life.care/covid-19/r4/ValueSet/chronic-condition-set  | ChronicConditions |
http://fhir.data4life.care/covid-19/r4/ValueSet/covapp-symptoms-group-1  | Symptoms |
http://fhir.data4life.care/covid-19/r4/ValueSet/covapp-symptoms-group-2  | Symptoms |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-ventilation-observable-sct  | Ventilation Observable SCT |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ACVPU-1  | Care Connect ACVPU |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-AllergyCertainty-1  | Care Connect Allergy Certainty |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-InspiredOxygen-1  | Care Connect Inspired Oxygen |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-SaturatedOxygenSp02Scale-1  | Care Connect Saturated Oxygen Sp02 Scale |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ObservationMethod-1  | Care Connect Observation Method |
https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ObservationType-1  | Care Connect Observation Type |
https://demis.rki.de/fhir/ValueSet/materialWBGP  | Material für Meldepflicht für die Meldepflicht von Krankheitserregern mit Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Initiated_Services_SNOMED_CT  | Veranlasste Leistungen |
https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Results_Type  | Befundtyp |
https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/Laborergebnis-semiquantitativ  | MII VS Labor Laborergbenis Semiquantitativ |
https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/Laborergebnis-qualitativ  | MII VS Labor Laborergebnis Qualitativ |
https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/QuelleKlinischesBezugsdatum  | MII VS Labor Quelle klinisches Bezugsdatum |
http://hl7.org/fhir/us/immds/ValueSet/targetDisease  | Vaccine Target Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.1280649  | Sneezing and Itching Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.15972546  | Conditions Indicating Appropriate Sinonasal Imaging |
http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.16432390  | Cerumen Impaction |
http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.16929355  | Allergic Rhinitis Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.18316962  | Severe Asthma |
http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.23618223  | Hearing Aids Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45  | Comfort Measures |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1  | Selected non pharmaceutical therapies for moderate to severe chronic pain |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1  | pain medication action plan |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1  | selected follow up visit intervals for opioid monitoring |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.7  | malignant neoplasms and cancer pain |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.9  | malignancy or cancer related pain |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150  | Cerumen on Otoscopy |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172  | Hearing Loss |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175  | Tinnitus |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178  | Ear Congestion |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179  | Ear Pruritus |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180  | Otalgia |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96  | Initial Encounter with Otolaryngologist or undefined clinician |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81  | Cerumen Impaction |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188  | Radiotherapy |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191  | Head and Neck Anatomic Locations |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194  | Ear Canal Stenosis |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197  | Exostoses |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200  | Non intact Tympanic Membrane |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246  | Hearing Aids |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250  | DO NOT USE |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252  | Irrigation |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288  | Otoscopy performed on exam |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291  | Otolaryngologist as a Clinician or Service |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275  | Dermatologic Diseases of the Ear |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20  | Keratoses Obturans |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221  | Tympanoplasty |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223  | Myringoplasty |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225  | Mastoidectomy |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227  | Ear Surgery, Other |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336  | Sleep Apnea |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237  | Allergic Rhinitis |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263  | Uncontrolled or severe asthma |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302  | Rhinosinusitis |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305  | Nasal Polyposis |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308  | Suspected Nasal Neoplasm |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215  | Sneezing as a finding |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217  | Pruritus Unspecified or Other Location |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290  | Clinicians who perform allergy testing |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279  | Radiography of face, head or neck |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318  | Eustachian Tube Dysfunction |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267  | Immunotherapy that is not Identified as Subcutaneous |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268  | Immunotherapy |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657  | Clostridium difficile infection |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724  | Ileus due to infection |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727  | Vomiting potentially due to CDI |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730  | Toxic Megacolon in adults |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732  | Abdominal Distension |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690  | Septic Shock due to C. Diff |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660  | History of CDI |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661  | Consult Infectious Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691  | Abdominal Xrays for CDI |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692  | CT of abdomen with contrast for fulminant CDI |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693  | Surgical consult for CDI |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694  | Fecal microbiota transplantation |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645  | Hospitalist |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697  | Positive result indicator |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646  | Body Temperature |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648  | Diarrhea Potentially due to CDI |
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652  | Inpatient Setting |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.1  | Substance Reactant for Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.2  | Clinical Substance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9  | Substance Other Than Clinical Drug |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.240  | SNOMED CT CORE Problem List |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98  | Route of Administration |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.101  | Gender Identity USCDI core |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.120  | Patient Sex for Quality Measurement |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.121  | Federal Administrative Sex |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.14  | Published test VS |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.33  | Sexual Orientation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.40  | MDP Test Intensional |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.56  | Medical Reason Not Done SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.120  | Phototherapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.121  | Phototherapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.123  | Neonatal Jaundice |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.124  | Neonatal Jaundice |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.126  | Maternal Drug Use |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.127  | Maternal Drug Use |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.129  | Fetal Conditions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.130  | Fetal Conditions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.132  | Congenital Malformations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.133  | Congenital Malformations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.135  | Social Indications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.136  | Social Indications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.138  | Neonatal Severe Birth Trauma |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.139  | Neonatal Severe Birth Trauma |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.141  | Neonatal Severe Hypoxia or Asphyxia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.142  | Neonatal Severe Hypoxia or Asphyxia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.144  | Neonatal Severe Shock and Resuscitation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.145  | Neonatal Severe Shock and Resuscitation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.147  | Neonatal Severe Respiratory Complications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.148  | Neonatal Severe Respiratory Complications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.150  | Neonatal Severe Infection |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.151  | Neonatal Severe Infection |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.153  | Neonatal Severe Neurological Complications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.154  | Neonatal Severe Neurological Complications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.156  | Neonatal Severe Shock and Resuscitation Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.157  | Neonatal Severe Shock and Resuscitation Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.159  | Neonatal Severe Respiratory Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.160  | Neonatal Severe Respiratory Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.162  | Neonatal Severe Neurological Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.163  | Neonatal Severe Neurological Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.165  | Neonatal Severe Septicemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.166  | Neonatal Severe Septicemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.168  | Neonatal Moderate Birth Trauma |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.169  | Neonatal Moderate Birth Trauma |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.171  | Neonatal Moderate Respiratory Complications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.172  | Neonatal Moderate Respiratory Complications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.174  | Neonatal Moderate Respiratory Complications Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.175  | Neonatal Moderate Respiratory Complications Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.177  | Neonatal Moderate Birth Trauma with LOS |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.178  | Neonatal Moderate Birth Trauma with LOS |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.180  | Neonatal Moderate Respiratory Complications with LOS |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.181  | Neonatal Moderate Respiratory Complications with LOS |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.186  | Neonatal Moderate Respiratory complications with LOS Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.187  | Neonatal Moderate Respiratory complications with LOS Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.189  | Single Liveborn Newborn Vaginal |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.190  | Single Liveborn Newborn Vaginal |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.192  | Single Liveborn Newborn Cesarean |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.193  | Single Liveborn Newborn Cesarean |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.196  | Neonatal Moderate Infection with LOS |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.197  | Neonatal Moderate Infection with LOS |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.205  | Neonatal Intensive Care Unit |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.206  | Intensive Care Unit |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.209  | Blood Transfusion Administration |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.213  | Blood Transfusion |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.220  | Aortic Aneurysm |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.228  | Heart Failure Cardiac Arrest Related to Procedure or Surgery |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.24  | Blood Transfusion Administration |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.246  | Blood Transfusion |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.248  | Conversion of Cardiac Rhythm |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.250  | Hysterectomy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.252  | Tracheostomy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.254  | Ventilation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.256  | Severe Maternal Morbidity Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.344  | Aortic Aneurysm |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.357  | Conversion of Cardiac Rhythm |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.358  | Hysterectomy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.359  | Tracheostomy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.360  | Ventilation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.368  | Preadmission Observation Undelivered Mother |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.369  | ED Visit and OB Triage |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.372  | COVID 19 Confirmed |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.373  | COVID 19 Confirmed |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.375  | Respiratory Conditions Related to COVID 19 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.376  | Respiratory Conditions Related to COVID 19 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.378  | Respiratory Support Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.379  | Respiratory Support Procedures Related to COVID 19 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.67  | Other Health Care Facility |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10  | Non essential Hypertension SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.102  | Suicide Attempt |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.13  | Cirrhosis SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.14  | Cirrhosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.151  | Polycystic Ovary Syndrome |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.230  | Gestational Diabetes SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.233  | All Results of High Risk HPV Test |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.234  | High Risk HPV Positive Results |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.248  | Suicide Attempt SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.263  | High Risk Positive HPV Results Without HPV16 or HPV18 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.264  | CDS Pregnancy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.266  | Rhabdomyolysis Intensional |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.267  | CDS Rhabdomyolysis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.268  | HPV Negative Results |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.29  | Non pharmacologic treatments for chronic pain SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.296  | SCT Findings 202209 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.302  | Test Cervical Excision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.307  | Counseling for Physical Activity CDS |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.309  | SCT Findings 202309 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.311  | SCT Procedures 202209 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.312  | SCT Procedures 202309 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.313  | Statin Allergen Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.36  | Non pharmacologic treatments for chronic pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.48  | Anxiety |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.51  | Sleep disordered breathing |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.52  | Anxiety |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.53  | Sleep disordered breathing |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.79  | Behavioral Counseling for Nutrition and Activity Referral |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.85  | Impaired Glucose Tolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.9  | Hypertension |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.90  | Gestational Diabetes |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.96  | Dependence on dialysis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.464  | Cluster Headache |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.555  | Patient Declines Treatment for Cluster Headache (SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.641  | Neuromodulation for migraine |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.642  | No pain with headache |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.646  | Anxiety Disorders (ICD10 and SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.648  | Depression Diagnosis (ICD10 and SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.649  | Psychosis (ICD10 and SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.650  | Cluster Headache (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.660  | Acute cluster headache treatment |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.662  | Long term preventive treatment for cluster headache |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.105  | Abnormal Presentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.15  | Intravenous Thrombolytic tPA Therapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.16  | Intraarterial Thrombolytic tPA Therapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.171  | Abnormal Presentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.173  | Delivery of Singleton |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.21  | Intravenous or Intraarterial Thrombolytic tPA Therapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.27  | Cornual Ectopic Pregnancy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.59  | Delivery Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.67  | PCI |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.69  | Endotracheal Intubation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.99  | Delivery of Singleton |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.225  | Opioid Medication Assisted Treatment (MAT) SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.243  | Opioid Use Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.279  | Triage |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.283  | Emergency Department Location |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.284  | Emergency Department Location |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.285  | Mental Health Diagnosis without Substance Use Disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.286  | Decision to Transfer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.10  | Breastfeeding |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.100  | Familial Hypercholesterolemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.102  | Rhabdomyolysis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.12  | Liver Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.13  | Rhabdomyolysis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.20  | Atherosclerosis and Peripheral Arterial Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.21  | Atherosclerosis and Peripheral Arterial Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.42  | Liver Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.44  | Cerebrovascular Disease Stroke or TIA |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.46  | Ischemic Heart Disease or Related Diagnoses |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.47  | Stable and Unstable Angina |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.502  | Overweight or Obese |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.513  | Elevated Blood Pressure Reading |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.514  | Finding of Elevated Blood Pressure or Hypertension |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.525  | Referral (ophthalmology) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.527  | Retina visualization inadequate |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.528  | Refusal or Noncompliance with treatment |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.530  | Vitreous hemorrhage |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.553  | Uveitis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.560  | Tonometry |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.576  | Vitreous hemorrhage |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.580  | Intravitreal and Periocular Injections |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.581  | Intravitreal and Periocular Injections |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.587  | Lost to follow up |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.588  | Uveitis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.611  | 3 Mirror Goldmann exam |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.612  | Scleral depressed exam |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.615  | Physical Disability |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.616  | Financial difficulty |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.619  | Scleral depressed exam |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.69  | Stable and Unstable Angina |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.70  | Ischemic Heart Disease or Related Diagnoses |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.71  | Cerebrovascular Disease Stroke or TIA |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.73  | Breastfeeding |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.85  | Familial Hypercholesterolemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.9  | Outpatient Encounters for Preventive Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.53  | Indicators of Human Immunodeficiency Virus (HIV) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1003  | OIA_RFs_Secondary_Prevention_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1005  | OIA_RFs_Secondary_Prevention_ICD_SM_CPT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1009  | PAE_Patient_Conditions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1012  | PAE Conditions Short |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1044  | Anemia for Erythropoesis Simulating Agents SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1045  | Anemia for Erythropoesis Simulating Agents |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1049  | Knee pain SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.105  | conditions_heartfailure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1050  | Knee pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1051  | Knee decreased ROM SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1055  | Knee crepitus SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1069  | Urinary incontinence SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1071  | Urinary incontinence |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1073  | Hemifacial spasm SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1075  | Hemifacial spasm |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1076  | Spasmodic dysphonia SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1077  | Physical therapy procedure SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1078  | Occupational therapy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1079  | Hyperhidrosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1081  | Hyperhidrosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1083  | Tic disorder SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1084  | Tic disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1085  | Esophageal achalasia SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1087  | Esophageal achalasia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1090  | Blephraospasm SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1092  | Blepharospasm |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1093  | Strabismus SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1095  | Strabismus |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1096  | Overactive bladder SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1098  | Overactive bladder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1099  | Movement disorders SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.110  | CKD stage4above SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1101  | Movement disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1102  | Lateral epicondylitis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1104  | Lateral epicondylitis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1105  | Plantar fasciitis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1107  | Plantar fasciitits |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1108  | Cardiac CT SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.111  | CKD stage4above |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1111  | Cardiac CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1112  | Cardiac MRI SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1114  | Cardiac MRI |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1115  | CT Angiography of Coronary Artery SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1117  | CT Angiography of Coronary Artery |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.113  | Chronic kidney disease SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.117  | DigTx Cognitive Impairment SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.120  | Diabetic ketoacidosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.121  | Diabetic ketoacidosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.124  | DKD |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.147  | HFrEF SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.151  | History of Hypoglycemia SCD |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.17  | Atrial fibrillation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.175  | Asthma |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.184  | DigTx Virtual Reality Contraindications Visual Impairment |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.21  | Thoracic aorta disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.214  | Type 1 Diabetes Mellitus SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.226  | Systolic Heart Failure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.244  | MRA Mineralocorticoid Receptor Antagonist Allergy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.260  | UACR SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.281  | Statins Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.282  | Statin Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.37  | relatedconditions_hypertension SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.440  | relatedconditions_T2DM SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.459  | Liver cancer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.47  | ACE inhibitor allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.474  | Allergy to Tdap Vaccine |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.475  | Allergy to Td Vaccine |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.476  | Allergy To Vaccine Component |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.478  | Allergy to HPV Vaccine |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.492  | Inhaled Corticosteroids Allergy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.498  | Metformin AllergyIntolerance SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.5  | Delivery - Procedure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.516  | Allergy to Herpes Zoster Vaccine SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.519  | Drug hypersensitivity SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.520  | Drug hypersensitivity |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.524  | Chronic Hepatitis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.525  | Chronic Hepatitis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.535  | Vasospastic disease SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.536  | Vasospastic disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.538  | Hemiplegic and basilar migraine SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.539  | Hemiplegic and basilar migraine |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.541  | Peptic ulcer disease SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.542  | Peptic ulcer disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.545  | Bleeding disorder SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.548  | Electronic cigarettes or Vaping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.549  | Bleeding disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.561  | conditions_migraine |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.562  | relatedconditions_migraine SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.563  | relatedconditions_migraine |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.564  | Triptan Allergy Intolerance SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.565  | Triptan Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.566  | Ischemic bowel disease SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.568  | Ischemic bowel disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.570  | Allergy to house dust mites SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.572  | Allergy to house dust mites |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.574  | conditions_hyperlipidemia SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.575  | conditions_hyperlipidemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.594  | Intolerance to ARB SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.612  | Wolff Parkinson White SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.614  | Wolff Parkinson White |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.618  | relatedconditions_Asthma SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.622  | relatedconditions_Asthma |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.623  | LAMA Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.624  | LABA Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.625  | BetaBlock NonCS Secondary Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.626  | Eplerenone Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.627  | Spironolactone Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.628  | SGLT2 Inhibitors Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.630  | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.631  | Pneumococcal Vaccine Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.632  | Meglitinides Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.633  | DPP4i Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.635  | Alpha_glucosidase inhibitors allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.636  | Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.637  | Insulins Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.638  | TZD Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.639  | T2DM_Medications Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.643  | T2DM_Medications Allergy SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.646  | T2DM_Medication Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.647  | Statins Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.649  | ACE Inhibitors Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.650  | ARB Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.652  | Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.653  | Long Acting Beta Agonists (LABA) Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.654  | BetaBlocker NonCS Secondary Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.656  | MRA Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.657  | Eplerenone Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.658  | Spironolactone Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.659  | SGLT2i Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.660  | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.661  | Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.665  | Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.666  | Human Papillomavirus (HPV) vaccine Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.670  | Pneumococcal Vaccine Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.671  | Inhaled Corticosteroids(ICS) Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.675  | GLP1RA Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.713  | PIM_IHD_CHD_CAD_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.723  | Macrolide Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.724  | Macrolide Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.725  | Prednisone Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.727  | Tetracycline Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.728  | Tetracycline Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.729  | Fluoroquinolones Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.730  | Fluoroquinolone Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.732  | Penicillin Allergy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.733  | Penicillin Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.737  | Pneumonia SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.738  | Pneumonia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.742  | Pulmonary Embolism SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.743  | Pulmonary Embolism |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.745  | Influenza SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.747  | Influenza |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.749  | COVID19 SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.750  | COVID19 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.753  | RSV SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.754  | RSV |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.755  | Respiratory Rate SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.757  | Respiratory Rate |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.759  | Acute Respiratory Failure SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.760  | Acute Respiratory Failure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.761  | Dyspnea SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.763  | Dyspnea |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.765  | Confusion SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.766  | Confusion |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.767  | Drowsiness SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.769  | Drowsiness |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.771  | Cyanosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.772  | Cyanosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.776  | Arterial oxygen saturation SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.777  | Arterial oxygen saturation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.790  | Simple Knee Pain SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.791  | Simple Knee Pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.792  | Simple Left Knee Pain SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.793  | Simple Right Knee Pain SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.796  | Simple Right Knee Pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.797  | Simple Left Knee pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.799  | Knee joint surgery SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.800  | Knee joint surgery |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.802  | Knee Osteoarthritis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.803  | Knee Osteoarthritis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.804  | Osteoarthritis of right knee SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.805  | Osteoarthritis of left knee SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.808  | Osteoarthritis of right knee |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.809  | Osteoarthritis of left knee |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.810  | Hip Osteoarthritis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.812  | Hip Osteoarthritis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.814  | Hip joint surgery SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.815  | Hip joint surgery |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.818  | Osteoarthritis of right hip SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.819  | Osteoarthritis of left hip SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.820  | Osteoarthritis of right hip |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.821  | Osteoarthritis of left hip |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.853  | Hyperkalemia_SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.854  | Hyperkalemia Conditions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.862  | PIM_Ambulatory_Visits_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.876  | Alpha Glucosidase Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.878  | Inflammatory bowel disease SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.879  | Inflammatory bowel disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.88  | DEPRECATED Diabetes |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.880  | Gastrointestinal obstruction SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.882  | Gastrointestinal obstruction |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.883  | DPP4i Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.884  | Multiple endocrine neoplasia type 2 (MEN II) SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.886  | Multiple endocrine neoplasia type 2 (MEN II) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.887  | Gastroparesis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.889  | Gastroparesis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.890  | Meglitinide Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.891  | Sulfonylurea Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.893  | Peripheral edema SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.894  | Peripheral edema |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.895  | TZD Allergy Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.911  | CKD stage5OrESRD SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.912  | CKD stage5OrESRD |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.915  | Anxiety_SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.916  | Anxiety |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.918  | Stress_SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.92  | ASCVD |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.920  | Stress |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.921  | PBH_Anxiety_SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.922  | PBH_Depression_SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.923  | PBH_Stress_SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.924  | PBH_Insomnia_SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.938  | Crohn disease SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.94  | Albuminuria SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.940  | Crohn disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.941  | Celiac disease SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.943  | Celiac disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.95  | Albuminuria |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.953  | OIA_DM_SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.954  | OIA_CAD_SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.955  | OIA_PVD_SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.956  | OIA_DM_ICD10_SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.957  | OIA_CAD_ICD10_SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.958  | OIA_PVD_ICD10_SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.964  | OIA_RFs_ACS_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.965  | OIA_RFs_ACS__ICD10_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.967  | OIA_Aortic_Calcifications_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.968  | OIA_Aortic_Calcifications_ICD10_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.97  | Sulfonylurea AllergyIntolerance SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.973  | MASLD SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.974  | MASLD |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.979  | OIA_RFs_ASCVD_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.980  | OIA_RFs_ASCVD_ICD10_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.982  | OIA_TIA_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.983  | OIA_TIA_ICD10_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.985  | OIA_Angina_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.987  | OIA_Angina_ICD10_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.989  | OIA_Ischemic_Hemorrhagic_Stroke_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.99  | BMI SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.990  | OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.992  | OIA_Myocardial_Infarction_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.993  | OIA_Myocardial_Infarction_ICD10_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.996  | OIA_PAD_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.997  | OIA_PAD_ICD10_SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.10  | Nutrition Diagnosis SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.101  | Hospice Status |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.11  | Nutrition Focused Physical Findings SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.14  | Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.17  | Pediatric Enteral Formulas SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.18  | Modified Amino Acid Formulas SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.19  | Nutrition Counseling Approach and Strategies SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.2  | Food and Nutrient Delivery SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.20  | Enteral Nutrition Management SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.24  | Malnutrition Assessment |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.29  | Malnutrition Assessment |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.30  | Malnutrition Risk Screening |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.33  | Nutrition Assessment Procedure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.38  | Malnutrition Screening Finding of At Risk Result |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.40  | Malnutrition Risk Screening |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.42  | Nutrition Assessment Status Finding of Severely Malnourished |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.43  | Nutrition Assessment Status Finding of Severely Malnourished |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.44  | Nutrition Assessment Status Finding of Moderately Malnourished |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.47  | Nutrition Assessment Status Finding of Moderately Malnourished |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.48  | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.49  | Nutrition Focused Physical Findings Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.5  | Adult Enteral Formulas SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.50  | Enteral Nutrition Composition SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.51  | Enteral Nutrition Composition Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.52  | Parenteral Nutrition Management SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.53  | Malnutrition Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.55  | Malnutrition Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.58  | Nutrition Order Item Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.59  | Diet Item Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.60  | Edible Substances |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.61  | Feeding Device SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.65  | Nutrition Recommendation Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.7  | Modular Nutrition Formulas SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.70  | Nutrition Education SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.71  | Coordination of Care by a Nutrition Professional SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.73  | Nutrition Anthropometric Measurement SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.75  | Nutrition Anthropometric Measurements Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.76  | Manage Feeding Environment |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.77  | Special Food Items and Regime/Therapy for Special Food Items SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.82  | Food and Nutrition Related History Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.84  | Food and Nutrition Related History SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.85  | Nutrition Diagnosis Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.87  | Feeding Device Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.88  | Nutrition Intervention Care Planning |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.89  | Malnutrition Screening Finding of At Risk Result |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.91  | Dietitian Referral |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.93  | Nutrition Care Plan |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.96  | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.99  | Nutrition Diagnosis SNOMED CT (2) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.1  | Findings Related to Medication Management, Referral Source |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.100  | Recommendations Related to Medication Regimen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.101  | Interventions Related to Medication Regimen, Initiate Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.102  | Interventions Related to Medication Regimen, Change Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.103  | Interventions Related to Medication Regimen, Change Medication Dose |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.104  | Interventions Related to Medication Regimen, Change Medication Dosage Form |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.105  | Interventions Related to Medication Regimen, Change Medication Course |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.106  | Interventions Related to Medication Regimen, Change Medication Dosing Interval |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.107  | Interventions Related to Medication Regimen, Discontinue Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.109  | Interventions Related to Medication Regimen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.11  | Interventions Related to Medication Management, Medication Reconciliation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.110  | Interventions Related to Education, Medications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.111  | Interventions Related to Education, Medical Equiptment and Devices |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.112  | Interventions Related to Medication Management, Notifications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.113  | Interventions Related to Medication Management, Refill Synchronization |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.114  | Status of Patient Condition |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.115  | Interventions Related to Education, Diseases and Disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.116  | Interventions Related to Education |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.118  | Interventions Related to Medication Management |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.119  | Interventions Related to Medication Management, Targeted Medication Review |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.120  | Interventions Related to Medication Management, Discussion |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.121  | Reasons for Interventions Related to Medication Management, Cost |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.122  | Interventions Related to Education, Immunizations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.123  | Status of Recommendations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.124  | Interventions Related to Medication Management, Provision of Documents |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.125  | Status of Compliance Ability |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.126  | Status of Interventions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.127  | Status of Disease Control |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.128  | Status of Compliance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.129  | Occupations of Providers |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.130  | Environments of Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.131  | Findings Related to Medication Management, Body Mass Index |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.132  | Findings Related to Medication Management, Alcohol Use |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.133  | Findings Related to Medication Management, Caffeine Use |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.134  | Interventions Related to Education, Diet |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.136  | Findings Related to Medication Management, Exercise |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.137  | Interventions Related to Education, Behavior |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.138  | Findings Related to Medication Management, Diet |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.139  | Status of Care Goal |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.140  | Findings Related to Medication Management, Illicit Drug Use |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.141  | Interventions Related to Administration, Immunizations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.142  | Interventions Related to Care Coordination, Communication Needs |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.144  | Findings Related to Medication Management, Life Event |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.145  | Interventions Related to Medication Management, Device or Equipment Fitting |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.146  | Findings Related to Medication Management, Immunizations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.148  | Findings Related to Medication Management, Cultural Beliefs |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.149  | Findings Related to Medication Management, Tobacco Use |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.150  | Interventions Related to Medication Regimen, Continue Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.151  | Encounter Type |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.152  | Encounter Class |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.156  | Allergy/Intolerance Severity |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.16  | Reasons for Interventions Related to Medication Management |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.160  | Allergy/Intolerance Manifestation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.162  | Allergy/Intolerance Substance & Negation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.163  | Allergy/Intolerance Negation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.165  | Interventions Related to Care Coordination, Benefit Management |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.166  | Interventions Related to Administration |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.167  | Interventions Related to Administration, Medications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.168  | Findings Related to Medication Management, Eating Habits |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.169  | Findings Related to Medication Management, Tobacco Exposure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.170  | Interventions Related to Care Coordination |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.176  | Interventions Related to Medication Management, Information Gathering |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.177  | Interventions Related to Medication Management, Care Planning |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.178  | Interventions Related to Medication Management, Documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.179  | Allergy/Intolerance Substance, Food |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.180  | Allergy/Intolerance Substance, Environmental |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.181  | PharmacyEncounterReason |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.182  | Encounter Reason |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.183  | Findings Related to Medication Management, Medication related |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.197  | PharmacyAllergies |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.198  | PharmacyInterventions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.200  | PharmacyReasonsForInterventions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.201  | PharmacyInterventionStatus |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.202  | PharmacyCareCoordination |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.203  | PharmacyReferralsTo |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.204  | PharmacyGoalStatusOutcome |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.205  | PharmacyTypeOfProfession |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.207  | PharmacyEnvironmentsOfCare |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.208  | PharmacyEncounterType |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.209  | PharmacytEncounterClass |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.212  | PharmacyAllergyIntoleranceManifestation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.213  | PharmacyReasonForMedicationChange |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.214  | PharmacyEducation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.215  | PharmacyEducationStatus |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.216  | PharmacyReferralsFrom |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.218  | Reasons for Interventions Related to Medication Management, Discontinue Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.224  | Social Determinants of Health Problem Observation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.227  | Findings Related to Medication Management, Infectious Disease Symptoms |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.229  | COVID19 Related Disease, Test, or Exposure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.230  | Maternity Health Interventions Value Set |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.231  | Social Determinants of Health Interventions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.232  | Maternity Health Findings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.233  | Reason Medication Discontinued Lack of Indication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.234  | Reason Medication Discontinued Lack of Effectiveness |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.235  | Reason Medication Discontinued Safety Issue Occurred |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.236  | Reason Medication Discontinued Compliance Issue other than cost |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.237  | Recommendation to Resolve Medication Therapy Problem |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.239  | Reason Medication Discontinued Patient Unable to Afford |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.3  | Findings Related to Medication Management, Transitions Between Health Care Settings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.35  | Interventions Related to Medication Management, Comprehensive Medication Review |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.5  | Reasons for Interventions Related to Medication Management, Unnecessary Therapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.53  | Reasons for Interventions Related to Medication Management, Adverse Events |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.55  | Reasons for Interventions Related to Medication Management, Adherence |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.56  | Findings Related to Medication Management, Multiple Providers |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.58  | Findings Related to Medication Management, Chronic Disease Present |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.59  | Findings Related to Medication Management, Taking Medication for Chronic Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.6  | Reasons for Interventions Related to Medication Management, New or Additional Therapy Required |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.60  | Findings Related to Medication Management, Health Literacy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.61  | Findings Related to Medication Management |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.7  | Reasons for Interventions Related to Medication Management, Ineffective Therapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.8  | Reasons for Interventions Related to Medication Management, Dose Too Low |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.83  | Assessments Related to Medication Management, General Assessments |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.84  | Assessments Related to Medication Management |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.85  | Assessments Related to Medication Management, Assessments Using Assessment Scales |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.86  | Interventions Related to Medication Regimen, Monitoring |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.87  | Interventions Related to Care Coordination, Consultations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.88  | Interventions Related to Care Coordination, Referrals to Other Providers |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.89  | Interventions Related to Care Coordination, Referrals for Specific Services |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.9  | Reasons for Interventions Related to Medication Management, Dose Too High |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.90  | Recommendations Related to Medication Regimen, Continue Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.91  | Recommendations Related to Medication Regimen, Initiate Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.92  | Recommendations Related to Medication Regimen, Change Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.93  | Recommendations Related to Medication Regimen, Change Medication Dose |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.94  | Recommendations Related to Medication Regimen, Change Medication Dosage Form |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.95  | Recommendations Related to Medication Regimen, Change Medication Course |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.97  | Recommendations Related to Medication Regimen, Change Medication Dosing Interval |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.98  | Recommendations Related to Medication Regimen, Discontinue Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.99  | Recommendations Related to Medication Regimen, Monitoring |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.12  | Medication Route |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.24  | Extended Pregnancy Status |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.27  | Care Team Member Function (SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.29  | Allergy Clinical Status |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.30  | Care Team Member Function |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.35  | Arthritis Feedback Types (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.45  | Bidirectional Services eReferral Type |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.46  | Bidirectional Services eReferral Reason |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.50  | Transport vehicle type |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.53  | Sex |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.54  | Specimen type |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.58  | Acute COVID 19 Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.59  | Medication Adherence SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.101  | Myocardial Infarction |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.124  | Follow Up Within 6 Months |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.125  | Follow Up Within 6 Months |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.15  | Hospice Care Ambulatory |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.175  | Office and Wellness Visits for General Screening |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.178  | Office and Wellness Visits for General Screening |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.179  | Hypertensive disorders in pregnancy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.182  | Eclampsia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.183  | Gestational Hypertension |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.184  | Preexisting Hypertension in Pregnancy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.185  | Postpartum Encounter |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.187  | Postpartum Encounter |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.188  | Preexisting Hypertension in Pregnancy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.190  | Spontaneous or Elective Abortion |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.191  | Preeclampsia or Eclampsia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.193  | Spontaneous or Elective Abortion |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.84  | Statin Associated Muscle Symptoms |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.85  | Statin Associated Muscle Symptoms |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.12  | Cornual Ectopic Pregnancy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.14  | Perforation of Uterus |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.16  | Uterine Rupture |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.18  | Transabdominal Cerclage |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.2  | Transabdominal Cerclage |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.23  | Intensive Care Unit |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.24  | Uterine Horn |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.25  | Metroplasty |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.36  | Placenta Accreta Spectrum Previa or Vasa Previa |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.37  | Placenta Accreta Spectrum Previa or Vasa Previa |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.38  | Outpatient Surgery Service |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.41  | Statin Allergen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.42  | Statin Allergen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.54  | Total Parenteral Nutrition |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.57  | Ischemic Stroke Thrombosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.60  | Ischemic Stroke Other |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.64  | Application of Venous Foot Pumps |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.65  | Application of Intermittent Pneumatic Compression Devices |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.66  | Application of Graduated Compression Stockings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.67  | 20 to 42 Plus Weeks Gestation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.68  | 37 to 42 Plus Weeks Gestation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.69  | 37 to 38 Weeks Gestation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.71  | 20 to 42 Plus Weeks Gestation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.73  | 37 to 42 Plus Weeks Gestation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.75  | 37 to 38 Weeks Gestation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.76  | History of Atrial Ablation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.126  | Hospital Settings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143  | Observation Services |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.161  | All Primary and Secondary Cancer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.164  | Admit Inpatient |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.171  | Opioid Use Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.173  | Sickle Cell Disease with and without Crisis SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.175  | Sickle Cell Disease with and without Crisis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.177  | Opioid Medication Assisted Treatment (MAT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.179  | Cancer Related Pain SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.180  | Cancer Related Pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1114.14  | Medication drug class for allergen intolerance SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.12  | Healthcare Agent Ordinality |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.19  | Obligation or Prohibition Instruction Type Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.30  | Cardiopulmonary Resuscitation Order Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.31  | Cardiopulmonary Resuscitation Procedures Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.32  | Additional Portable Medical Order Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.33  | Initial Treatment Portable Medical Order Procedures Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.34  | Additional portable medical order Procedures Grouping |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.5  | Advance Directive Content Type SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.100  | Pathological M Stage M1c |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.101  | Pathological N Stage N3 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.102  | N Stage pN1a |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.103  | N Stage pN1b |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.105  | Pathological N Stage pN1mi |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.106  | Pathological N Stage N2b |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.107  | Pathological N Stage N2a |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.108  | Pathological N Stage N2 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.109  | Pathological N Stage N1b |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.110  | Pathological N Stage N1a |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.112  | Pathological N Stage N0 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.114  | Pathological T Stage T4d |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.115  | Pathological T Stage T4c |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.116  | Pathological T Stage T4b |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.117  | Pathological T Stage T4a |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.118  | Pathological T Stage T4 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.120  | N Stage N2C |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.121  | T Stage T3c |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.122  | T Stage T3b |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.123  | T Stage T3a |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.124  | Pathological T Stage T3 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.125  | T Stage T2c |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.126  | T Stage T2b |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.127  | T Stage T2a |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.128  | Pathological T Stage T2 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.129  | Pathological T Stage T1c |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.132  | Pathological T Stage T1b |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.135  | Pathological T Stage T1a |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.136  | Pathological T Stage T1 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.137  | Pathological T Stage T1mic |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.139  | Pathological T Stage T0 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.142  | Cancer Stage III |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.143  | Cancer Stage IIIA |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.144  | Cancer Stage IIIB |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.145  | Cancer Stage IIIC |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.146  | Cancer Stage IV |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.147  | Cancer Stage IVA |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.148  | Cancer Stage IVB |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.149  | Cancer Stage IVC |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.160  | ECOG Performance Status |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.162  | ECOG Performance Status |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.164  | Karnofsky Performance Status |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.185  | Breast Cancer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.191  | Cancer Stage II |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.192  | Cancer Stage IIA |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.193  | Cancer Stage IIB |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.256  | Colorectal Cancer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.280  | Cancer Stage IA |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.281  | Cancer Stage IB |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.286  | Cancer Stage IIC |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.291  | Positive Result |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.292  | Negative Result |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.300  | Pathological N Stage N1C |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.365  | Hospice Care Referral or Admission |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.439  | T Category |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.440  | N Category |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.441  | M Category |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.442  | TNM Stage Group |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.539  | Fallopian Tube Cancer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.547  | Cancer Stage 1C |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.555  | Gender Female |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.556  | Gender Male |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.557  | Pathological N Stage N3a |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.558  | Pathological N Stage N3b |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.95  | M Stage M0 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.97  | Pathological M Stage M1 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.98  | Pathological M Stage M1a |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.99  | Pathological M Stage M1b |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.6  | Most/Moderately Effective Contraceptive SNOMED Findings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.11  | Sleep Apnea |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.12  | Toxic Megacolon in adults |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.13  | Septic Shock due to C. Diff |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.15  | Body Temperature |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.16  | Diarrhea Potentially due to CDI |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.17  | Abdominal Distension |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.18  | Vomiting potentially due to CDI |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.19  | Ileus due to infection |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.20  | Clostridium difficile infection |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.9  | Immunotherapy For Allergic Rhinitis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.1  | C2S Alcohol Use Disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.11  | C2S Amphetamine Use Disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.15  | C2S Cannabis Use DIsorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.18  | C2S Cocaine Use Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.22  | C2S Hallucinogens |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.27  | C2S HIV/AIDS Information Sensitivity |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.30  | C2S Inhalants |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.36  | C2S Mental Health Disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.42  | C2S Opioids |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.43  | C2S Other Psychoactive Substance
Use Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.46  | C2S Sedative Hypnotic, or anxiolytic related disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.51  | C2S Tobacco Use Disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.58  | C2S Sensitive Categories |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.65  | Test C2S Alcohol Use Disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.67  | Test C2S HIV/AIDS Information Sensitivity |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1012  | S. Typhi Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1016  | S. Paratyphi Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1021  | Dark Urine (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1022  | Acute Onset [Qualifier Value] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1024  | Acute Viral Hepatitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1029  | Listeriosis [Listeria species] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1033  | Encephalitis [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1035  | Indeterminate or Equivocal Lab Result Value |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1037  | Smoking Status [Current Nonsmoker] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1048  | Parkinson’s disease (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1050  | Parkinsonism [Secondary] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1065  | Consciousness [Decreased Level] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1071  | Drug Use [IV Evidence] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1072  | Miosis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1077  | Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1083  | Rash [Pustular Vesicular] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1084  | Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1090  | Syphilis [Congenital] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1091  | Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1092  | Congenital heart disease (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1093  | Hearing impairment (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1095  | Microcephaly (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1096  | Developmental delay (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.112  | Tetanus (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1124  | COVID_19 (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1143  | COVID_19 (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1145  | Resistant Lab Result Value |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.115  | Mumps (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1156  | Staphylococcus aureus (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1197  | Cervical Lymphadenitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1207  | CRE (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1210  | Enterobacter spp., E. coli, or Klebsiella spp. (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1212  | Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1213  | NU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1214  | Carbapenemase resistance mechanism (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1224  | Therapeutic Response to Medication [Improved] |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1225  | Altered Mental Status (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1230  | Eschar (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1231  | Hypotension (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1233  | Localized Edema (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1237  | Tachycardia (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1239  | RCKMS Conditions (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.124  | Poliomyelitis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1240  | Maternal Condition Puerperium (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1242  | Non pestis Yersiniosis Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1244  | Blastomycosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1246  | Blastomycosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1269  | Tuberculosis [Latent Infection] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1274  | Histoplasmosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1294  | Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1295  | Seizure [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.130  | Influenza (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1309  | RSV (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1314  | Wheezing (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1325  | Tobacco Use and Exposure (Social History) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1335  | Hospitalized [Inpatient] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1336  | Creutzfeldt Jakob Disease (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1337  | Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1349  | Cerebrospinal Fluid (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.135  | Chronic Hepatitis B Virus Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1350  | Endocervical (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1351  | Tissue (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1352  | Specimen from a Normally Sterile Site (Specimen Type)(SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1353  | Urethral Swab (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1355  | Wound (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.136  | Invasive Pneumococcal Disease (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1369  | Serum (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1379  | Fish Poisoning (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1388  | Occupational Asthma (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1389  | Asthma (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1391  | Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1393  | WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1405  | Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1407  | Cancer [Malignant Neoplasms] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1418  | Alpha gal syndrome (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1422  | Ptosis of Eyelid [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1424  | Constipation [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1426  | Intubation [Respiratory Tract] (Procedure) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1430  | Infant Botulism (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1446  | Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1447  | MRSA (Disorders (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1449  | Staphylococcus aureus infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.145  | Varicella (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1463  | VRE (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1464  | VRE (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1468  | Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1469  | Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1470  | Enterococcus species (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1471  | Amebiasis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1485  | Norovirus (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1487  | Clostridioides difficile infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1505  | Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1507  | Arsenic Exposure and Toxicity (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1513  | Urine (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1514  | Mercury Exposure and Toxicity (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1516  | Cryptococcosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1532  | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1533  | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1534  | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1538  | Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.154  | Hepatitis C Virus Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1546  | Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1551  | Meningitis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1552  | Bacterial Meningitis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1553  | Fungal Meningitis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1554  | Parasitic Meningitis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1559  | Photophobia (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1562  | Bacteria [Causing Meningitis] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1563  | Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1564  | Viruses [Causing Meningitis] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1580  | Animal Bite [Dog] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1581  | Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1582  | Animal Bite [Excluding Mammals] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1584  | Animal Bite [Unspecified Animal] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1605  | Vaccine Adverse Event (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1606  | Vaccinia disease or adverse event (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.161  | Vibriosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1613  | Keratitis [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1626  | Thrombocytopenic Purpura [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1651  | Chagas Disease (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1661  | Cervical lymphadenopathy [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1662  | Conjunctival injection (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1663  | Drying of lips (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1667  | Edema of hands or feet (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1679  | Pseudomonas aeruginosa (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1687  | NU_Gunshot Wound (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.169  | Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.170  | Chlamydia trachomatis Infection (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1700  | Encephalitis [Viral] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1702  | Encephalitis [Parasitic] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1712  | Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1714  | Parasites [Causing Encephalitis] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1715  | Viruses [Causing Encephalitis] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1716  | Drowning and Submersion (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1718  | Motor Vehicle Injury (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1720  | Enterovirus Infection [Non polio] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1722  | Enterovirus Infection [Non polio] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1739  | Head Injury (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1745  | Rotavirus Disease (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1748  | Chemical Pneumonitis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1755  | Vomitus (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1758  | Asbestosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1772  | Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1773  | CLABSI (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1775  | Ophthalmia neonatorum (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1778  | Genital herpes (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1785  | Elevated liver enzyme (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1789  | Granuloma Inguinale (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1791  | Ulcer [Genital, Perineal, or Perianal Area] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1797  | Bronchial Wash (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1800  | Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.181  | Coccidioidomycosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1823  | Borrelia species (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1824  | Spirochetes (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1829  | Polyarthritis [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1835  | Rheumatoid nodules (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1842  | Ventilator associated event (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1844  | Leishmaniasis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.185  | Brucellosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1864  | Taeniasis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1866  | Taeniasis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.187  | Dengue Virus Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1878  | Surgical Site Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1882  | Carbapenemase production (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1892  | Toxoplasmosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1895  | Toxoplasmosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1902  | Orthopox (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1923  | Coronary artery aneurysm (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1924  | Coronary artery dilatation (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1925  | Ectatic coronary artery (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1926  | Left ventricular ejection fraction [Decreased Level] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1928  | Shock (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1930  | Troponin [Elevated Level] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1931  | Oral mucosa Inflammation (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1935  | Strongyloidiasis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1941  | Strongyloidiasis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1942  | Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1943  | Jamestown Canyon Virus Diseases (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1947  | Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1948  | Keystone Virus Diseases (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1949  | La Crosse Virus Diseases (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1950  | Snowshoe hare Virus Diseases (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1951  | Trivittatus Virus Diseases (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1959  | Keystone Virus Diseases (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1960  | La Crosse Virus Diseases (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1961  | Snowshoe hare Virus Diseases (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1962  | Trivittatus Virus Diseases (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1963  | Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1964  | Encephalomyelitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1966  | Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1968  | Hepatitis D Virus Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1973  | Hepatitis D Virus Infection (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1974  | Baylisascariasis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1975  | Baylisascariasis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1978  | Larva Migrans (Neural, Ocular, or Visceral) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1980  | California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1982  | California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1987  | Flank Pain (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1988  | Bone Pain (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1989  | Abscess (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1991  | Focal Brain Lesions (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1992  | Pathologic Fractures [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1994  | Granulomas (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1996  | Skin Lesions (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1998  | Angiostrongyliasis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1999  | Lymphocytic Choriomeningitis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2001  | Lymphocytic Choriomeningitis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2007  | Eosinophilic meningitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2017  | Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.202  | Trichinellosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2020  | Lymphadenopathy [Acute] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2023  | Tick Paralysis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2024  | Bacillary angiomatosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2025  | Animal Bite or Scratch [Cat] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2027  | Bartonellosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2029  | Bartonellosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2030  | Bartonella henselae infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2031  | Bartonella quintana infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2032  | Bartonella bacilliformis infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2036  | Bartonella henselae (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2037  | Bartonella quintana (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2038  | Bartonella bacilliformis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.204  | Giardiasis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2052  | Echinococcosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2054  | Cystic Echinococcosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2056  | Alveolar Echinococcosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2060  | Echinococcosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2061  | Genital Warts (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2062  | Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2064  | Diphyllobothriasis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2066  | Diphyllobothriasis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2068  | Angiostrongyliasis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2069  | Pelvic Inflammatory Disease (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2070  | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2071  | Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2075  | Lower Abdominal Tenderness (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2077  | Tenderness with motion of the cervix (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2078  | Adnexal Tenderness (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2079  | Uterine Tenderness (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2080  | Leukocytosis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2082  | Purulent material in the peritoneal cavity (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2083  | Pelvic Abscess (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2087  | Nongonococcal Urethritis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2089  | Urethritis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2091  | Urethral discharge (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2093  | Dysuria (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2096  | Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2098  | Rhinitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2101  | Pleuritis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2105  | Methemoglobinemia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2106  | Methemoglobinemia [Non Congenital] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2110  | Anencephaly (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2112  | Fetal Anencephaly (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2114  | Cleft Lip Alone (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2116  | Fetal Cleft Lip (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2117  | Cleft Palate Alone (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2119  | Cleft Lip with Cleft Palate (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2121  | Fetal Spina Bifida (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2122  | Spina Bifida (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2124  | Down Syndrome (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2126  | Fetal Down Syndrome (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2129  | Bacteremia (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2131  | Gastroschisis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2133  | Fatal Familial Insomnia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2135  | Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2137  | Prion Disease (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2140  | Phenylketonuria (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2145  | Tuberculosis [Suspected] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2146  | Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2147  | Limb Reduction (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2150  | Congenital Hearing Loss (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2153  | Primary Congenital Hypothyroidism (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2154  | Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2163  | Dengue Virus Infection [Suspected] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2164  | Mumps [Suspected] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2165  | Pertussis [Suspected] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2196  | Lung Tissue (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2197  | Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2202  | Abnormal Lung Sounds (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2204  | Anemia [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2209  | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2212  | Invasive Cronobacter Infection (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2214  | Necrotizing Enterocolitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2216  | Abscess [Brain] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2218  | Urinary Tract Infection (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2220  | Amniotic Fluid (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2221  | Congenital Cytomegalovirus (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2231  | Congenital Cytomegalovirus Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2233  | Cytomegalovirus Disease (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2241  | Stillbirth (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2247  | Extrapulmonary [NTM] (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2250  | Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2255  | Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2256  | CP_CRE (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2259  | Neonatal Abstinence Syndrome (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.226  | Lyme Disease (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2261  | High Pitched Cry (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2262  | Inability to Console (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2264  | Hypertonia (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2266  | Tremors (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2268  | Myoclonus (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2270  | Poor Sleep (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2272  | Alterations in Feeding (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2274  | Excoriation (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2276  | Sneezing (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2278  | Nasal Congestion (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2280  | Yawning (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2281  | Cutaneous Mottling (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2282  | Sweating (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2284  | Feeding Intolerance (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2286  | Respiratory Distress or Nasal Flaring (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2289  | In Utero Substance Exposure (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2291  | Childbirth (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2295  | Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2296  | NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2297  | Exposure or suspected exposure to harmful algae or algae toxins (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2305  | Gram_negative Diplococcus (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2307  | D_Transposition of the Great Arteries (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2308  | L_Transposition of the Great Arteries (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2309  | Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2311  | Interrupted Aortic Arch (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2313  | Coarctation of the Aorta (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2315  | Ebstein Anomaly (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2317  | Pulmonary valve atresia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2319  | Pulmonary valve stenosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2321  | Fetal Pulmonary valve stenosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2322  | Double Outlet Right Ventricle (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2324  | Hypoplastic left heart syndrome (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2326  | Single Ventricle (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2328  | Tetralogy of Fallot (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2330  | Truncus Arteriosus (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2332  | Atrioventricular septal defect (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2334  | Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2336  | Tricuspid valve atresia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2338  | Tricuspid valve stenosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2340  | Fetal Tricuspid valve stenosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2341  | Exposure to Measles (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2342  | Increased Risk for Exposure to Measles (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2349  | Consistent with Tuberculosis (Finding in Chest Xray Imaging Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2356  | Skin (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2358  | Unspecified Tissue (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2368  | Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2369  | Necrotizing Fasciitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2371  | Renal Impairment [Acute or Unspecified] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2373  | Coagulopathy [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2375  | Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2377  | Soft Tissue Necrosis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2381  | Specimen from a Nonsterile Site (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2383  | Absence of Skin Lesions (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2384  | Neuralgia (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2386  | Peripheral Nerve Thickening (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2387  | Nerve (Specimen Type) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2407  | Firearm Injury (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2415  | Cranial Nerve Involvement (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2416  | Unusual Change in Behavior (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2417  | Radiculitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2418  | Subarachnoid Hemorrhage (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2420  | Discitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2423  | Respiratory Insufficiency [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2425  | Conjunctival Suffusion (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2430  | Pleural effusion (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2432  | Abdominal swelling (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2434  | Neck swelling (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2436  | Diaphoresis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2438  | Edema (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2442  | Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2443  | Influenza A (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2444  | Influenza B (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2445  | Influenza [Unspecified] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2452  | Influenza (unspecified influenza virus in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2453  | Influenza (influenza B virus in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2463  | Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2464  | CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2470  | Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2471  | Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2473  | Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2474  | Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2475  | Aortic valve stenosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2479  | Microtia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2480  | Anotia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2482  | Anophthalmia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2484  | Microphthalmia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2486  | Atrial septal defect (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2488  | Fetal Aortic valve stenosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2489  | Congenital Posterior Urethral Valves (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2491  | Bladder Exstrophy (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2493  | Encephalocele (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2496  | Choanal Atresia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2498  | Cloacal Exstrophy (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2500  | Renal Agenesis or Hypoplasia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2502  | Trisomy 13 (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2504  | Fetal Trisomy 13 (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2506  | Galactosemia (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2516  | Hypospadias (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2518  | Trisomy 18 (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2519  | Fetal Trisomy 18 (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2527  | Chlamydia species [Unspecified] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2528  | Ventricular septal defect (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2531  | Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.264  | Viral Hemorrhagic Fever (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.272  | Present or Positive Lab Result Value |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.287  | Varicella (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.300  | Meningococcal Disease (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.304  | Pesticide Related Illness (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.329  | Apnea (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.333  | Shigellosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.340  | Influenza (influenza A or B virus in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.341  | Campylobacteriosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.353  | Diarrhea (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.356  | HIV Infection (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.359  | Botulism (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.362  | Hansen’s Disease (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.365  | Silicosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.371  | Cryptosporidiosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.375  | Cyclosporiasis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.386  | Vibriosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.395  | Syphilis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.40  | STEC Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.408  | Hepatitis B Virus Infection (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.422  | Tuberculosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.43  | Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.460  | HIV Infection or AIDS (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.48  | Salmonellosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.494  | Ehrlichiosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.505  | Toxic Shock Syndrome (TSS) (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.516  | Brucellosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.534  | Smallpox (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.542  | Spotted Fever Rickettsiosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.580  | Arboviral Disease [Other] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.586  | Viral Hemorrhagic Fever (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.6  | Diphtheria (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.606  | Tuberculosis (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.632  | Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.650  | Jaundice (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.660  | Hypertonia [Excluding Congenital Hypertonia] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.663  | Erythema Nodosum (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.664  | Congenital Zika Syndromes (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.666  | Guillain Barré syndrome (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.668  | Rash (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.672  | Arthralgia (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.674  | Conjunctivitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.676  | Pregnant (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.677  | Postpartum (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.679  | Hearing Loss (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.681  | Abdominal Pain (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.686  | Erythema Multiforme (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.692  | Eosinophilia (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.702  | Weight Loss (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.709  | Cough [Non Productive] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.711  | Wound Infection (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.714  | Sepsis [Septicemia] [Unspecified Organism] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.715  | Meningitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.718  | Cellulitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.719  | Myositis [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.721  | Otitis Media (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.723  | Otitis Externa (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.727  | Acute Upper Respiratory Illness (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.733  | Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.750  | Chest Pain (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.758  | Muscle Spasms (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.763  | Parotitis [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.765  | Aseptic Meningitis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.766  | Encephalitis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.777  | Mastitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.779  | Pancreatitis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.789  | Purpura (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.79  | Campylobacteriosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.793  | Novel Influenza A Virus Infection (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.794  | Sore Throat (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.795  | Influenza (influenza A virus in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.796  | Influenza (Novel influenza A virus in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.809  | Headache (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.810  | Backache (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.823  | Pneumoconiosis (Unspecified) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.836  | Lead in Blood (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.839  | Acid Fast Bacilli (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.86  | Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.864  | Nausea (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.865  | Confusion (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.867  | Dyspnea (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.869  | Loss of Consciousness (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.87  | Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.875  | SARS (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.881  | Difficulty Breathing (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.895  | Rhinorrhea (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.907  | Arthritis [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.91  | Cough (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.910  | Epididymitis [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.914  | Osteomyelitis [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.918  | Spondylitis [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.928  | Bleeding [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.930  | ECG Abnormalities [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.931  | Hematemesis [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.934  | Hematuria [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.935  | Hemoptysis (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.937  | Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.942  | Petechiae [Non Traumatic] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.952  | Thrombocytopenia [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.956  | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.957  | Regional Lymphadenitis [Including Bubo] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.96  | Salmonellosis [Salmonella Species and Subspecies] (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.963  | Arboviral Disease [Other] (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.969  | Proteinuria [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.970  | Bulbar Weakness (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.976  | Dysphagia (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.978  | Impaired Respiration [Unspecified Cause] (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.979  | Botulism (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.98  | Shigellosis (Disorders) (SNOMED) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.999  | Chlamydia species (Organism or Substance in Lab Results) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.110  | Pressure Injury Stage 2, 3, 4 or Unstageable |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.112  | Pressure Injury Deep Tissue |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.113  | Pressure Injury Stage 2, 3, 4 or Unstageable |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.122  | Inpatient Falls |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.125  | Bleeding at Non Critical Site |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.143  | Bleeding at Critical Site |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.144  | Bleeding at Critical Site |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.146  | Bleeding at Non Critical Site |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.160  | Abdominal or Pelvic CT Scan with Contrast |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.163  | Ultrasound of Lower Extremities |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.165  | Ultrasound of Lower Extremities |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.171  | Inpatient Falls |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.188  | Extracorporeal Membrane Oxygenation (ECMO) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.191  | Intra Aortic Balloon Pump |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.11  | Bladder Cancer Staging Ta for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.12  | Bladder Cancer staging T1 for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.13  | Bladder Cancer staging Tis for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.15  | Carcinoma of urinary bladder, superficial |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.17  | High grade bladder cancer Ta for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.18  | Immunocompromised state for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.19  | Systemic chemotherapy for urology care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.20  | Corticosteroids for patients receiving Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.21  | Calcineurin inhibitors for patients receiving Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.23  | Immunomodulators for patients undergoing Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.24  | Monoclonal antibody for patient undergoing Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.28  | Radiotherapy for patients undergoing Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.29  | Plasmacytoid cell, morphologic abnormality for urology care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.30  | Sarcomatoid, morphologic abnormality for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.31  | Micropapillary, morphologic abnormality, for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.39  | Mixed histology urothelial cell carcinoma for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.40  | Cystectomy for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.44  | Unavailability of Bacillus Calmette Guerin for urology care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.55  | Cystectomy for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.56  | Active Tuberculosis for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.58  | Bladder Cancer Staging Tis for Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.8  | Tuberculosis Diagnosis Prior to Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.9  | Leukemia Diagnosis Prior to Urology Care |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.13  | Preventative Clinical Encounters |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.16  | Intensive Lifestyle Interventions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.17  | Intensive lifestyle interventions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.23  | Outpatient Clinical Encounters |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.24  | Outpatient Clinical Encounters |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.25  | Reason for No Intensive Lifestyle Intervention |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.28  | Type 2 Diabetes Diagnoses |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.29  | Type 2 Diabetes Diagnoses |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.41  | Sickle Cell Disease with Vaso Occlusive Episode |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.42  | Sickle Cell Disease with Vaso Occlusive Episode |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.49  | Medication Therapy Management Services for Essential Hypertension |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.79  | Medication Therapy Management Services for Essential Hypertension |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.85  | Renal Colic |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.86  | Renal Colic |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.9  | Preventative Clinical Encounters |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.50  | Urinary retention |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.52  | Urinary retention |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.66  | Morbid Obesity |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.67  | Morbid Obesity |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.1  | Pregnancy Status |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.109  | Sterilization SNOMED Findings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.113  | Prenatal Care Specific Visits SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.114  | Prenatal Care Specific Visits |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.122  | Prenatal Care Visits SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.124  | Pregnancy Related Diagnoses SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.126  | Non Live Birth Diagnoses SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.133  | Pregnancy Related Diagnoses |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.134  | Female Sterilization SNOMED Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.135  | General Prenatal Care Visits |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.137  | Non Live Birth Diagnoses |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.138  | IUD Surveillance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.139  | IUD Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.140  | IUD Devices |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.141  | Contraceptive Patch SNOMED Devices |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.142  | Female Sterilization Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.144  | Contraceptive Patch SNOMED Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.145  | Contraceptive Patch SNOMED Findings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.151  | Infecund Not for Contraceptive Reasons Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.152  | Live Birth Delivery Procedures SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.153  | Contraceptive Ring SNOMED Surveillance Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.154  | Contraceptive Ring SNOMED Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.155  | Contraceptive Ring SNOMED Findings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.161  | Contraceptive Implant SNOMED Devices |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.163  | Contraceptive Implant SNOMED Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.164  | Contraceptive Implant SNOMED Findings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.165  | Infecund Not for Contraceptive Reasons SNOMED Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.17  | Contraceptive Type |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.174  | Contraceptive Patch Devices |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.177  | Live Birth Delivery Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.178  | Contraceptive Ring Surveillance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.18  | Contraception Not Used Reason |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.181  | Injectable Contraceptive SNOMED Surveillance Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.182  | Injectable Contraceptive SNOMED Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.183  | Injectable Contraceptive SNOMED Findings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.189  | Oral Contraceptive Pill SNOMED Surveillance Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.190  | Oral Contraceptive Pill SNOMED Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.191  | Oral Contraceptive Pill SNOMED Findings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.192  | Contraceptive Implant SNOMED Surveillance Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.197  | Injectable Contraceptive Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.198  | Injectable Contraceptive Surveillance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.199  | Oral Contraceptive Pill Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.200  | Oral Contraceptive Pill Surveillance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.201  | Contraceptive Implant Devices |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.202  | Contraceptive Implant Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.203  | Contraceptive Implant Surveillance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.209  | Yes and No Answers |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.21  | Contraceptive Provision Method |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.210  | Pap Smear Results |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.22  | Pregnancy Intention |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.24  | Clinical Provider Role |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.3  | Organism Detection |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.31  | English Proficiency |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.86  | Intrauterine Devices SNOMED Devices |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.87  | Intrauterine Devices SNOMED Findings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.88  | Intrauterine Device SNOMED Provision Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.89  | Intrauterine Devices SNOMED Surveillance Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.96  | Infecund Not for Contraceptive Reasons SNOMED Findings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.10  | ASN Screening Declined |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.15  | Intervention for Positive Transportation Insecurity Screen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.16  | Intervention for Positive Food Insecurity Screen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.19  | Intervention for Positive Food Insecurity Screen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.2  | Intracranial or Intraspinal surgery |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.20  | Intervention for Positive Homelessness Screen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.21  | Intervention for Positive Housing Instability Screen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.27  | Mental Health Diagnosis without Substance Use Disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.29  | Bed Assigned |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.3  | Malignant Intracranial Neoplasm Group |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.31  | Healthcare Agent & Power of Attorney Documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.34  | Advance Directive Documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.37  | Portable Medical Order(s) Documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.38  | Advance Care Planning Discussion Documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.42  | Healthcare Agent & Power of Attorney Documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.43  | Advance Directive Documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.45  | Advance Care Planning Documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.47  | Portable Medical Order(s) Documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.48  | Portable Medical Order(s) Documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.5  | Allergy to thrombolytics |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.50  | Intervention for Positive Utility Insecurity Screen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.52  | Intervention for Positive Transportation Insecurity Screen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.54  | Intervention for Positive Housing Instability Screen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.56  | Intervention for Positive Homelessness Screen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.57  | Non Invasive Oxygen Therapy Device Codes |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.6  | Thrombolytics Adverse Event |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.8  | Intervention for Positive Utility Insecurity Screen |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1176.58  | Food Insecurity Screening Positive |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.100  | Allergy or Intolerance to ACE Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.101  | Allergy or Intolerance to ARB Medication |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.102  | Chronic Kidney Disease Stage 1 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.103  | Chronic Kidney Disease Stage 2 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.104  | Chronic Kidney Disease Stage 3 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.105  | Chronic Kidney Disease Stage 4 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.106  | Chronic Kidney Disease Stage 5 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.111  | AHA GWTG Chronic Kidney Disease Stage 2 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.115  | AHA GWTG Chronic Kidney Disease Stage 1 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.116  | AHA GWTG Chronic Kidney Disease Stage 3 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.117  | AHA GWTG Chronic Kidney Disease Stage 4 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.118  | SNOMED CT Atrial Fibrillation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.121  | AHA GWTG Atrial Fibrillation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.123  | SNOMED CT Hyperlipidemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.125  | AHA GWTG Hyperlipidemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.126  | SNOMED CT Hypertriglyceridemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.129  | AHA GWTG Hypertriglyceridemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.130  | SNOMED CT Gestational Diabetes |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.132  | AHA GWTG Gestational Diabetes |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.133  | SNOMED CT Hyperglycemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.135  | AHA GWTG Hyperglycemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.136  | SNOMED CT Nonobstructive CAD |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.138  | AHA GWTG Nonobstructive coronary artery disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.15  | Non Tobacco Smoking Product User |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.21  | Referral to cardiac rehab |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.22  | Cardiac Rehabilitation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.32  | Heart Transplant |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.33  | Heart Transplant |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.34  | Allergy to MRA Therapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.40  | Cardiac Rehabilitation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.5  | Hypothyroidism |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.52  | Cardiac Pacer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.53  | Cardiac Pacer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.55  | Heart Transplant Complications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.56  | Heart Transplant Complications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.57  | Left Ventricular Assist Device Complications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.58  | Left Ventricular Assist Device Complications |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.6  | Hypothyroidism |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.60  | Left Ventricular Assist Device Placement |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.61  | Left Ventricular Assist Device Placement |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.67  | Diastolic Heart Failure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.68  | Diastolic Heart Failure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.69  | Allergy to SGLT2 Inhibitors |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.70  | Intolerance to SGLT2 Inhibitors |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.71  | Intolerance to MRA Therapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.74  | Mitral Stenosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.75  | Mitral Stenosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.77  | Mechanical Prosthetic Heart Valve |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.78  | Mechanical Prosthetic Heart Valve |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.8  | Anorexia Nervosa |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.83  | Systolic Heart Failure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.84  | Systolic Heart Failure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.9  | Anorexia Nervosa |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.96  | AHA GWTG Long COVID19 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.97  | AHA GWTG Long COVID19 SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.1  | Wound internal item and/or body structure visible value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.11  | Wound exudate appearance value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.12  | Wound exudate color value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.13  | Exudate odor value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.14  | Wound anatomic location value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.16  | Skin temperature value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.17  | Skin color enumerated value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.18  | Skin turgor value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.19  | Skin and mucous membrane integrity value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.2  | Periwound condition value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.20  | Skin moisture value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.3  | Wound Type Etiology value set |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.4  | Wound episode value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.6  | Wound bed appearance value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.60  | Wound type reference set |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.7  | Wound bed color value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.74  | Nonverbal pain indicators reference set |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.76  | Pain associated signs and symptoms reference set |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.77  | Pain body location reference set |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.8  | Wound edge description value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.80  | Pain quality reference set |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.81  | Pain speed of onset reference set |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.9  | Presence absence value set (foundation metadata concept) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.2  | Common drug classes for allergy and intolerance documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.3  | Common dietary substances for allergy and intolerance documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.4  | Common environmental substances for allergy and intolerance documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.5  | Common refutations for substance causes for allergy and intolerance documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.7  | Common substances for allergy and intolerance documentation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.8  | Common substances for allergy and intolerance documentation including refutations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.11  | NHSNCriterionOfDiagnosisCode(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.13  | NHSNInfectionConditionCode(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.15  | NHSNInfectionTypeCode(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.17  | NHSNInfectionFirstReportedSource(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.19  | NHSNLOS/MENDischargeDisposition(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.23  | NHSNSameDayOutcomeMeasure(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.25  | NHSNSignificantPathogenCode(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.27  | NHSNSpinalFusionApproachCode(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.29  | NHSNVascularAccessTypeCode(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.31  | NHSNVascularSpecimenCollectionSite(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.6  | NHSNPathogenCodeARO |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.74  | Enteral Medication Route |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.75  | Intravenous Medication Route |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.8  | NHSNRoleOfPerformerCode(SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.88  | Digestive, Intramuscular, Intravenous Route of Administration |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.91  | Long Term Care Discharge Disposition |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1139  | S4G Hyperlipidemia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1291  | S4G Cardiomyopathy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1292  | S4G Tricuspid valve disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1293  | S4G Pompe disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1294  | S4G Malignant hyperthermia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1295  | S4G Malignancy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1297  | S4G Intestinal polyp |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1298  | S4G Hamartoma |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1299  | S4G Diabetes mellitus |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1300  | S4G Muscular dystrophy and weakness |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1325  | S4G Hamartoma and S4G Intestinal Polyp |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1326  | S4G Malignancy and S4G Intestinal Polyp |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1358  | Beta lactam medicinal product SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4466  | Pharyngeal specimens |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4467  | Urogenital & Anorectal Specimens |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.788  | Social Determinants of Health Conditions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.789  | Social Determinants of Health Procedures |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.790  | Social Determinants of Health Service Requests |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.51  | VTE Symptoms |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.53  | Provider Types |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.60  | Screening Mammogram (SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.64  | Diagnostic Mammography (SNOMEDCT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.67  | BI_RADS Categories 0, 4, and 5 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.68  | BI_RADS Categories 1, 2, and 3 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.115  | Kratom containing compounds |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.121  | Gastrointestinal bleeding episode and Risk of GI Bleeding 1 |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.123  | Gastrointestinal bleeding episode and Risk of GI Bleeding |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.1  | Bronchiectasis Disorder SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.101  | Occupational Therapy Procedure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.103  | Speech Language Therapy Procedure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.105  | Intermittent Skilled Nursing Home Health Procedure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.107  | Breathing Test Procedure During Sleep |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.11  | Interstitial Lung Disease SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.115  | Spine or Neck Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.117  | Spine or Neck Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.119  | Hypoventilation Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.12  | Interstitial Lung Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.121  | Hypoventilation Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.122  | Respiratory Assist Device Qualifying Condition |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.134  | Sleep Related Symptom for Positive Airway Pressure Device Use Evaluation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.135  | Past Medical History Condition Related to Need for Positive Airway Pressure Device |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.136  | Home or Facility Care Location |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.137  | Fracture of Bone Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.139  | Fracture of Bone Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.14  | Cystic Fibrosis Lung Disease SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.140  | Severe Obesity Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.142  | Severe Obesity Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.143  | Transfer from Bed Impairment SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.145  | Transfer from Bed Impairment |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.146  | Ability to Safely Sit in Chair or Wheelchair Impairment SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.148  | Ability to Safely Sit in Chair or Wheelchair Impairment |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.149  | Fall or Fall Risk from Wheelchair or Stretcher SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.15  | Cystic Fibrosis Lung Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.152  | Muscle, Tendon or Joint Contracture Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.154  | Muscle, Tendon or Joint Contracture Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.155  | Muscle Weakness or Myasthenia Gravis Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.158  | Myocardial Infarction Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.16  | Neoplasm of Lung or Trachea Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.160  | Myocardial Infarction Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.161  | Amputation Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.164  | Lower Extremity Deep Vein Thrombosis Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.167  | Spinal Cord Injury or Paralysis Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.169  | Spinal Cord Injury or Paralysis Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.170  | Demyelinating Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.172  | Demyelinating Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.173  | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.176  | Wound Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.178  | Wound Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.179  | Danger to Self or Others Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.18  | Neoplasm of Lung or Trachea Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.181  | Danger to Self or Others Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.182  | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.184  | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.185  | Pain on Movement or Joint Pain Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.187  | Pain on Movement or Joint Pain Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.188  | Non Emergency Ambulance Transport Reason |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.189  | Osteoarthritis Disorder SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.19  | Secondary Erythrocytosis Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.191  | Osteoarthritis Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.194  | Non Emergency Ambulance Transport Qualifying Procedure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.198  | Hepatic Medical History |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.21  | Secondary Erythrocytosis Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.23  | Acute or Chronic Heart Failure Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.24  | Acute or Chronic Heart Failure Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.25  | Home Oxygen Therapy Qualifying Condition |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.26  | Device Use Patient Activity Level |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.29  | Sleep Apnea or Breathing Related Sleep Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.3  | Bronchiectasis Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.31  | Sleep Apnea or Breathing Related Sleep Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.34  | Diabetes Mellitus Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.35  | Diabetes Mellitus Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.36  | Restrictive Lung Disease SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.38  | Restrictive Lung Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.39  | Chest Wall Deformity Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.41  | Chest Wall Deformity Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.42  | Motor Neuron Disease or Spinal Muscular Atrophy Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.44  | Motor Neuron Disease or Spinal Muscular Atrophy Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.45  | Chronic Respiratory Failure Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.47  | Chronic Respiratory Failure Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.48  | Ventilator Therapy Qualifying Condition |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.5  | Chronic Obstructive Lung Disease SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.6  | Chronic Obstructive Lung Disease (COPD) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.64  | Urinary Incontinence Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.66  | Urinary Incontinence Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.67  | Chronic Urinary Retention Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.69  | Chronic Urinary Retention Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.70  | Urinary Incontinence or Chronic Urinary Retention Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.8  | Hypoxemia Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.81  | Organ Transplant History Significant to Immunosuppressive Therapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.86  | Hyperglycemia or Hypoglycemia Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.88  | Hyperglycemia or Hypoglycemia Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.9  | Hypoxemia Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.90  | Organ Transplant Procedure Significant to Immunosuppressive Therapy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.91  | Pulmonary Hypertension Disorder SNOMEDCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.93  | Pulmonary Hypertension Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.95  | Physical Therapy Procedure SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.96  | Occupational Therapy Procedure SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.97  | Speech Language Therapy Procedure SNOMED CT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.99  | Physical Therapy Procedure |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.135  | Last Menstrual Period (LMP) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.149  | Abortion, All (SNOMED CT) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.150  | Abortion, All |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.156  | Abortion, Elective |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.165  | Abortion, Elective |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.167  | Abortion, Surgical Management |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.168  | Abortion, Surgical Management |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.170  | Abortion, Spontaneous / Miscarriage |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.171  | Abortion, Spontaneous / Miscarriage |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.173  | Contraception, Counseling |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.174  | Contraception, Counseling |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.180  | Contraception, Surveillance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.182  | Contraception, Surveillance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.187  | Infertility, Female |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.188  | Infertility, Female |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.190  | Infertility, Male |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.191  | Infertility, Male |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.192  | Infertility, All |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.194  | Gender Identity |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.195  | Intersex Surgery, History |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.196  | Intersex Surgery, Non specific |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.197  | Intersex Surgery, Female to Male |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.199  | Intersex Surgery, Female to Male |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.200  | Intersex Surgery, Male to Female Sex |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.202  | Intersex Surgery, Male to Female Sex |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.203  | Intersex Surgery, All |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.205  | Stillbirth |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.208  | Sexual Orientation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.100  | Sleep Apnea Disorders SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.102  | Sleep Apnea Disorders |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.103  | PostTraumatic Stress Disorder PTSD |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.105  | PostTraumatic Stress Disorder PTSD SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1203  | Medication Literacy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1213  | Elder and Child Abuse SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1229  | Education Level SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1281  | Elder and Child Abuse |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1375  | Tinnitus |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1377  | Brain Fog |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1378  | Depression Symptoms |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1379  | Mood Swings |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1380  | Anxiety |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1381  | Lightheadedness |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1382  | Stress |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1383  | Grief and Suffering |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1384  | Insomnia and Other Sleep Difficulties |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1385  | Impaired Sense of Taste |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1386  | Pink Eye Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1388  | Pink Eye Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1392  | Lymphadenopathy Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1394  | Lymphadenopathy Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1395  | Visual Changes |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1396  | Impaired Sense of Smell |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1398  | Fatigue |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1399  | Chills |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1400  | Fever |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1401  | Functional and Mobility Impairment |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1403  | Orthostatic Intolerance |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1405  | Cough |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1406  | Dyspnea |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1409  | Wheezing |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1413  | Sinonasal Congestion |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1414  | Respiratory Distress |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1415  | Edema |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1419  | Weight Changes |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1422  | Immunologic Changes |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1424  | Pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1425  | Arthralgia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1426  | Chest Pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1427  | Headache |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1428  | Myalgia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1429  | Back Pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1430  | Pain in Extremities |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1431  | Pain in Throat |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1432  | Palpitations |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1433  | Tachycardia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1434  | Bleeding |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1435  | Abdominal Pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1436  | Diarrhea |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1437  | Gastroesophageal Reflux |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1438  | Nausea |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1439  | Vomiting |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1440  | Constipation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1441  | Difficulty Swallowing |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1443  | Loss of Appetite |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1444  | Paresthesia |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1445  | Rash |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1446  | Covid Toes (Toes and/or Fingers) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1447  | Itching |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1448  | Menstrual Cycle Irregularities |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1449  | Lower Urinary Tract Symptoms |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1450  | Urinary Incontinence |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1451  | Dizziness |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1453  | Hair Loss |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1455  | Disability Severity |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1456  | Hypercoagulability |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1457  | Post Exertional Malaise |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1458  | Chronic Pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1459  | Neurogenic Pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1460  | Impaired Hearing |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1461  | Parkinsonia Like Symptoms |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1462  | Bronchiectasis Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1463  | Bronchiectasis Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1464  | Chronic obstructive pulmonary disease (COPD) Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1466  | Chronic obstructive pulmonary disease (COPD) Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1467  | Interstitial lung disease Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1469  | Interstitial lung disease Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1470  | Asthma Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1472  | Asthma Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1473  | Fibromyalgia Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1475  | Fibromyalgia Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1477  | Herpes zoster Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1478  | Herpes zoster |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1479  | Pulmonary embolism Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1481  | Pulmonary embolism Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1482  | Hypertension, Pulmonary Hypertension SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1484  | Hypertension, Pulmonary Hypertension |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1485  | Language and Speech Problems |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1486  | Postural tachycardia syndrome (POTS) Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1488  | Postural tachycardia syndrome (POTS) Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1489  | Functional disorder of gastrointestinal tract Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1491  | Functional disorder of gastrointestinal tract Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1492  | Autonomic dysfunction |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1496  | Mast Cell Activation Syndrome (MCAS) Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1498  | Mast Cell Activation Syndrome (MCAS) Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1500  | Debility or Frailty SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1502  | Debility or Frailty |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1503  | Ehlers Danlos syndrome (EDS) Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1505  | Ehlers Danlos syndrome (EDS) Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1506  | Malnutrition Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1508  | Narcolepsy Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1510  | Narcolepsy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1514  | Small Fiber Neuropathy Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1516  | Small Fiber Neuropathy Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1517  | Malnutrition Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1518  | Neuropathy Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1519  | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1521  | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1522  | Congestive heart failure Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1524  | Congestive heart failure Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1526  | Cognitive disorder SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1527  | Post Acute Sequelae of Sars Cov 2 infection (PASC) SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1530  | Post Acute Sequelae of Sars Cov 2 infection (PASC) Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1531  | Hypertension, Persistent SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1532  | Acute Renal Failure Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1534  | Acute Renal Failure Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1535  | Complication due to Diabetes Mellitus Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1537  | Complication due to Diabetes Mellitus Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1538  | Coronary Revascularization History SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1540  | Coronary Revascularization History |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1541  | Heart Failure Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1543  | Heart Failure Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1547  | Hypertension, Primary and Secondary Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1548  | Cerebrovascular Disease Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1549  | Cerebrovascular Disease Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1550  | Migraine Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1552  | Migraine Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1553  | Chronic Tension type Headache Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1555  | Chronic Tension type Headache Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1556  | Low Back Pain SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1558  | Low Back Pain |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1559  | Metabolic Syndrome Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1561  | Metabolic Syndrome Diagnosis |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1563  | Hypertension, Persistent |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1564  | Pregnancy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1566  | Pregnancy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.157  | Chronic Kidney Disease All Stages (1 through 5) SNOMED |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.159  | Chronic Kidney Disease All Stages (1 through 5) |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1595  | Acute COVID 19 Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1599  | Cardiomyopathy Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1601  | Atherosclerotic Cardiovascular Disease SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1603  | Neuropathy Diagnosis SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1606  | Left Ventricular Hypertrophy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.22  | Alcohol Use Disorder SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.24  | Alcohol Use Disorder |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.25  | Peripheral Vascular Disease SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.27  | Peripheral Vascular Disease |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.28  | Hepatitis C Condition SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.30  | Hepatitis C Conditions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.31  | Diabetic Neuropathy SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.33  | Diabetic Neuropathy Conditions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.36  | Obesity Conditions |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.37  | Obesity SCT |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.4  |